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Chapter 1  
Outline of the thesis 
Organic acids are important products that can be produced by multiple micro-organisms. Due 
to the growing demand for biological production platforms producing organic acids, several 
development programs have been initiated in order to create better cell factories. Chapter 2 
gives a general introduction to biotechnological processes and techniques used in this area 
of research. Chapter 3 is focusing on cellular production platforms around succinic acid. 
 
The aim of this work was to develop a cell factory for organic acid production, with the focus 
on succinate, and to gain more physiological knowledge of organic acid production using a 
system level approach. The micro-organism of choice for this research was the filamentous 
fungus Aspergillus niger. There are several reasons for choosing this particular micro-
organism as cell factory for organic acid production: 
1) it tolerates low pH (important when producing acids) 
2) a wide variety of carbon sources can be used, including lignocellulose 
3) it ensures high conversion rates of different substrates 
4) high product yields can be achieved 
5) it is a well studied micro-organism (lot of biochemical data available) 
6) it has GRAS status (industrial production of e.g. citric acid and glucoamylase) 
 
In order to create a better organic acid producer, we performed an in depth investigation on 
the effects of environmental factors in the central carbon metabolism of Aspergillus niger and 
assessed how they influence the organic acid production. Chapter 4 describes a medium 
optimisation study that determined the effect of different factors on the cellular behaviour of 
Aspergillus niger. A factorial design of experiments was used to determine the optimal 
medium composition for studying organic acid production. A separate study on the effect of 
oxygen on organic acid production was thereafter performed in well controlled fermentors. 
Chapter 5 is devoted to this oxygen effect on cellular behaviour, especially on the intra- and 
extra-cellular metabolite profiles, as well as the activities of several enzymes in the central 
carbon metabolism.  
 
After these two physiological studies (described in chapter 4 and 5), different metabolic 
engineering strategies to improve succinate production were designed based on either 
metabolic model predictions or on rational thinking. Chapter 6 outlines two different gene 
deletions (∆sdh and ∆acl) and gene targeting methods used to establish complete gene 
CHAPTER 1. Outline of the thesis 
 
 2
deletions. The two deleted genes are involved in the primary metabolism of A. niger and 
have therefore a direct effect on the flux distribution, leading to different organic acid profiles. 
Also a batch characterisation of one of the deletion mutants is presented in this chapter. 
Chapter 7 gives a deeper inside into regulatory pathways that influence organic acid 
production. In this chapter a ∆acuB strain is characterised. AcuB is known to regulate genes 
involved in the glyoxylate pathway. This is one of the pathways leading to the organic acids 
succinate and malate, and therefore the influence of this regulatory node on the metabolic 
behaviour of the cells is expected to give us valuable information. 
 
Instead of gene deletion, gene insertion also serves as a useful tool for metabolic 
engineering, and in chapter 8 and 9 two different gene insertion strategies are described and 
their influence on transcription, flux and organic acid production in the metabolic network is 
evaluated. In chapter 8 the isocitrate lyase (icl) gene was selected for overexpression, since 
this is expected to lead to an upregulation of the glyoxylate pathway. In chapter 9 two 
heterologous genes, fumarate reductase (frds) and fumarase (fum), have been inserted in 
the genome of A. niger, thereby creating a cytosolic reductive pathway towards succinate. 
 
Finally, chapter 10 will summarize the results presented in this dissertation. It describes how 
the use of different –ome technologies can lead to a better understanding of the cell 
behaviour, which can lead to the development of better cell factories. Also a future outlook is 
given in chapter 10. 
  3
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Chapter 2  
Introduction 
In this chapter the relevance of biotechnology and industrial applications is discussed. 
Additionally, an overview of techniques used for cell factory understanding and improvement 
is given. 
2.1 Biotechnology 
2.1.1 Biotechnological relevance 
Biotechnology has developed rapidly during the last decades and has become one of the 
most promising future technologies. Especially industrial biotechnology, also called ‘’White 
biotechnology’’, has had a profound effect on the history of science and technology. 
Biochemical and microbiological processes belong to the oldest processes used by mankind. 
According to ancient history, bread making and beer brewing have already been established 
more than 6000 years ago (Boulton et al. 2004).  
 
Major advances in molecular biology during the second half of the 20th century made 
biotechnology even more important and integrated it with industrial processes (Bud 1989). 
The technical improvements have made it possible for biotechnological processes to 
compete with the chemical industry. It is by no means new that biotechnology is applied in 
industry and environment. Biotech products are part of our daily live. Just think of the food 
industry (Beck and Ulrich 1993), where defined microbial cultures convert milk to yoghurt, 
yeasts produce bread, and pectinolytic enzymes remove cloudiness from fruit juices. Other 
examples of food products produced by biotechnological methods are: beer, wine, spirits, 
vinegar, cheese, sauerkraut, pickles and tea. Also in other parts of the world there are 
numerous biotechnologically produced foods such as sake, soya sauce, tempeh, tofu and 
kwas. 
 
Biotechnology has also contributed to the environment in a variety of ways. Since the turn of 
the 19th to the 20th century the application of microbiological processes in waste water 
purification has led to a a major improvement on the purity of our drink water, but also rivers, 
lakes and other surface waters (Daims et al. 2006). Additionally, biotechnology offers 
methods for soil remediation. Micro-organisms are able to change the valency of inorganic 
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matter, e.g. uranium, thereby removing it from soil and groundwater. So biotechnology is 
closely connected to the environment.  
2.1.2 Advantages and disadvantages of biotechnological processes 
Biotechnology has contributed significantly to converting traditional production methods into 
modern, more effective ones and to increase the quality of the products. For example, beer 
brewing in the second half of the 20th century was switched from an open liquid surface 
production method to a closed submerged method. As a result many vats gave way for large 
fermentors with automatic control. Therefore, beer brewing processes nowadays use less 
than one tenth of the operating space compared to the early days, saving a lot equipment, 
manpower and additionally they ensure a consistent product quality (Boulton and Quain 
2001). 
 
Unfortunately, the use of biological systems also has a drawback compared to the use of 
physical or chemical processes. Biological systems often show a limited stability and have 
low productivities. One of the main goals in biotechnology is therefore to overcome the limits 
of biological systems. With the developments in molecular biology and systems biology we 
are able to improve the biological systems drastically. However, we must keep in mind that 
biotechnology is always competing with the petrochemical industry. In case a non-
biotechnological method is developed fulfilling the qualitative requirements with a higher 
economic benefit than the biotechnological process, the former is still preferred. Products 
consisting of small molecules are considerably more susceptible to this economic selection 
than products consisting of large, specifically built molecules. For example, 
biotechnologically produced pharmaceuticals do not have the competitive pressure as for 
instance organic acids since no chemical process can produce the complex structure of the 
pharmaceutical economically, while organic acids can easily be produced by a handful of 
chemical reactions.  
 
On the other hand, the products that are chemically synthesized are often accompanied by 
unwanted side products and their production processes imply unacceptable effects on the 
environment. This may result in choosing quantitatively submaximal production methods in 
order to stay in an acceptable range of quality.  In this area biotechnological processes 
clearly have an advantage that eventually can lead to cost savings in e.g. the omission of 
environmental protection measures. Basically, this corresponds to the actual request of 
sustainability. Biotechnology has an advantage when sustainability becomes priority. 
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2.1.3 Future of biotechnology 
The future of biotechnology lies in the increasing demand for environmental friendly 
processes, mainly driven by increasing political pressure. Biotechnological processes are 
believed to be a starting point in the battle against global warming. Furthermore, the prices of 
petroleum-derived carbon backbone molecules, used in chemical synthesis, are expected to 
increase in the near future (fossils become scarce), which will make biotechnology thrive. 
The future of biotechnology is very promising for improved processing, as well as healthier 
and higher quality products (e.g. rice with higher content of Vitamin A, allergen-free cashew 
nuts). Such advantageous properties of products could be achieved by metabolic 
engineering. Also technical advances, especially the upcoming nanotechnology, opens new 
possibilities for biotechnology, transferring the successful principles of application of 
machines into the molecular range.  
 
The Biomass Program from the United States Government has identified a top ten of value-
added chemicals, that can be produced from biomass, that would economically and 
technically be applicable in industry (Werpy and Petersen 2004). The top ten building blocks 
are shown in Table 2.1. Notice that the list contains eight low molecular weight organic acids. 
Even though these compounds suffer from a huge competition with the chemical industry, 
they are still believed to have potential for being manufactured in a biological way, indicating 
that biotechnology is getting more important over time.  
 
Table 2.1 Top ten value added building blocks determined by the Biomass Program from the United 
States Government (Werpy and Petersen 2004). 
 
Building Blocks
1,4 diacids (succinate, fumarate and malate)
2,5 furan dicarboxylic acid
3 hydroxy propionic acid
aspartic acid
glucaric acid
glutamic acid
itaconic acid
levulinic acid
3-hydroxybutyrolactone
glycerol  
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2.1.4 Biotechnologically important micro-organisms 
In biotechnological processes different micro-organisms are being used for different 
purposes. It is important to find a suitable micro-organism for the biotechnological process in 
question. Bacteria and fungi are examples of organisms used in industry. However, fungi are 
definitely the main source of micro-organisms used in industrial application. 
 
Fungi are a large and diverse group of eukaryotes having their own kingdom on equal footing 
with plants and animals (Bennett 1997). They distinguish themselves by spore formation, 
efficient secretion pathways and wide absorption spectra for different nutrients. Fungi have 
the most diverse and effective range of adaptation of all eukaryotes. They can stand severe 
dryness, extreme pH and are able to survive a range of other environmental stresses. Due to 
their versatile biochemical nature, fungi produce a wide array of acids and degradative 
enzymes to support their absorptive life style. This fungal variability in enzymes and 
metabolites is so astonishing, that we can exploit it for biotechnological purposes.  
 
A large group of biotechnological products are enzymes. They are not only used in the food 
industry, like in meat and dairy production, or in fruit and vegetable processing, but also for 
bleaching paper, in washing powders, in the starch industry and in leather finishing. Another 
class of products produced in a biotechnological way are low molecular-weight organic 
chemicals, such as ethanol and citric acid. These chemicals are produced in bulk and have a 
wide area of application. Citric acid is widely used as an acidulant in soft drinks and many 
foods, as a buffer, and as an emulsifying agent. Ethanol is used as biofuel. Also complex 
molecules are made in a biotechnological way. Some fungal products are exploited as 
antibiotics (e.g. penicillin), immune response suppressants (e.g. cyclosporin A), blood 
pressure lowering agents (e.g. mevalonin), or other pharmaceuticals. Finally, many fungi are 
used directly as food and food flavoring agents. Asian food fermentations such as soy sauce, 
and tempeh are worldwide known as a food source. 
2.1.5 Yeast versus filamentous fungi 
The best studied fungus is the yeast Saccharomyces cerevisiae, not only because of its 
importance in baking, brewing, and fermentation processes, but also because it is one of the 
best understood species and most important eukaryotic model organism. Mark Adams once 
said: ‘‘Yeast is the unicellular human’’ (at the Oklahoma State University meeting). S. 
cerevisiae has been used not only as a model for studying human disease, but also as a 
model for all fungi. However, yeast is not as evolved as filamentous fungi. Filamentous fungi 
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have more genes and bigger genomes. They have more adaptation capabilities and form 
secondary metabolites unlike yeast. The genes controlling these functions can only be 
studied in organisms that possess them. That is why modelling of other filamentous fungi is 
so crucial in understanding their behaviour.  
 
Two other well studied fungi are Aspergillus nidulans and Neurospora crassa. These 
filamentous organisms are often used as model organisms and were one of the first 
filamentous fungi to be sequenced. One of their big advantages is that more than 50 years of 
research data are available for these organisms in the area of classical genetics and 
biochemistry. Detailed genetic maps and hundreds of mutants are available for both species. 
Few experimental organisms have been so well characterised with respect to biological 
function. Aspergillus species are one of the most important fungal species used in industry.  
 
Members of the genus Aspergillus biosynthesize a variety of economically important primary 
and secondary metabolites, including citric acid, mevalonin, and aflatoxin. They are able to 
secrete large amounts of their own proteins (‘‘homologous proteins’’), such as glucoamylase. 
Sophisticated technologies have been developed to handle large-scale Aspergillus 
fermentations. Although most of these fermentation processes are well established, the 
underlying genetics are still poorly understood (Cullen 2007). With the current increase in 
sequencing projects, making more complete genomic sequences available, we should be 
able to achieve a better physiological understanding and improve the production of 
chemicals and enzymes using these micro-organisms. The availability of genome data from 
related fungi gives us the possibility to compare genomes, their structure and get a feeling for 
evolutionary events. Nine Aspergillus species have been sequenced (Galagan et al. 2005; 
Machida et al. 2005; Nierman et al. 2005). An overview of the genome content and 
characteristics of four Aspergillus species is given in Table 2.2. Two genomes of Aspergillus 
niger are sequenced and have recently been released, the mutagenized CBS 513.88 strain 
(Pel et al. 2007) and the wild-type strain ATCC1015 (Baker 2006) (http:// genome.jgi-
psf.org/Aspni1/Aspni1.home. html). The combination of sequence information and the 
existing biochemical, morphological, and genetic data, will make it easier to assign meaning 
to sequence data and help in designing new strategies for strain optimisation. So genomes 
are very important in the development of industrial production strains. However, genome 
information alone is not sufficient.  
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Table 2.2 Summary of four different Aspergillus genomes (data from Archer and Dyer 2004). 
 
2.2 Biotechnological techniques 
With the increase in biological applications and sequence information we also need to 
develop ways to better understand and control the microbial systems. The classical approach 
has been to analyse the role of individual components (genes or proteins) in the overall cell 
function. As a consequence of large sequencing programs, an increasing number of 
complete genomic sequences from different micro-organisms have become available. This 
led to substantial research efforts assigning function to all identified open reading frames, 
also referred to as functional genomics. Furthermore, there has been a significant 
development in molecular biology techniques, which have made it possible to optimise 
industrial fermentations through introduction of directed genetic modifications, an approach 
referred to as metabolic engineering. These two very important advances have changed the 
traditional way of looking at cellular behaviour (Nielsen and Olsson 2002). 
 
Instead of looking at single cell components in the cell we now try to integrate data in order to 
retrieve a more holistic view on cell function. As a result we reach an increased 
understanding of the molecular mechanisms that make it possible to describe the interaction 
between all the components in the cell, which is called systems biology. However, to really 
establish a system-level understanding of the cell, information about the DNA sequence, 
RNA expression profiles, protein levels and metabolite levels is obligatory. But also 
information about the interaction between the different levels, such as protein-protein 
interactions, protein-DNA interactions and protein-metabolite interactions is needed. All these 
levels of information depend on each other and control the mechanisms in the cell, e.g. 
transcriptional control, control of mRNA degradation, translational control, protein 
activation/inactivation, and allosteric control of enzymes. We can divide the different levels of 
information into several classes namely: genome, transcriptome, proteome, interactome, 
metabolome and fluxome (Figure 2.1). Different strategies and technologies are used in the 
A. niger A. nidulans A. oryzae A. fumigatus
Genome size (Mb) 35.9 30.1 36.7 28.6
GC content (mole%) 50 50 48 50
Predicted genes 14097 9967 14063 9746
Coding sequences (% of total) 55.2 50.9 45.1 49.1
Mean gene length (bp) 1323 1536 1178 1442
Genes with introns (%) 87 89 81 76
Genes with Pfam hits 5306 4512 5306 4403
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different classes and an overview of the most used and advanced technologies is described 
below.  
 
2.2.1 Genome analysis 
In comparative sequence analysis the sequenced genomes of two or more organisms are 
compared, thereby facilitating annotation of protein coding genes and important functional 
sequences within proteins and in nonprotein-coding DNA, such as promoters (Casselton and 
Zolan 2002). As stated before, this field has gained a lot of attention since the introduction of 
high-throughput sequencing methods. There are many successful examples of comparative 
Figure 2.1 The different information levels in the cell that determine the functional behaviour of 
micro-organisms. Model integration of the different levels is required for enabling a systematic 
comprehension of the cells. 
1001011100101010101010001011100
1100110011001110010101101000110
1010111001101001100101101010010
1011000100101010100101101001110
1100101011001101010101010101010
1101101001010110101010010111011
0100100101011010000111100101010
1010101001111001000011110010101
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sequence analysis among different organisms for annotation of protein coding sequences 
and functional sequences in proteins. However, identification of functional sequence 
elements not coding for proteins, e.g. sequences regulating gene expression, is much more 
complicated due to the relative rapid rate of change of non-protein-coding sequences in 
evolution and their relative simple structures (Archer and Dyer 2004; Cliften et al. 2001). 
Therefore, comparison of relative closely related organisms is more likely to identify potential 
non-protein-coding elements. These comparisons now become available, but only on a small 
scale in comparison to the protein coding comparisons. 
2.2.2 Transcriptome analysis 
Nowadays, DNA micro arrays are the common tool for transcriptome analysis and they are 
used in many laboratories. DNA microarrays measure relative expression levels of genes 
and have made it possible to estimate the level of expression of thousands of genes 
simultaneously (Butte 2002). This makes it possible to identify changes in expression 
between different biological states or when some genes are deleted or over-expressed.  
 
Microarrays may give indications of gene function and regulation. Genes that participate in 
the same cellular processes often share similar transcription profiles. By mining expression 
data, using software applying clustering algorithms that group together genes with similar 
transcription profiles, genes with similar expression can be identified (Chou et al. 2007). 
Function of “orphan” genes may then be inferred from function of genes that have a similar 
transcription profile. 
 
Genes with similar transcription might also be regulated by the same mechanisms, and 
therefore have similar regulatory elements in their promoters. Promoter analysis of such 
genes can reveal new regulatory elements and identify genes that are under regulation of a 
certain transcription factor. This has been demonstrated by Ideker et al. (2001a) in yeast, 
who identified potential Gal4 binding sites in nine new genes by promoter analysis of the 
genes in the same expression clusters as the genes with established Gal4-binding sites. 
Ideker et al. (2001b) also analysed the transcriptome of a number of mutants with deleted 
galactose genes against a reference strain. This yielded valuable information about the 
regulatory network of the galactose utilisation pathway. Apparently, transcriptome analysis 
can be used for reconstruction of regulatory pathways. Moreover, methods have been 
developed, in which the transcriptional responses have been correlated with metabolic 
networks, based on information from genome-scale metabolic models. This has resulted in 
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the discovery of so-called reporter metabolites, that are metabolites around which the most 
significant transcriptional changes occur (Patil and Nielsen 2005).  
 
Microarrays seem to be promising, but it is an extremely difficult task. There are problems 
with sample taking, (m)RNA extraction and normalisation of the arrays. Sample taking and 
extraction of (m)RNA cause deviation in measurements. Normalisation is a process for 
removing variation in the arrays. This variation can stem from a variety of factors including 
physical properties of the dyes (heat and light sensitivity, relative half-life), efficiency of dye 
incorporation, experimental variability in probe coupling and processing procedures, and 
scanner settings at the data collection step. So it is difficult to retrieve representable data 
from the arrays due to all this variation, making it an elaborate and difficult process. Another 
question is how useful the information of mRNA is, if no information of other levels such as 
protein level and post transcriptional modification are taken into account. 
 
In this dissertation microarray experiments have been used to analyse the metabolic 
pathway regulation on a gene expression level and the information is incorporated with other 
analyses to discover metabolic regulation mechanisms (Chapter 8 and 9). 
2.2.3 Proteome analysis 
Investigations of the correlation between mRNA and protein expression in S. cerevisiae have 
shown the difficulties of predicting the yeast proteome directly from the transcriptome (Ideker 
et al. 2001a; Gygi et al. 1999a). The correlation between mRNA and protein abundance is 
poor for some genes, suggesting that post-transcriptional regulation plays an important role. 
 
Therefore, proteomics brings us one step closer in understanding gene function than 
transcriptome analysis, but the analysis is more difficult. Proteome analysis is aiming at the 
simultaneous large-scale analysis of the protein composition of an organism and covers 
many aspects of protein characterisation, such as identification, quantification, 
characterisation and identification of post-translational modifications, and cellular localisation 
(Gygi et al. 1999b). Two-dimensional (2D) gel electrophoresis has been used for analysis of 
the proteome since the late 1970’s and is still an important technique for separation and 
quantification in proteomics today. The proteins resolved by 2D electrophoresis can be 
identified and analysed for e.g. post-translational modifications by mass spectroscopy 
combined with genomic information. However, specific classes of proteins (membrane or 
glycosylated proteins) and low abundance proteins are known to be absent or 
underrepresented in 2D gel patterns, moreover quantification in gels is very difficult. Due to 
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these limitations new methods for analysis of proteins in complex mixtures have been 
developed, avoiding the use of 2D gels (Kocher and Superti-Furga 2007). All these 
techniques rely on mass spectrometry for identification and quantification of the different 
proteins. 
 
The focus of recent efforts in proteomics has shifted to quantitative methods that allow 
protein levels to be measured globally. Global analysis methods in proteomics are still under 
development. They are used for determination of protein biochemistry and cellular 
localisation, which gives important information about protein function and regulation.  
2.2.4 Interactome analysis 
Analysis of interactions between proteins and between proteins and DNA is very important 
for unravelling signal transduction pathways and can be used to generate functional 
annotations for proteins with unknown function. The yeast two-hybrid system, for example, 
identifies pairs of interacting proteins and has been used for genome-wide studies 
(Mukherjee et al. 2001). Future two-hybrid technologies might overcome some of the 
present-day limitations, but protein-protein interactions may also be analysed with protein 
chips (Phizicky et al. 2003).  
 
Furthermore, with ultrasensitive mass spectrometric protein identification methods, it is 
possible to identify directly protein complexes on a proteome-wide scale. Two large-scale 
affinity tagging and mass spectroscopy analyses of protein complexes in yeast have been 
published (Gavin et al. 2002; Ho et al. 2002). These studies identified hundreds of novel 
protein-protein interactions and protein complexes and provide insight into the mechanisms 
by which protein complexes are co-ordinated into high-order networks responsible for many 
fundamental cellular processes. 
 
Analysis of protein-DNA interactions gives valuable information about transcription factors 
and is required to construct a complete map of transcriptional regulation. A methodology, 
which can be applied genome-wide, has been developed. This method, which combines 
DNA arrays with chromatin immunoprecipitation, identifies sequences that are directly bound 
by a specific transcription factor of interest in vivo. It has discovered many new putative 
targets of some transcription factors (Iyer et al. 2001). Also protein chips have potential for 
studying protein-DNA interactions. 
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2.2.5 Metabolome analysis 
The metabolome represents integrative information, and therefore, analysis of the 
metabolome may give further insight into the function of genes (Jewett et al. 2006; Wu et al. 
2005). With the development of analytical technologies for separation, quantification, and 
identification, it is nowadays possible to measure hundreds of intracellular metabolites by 
using GC-MS (gas chromatography and mass spectroscopy) and LC-MS (Mashego et al. 
2007).  
 
The power of metabolomics has been illustrated by a study on S. cerevisiae. Raamsdonk et 
al. (2001) found that, even when mutation of a gene causes no obvious phenotype, 
metabolite profiling can still give clues to gene function. Raamsdonk et al. (2001) also 
showed that deletion mutants, having lost similar functions, have similar metabolite profiles. 
They propose that this can be used for assigning function to orphan genes by comparing the 
changes in metabolite profile, produced by deleting the gene, with a library of such profiles 
generated by individually deleting genes of known function.  
 
Metabolome profiling has been used in order to find specific physiological states under 
different cultivation conditions and in different strains (see Chapter 5 and 7).  
2.2.6 Fluxome analysis 
Analysis of the fluxome (all fluxes in the cell) gives information about, which pathways are 
active and to what extent. In this way, a better understanding of what is occurring inside the 
cell at a given time is obtained. Fluxes cannot be measured directly in vivo, but some fluxes 
can be estimated from the uptake rates of substrates and secretion rates of metabolic 
products (Metabolic Flux Balance). Furthermore, an estimation of the flux distribution at 
metabolic branch points can be obtained using a mathematical model of the metabolism 
combined with the analysis of 13C-labelling patterns of intracellular metabolites (Metabolic 
Network Analysis). The labelling pattern of 13C in intracellular metabolites may be analysed 
using either GC-MS, LC-MS or NMR and has been proven very useful for identification of the 
metabolic network structures. From the labelling pattern and metabolite balancing a detailed 
analysis can be obtained, including flux estimation, identification of the network topology, 
metabolic channelling and subcellular compartmentation (Christensen and Nielsen 2000). 
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Metabolic Network Analysis has been used to get a better comprehension of the changes in 
primary metabolism instigated by metabolic engineering of Aspergillus niger (see Chapter 8 
and 9). 
2.2.7 Databases 
Due to the development of all the above mentioned experimental techniques a lot of data are 
acquired in a short time. Therefore, comprehensive data sets are needed to grasp an entire 
picture of the organism of interest. Baxevanis (2003a+b) has given an overview of the 
available databases. Extensive computer databases first arose when the large-scale 
sequencing projects started. Although databases of nucleic acids and amino acids 
sequences, such as EMBL, Genbank and Swiss Prot, are still the largest, most utilised and 
best maintained, there is also a great interest in databases to store other types of molecular 
data. For instance, the Database of Interacting Proteins, BIND and MIPS contain searchable 
indices of known protein-protein interactions. TRANSFAC and SCPD catalogue interactions 
between proteins and DNA. Furthermore, databases of metabolic pathways have been 
established, such as EcoCyc (for E. coli), MetaCyc (different organisms), KEGG and WIT. 
 
This recent explosion in both variety and amount of information poses two challenges to 
databases. Firstly, the information must be maintained systematically in a format that is 
compatible with both single queries and global searches. Secondly, the databases must be 
updated against the ever-increasing biological knowledge. It is also important to control the 
quality of the incoming data. Because conditions, under which experiments are performed, 
differ from lab to lab and even within labs, a reference point must be defined to which all the 
data can be compared and which can be used for simulation, modelling and system 
identification. This is a complicated task and means that many of the current experimental 
procedures must be automated to enable high-throughput experiments to be carried out with 
precise control of quality. This development is already seen in the collection of microarray 
data that have set some defined guidelines for the information on experiments (MIAME) 
(Maurer et al. 2005). 
 
Because of the large amount of information, programs are developed using algorithms for 
database similarity searches. BLAST, FASTA and CLUSTAL are examples of these 
programs and make it possible to search through the databases.  
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Due to the rapid increase of information collected in the databases it is crucial not to neglect 
the importance of developing useful and reliable programs for updating and searching 
through the databases.  
2.2.8 Modelling 
With all technical advances mentioned above our understanding of the molecular 
mechanisms in biological systems is accelerating. Nevertheless, such knowledge does not 
provide us with an understanding of biological systems as systems (Kitano 2002a+b). Genes 
and proteins are components of the system. While an understanding of what constitutes the 
system is necessary for understanding the system, this is not sufficient. In order to 
understand biological systems, firstly the structures of the system need to be identified. This 
means that the regulatory relationships of genes and interactions of proteins that provides 
signal transduction and metabolic pathways, need to be identified. Besides, physical 
structures of organisms, cells, organelles, chromatin and other components need to be 
established. Secondly, we need a set of principles and methodologies that link the behaviour 
of molecules to system characteristics and functions. Different computer aided models have 
been developed that try to explain and predict cellular behaviour. Roughly, these models can 
be grouped into two kinds (Figure 2.2): stoichiometric models and kinetic models (Wiechert 
2002). Each method has its own advantages and disadvantages. 
 
Kinetic models are used for describing and predicting the dynamic behaviour of cells. 
However, building successful dynamic or kinetic models is heavily dependent on knowing or 
discovering the underlying biological mechanisms. Therefore, these models are severely 
constrained by the lack of enzymatic kinetic data and the discrepancy between in vivo and in 
vitro enzyme activities. Kinetic models try to simulate the physical and chemical processes 
(known or hypothesized) that take place in the biological system of interest. Mechanism and 
dynamics are closely related, and much of the value of kinetic modelling lies in the unique 
ability of dynamic experiments to reveal new and useful information about the complex 
biological systems. Kinetic models are able to extract more information about the dynamic 
behaviour of the cell compared to stoichiometric models that simulate steady state behaviour 
of the biological system.  
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Figure 2.2 Schematic overview of a metabolic network structure and different kinds of models that are 
used to describe metabolic behaviour (Wiechert 2002). 
 
 
Stoichiometric models are used to simulate a ‘’special’’ steady state in the biological system. 
They describe the biochemical reactions in the cell as a set of algebraic equations. The 
advantage of stoichiometric models is that they do not require any kinetic information about 
the biological system. Therefore, they can be used for large scale metabolic networks. For 
several micro-organisms these stoichiometric models are available, such as E. coli, S. 
cerevisiae, A. niger, A. nidulans, S. coelicolor (Pramanik and Keasling 1997; Foster et al. 
2003; David et al. 2003; David et al. 2006, Borodina et al. 2005, respectively). They have 
already shown to be very useful in predicting cellular behaviour and discovering new genetic 
targets for optimisation of biological systems. Stoichiometric models are particularly useful in 
the field of Metabolic Engineering and were used in chapter 6, 8 and 9. The disadvantage of 
the stoichiometric model is that it cannot take into account the regulatory mechanisms that 
the cell possesses in contrast to the kinetic models. 
 
Nevertheless, computer aided models are an important feature in understanding cellular 
behaviour. With the development of more advanced algorithms and models the behaviour of 
biological systems will be better understood and predicted.    
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Chapter 3  
Succinic acid 
Improving the organic acid production in A. niger will be assessed in a targeted approach. 
Since it is not possible to increase all organic acid yields at the same time succinate was 
used as model organic acid. It was attempted to divert fluxes toward succinate production. A 
short introduction to succinate and its relevance for biotechnology is presented in this 
chapter.  
3.1 Industrial relevance of succinic acid 
Succinic acid can be seen as a platform chemical from which several other industrially 
relevant compounds can be produced. Succinic acid and its derivatives are widely used as 
specialty chemicals with applications in polymers, foods, pharmaceuticals and cosmetics. 
This acid is a valuable four-carbon intermediate that can be converted by catalytic processes 
into a number of compounds, such as 1,4 – butanediol, tetrahydrofuran, and γ-butyrolactone. 
The chemistry of succinic acid to the primary families of derivatives is shown in Figure 3.1. 
 
 
Figure 3.1 The platform chemical succinic acid and its primary families of derivatives that are widely 
used in industry (Werpy and Petersen 2004). 
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Nowadays there are four major markets for succinic acid:  
− The first and largest is as a surfactant/detergent/foaming agent. Succinic acid can be 
esterified to dimethyl succinate, which is marketed as an environmentally friendly 
solvent.  
− The second market is as an ion chelator, where it is used in electroplating to prevent 
corrosion of metals.  
− The third is the food market, where it is used as an acidulant/pH modifier, as flavouring 
agent or as an anti-microbial agent.  
− The fourth market is the production of health related agents, including pharmaceuticals, 
antibiotics, amino acids and vitamins.  
 
Biotechnologically produced succinic acid has the potential to become a large-volume 
commodity chemical that would form the basis for supplying many important intermediate 
and specialty chemicals for the consumer product industry. As a commodity chemical, 
succinic acid can replace many commodities based on benzene and intermediate 
petrochemicals, resulting in a large reduction in pollution of the environment. The 
development of low-cost routes would have a significant impact on the demand for succinic 
acid. It would expand current markets and open up new markets for the acid. If the price can 
be reduced, the total succinic acid production could be bigger than the citric acid production 
and will come in the range of ethanol production. In 2004 the total trade market for succinic 
acid was $ 1.3 billion dollars and is still expanding (Werpy and Petersen 2004). The total 
production requirement was around 2.72 * 108 kgs of succinic acid per year in 1999 (Zeikus 
et al. 1999).  
 
Succinic acid is an expensive compound and attempts are made to lower the production 
costs. Currently, succinic acid is manufactured by the hydrogenation of maleic anhydride to 
succinic anhydride, followed by hydration to succinic acid. A fermentation process for 
succinic acid production is desirable because in such processes, renewable resources such 
as starchy crops and other agricultural products can be used as feedstock. The cost price for 
succinic acid produced petrochemically ranged from $5.90 to $8.80 per kgs in the year 1999, 
which was 10 times more than the costs of citric acid (Zeikus et al. 1999). Due to advances 
in fermentation and separation technology for the biological process, the production costs 
have been reduced to $ 2/kgs and, therefore, it is attractive to produce it biochemically 
(Potera 2005). However, in order to compete with other petrochemical derived products and 
to open up new specialty and commodity markets for succinic acid, the fermentation costs 
need to be at or below $0.5/kgs (Werpy and Petersen 2004). This is a significant technical 
challenge that could be met by further advances in the biobased succinic acid process.
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3.2 Process improvements regarding succinic acid production 
There are several key areas for improvement in the fermentation process for succinic acid. 
First of all, the productivity is an important factor for improvement. This will reduce the capital 
and operating costs of fermentation. We need to achieve a productivity of at least 2.5 g/L/hr 
in order for the process to be economically competitive with the petrochemical industry. Most 
likely this will be achieved by metabolic engineering strategies. A second key area for 
improvement is the medium composition. Medium designs for commercial fermentations can 
save a lot of money, since for bulk chemical production the medium costs have a large 
influence on the cost price. There is a thrive towards a minimal amount of nutrients. 
Furthermore, expensive nutrient components, such as yeast extract and biotin, must be 
avoided. Waste materials like molasses, corn steep liquor or equivalents are desirable. The 
final titer is also a point for reducing the overall process costs. Although this is not the most 
important aspect, a high final titer will drastically reduce the downstream processing costs. 
The separation and concentration of succinic acid will be simplified immensely if high product 
titers are achieved. Since downstream processing costs are often substantial this will affect 
the total production costs. Finally, the fermentation conditions can be optimised. The 
fermentation should be run at a low pH, and preferably without requiring any neutralisation. 
Both the cost of neutralisation and the conversion of the succinic acid salt to the free acid 
add significant costs to the fermentation process. This can be avoided when the fermentation 
process is run at a low pH, as can be achieved with Aspergillus. 
3.3 Metabolic pathways leading to succinic acid 
There are three possible metabolic pathways leading towards succinate: the oxidative part of 
the TCA cycle, the reductive part of the TCA cycle, and the glyoxylate bypass (Figure 3.2) 
(Magnuson and Lasure 2004). Metabolism by either the oxidative part of the TCA cycle or 
the glyoxylate bypass pathway conserves only four of the six carbons from glucose in the 
four-carbon succinic acid product. On the other hand, the reductive part of the TCA cycle 
produces two four-carbon acids for every glucose molecule metabolised via glycolysis, 
operating in conjunction with the caboxylation reaction catalysed by pyruvate carboxylase 
(Figure 3.2). Thus, anaerobic metabolism is preferred for succinic acid production, since it 
can theoretically generate a very high yield of 2 mol succinic acid / mol glucose. Under 
anaerobic conditions NAD+ can be regenerated by reducing fumarate to succinate, which is 
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also called fumarate respiration. This strategy is used by several anaerobic bacteria that 
naturally produce a lot of succinate. 
 
The disadvantage of using these anaerobic bacteria is that they are not tolerant to acidic 
conditions and the fermentation needs to be neutralised. The fermentations are operated at 
pH values around 6.5 and the pKa values for succinate are 4.21 and 5.64 at 22 ºC. Therefore 
in bacterial fermentations the succinic acid salt is produced (Datta 1992). However, the free 
acid is required to manufacture commodity and specialty chemicals. This raises the costs of 
fermentation immensely, because a lot of base is needed to neutralise the medium, thereby 
producing succinic acid salt. During the downstream processing the succinic acid needs to 
be separated from the fermentation broth and acidification is required to retrieve again the 
acid form of succinic acid. Normally, the downstream processing costs account for 60-70% of 
the product costs (Baniel and Eyal 1995). Therefore, the major cost inefficiencies associated 
with product recovery, concentration, acidification and purification have made it unattractive 
to create a fermentation-based succinate production process in these anaerobic bacteria. 
 
Figure 3.2 The metabolic pathways leading to succinate. 1 = oxidative TCA cycle, 2 = glyoxylate 
bypass, 3 = reductive TCA cycle. 
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Over the past 5-10 years there has been considerable research in order to develop improved 
micro-organisms and separation technologies to reduce the overall cost of biobased succinic 
acid. All these advances have made the production of succinic acid based chemicals from 
carbohydrates via fermentation practical and economically feasible. Therefore, it has been 
designated to one of the top ten value-added compounds for which a biological process route 
is more desirable than the traditional chemical production route (Werpy and Petersen 2004). 
However, more improvements are needed to make the biological process out-compete the 
chemical process. The two main areas of improvement are: 
- the development of better succinic acid producing micro-organisms 
- the development of better downstream processing technologies 
3.4 Micro-organisms producing succinic acid 
Until now most emphasis has been on bacterial fermentations for biological succinic acid 
production, as relatively efficient processes have been developed for anaerobic bacteria (see 
McKinlay et al 2007, for a recent review). However, some eukaryotic micro-organisms are 
also known to produce succinic acid. The yeast Saccharomyces cerevisiae, for example, 
produces succinate when the CO2 concentration is held at high levels during the fermentation 
(Aguilera et al 2005). Arikawa et al. (1999) studied the effect of TCA cycle enzymes on 
succinic acid production and found that in S. cerevisiae succinic acid is mainly produced by 
the reductive part of the TCA cycle, fumarate respiration. Also filamentous fungi are known to 
produce succinic acid in small amounts as by-product. Fusarium spp. (Foster 1949), 
Aspergillus spp. (Bercovitz et al. 1990), and Penicillium simplicissimum (Gallmetzer et al. 
2002) are known to produce and secrete the acid in low concentrations. Nowadays, succinic 
acid is produced biochemically from glucose using several bacteria like an engineered 
Anaerobiospirillum succiniciproducens, an engineered Eschericia coli, and most recently via 
an engineered Mannheimia succiniciproducens. For a comparison between their production 
capabilities see Table 3.1. 
 
Table 3.1 The succinic acids yields and productivities achieved in two naturally producing micro-
organisms and in metabolically engineered E. coli.  
Organism Yield (g/g) Productivity (g/L/h)
Anaerobiospirullum succiniciproducens 0.98 0.6
Mannheimia succiniciproducens 0.7 1.2
Escherichia coli (anaerobic) 1.1 1.3
Escherichia coli (aerobic) 0.94 1.1  
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3.4.1 Bacterial micro-organisms naturally producing succinic acid 
The natural over-producers A. succiniciproducens and M. succiniciproducens produce 
succinate at relatively high rates and concentrations during anaerobic fermentation at pH 7 
(Zeikus et al. 1999; Song et al. 2006). However, a wide range of fermentation by-products, 
such as ethanol, acetic, formic and lactic acids are also formed. This leads to reduced 
succinate yield and increases the complexity of the purification process. It has been 
observed that M. succiniciproducens and A. succiniciproducens mainly use the 
phosphoenolpyruvate carboxykinase (PEPCK) and the reductive TCA cycle route for 
succinate production. Therefore, phosphoenolpyruvate is an important branching point in the 
formation of succinate. Two pathways originate here: one towards succinate and another 
towards the major by-products. PEPCK is a carboxylating enzyme fixating CO2, making the 
CO2 availability a critical parameter for the enzyme kinetics. The dissolved CO2 concentration 
should ideally be as close to its maximum as possible. This can be ensured by CO2 sparging 
and/or addition of carbonate to the fermentation media (Lee et al. 1999; Zeikus et al. 1999; 
Song et al. 2006).  Also the addition of external electron donors e.g. hydrogen have shown to 
positively influence the cell growth and productivity of succinate. These electron donors 
seem to improve NAD+/NADH regeneration leading to an increased succinate yield, since 
succinate production is a redox consuming process (Lee et al. 1999). The redox balance is 
an important factor in the succinate process. Lin et al. (2005a) showed that also the oxidation 
state of the carbon source had a significant impact on succinate production.  
 
The two species mentioned above are both good candidates for succinate production, as 
they produce succinate with high productivity and with high yield on a broad range of carbon 
sources. However, the by-product formation needs to be decreased before the strains can be 
used in an economic feasible process. 
 
The M. succiniciproducens genome has recently been sequenced, which made genomic-
based metabolic engineering possible. Disruptions of the genes lactate dehydrogenase 
(LDH), pyruvate:formate lyase (PFL), phosphotransacetylase (PTA) and acetate kinase 
(ACK) have been conducted, with a nearly complete elimination of the by-products acetate, 
formate and lactate as a result (Song et al. 2006). These disruptions together with 
fermentation optimisation (batch Æ fed batch) have increased the succinate yield from 0.7 to 
0.76 g/g and the productivity from 1.2 to 1.8 g/L/h. The highest product titer achieved was 
52.8 g/L. Unfortunately, this approach is impossible for A. succiniciproducens as its genome 
has not yet been sequenced.  
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3.4.2 Metabolically engineered E. coli for succinic acid over-production 
E. coli is not a natural succinate over-producer. Under anaerobic conditions, it produces 
succinate as a minor by-product, while under aerobic conditions succinate is not 
accumulated at all. However, because E. coli has a well-studied metabolism and many 
molecular tools are available, research has been done on succinate production in this micro-
organism. In literature three methods for succinate production by E. coli have been exploited: 
anaerobic-, aerobic- and dual-phase fermentation. During anaerobic fermentation only one 
metabolic pathway leads towards succinate, which is the reductive part of the TCA cycle. In 
aerobic fermentations there are two additional metabolic pathways that make succinate 
production possible. These pathways are the glyoxylate cycle and the oxidative portion of the 
TCA cycle (Magnuson and Lasure 2004). Because of this difference in metabolic pathways 
being used also different metabolic engineering strategies are needed for product 
optimisation.  
 
To enhance succinate production and minimise by-product formation under anaerobic 
fermentation of E. coli, numerous metabolic engineering approaches have been tested with 
different degrees of success. Increasing flux towards succinate by over-expression of 
enzymes has been one approach. PEP carboxylase, pyruvate carboxykinase (PYCK) and 
fumurate reductase (FRDS) are examples of enzymes that result in increased succinate 
production when being overexpressed (Goldberg et al. 1983; Gokarn et al. 2000). PEP 
carboxylase catalyses the formation of oxaloacetate (OAA) from PEP, but without the gain of 
ATP as with PEP carboxykinase. A 50 fold higher activity of PEP carboxylase gave a 3.5 fold 
increase in the succinate concentration, making it one of the major fermentation products 
achieving a final yield of 0.45 mol/mol glucose (Millard et al. 1996). Increasing PEP 
carboxykinase activity had no effect in E. coli. PYCK catalyses the formation of OAA from 
pyruvate in a similar reaction as PEP carboxykinase, and insertion of the PYCK gene from 
Rhizobium etli (PYCK is not indigenous in E. coli) raised the succinate concentration to a 
final yield of 0.23 mol/mol glucose and it was sufficient to restore succinate production in a 
PEPCK deletion strain (Gokarn et al. 2000). Finally, also multiple copies of native FRDS 
have shown to improve the conversion rate of fumarate to succinate (Goldberg et al. 1983; 
Wang et al. 1998). 
 
A second strategy for improving succinate production is deleting by-product forming 
pathways. The genes coding for pyruvate:formate lyase (PFL) and lactate dehydrogenase 
(LDH) have been deleted. This has shown to result in an increased malate yield at the 
expense of ethanol-, acetate-, formate- and lactate yields (Stols and Donnelly 1997). An 
additional side effect of these deletions is that pyruvate is accumulated, which seriously 
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reduced growth due to inadequate NADH regeneration (Hong and Lee 2001). In order to 
reduce the accumulation of pyruvate a number of approaches have been investigated, 
including over-expression of the gene sfcA encoding for malic enzyme (ME) (Hong and Lee 
2001). At normal conditions ME catalyses the conversion of malate to pyruvate, but at 
elevated pyruvate concentrations the reaction is reversed and reduces the pyruvate pool. 
Another approach is to delete the ptsG gene. PtsG is a glucose-specific membrane-bound 
permease that catalyses a glucose phosphotransferase system, responsible for the transport 
of glucose across the cell membrane. During the process glucose is phosphorylated to 
glucose-6-P with the concomitant dephosphorylation of PEP to pyruvate. A ptsG deletion 
therefore eliminates the cell’s ability to combine glucose uptake with pyruvate formation. This 
has shown to result in a reduced pyruvate pool. This strategy was discovered from 
investigations of a derivate of the Δpfl Δldh strain that had restored cell growth due to a 
mutation in the ptsG gene and led to a yield of 1 mol succinic acid / mol glucose (Donnelly et 
al. 1998; Chatterjee et al. 2001).  
 
The over-expression and deletion strategies mentioned above can also be combined. A 
strain with an over-expression of the pyck and sfcA genes and a deletion of the ptsG, ldh, 
and pfl genes, operated in a dual-phase fermentation, has shown to be one of the most 
efficient methods for succinate production in E. coli, giving a succinic acid yield of 1.7 
mol/mol glucose (Lin et al. 2005a; Vemuri et al. 2002). This process is not completely 
anaerobic, but uses an initial aerobic phase to build up biomass, followed by an anaerobic 
phase, where succinate production occurs. At anaerobic conditions the production of 
biomass is not very efficient, which subsequently limits the succinate productivity due to a 
low specific growth rate and a low NADH regeneration rate.  
 
In order to initiate an accumulation of succinate under aerobic conditions, inactivation of 
succinate dehydrogenase (SDH) is important. Two mutated strains, one with five gene 
deletions and one with four gene deletions, were investigated. The construct with five 
deletions (ΔsdhAB, Δicd, ΔiclR, ΔpoxB and ΔackA-pta) created a strain in which the 
glyoxylate cycle was the only metabolic route able to produce succinate, yielding 0.95 
mol/mol glucose (Lin et al. 2005b). It was the first platform in E. coli that has shown a 
feasible production of succinate entirely under aerobic conditions. The disadvantage of this 
approach is the simultaneous accumulation of pyruvate, citrate and isocitrate. To prevent 
these accumulations a second production system was constructed, in which sdhAB, iclR, 
poxB and ackA-pta were deleted. This has created a two route system with the glyoxylate 
cycle and the oxidative branch of the TCA cycle producing succinate (Lin et al. 2005c). Both 
pathways branch from isocitrate and reduce the accumulation of the C6 intermediates from 
the TCA cycle. A final strategy to further reduce the accumulation of by-products was made 
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by introducing a ptsG deletion and an over-expression of pepC. This strain finally achieved 
the maximum aerobic theoretical succinate yield of 1.0 mol / mol glucose (Lin et al. 
2005c+d).  
 
Although E. coli is not a natural succinate producer a large spectrum of metabolic 
engineering strategies has drastically improved the succinate yield. By genetically 
engineering E. coli it is possible to reach economically interesting succinate yields, showing 
the potential of metabolic engineering. 
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Chapter 4  
The effect of medium composition on growth and organic 
acid production in Aspergillus niger 
 
 
 
 
 
4.1 Abstract 
The medium composition has a significant impact on the physiology of Aspergillus niger. The 
effect of different medium components has been intensively studied for the citric acid 
process. By modifying the medium composition, it is possible to produce certain 
morphologies of A. niger and also to change the product formation spectrum produced by the 
micro-organism. In this study, it was attempted to create an optimal medium composition for 
succinate production in A. niger. Several salt and trace element combinations were tested, 
using a fractional factorial design of experiments. It was observed that the experiments 
resulted in very distinct outcomes. A well defined optimum medium composition could not be 
determined under the cultivation conditions used. It was hypothesized that the oxygen 
transfer rate had a significant influence on the physiology of A. niger using the cultivation 
conditions applied in this study. Therefore, the effect of the oxygen availability needs to be 
studied in more detail under controlled cultivation conditions using a medium composition 
assessed by this medium optimisation study. 
 
 
 
Keywords: Aspergillus niger, medium optimisation, Design of Experiments, organic acids 
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4.2 Introduction 
 Aspergillus niger is a morphologically complex organism, showing different morphologies at 
different times of its life cycle, differing in form between surface and submerged growth and 
also differing with the nature of the growth medium and physical environment (Papagianni 
2004). When grown in submerged culture, A. niger can exhibit different morphological forms, 
ranging from dispersed mycelial filaments to densely packed mycelial spheres better known 
as pellets (Figure 4.1). 
 
 
 
The different morphological states have a significant effect on the rheology of the 
fermentation medium. Filamentous growth results in very viscous media, leading to a 
significant change in the mass transfer properties of the medium, specially the gas-liquid 
mass transfer. Pelleted growth exhibits low viscosity and therefore achieves better agitation 
and oxygen transfer compared to filamentous growth. However, the central region of larger 
pellets is prone to autolysis as a result of nutrient and oxygen deficiency. This autolysis can 
have a significant effect on the cellular behaviour and product synthesis (Phillips 1966; 
Elmayerg and Scharer et al. 1973). The morphological form is very important to achieve the 
maximal performance. For example, filamentous growth of A. niger is preferred for pectic 
enzyme production, whereas the pelleted form is preferred for citric acid production (Steel et 
al. 1954; Kristiansen and Bullock 1988). 
 
The particular form exhibited is not only stipulated by the genetic material in the cell, but also 
by other factors. Factors affecting the fungal morphology include the nature of the inoculum, 
the type and concentration of the carbon source, the levels of nitrogen and phosphate, the 
 
Figure 4.1 The two extreme shapes of Aspergillus niger : pellet morphology (left) and filamentous 
morphology (right) (Diano 2007). 
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levels of trace minerals, and the concentrations of dissolved oxygen and carbon dioxide. At 
least 13 elements are essential for growth of Aspergillus niger, namely oxygen, carbon, 
hydrogen, nitrogen, phosphorus, potassium, sulfur, magnesium, manganese, iron, zinc, 
copper and molybdenum (Papagianni 2004). The first eight are macronutrients, needed in 
relatively large quantities (in the order of g/L). The latter five are micronutrients, which are 
required in small amounts (in the order of mg/L). Also physical factors affect the morphology 
like agitation, pH, temperature and culture mode. These will not be discussed here, as we 
only focused on the composition of a succinate production medium for A.niger. 
 
Since A. niger is used as production organism for citric acid production a lot of research has 
been done on medium optimisation. Clear medium requirements are defined for the citric 
acid fermentation process. Because A. niger has a wide range of organic compounds that it 
can use for its metabolism, a lot of research has been focused on the carbon source usage 
for citric acid production. Not only the type of carbon source, but also the concentration is 
important (Xu et al. 1989). In general, it is believed that only carbon sources allowing fast 
growth (sucrose, glucose, etc.) lead to rates of carbon catabolism necessary for citrate 
overflow (Wolschek and Kubicek 1999). Additionally, the carbon source exerts a strong effect 
on the levels of enzymes in the TCA cycle, leading to high final molar yields of citric acid 
(Hossain et al. 1984). It is known that carbon concentrations higher than 50 g/L are needed 
in order to produce citric acid (Papagianni 2007). Another important feature in the citric acid 
process by A. niger is that growth needs to be restricted, although it is still not clear whether 
phosphate or nitrogen is the necessary limiting factor (Shu and Johnson 1984; Kubicek and 
Rohr 1977; Kristiansen and Sinclair 1979).  
 
Oxygen availability is a critical parameter for A. niger, since it is unable to grow without it. 
The oxygen availability in the reactor is measured by the dissolved oxygen tension (DOT). 
There are critical DOT levels for growth, but also for product formation. This indicates a 
general role of oxygen in metabolic regulation. In the case of citric acid production, the 
influence of oxygen has been well established (Clark and Lentz 1961). Interruptions of 
aeration do not reduce the viability of the cells, but result in complete loss of ability to 
produce citric acid (Kubicek et al. 1980). 
 
Carbon dioxide fixation has also a major role in the production of commercially important 
organic acids. The formation of citric acid from hexoses by A. niger proceeds via the 
glycolysis that splits into two C3 compounds, one of which is decarboxylated to C2 and the 
other is carboxylated to C4. Condensation of the C2 and C4 products then occurs to form citric 
acid (Bentley and Thiessen 1957; Kubicek and Rohr 1989). In order to increase the 
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carboxylation reaction in the cells and thereby increasing the product yield, carbon dioxide 
can both be added via the gas phase to the bioreactor or in a liquid form as NaHCO3 (Bushell 
and Bull 1981).  
 
Furthermore, it is well known that for fungal growth certain essential metals are required. 
Once taken up some trace metals, like iron and zinc, are incorporated into enzymes that 
catalyse biochemical transformations occurring at key points in the carbon cycle. The effect 
of trace metals on growth and citric acid production in A. niger has been extensively 
investigated. Zinc (Zn), manganese (Mn), copper (Cu) and iron (Fe) have been shown to 
affect both fungal morphology and citric acid production (Papagianni 2004). It is thought that 
the levels of Fe and Zn are related to the split of carbon between biomass and citric acid 
(Mattey 1992). It has been shown that addition of zinc during the citric acid production phase 
resulted in a reversion to growth (Wold and Suzuki 1976). Also copper ions have been 
reported to effect the morphology and citric acid production. The copper ions induced a loose 
pelleted form of growth, reduced biomass levels and increased the volumetric productivity of 
citric acid (Haq et al. 2002). Manganese is known to drastically inhibit citric acid production. 
Mn2+ ions have shown to be specifically involved in many cellular processes, such as cell 
wall synthesis and sporulation (Kisser et al. 1980). The influence of Mn on de novo protein 
synthesis seems to play an important role in citric acid production.  Under Mn deficiency it is 
believed that there is relatively more protein breakdown resulting in a high intracellular NH4+ 
concentration. As a consequence there is a release of the inhibition of phosphofructokinase, 
leading to a flux through glycolysis and the formation of citric acid (Kubicek and Rohr 1977; 
Habison et al. 1979).  
 
Finally, the pH is an important parameter in the cultivation of micro-organisms. It is a 
measure of the concentration of H+ ions present in the medium. A. niger can grow over a 
wide range of pH ranging from 1.5 to 8. However, its metabolite production profile changes 
completely at different pH. At pH < 3 the major acid produced is citrate (Papagianni et al. 
1994), while at a pH between 3 - 6 mainly oxalate is produced (Kubicek and Rohr 1986; 
Ruijter et al. 1999). When pH values reach 5.5 or higher gluconate production may occur 
(Rohr et al. 1983; Mattey 1992)). This indicates that the pH has a major impact on the flux 
distributions inside the cell as well as on the in vitro enzyme activities. The pH also 
influences the solubility of compounds, like CO2, that will dissolve better at higher pH in the 
form of bicarbonate. 
 
It is obvious that the medium composition can have a huge influence on the production 
profiles of metabolites. Therefore, the influence of different medium components and their 
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effect on growth and succinate production was investigated, as a basis for more detailed 
studies on the physiology of wild-type and metabolically engineered strains. 
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4.3 Materials and Methods 
4.3.1 Cultivation conditions 
Conidiospores were propagated on solid medium at 37°C in darkness for 5-7 days. The 
medium consisted of 10 g/L glucose, 6 g/L NaNO3, 0.5 g/L KCl, 0.5 g/L MgSO4 . 7H2O, 1.5 
g/L KH2PO4, 2.2 mg/L ZnSO4 . 7H2O, 1.1 mg/L H3BO3, 0.5 mg/L MnCl2 . 4H2O, 0.5 mg/L 
FeSO4 . 7H2O, 0.17 mg/L CoCl2 . 6H2O, 0.16 mg/L CuSO4 . 5H2O, 0.15 mg/L Na2MoO4 . 2H2O, 
5 mg/L Na4EDTA and 18 g/L agar.  
 
Spores were harvested from the agar plates using 0.01% Tween-80 (v/v). The shake flasks 
were filled with 100 ml of appropriate medium and adjusted to the correct pH (see Appendix 
1, 3 and 4) after which they were inoculated with spores to a final concentration of 109 
spores/L. The cultures were grown at 30°C and 80 rpm in 500 ml baffled shake flasks. 
4.3.2 Cell dry weight determination 
The concentration of biomass was determined on a dry weight basis. Filters were dried in a 
microwave oven at 150W for ten minutes, cooled for 2 hours in a desiccator and finally the 
dry weight of each filter was determined. A known quantity of culture broth was taken and 
vacuum filtered. The filtrate was frozen for quantification of extracellular metabolites. The 
filter cake was dried at 150W in the microwave oven for 15 minutes before being cooled for 2 
hours in a desiccator and finally weighed to determine the dry cell weight. 
4.3.3 Extracellular metabolites quantification 
Acetate, pyruvate, oxalate, malate, fumarate, glycerol, ethanol, citrate, succinate and xylose 
were separated by high pressure liquid chromatography (HPLC). The HPLC system (Dionex, 
Rødovre, Denmark) used was equipped with an ion exclusion column Aminex HPX-87H 
(Biorad, Hercules, CA). The column was kept at 65°C and eluted at 0.6 ml/min with a mobile 
phase consisting of 5mM H2SO4. Acetate, oxalate, citrate, fumarate and succinate were 
detected by an UV detector (Waters 486 turnable absorbance detector) at 210 nm. Ethanol, 
glycerol and xylose were detected by a differential refractive index (RI) detector (Waters 
410). For acquisition and analysis of the data, the software Chromoleon 3D (Dionex, 
Rødovre, Denmark) was used. 
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4.3.4 Design of experiments for medium optimisation 
In order to investigate the effect that medium components have on growth and succinate 
production in A. niger, a reference medium had to be chosen as starting point for the medium 
optimisation. Two reference media, that have been developed for different purposes, were 
selected. One medium is applied for enzyme production in A. niger (Pedersen et al. 2000) 
and the other medium is used for citric acid production (Kristiansen and Sinclair 1979). The 
composition of both media is shown in Table 4.1. 
 
Table 4.1 Reference media used for media optimisation of succinate production. 
 
Medium
Carbon source (g/L) Glucose 20 Glucose 50
Nitrogen source (g/L) (NH4)2SO4 7.3 NH4NO3 0.5
Salts (g/L) KH2PO4 1.5 KH2PO4 0.1
MgSO4 
. 7H20 1 MgSO4 
. 7H20 0.1
NaCl 1 KCl 0 
CaCl2 
. 2H2O 0.1 CaCl2 
. 2H2O 0 
Trace elements (mg/L) ZnSO4 
. 7H20 7.2 ZnSO4 
. 7H20 0.1
CuSO4 
. 5H2O 1.3 CuSO4 
. 5H2O 0.1
NiCl2 
. 6H2O 0.3 NiCl2 
. 6H2O 0 
MnCl2 
. 4H2O 3.5 MnCl2 
. 4H2O 0 
FeSO4 
. 7H2O 6.9 (NH4)2SO4Fe2(SO4)2 
. 24H2O 0.1
Limitation N N
Pedersen et al. (2000) Kristiansen and Sinclair (1979)
 
 
 
After choosing the reference media, a set of experiments was developed to determine the 
effect of the medium components on growth and succinate production. The design of 
experiments and statistical analysis of the response on biomass (Rs,x) and succinate 
(Rs,suc) yield (C-mol/C-mol) was carried out using a modelling and design program (Modde 
version 7.0, UMETRICS, UMETRI AB, Umeå, SWEDEN).  
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In Figure 4.2 the experimental design is schematised and shows the in- and output of the 
system. In this study, A. niger is the black box system and by changing the environmental 
conditions (input), we want to predict the growth and succinate yields (output).  The Design 
Of Experiments (DOE) method permits us to determine the effect of the factors on the 
response and thereby minimising the variance of the effects with a minimal number of 
experiments. In this design set-up multiple factors are changed simultaneously in an ordered 
fashion, enabling a statistical analysis of the effect of factors on the response and 
identification of interactions between the different factors.  
 
 
The procedure applied in this statistical experimental design for process optimisation is 
divided into three steps: 
1) identification of the media components that have most influence on the response 
(“screening”) 
2) optimum determination (‘’RSM’’)   
3) verification of the model (‘’checking experiment’’) 
4.3.4.1 Screening 
For the identification of the most important media components, a fractional factorial design 
was used. A complete factorial design would be most accurate, but requires too many 
experiments. With statistical programming methods it is possible to determine the effect of 
factors and the interaction between factors using the fractional factorial design. When it is 
likely that there are some important interactions between the factors, the appropriate design 
to use for the screening experiment is a fractional factorial design of resolution IV. This 
  
FACTORS  : Xi   
Environmental conditions  
RESPONSES:   : Yi   
Yield in succinate Rs,s   
Yield in biomass Rs,x   
 
 
SYSTEM   
Aspergillus niger  
. 
  . 
  . 
    
X 1   
X 2   
X 3   
X n   
Y 1   
Y 2   
.
 .
 .
  
Y 3   
Y n   
Figure 4.2 Schematised design of experiment set-up for medium optimisation. 
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design permits to describe the data by a linear model of the 1st order with interactions of the 
1st order (eq.1).  
 
ŷ = a0 + a1 X1 + a2X2 +……akXk + a12 X1X2 + …..+ ajk XjXk                 eq. 1 
 
The design of resolution IV determines the main effects, but the effects of the interactions 
between factors are confounded. The global effect of all the confounded interactions can be 
calculated, but the ability to determine the effect of each interaction is lost. 
4.3.4.2 Response surface modelling - RSM 
Factors that influence the response the most are selected by the screening experiment. The 
optimal point found by screening is then used for a more thorough study. This second 
investigation is done with a design at three levels, like a Box Benhken design or central 
composite design. This step is called “response surface modelling” (RSM) and permits to 
describe the response by a quadratic model detecting curvature in the response (eq. 2).  
 
ŷ= ao + a1X1 + a2X2 + a3X3 + a12X1X2 + a13X1X3 + a23X2X3 + a11X12 + a22 X22 + a33 X32     eq.2 
 
In the Box Benhken Factorial (BBF) design, the treatment combinations are at the midpoints 
of edges of the process space and at the center (Figure 4.3). This design requires 3 levels of 
each factor but the third factor is determined from the two first levels (the low and high level).  
 
 
 
 
 
 
 
 
 
 
 
A Central Composite Factorial (CCF) design contains an imbedded factorial or fractional 
factorial design with center points that are augmented with a group of ‘’star points'’ allowing 
estimation of curvature. In the CCF the star points are at the center of each face of the 
process space (Figure 4.4). 
 
Figure 4.3 Box Benhken design for surface modelling of the optimal medium composition. The cube 
indicates the process space. Each direction corresponds to a factor. A point indicates a treatment 
combination. 
X2 
X3 
X1 
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4.3.4.3 Model performance 
After running the factorial design (both for screening and optimum search experiments) the 
results were analysed according to the flowchart below (Figure 4.5). First of all, it was verified 
if the normal assumption holds for the residuals. Residuals are estimates of experimental 
error obtained by subtracting the observed responses from the predicted responses. The 
predicted response is calculated from the chosen model after all the unknown model 
parameters have been estimated from the experimental data. Residuals are elements of 
variation unexplained by the fitted model. Since this is a form of error, the same general 
assumptions apply as to errors in general, meaning one expects them to be (roughly) normal 
and (approximately) independently distributed with a mean of 0 and some constant variance. 
After removing outliers the model is statistically validated. 
 
For the statistical validation of the model three values are important: 
− the R2 is the percentage of the response variation explained by the model. R2 is a 
measure of fit. It means how well the model fits the data. 
− the Q2 is the percentage of the response variation predicted by the model according 
to cross validation. Q2 tells you how well the model predicts new data. 
− the validity of the model, meaning it compares the model error with the pure error. 
The pure error is a measure of the reproducibility of the experiments. 
 
Finally, the confidence interval is calculated for each coefficient based on the residual 
standard deviation and determines if an effect is statistically significant. The coefficient is 
significant (different from noise) when the confidence interval does not cross zero. 
 
 
X1 
X3 X2 
Figure 4.4 Central Composite Factorial design for surface modelling of the optimal medium 
composition. The cube indicates the process space. Each direction corresponds to a factor. A 
point indicates a treatment combination. 
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Figure 4.5 Flowchart of model development for response surface modelling experiment. The thin-lined 
boxes indicate the model development and the bold-lined boxes represent the model performance 
check.  
 
4.3.4.4 Checking 
The model needs to be validated. This is done by checking the reproducibility of the 
experiments. Some conditions are randomly selected and replicated for testing the 
reproducibility and thus the reliability of the model. 
 
 
(1) An outlier is an experimental point which does not verify the normality assumption of the residual. 
The results are 
used to answer 
the questions in 
the experimental 
objectives
DATA
Creation of 
the theoretical 
model
The model is 
fitted to the 
data
1. Are the 
residuals randomly 
and normally 
distributed ?
No
Exclusion of the outlier(s) from the data(1)
Yes
2. Is there a 
significant lack of 
fit of the model ?
The model is edited. 
Terms are added or 
removed Yes
3.The significance 
of the effects is 
examined
Is it possible to simplify 
the model or improve its 
statistical characteristics ?Yes No
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4.4 Results and discussion 
4.4.1 Definition of standard medium and operating ranges 
The reference media taken from literature (Table 4.1) were slightly adjusted towards the 
testing conditions that were relevant in this study (Table 4.2). The carbon source was 
changed from glucose to xylose. The most common organic compounds that support growth, 
and thereby supply a lot of carbon and energy to the cells, are sugars like glucose and 
sucrose, which are rapidly taken up. However, A. niger has a wide range of organic 
compounds that can be used for its metabolism, including xylose. We changed the carbon 
source from glucose to xylose, since it is the second most abundant carbon source in nature 
and we believe that the pathway from xylose towards succinate might contribute positively to 
the redox balance in the cell, thereby favouring succinate production. A second reason for 
using xylose is that it has been shown that different carbon sources can induce certain 
enzymes in the Embden-Meyerhof-Parnas (EMP) and pentose phosphate (PP) pathway, 
thereby redirecting fluxes in the cells (Papagianni 2004). However, not only metabolic 
pathways are influenced by the carbon source, but also signal transduction pathways like 
carbon catabolite repression are affected by the carbon source (Ruijter and Visser 1997). 
Therefore the carbon source is an important factor regulating the cellular behaviour. By using 
xylose we change the regulatory circuits that might benefit the succinate production. The 
concentration of the carbon source is important, as stated before. Therefore, a high 
concentration (50g/L) of carbon source was used to achieve a carbon overflow towards 
succinate production. 
 
A second change made in the medium was the nitrogen source. Nitrogen may be supplied as 
ammonia, as nitrate or in organic compounds, such as amino acids, proteins or yeast extract. 
In this study NaNO3 was used as nitrogen source, since in a previous experiment (data not 
shown) it was shown that more growth could be achieved under oxygen limited conditions. 
This illustrates that nitrate might give more reducing power to the cells under oxygen limited 
conditions. Since in shake flask cultivations the air supply is sub-optimal, nitrate is believed 
to reduce oxygen limiting effects. 
 
With these factors (carbon and nitrogen source) set, an experimental space was designed, 
where the influence of certain salts and trace elements on the growth and succinate 
production was determined. The aim was to increase succinate production and limit by-
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product formation, which mainly occurs in the form of citrate and oxalate at pH<5 using 
xylose as carbon source. The levels of nitrogen and phosphate have been chosen to be 
either in phosphate or nitrogen limitation. Table 4.3 describes the variables used in this study 
and their operating ranges. 
 
Table 4.2 Adjusted media compositions of the two reference media used as starting media for the 
medium optimisation study. 
 
Medium 1 2
Carbon source (g/L) Xylose 50 50
Nitrogen source (g/L) NaNO3 2 2
Salts (g/L) KH2PO4 0.4 1.5
MgSO4 
. 7H20 0.4 1
NaCl 0 1
CaCl2 
. 2H2O 0 0.1
Antifoam (μL) sb2121 50 50
Trace elements (mg/L) ZnSO4 
. 7H20 0.4 7.2
CuSO4 
. 5H2O 0.4 1.3
NiCl2 
. 6H2O 0 0.3
MnCl2 
. 4H2O 0 3.5
FeSO4 
. 7H2O 0.2 6.9  
4.4.2 Screening experiment 
The screening experiment was carried out with a two level fractional factorial design and the 
11 variables that are presented in Table 4.3. A resolution IV design was used containing 3 
center points and a total of 35 runs. In Appendix 1 the complete worksheet is presented and 
in Appendix 2 the confoundings are listed.  
 
The A. niger cultivations on the different media gave distinct biomass and succinic acid yields 
(Appendix 5) as well as varying physiologies. Some conditions showed large pellet 
morphologies, while under other conditions mycelia were observed. 
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Table 4.3 Factors and experimental ranges used in the screening experiment. 
 
Factor's name Abbreviation Unit Factor type Level - Level +
MgSO4 
. 7H20 Mg g/L Quantitative 0.2 2
NaCl NaCl g/L Quantitative 0.1 10
CaCl2 
. 2H2O CaCl2 g/L Quantitative 0.1 1.5
ZnSO4 
. 7H20 Zn mg/L Quantitative 0.08 8
CuSO4 
. 5H2O Cu mg/L Quantitative 0.2 5
NiCl2 
. 6H2O Ni Mg/L Quantitative 0 0.5
FeSO4 
. 7H2O Fe mg/L Quantitative 0.2 10
NaNO3 N g/L Quantitative 2 10
KH2PO4 P g/L Quantitative 0.1 2.5
MnCl2 
. 4H2O Mn mg/L Quantitative 0 16
pH pH pH units Quantitative 2 3.5  
 
The biomass yield ranged from 19 % to 57 % (C-mol/ C-mol of xylose).  One response has 
been removed because it did not conform to the normal distribution of residuals (outlier see 
Table 4.4 A). The succinate yield ranged from 0.01 % to 0.63 % (maximal concentration 
reached 0.30 g/L).  Another outlier was removed based on this yield’s normal distribution of 
the residuals (Table 4.4 B). 
 
Table 4.4 Terms of the optimal models for biomass and succinic acid response. 
             A. Biomass response modelling, B. Succinic acid response modelling  
 
A.         B. 
 
(1) The couples of factors indicated are the ones associated to the interaction coefficients after 
simplification of the table of confoundings.  
 
Outliers removed
Main effects Interactions(1) Experiment nr.
Mg CaCl2*Cu 18
Cu Mg*CaCl2/Mn*N
CaCl2 Mg*Zn
Fe NaCl*Zn
N Mg*Fe
P Mg*N
Mn Mg*P
Mg*Mn
Biomass response modelling
Terms of the model Outliers removed
Main effects Interactions(1) Experiment nr.
Mg Cu*Mn 4
Cu Fe*N
CaCl2 CaCl*N
Fe Cu*N
N Zn*Fe
P N*Mn
Mn
Zn
Succinic acid response modelling
Terms of the model
CHAPTER 4. Medium optimisation for organic acid production 
 
 53
During the cultivation different morphological growth forms were observed, ranging from 
loosely packed hyphae forming viscous medium to compact pellets of different sizes and 
colors. These different kinds of morphologies indicate the importance of the medium 
composition on cellular aggregation, which has consequences on nutrient and oxygen 
diffusion and therefore a consequence on growth and metabolite production.   
4.4.2.1 Modelling and statistical analysis 
After exclusion of the two outliers detected by the normality plot the residuals were evenly 
distributed. Two models were designed to describe on one hand succinic acid production and 
on the other hand biomass production. They have been fitted by multiple linear regression 
(MLR). Both models showed a good ability to describe the data (good R2), but a poor ability 
to predict them (weak Q2) (Table 4.5 A and B). There appeared to be a lack of reproducibility 
of the results in case of the succinate production. With regard to the biomass the weak 
validity of the model was due to a very good reproducibility of the centre points (the validity of 
the model was calculated comparing the residual standard deviation to the standard 
deviation of the centre points). Nevertheless, the regression was significant in the two cases 
(see Table 4.5 A and B). 
 
Table 4.5 Statistical characteristics of the models fitted by multiple linear regressions.  
A. Characteristics of the biomass model, B. Characteristics of the succinic acid model. 
 
A.       B. 
 
 
The experimental design chosen (fractional factorial design IV) permitted to obtain models of 
the first order with interactions of the first order with confoundings among the interactions. 
However, by using the following two assumptions it is possible to considerably simplify the 
confoundings making it possible to associate one or two couples of factors to one term of 
interactions (see Table 4.4 A and B).  
 
 
Biomass
R2 0.77
Q2 0.07
p-value regression 0.00
Model validity 0.27
reproducibility 0.97
MLR
succinic acid
R2 0.67
Q2 -0.03
p-value regression 0.02
Model validity 0.96
reproducibility -0.13
MLR
CHAPTER 4. Medium optimisation for organic acid production 
 
 54
The assumptions are: 
- if the main effect of a factor does not appear in the model then an interaction, 
which implies this factor, can be neglected 
- the couple of factors that has the strongest probability to interact is the one with 
the strongest main effects. 
4.4.2.2 Effects of factors on biomass and succinate production 
Although a high residual standard deviation was observed in the experiments, it was still 
possible to retrieve five factors from the biomass model and three factors from the succinic 
acid model that were significant. In the biomass model (Figure 4.6) both magnesium and 
phosphate had a positive effect on growth that was statistically significant. This result is 
coherent with literature, since Shu and Johnson (1984) have shown that excess phosphate is 
increasing growth. Phosphate is a convenient and readily used source of phosphorus, while 
organic forms are also used in industrial processes. Both phosphate and magnesium play an 
important role in metabolite overproduction and effect fungal morphology. Magnesium is 
known to be a cofactor for a number of enzymes and also favours growth this way (Bowes 
and Mattey 1979).  
 
Manganese on the contrary has a strong negative effect on growth. Manganese also inhibits 
the positive effect of phosphate, since there is a negative interaction between phosphate and 
manganese. Manganese is known to be involved in a number of processes in the cell. It 
stimulates cell wall synthesis and sporulation and is therefore essential for growth (Kisser et 
al. 1980). Because of these properties, manganese has also a major influence on the 
morphology of the cells and that might be one of the reasons for observing several different 
morphological states in the experiments. 
 
In this model it was not possible to distinguish between the effects of phosphate or nitrogen 
limitation. No significant effects of nitrogen and interactions between N and P were detected 
that influenced biomass formation. Although other studies showed that nitrogen limitation 
resulted in induced pellet formation (Braun and Vecht-Lifshitz 1991), or that excess 
phosphate reduced pellet formation (Katz et al. 1972), none of these phenomena were 
observed in the shake flask cultivations performed in the screening experiment. Although 
nitrogen had no significant effect, its negative interaction with manganese was significant. It 
appeared that a high concentration of nitrogen increased the negative effect of manganese. 
However, this result has to be confirmed, because the interaction shown by the model can be 
due to other interactions, since this interaction is confounded in the design. 
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Looking at the succinate model (Figure 4.7) it was observed that none of the compounds, 
showing a significant effect on growth, had a significant effect on succinic acid production. 
Only Mn belonged to one of the 5 major effects in the succinate model and was also 
significant in the biomass model. 
 
Figure 4.6 Standardised and centered effects of medium compounds on biomass yield (ordered by 
decreasing effects from left to right) according to optimal biomass yield modelling. The effects that are 
surrounded by lines are the significant effects found by the model.  
Residual Standard Deviation (RSD) = 0.0499; Degree of Freedom (DF)= 18; Confidence level (1-α) = 0.95
Figure 4.7 Standardised and centered effects of medium compounds on succinic acid yield (ordered by 
decreasing effects from left to right) according to optimal succinic acid yield modelling. The effects that are 
surrounded by lines are the significant effects found by the model.  
Residual Standard Deviation (RSD) = 0.0012; Degree of Freedom (DF)= 19; Confidence level (1-α) = 0.95 
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The succinate model showed a negative effect for nitrate, meaning that high levels of nitrate 
decrease the succinic acid production significantly. It was not possible to conclude if either 
nitrogen or phosphate limitation was favourable, because there was no significant effect of 
phosphate concentration and no term of interaction between nitrogen and phosphate in the 
model. However, combining both models and knowing phosphate has a positive effect on 
growth and nitrate has a negative effect on succinate, it may be assumed that nitrogen 
limitation is more favourable.  
 
In the succinate model Zn and Fe had no significant effect independently, but at high levels 
both factors decreased the yield of succinate significantly. This indicates again the 
importance of a balanced medium composition. 
 
Copper had a positive effect on succinic acid production. Such a positive effect on organic 
acid production has already been shown by Haq et al. (2002) with citric acid production. 
Copper is known to reduce the iron concentration in the cell, thereby counteracting its growth 
inhibiting effect. The copper ions also induce pelleted growth and have a negative effect on 
biomass formation.  
 
From the screening experiment four factors seem to be interesting for use in further studies. 
These factors are copper, nitrogen, manganese and iron. Copper and nitrogen had a 
significant effect on succinic acid production. Manganese and iron did not have a significant 
effect in the succinate model, but manganese did have a significant effect in the biomass 
model. Iron had in both models not a significant but a relative important effect. Based on the 
results of this screening experiment, it was decided to continue in further studies with 
nitrogen limitation and phosphate in excess.  
4.4.3 The RSM experiment 
After the screening experiment four factors were selected that influenced the succinate 
production most. These factors, Cu, Fe, NaNO3 and Mn, were used for further study by a 
response surface modelling experiment. For the selected factors concentrations levels were 
chosen around the optimal zone found in the screening experiment. Other components were 
fixed to their low level, except phosphate. Phosphate was fixed at 2 g/L in order to achieve a 
nitrogen limitation in all the flasks. The experimental ranges of the four remaining factors 
were widened in order to better fine tune the optimal medium condition (Table 4.6). The 
design chosen for the response surface modelling experiment is the BBF design with 24 runs 
plus 3 center points (detailed worksheet in Appendix 3). 
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Table 4.6 Components and their experimental ranges for the RSM design. The factors in bold are the 
4 compounds varied during this experiment. 
 
Factor Abbreviation Unit Factor type Condition Range of values 
MgSO4 . 7H2O Mg g/L Quantitative Constant 0.2 
NaCl NaCl g/L Quantitative Constant 0.1 
CaCl2 . 2H2O CaCl2 g/L Quantitative Constant 0.1 
ZnSO4 . 7H2O Zn mg/L Quantitative Constant 0.08 
CuSO4 . 5H2O Cu mg/L Quantitative Controlled 2 to 16 
NiCl2 . 6H2O Ni mg/L Quantitative Constant 0 
FeSO4 . 7H2O Fe mg/L Quantitative Controlled 8 to 30 
NaNO3 N g/L Quantitative Controlled 0.5 to 3 
KH2PO4 P g/L Quantitative Constant 0.2 
MnCl2 . 2H20 Mn mg/L Quantitative Controlled 10 to 35 
pH pH pH units Quantitative Constant 2 
 
 
The biomass yield ranged from 28% to 67% in this modelling experiment. The succinate yield 
varied from 0.03 % to 0.41% (a maximum concentration of 0.20 g/L was achieved) and, 
unfortunately, is lower than the maximum yields reached during the screening experiment. In 
Appendix 6 the results of the BBF RSM experiment are listed. After exclusion of one outlier 
detected by the normality plot (for both biomass and succinic acid response) (Table 4.7 A and 
B), the residuals were randomly and normally distributed. 
4.4.3.1 Modelling and statistical analysis 
Models for biomass and succinic acid yields have been fitted by MLR. The models resulting 
from the optimised statistical characteristics appeared good models for both description and 
prediction of values. The reproducibility was better than during the screening experiment and 
also a good validity of the model was achieved (8 A and B). 
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Table 4.7 Terms of the optimal models for biomass and succinic acid response in the RSM 
experiment.  
            A. Biomass response modelling. B. Succinic acid response modelling  
 
A.                     B.      
Outliers removed
Main effects Interactions Experiment nr.
Mg Cu*Fe 19
Cu Fe*N
Fe
N
Succinic acid RSM
Terms of the model
 
 
 
The models found in this experiment were more simple than for the screening experiment. In 
these models only six terms were selected for describing each model (Table 4.7 A and B). 
No terms of curvature appeared in the succinic acid model, meaning that the potential 
optimum was not in the parameter range studied. In the biomass model two quadratic terms 
were determined, resulting in a curvature in the model. Looking at the significance of effects, 
it was observed that nitrogen and iron were significant factors for biomass in the RSM 
(Figure 4.8), which they were not after the screening experiment. Fe had a positive curve 
effect, whereas nitrogen had a negative curve effect. The manganese effect on biomass was 
found positive in this experiment, compared to a negative effect in the screening experiment. 
A maximum biomass yield was found using [Fe]= 30 mg and [Mn]=35 mg (respectively high 
levels) and an intermediary concentration in nitrogen of 2g/L. 
 
Table 4.8 Statistical characteristics of the models fitted by multiple linear regressions. 
A. Characteristics of the biomass model. B. Characteristics of the succinic acid model.  
 
A.                        B. 
 
 
 
Biomass
R2 0.75
Q2 0.34
p-value regression 0.00
Model validity 0.43
reproducibility 0.96
MLR
Succinic acid
R2 0.78
Q2 0.60
p-value regression 0.00
Model validity 0.91
reproducibility 0.68
MLR
Outliers removed
Main effects Interactions Quadratic terms Experiment nr.
Fe Fe*Mn Fe*Fe 19
N N*N
Mn
Terms of the model
Biomass RSM
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In the succinate model the only significant effect found was nitrogen (Figure 4.9). In contrast 
to the screening experiment the effect was found to be positive. It was also observed that in 
this model Fe alone had no significant effect. Nevertheless, iron increased the succinic acid 
yield in synergy with copper and inhibited the positive effect of nitrogen significantly. The 
response surface, created by succinic acid yield modelling, had a plane shape and, 
therefore, no optimum could be found in the experimental design space tested in this 
experiment (Figure 4.10). The optimum medium composition found for biomass yielded high 
nitrogen and copper levels and a low iron level. This result is in contradiction with the 
screening experiment. Even if the RSM model would predict a well defined optimum, the 
problem of the reproducibility between the two blocks of experiments (screening and RSM) 
still remains. An unknown factor seems to have a larger influence on succinate production 
than the medium components that have been varied in the two blocks of experiments.  
 
Figure 4.9 Standardised and centered effects of medium compounds on succinic acid yield (ordered by 
decreasing effects from left to right) according to optimal succinic acid yield modelling. The effects that are 
surrounded by lines are the significant effects found by the model.  
Residual Standard Deviation (RSD) = 0.0005; Degree of Freedom (DF)= 20; Confidence level (1-α) = 0.95
 
Figure 4.8 Standardised and centered effects of medium compounds on biomass yield (ordered by 
decreasing effects from left to right) according to optimal biomass yield modelling. The effects that are 
surrounded by lines are the significant effects found by the model.  
Residual Standard Deviation (RSD) = 0.046; Degree of Freedom (DF)= 19; Confidence level (1-α) = 0.95 
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4.4.3.2 Checking experiment 
Finally, the models needed to be validated by analysing the reproducibility of the results. 
Replicates of cultures from the screening and from the Box-Benhken design were made and 
compared, based on their biomass yield and succinic acid yield (Table 4.9). There were 
significant differences between the yields reached in the two replicates (Table 4.9). In most 
cases the relative standard deviation is larger than 10% (especially large variations were 
observed in the succinic acid yield). Furthermore, different morphologies (presence of 
pellets, pellet size, color of supernatant) could be distinguished in this experiment. The large 
variability in the relative standard deviations indicates that the experiments are difficult to 
repeat and this is most likely the main reason for the limited quality of the medium 
optimisation models. 
 
Table 4.9 Comparison of the yields reached in two replicate made of different experimental conditions. 
 
Experiment nr. Design of Experiment
STDEV STDEV
1 2 1 2
30 Screening 0.36 0.23 31 15.0 23.0 30
31 Screening 0.34 0.32 4 6.2 8.9 25
32 Screening 0.40 0.35 9 1.3 0.7 40
33 RSM 0.39 0.27 26 4.1 5.0 14
34 RSM 0.30 0.26 10 4.1 2.7 29
Biomass
Yield (g/g)
Succinic acid
Yield (mg/g)
 
STDEV is the relative standard deviation expressed in percentage, 1 and 2 are the replicates of each 
experiment. 
 
4.4.4 CCF modelling 
Since the BBF RSM experiment did not result in a clear optimum and the reproducibility test 
was performing poorly, it was decided to run a second RSM experiment. The design chosen 
was a CCF design in 26 runs plus 3 centre points (detailed worksheet in Appendix 4).  
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4.4.4.1 Modelling and statistical analysis of the CCF design 
By using this CCF design it was attempted to detect a curvature, which could explain the two 
different directions of optimisation found by the fractional factorial screening design and the 
BBF design. The variable and concentration ranges used in this CCF experiment can be 
found in Table 4.10. Zinc was added as variable, because the compound appeared three 
times in the screening experiment for succinic acid modelling (see Figure 4.7). This indicates 
that it may have an effect on succinate production and that the effect is often through 
interactions with other metals like Fe and Cu. These interactions are already known from 
literature (Papagianni 2004). Literature states that media lacking Zn2+ result in a lower 
glycolytic capacity, as aldolase is Zn2+ dependent (Mattey 1992). This shifts metabolism 
mainly towards gluconic acid production, but might also stimulate the PPPP, leading to 
different organic acid profiles. By using xylose the PPPP is already stimulated, but additional 
regulation by metals might be beneficial.  
Figure 4.10 4D contour plot of succinic acid yield in the Box Benhken RSM experiment space. 
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Table 4.10 Concentration values of the components for the CCF design : [Cu],[Fe],[NaNO3],[Mn] and 
[Zn] are considered as variables and are presented in bold. 
 
Factor Abbreviation Unit Factor type Condition Range of values 
MgSO4 . 7H2O Mg g/L Quantitative Constant 0.2 
NaCl NaCl g/L Quantitative Constant 0.1 
CaCl2 . 2H2O CaCl2 g/L Quantitative Constant 0.1 
ZnSO4 . 7H2O Zn mg/L Quantitative Controlled 0 to 0.16 
CuSO4 . 5H2O Cu mg/L Quantitative Controlled 2 to 9 
NiCl2 . 6H2O Ni Mg/L Quantitative Constant 0 
FeSO4 . 7H2O Fe mg/L Quantitative Controlled 7 to 11 
NaNO3 N g/L Quantitative Controlled 2 to 5 
KH2PO4 P g/L Quantitative Constant 0.2 
MnCl2 . 2H20 Mn mg/L Quantitative Controlled 10 to 16 
pH pH pH units Quantitative Constant 2 
 
 
The simulated model resulted in biomass yields varying from 21% to 40%, which is a narrow 
and low range compared to the screening and BBF RSM experiments.  
 
The succinate yield retrieved in this experiment covered a larger range than the BBF 
experiment and varied from 0.01 % to 0.67 % (maximum concentration of 0.33 g/L). This was 
highest succinate yield achieved, compared to the other two experiments. An overview of the 
results of the CCF responses can be found in Appendix 7.  
 
After having removed the outliers (Table 4.11 B), the residuals were again randomly and 
normally distributed. The optimal model for succinic acid response fitted by MLR had very 
good statistical characteristics (Table 4.11 A) and the center points were reproducible.   
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Table 4.11 Characteristics of the optimal CCF model for succinic acid yield. 
              A. Statistical characteristics of the model. B. Terms of the model. 
 
   A.            B. 
 
 
The residual standard deviation was very low and a lot of factors were significant. The terms 
of the model and their interactions are shown in Table 4.11 B, in which also two quadratic 
effects are integrated in the model.  
 
The results showed that the concentration of nitrogen presented a positive curve effect on 
the domain of values (2-5g/L) and negative interactions with metals (Cu, Fe, Zn and Mn) 
(Figure 4.11). Zinc had a strong negative effect and therefore a total deficiency in Zn seems 
suitable for succinic acid production. Iron had a significant negative effect. Furthermore, it 
could be seen that positive interactions appeared between the metals added. Metals have a 
huge impact on enzyme activities and can serve as electron donors or acceptors, Lewis 
acids or structural regulators (Riordan et al. 1977). A good balance between the metals is 
therefore necessary for achieving an optimal medium composition for succinate production. 
 
Unfortunately, in this experiment the response surface had again a plane shape and no 
optimum appeared. Therefore, it was not possible to define a real optimum medium 
composition. In the range of values studied in this second RSM experiment, the optimal 
levels for the factors would lead in the direction of a high concentration of nitrogen (5g/L) and 
low concentrations of metals: Zn (deficiency), Mn (10 mg/L), Cu (2mg/L), Fe (7mg/L).  
 
 
succinic acid
R2 0.97
Q2 0.42
p-value regression 0.00
Model validity 0.67
reproductibility 0.97
MLR
outliers removed
Main effects interactions quadratic terms experiment n°
Zn Zn*Cu Zn*Zn 23
Cu Zn*N N*N 24
Fe Zn*Mn 25
N Cu*Fe
Mn Cu*N
Cu*Mn
Fe*Mn
N*Mn
Succinic acid 
terms of the model
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Figure 4.11 Standardised and centered effects of medium compounds on succinic acid yield (ordered by 
decreasing effects from left to right) according to optimal succinic acid yield modelling. The effects that are 
surrounded by lines are the significant effects found by the model. 
Residual Standard Deviation (RSD) = 0.0004 Degree of Freedom (DF)= 10  Confidence level (1-α) = 0.95 
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4.5 Conclusion 
The strategy of medium optimisation by DOE (screening and response surface modelling) 
did not result in a clearly defined optimum for succinic acid production by A. niger. The yield 
in succinic acid has not significantly been improved by changing the medium components. 
However, a great variation in the succinate yields, reached in the different experiments, was 
detected. The main problem encountered in the design strategy was the reproducibility 
between the experiments and above all between the screening and response surface 
modelling experiments. These problems might be caused by a factor that can not be 
controlled in the shake flask cultivations and might have a major influence on the succinic 
acid yield. A possible candidate is the oxygen transfer rate.  
 
The aeration and shaking conditions in the flasks can easily induce metabolic and 
morphological changes that might have major influences on succinic acid production. If this is 
the case, it will be difficult to define a clear effect of the medium compounds, since the 
oxygen transfer capacity variation is too prominently present and thereby overshadowing the 
effect of the medium components. Different optimal medium compositions were retrieved in 
all the experiments performed in this study. For example, in the BBF design the optimum 
concentration of Fe and Mn was 30 and 35 mg/L respectively, while in the CCF design this 
was 7 and 10 mg/L respectively. It was decided to use medium 2 for further studies (shown 
in Table 4.2) and perform a more controlled experiment in fermentors, where the influence of 
different oxygen levels on the physiology of A. niger is determined (Chapter 5). 
 
Additionally, it was observed that the concentration of succinic acid strongly increases when 
autolysis of the biomass occurs. It would be interesting to study the secretion of succinic acid 
more carefully and to compare the intra- and extra-cellular profiles of succinic acid. 
Unfortunately, only little information is available on organic acid transporters in A. niger, but a 
comparison between intra- and extracellular metabolite concentrations of succinate has been 
made in a physiological experiment as mentioned above (see Chapter 5).   
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APPENDIX 1 
Worksheet of the screening experiment design 
  
MgSO4 .  7H2O; NaCl; NaNO3;  KH2PO4 and CaCl2 .  2H2O  are expressed in g/L. 
ZnSO4 .  7H2O; CuSO4 .  5H2O; NiCl2 .  6H2O; FeSO4 .  7H2O and MnCl2 .  2H20 are expressed in mg/L. 
Exp Nr. Run Order MgSO4 . 7H2O NaCl CaCl2 . 2H2O ZnSO4 . 7H2O CuSO4 . 5H2O NiCl2 . 6H2O FeSO4 . 7H2O NaNO3 KH2PO4 MnCl2 . 2H20 pH 
1 1 0.2 0.1 0.1 0.08 0.2 0 0.2 2 0.1 0 2 
35 2 1.1 5.05 0.8 4.04 2.6 0.25 5.1 6 1.3 8 2.75 
32 3 2 10 1.5 8 5 0.5 10 10 2.5 16 3.5 
9 4 0.2 0.1 0.1 8 0.2 0 10 10 2.5 16 3.5 
33 5 1.1 5.05 0.8 4.04 2.6 0.25 5.1 6 1.3 8 2.75 
7 6 0.2 10 1.5 0.08 0.2 0 0.2 10 2.5 0 3.5 
11 7 0.2 10 0.1 8 0.2 0.5 0.2 10 2.5 16 2 
12 8 2 10 0.1 8 0.2 0 0.2 10 0.1 0 2 
10 9 2 0.1 0.1 8 0.2 0.5 10 10 0.1 0 3.5 
23 10 0.2 10 1.5 0.08 5 0 0.2 2 2.5 16 2 
4 11 2 10 0.1 0.08 0.2 0 10 2 2.5 16 3.5 
19 12 0.2 10 0.1 0.08 5 0.5 10 10 0.1 16 2 
26 13 2 0.1 0.1 8 5 0.5 10 2 0.1 16 2 
31 14 0.2 10 1.5 8 5 0 10 10 0.1 0 3.5 
25 15 0.2 0.1 0.1 8 5 0 10 2 2.5 0 2 
21 16 0.2 0.1 1.5 0.08 5 0.5 10 2 2.5 16 3.5 
5 17 0.2 0.1 1.5 0.08 0.2 0.5 10 10 2.5 0 2 
18 18 2 0.1 0.1 0.08 5 0.5 0.2 10 2.5 0 3.5 
2 19 2 0.1 0.1 0.08 0.2 0.5 0.2 2 2.5 16 2 
16 20 2 10 1.5 8 0.2 0.5 10 2 2.5 0 2 
24 21 2 10 1.5 0.08 5 0.5 0.2 2 0.1 0 2 
8 22 2 10 1.5 0.08 0.2 0.5 0.2 10 0.1 16 3.5 
15 23 0.2 10 1.5 8 0.2 0 10 2 0.1 16 2 
29 24 0.2 0.1 1.5 8 5 0.5 0.2 10 0.1 0 2 
14 25 2 0.1 1.5 8 0.2 0 0.2 2 2.5 0 3.5 
27 26 0.2 10 0.1 8 5 0.5 0.2 2 2.5 0 3.5 
20 27 2 10 0.1 0.08 5 0 10 10 2.5 0 2 
13 28 0.2 0.1 1.5 8 0.2 0.5 0.2 2 0.1 16 3.5 
30 29 2 0.1 1.5 8 5 0 0.2 10 2.5 16 2 
28 30 2 10 0.1 8 5 0 0.2 2 0.1 16 3.5 
17 31 0.2 0.1 0.1 0.08 5 0 0.2 10 0.1 16 3.5 
34 32 1.1 5.05 0.8 4.04 2.6 0.25 5.1 6 1.3 8 2.75 
6 33 2 0.1 1.5 0.08 0.2 0 10 10 0.1 16 2 
3 34 0.2 10 0.1 0.08 0.2 0.5 10 2 0.1 0 3.5 
22 35 2 0.1 1.5 0.08 5 0 10 2 0.1 0 3.5 
  
 
 
 
 
 
Appendix 2 
Confoundings of factors in screening experiment 
  
  
Confounded 
with 
Confounded 
with 
Confounded 
with 
Zn*Ni Mg*Fe NaCl*P   
Zn*Fe Mg*Ni NaCl*CaCl2 N*pH 
Zn*N CaCl2*Cu Fe*pH P*Mn 
Zn*P Mg*CaCl2 NaCl*Ni N*Mn 
Zn*Mn Mg*Cu N*P   
Zn*pH NaCl*Cu Fe*N   
Cu*Ni Fe*Mn P*pH   
Cu*Fe NaCl*N CaCl2*pH Ni*Mn 
Cu*N Mg*P NaCl*Fe CaCl2*Zn 
Cu*P Mg*N CaCl2*Mn Ni*pH 
Cu*Mn Mg*Zn CaCl2*P Ni*Fe 
Cu*pH NaCl*Zn CaCl2*Fe Ni*P 
Ni*Fe Mg*Zn CaCl2*P Cu*Mn 
Ni*N Mg*pH NaCl*Mn   
Ni*P NaCl*Zn CaCl2*Fe Cu*pH 
Ni*Mn NaCl*N CaCl2*pH Cu*Fe 
Ni*pH Mg*N CaCl2*Mn Cu*P 
Fe*N NaCl*Cu Zn*pH   
Fe*P Mg*NaCl CaCl2*Ni Mn*pH 
Fe*Mn Cu*Ni P*pH   
Fe*pH CaCl2*Cu Zn*N P*Mn 
N*P Mg*Cu Zn*Mn   
N*Mn Mg*CaCl2 NaCl*Ni Zn*P 
N*pH Mg*Ni NaCl*CaCl2 Zn*Fe 
P*Mn CaCl2*Cu Zn*N Fe*pH 
P*pH Cu*Ni Fe*Mn   
Mn*pH Mg*NaCl CaCl2*Ni Fe*P 
 Confounded with 
Confounded 
with 
Confounded 
with 
 Mg*NaCl CaCl2*Ni Fe*P Mn*pH 
Mg*CaCl2 NaCl*Ni Zn*P N*Mn 
Mg*Zn CaCl2*P Cu*Mn Ni*Fe 
Mg*Cu Zn*Mn N*P  
Mg*Ni NaCl*CaCl2 Zn*Fe N*pH 
Mg*Fe NaCl*P Zn*Ni  
Mg*N CaCl2*Mn Cu*P Ni*pH 
Mg*P NaCl*Fe CaCl2*Zn Cu*N 
Mg*Mn NaCl*pH CaCl2*N Zn*Cu 
Mg*pH NaCl*Mn Ni*N  
NaCl*CaCl2 Mg*Ni Zn*Fe N*pH 
NaCl*Zn CaCl2*Fe Cu*pH Ni*P 
NaCl*Cu Zn*pH Fe*N  
NaCl*Ni Mg*CaCl2 Zn*P N*Mn 
NaCl*Fe Mg*P CaCl2*Zn Cu*N 
NaCl*N CaCl2*pH Cu*Fe Ni*Mn 
NaCl*P Mg*Fe Zn*Ni  
NaCl*Mn Mg*pH Ni*N  
NaCl*pH Mg*Mn CaCl2*N Zn*Cu 
CaCl2*Zn Mg*P NaCl*Fe Cu*N 
CaCl2*Cu Zn*N Fe*pH P*Mn 
CaCl2*Ni Mg*NaCl Fe*P Mn*pH 
CaCl2*Fe NaCl*Zn Cu*pH Ni*P 
CaCl2*N Mg*Mn NaCl*pH Zn*Cu 
CaCl2*P Mg*Zn Cu*Mn Ni*Fe 
CaCl2*Mn Mg*N Cu*P Ni*pH 
CaCl2*pH NaCl*N Cu*Fe Ni*Mn 
Zn*Cu Mg*Mn NaCl*pH CaCl2*N 
A * B represent the interaction between A and B.  
  
 
 
 
 
 
APPENDIX 3 
Worksheet of the Box-Benhken design for 
response surface modelling
  
MgSO4 .  7H2O; NaCl; NaNO3;  KH2PO4 and CaCl2 .  2H2O  are expressed in g/L. 
ZnSO4 .  7H2O; CuSO4 .  5H2O; NiCl2 .  6H2O; FeSO4 .  7H2O and MnCl2 .  2H20 are expressed in mg/L. 
The gray colums represent the compounds that are found in the screening experiment and are varied in concentration in order to find an optimal medium composition 
Exp Nr. Run Order MgSO4 . 7H2O NaCl CaCl2 . 2H2O ZnSO4 . 7H2O CuSO4 . 5H2O NiCl2 . 6H2O FeSO4 . 7H2O NaNO3 KH2PO4 MnCl2 . 2H20 pH 
17 1 0.2 0.1 0.1 0.08 2 0 19 0.5 0.2 22.5 2 
8 2 0.2 0.1 0.1 0.08 9 0 19 3 0.2 35 2 
2 3 0.2 0.1 0.1 0.08 16 0 8 1.75 0.2 22.5 2 
16 4 0.2 0.1 0.1 0.08 9 0 30 3 0.2 22.5 2 
9 5 0.2 0.1 0.1 0.08 2 0 19 1.75 0.2 10 2 
11 6 0.2 0.1 0.1 0.08 2 0 19 1.75 0.2 35 2 
26 7 0.2 0.1 0.1 0.08 9 0 19 1.75 0.2 22.5 2 
15 8 0.2 0.1 0.1 0.08 9 0 8 3 0.2 22.5 2 
25 9 0.2 0.1 0.1 0.08 9 0 19 1.75 0.2 22.5 2 
20 10 0.2 0.1 0.1 0.08 16 0 19 3 0.2 22.5 2 
10 11 0.2 0.1 0.1 0.08 16 0 19 1.75 0.2 10 2 
23 12 0.2 0.1 0.1 0.08 9 0 8 1.75 0.2 35 2 
1 13 0.2 0.1 0.1 0.08 2 0 8 1.75 0.2 22.5 2 
4 14 0.2 0.1 0.1 0.08 16 0 30 1.75 0.2 22.5 2 
12 15 0.2 0.1 0.1 0.08 16 0 19 1.75 0.2 35 2 
3 16 0.2 0.1 0.1 0.08 2 0 30 1.75 0.2 22.5 2 
18 17 0.2 0.1 0.1 0.08 16 0 19 0.5 0.2 22.5 2 
22 18 0.2 0.1 0.1 0.08 9 0 30 1.75 0.2 10 2 
6 19 0.2 0.1 0.1 0.08 9 0 19 3 0.2 10 2 
5 20 0.2 0.1 0.1 0.08 9 0 19 0.5 0.2 10 2 
27 21 0.2 0.1 0.1 0.08 9 0 19 1.75 0.2 22.5 2 
13 22 0.2 0.1 0.1 0.08 9 0 8 0.5 0.2 22.5 2 
7 23 0.2 0.1 0.1 0.08 9 0 19 0.5 0.2 35 2 
19 24 0.2 0.1 0.1 0.08 2 0 19 3 0.2 22.5 2 
21 25 0.2 0.1 0.1 0.08 9 0 8 1.75 0.2 10 2 
14 26 0.2 0.1 0.1 0.08 9 0 30 0.5 0.2 22.5 2 
24 27 0.2 0.1 0.1 0.08 9 0 30 1.75 0.2 35 2 
  
 
 
 
 
 
APPENDIX 4  
Worksheet of the 
CCF design for response surface modelling
  
 
* These experiments do not belong to the CCF design. The grey columns represent the compounds that are varied in concentration to find the medium optimum 
MgSO4 .  7H2O; NaCl; NaNO3;  KH2PO4 and CaCl2 .  2H2O  are expressed in g/L.  
ZnSO4 .  7H2O; CuSO4 .  5H2O; NiCl2 .  6H2O; FeSO4 .  7H2O and MnCl2 .  2H20 are expressed in mg/L. 
Exp Nr. Run Order MgSO4 . 7H2O NaCl CaCl2 . 2H2O ZnSO4 . 7H2O CuSO4 . 5H2O NiCl2 . 6H2O FeSO4 . 7H2O NaNO3 KH2PO4 MnCl2 . 2H20 pH 
11 1 0.2 0.1 0.1 0 9 0 7 5 0.2 16 2 
26 2 0.2 0.1 0.1 0.08 5.5 0 9 3.5 0.2 16 2 
1 3 0.2 0.1 0.1 0 2 0 7 2 0.2 16 2 
3 4 0.2 0.1 0.1 0 9 0 7 2 0.2 10 2 
27 5 0.2 0.1 0.1 0.08 5.5 0 9 3.5 0.2 13 2 
23 6 0.2 0.1 0.1 0.08 5.5 0 9 2 0.2 13 2 
15 7 0.2 0.1 0.1 0 9 0 11 5 0.2 10 2 
9 8 0.2 0.1 0.1 0 2 0 7 5 0.2 10 2 
2 9 0.2 0.1 0.1 0.16 2 0 7 2 0.2 10 2 
7 10 0.2 0.1 0.1 0 9 0 11 2 0.2 16 2 
29 11 0.2 0.1 0.1 0.08 5.5 0 9 3.5 0.2 13 2 
13 12 0.2 0.1 0.1 0 2 0 11 5 0.2 16 2 
17 13 0.2 0.1 0.1 0 5.5 0 9 3.5 0.2 13 2 
21 14 0.2 0.1 0.1 0.08 5.5 0 7 3.5 0.2 13 2 
18 15 0.2 0.1 0.1 0.16 5.5 0 9 3.5 0.2 13 2 
28 16 0.2 0.1 0.1 0.08 5.5 0 9 3.5 0.2 13 2 
22 17 0.2 0.1 0.1 0.08 5.5 0 11 3.5 0.2 13 2 
24 18 0.2 0.1 0.1 0.08 5.5 0 9 5 0.2 13 2 
6 19 0.2 0.1 0.1 0.16 2 0 11 2 0.2 16 2 
10 20 0.2 0.1 0.1 0.16 2 0 7 5 0.2 16 2 
14 21 0.2 0.1 0.1 0.16 2 0 11 5 0.2 10 2 
5 22 0.2 0.1 0.1 0 2 0 11 2 0.2 10 2 
25 23 0.2 0.1 0.1 0.08 5.5 0 9 3.5 0.2 10 2 
12 24 0.2 0.1 0.1 0.16 9 0 7 5 0.2 10 2 
4 25 0.2 0.1 0.1 0.16 9 0 7 2 0.2 16 2 
20 26 0.2 0.1 0.1 0.08 9 0 9 3.5 0.2 13 2 
19 27 0.2 0.1 0.1 0.08 2 0 9 3.5 0.2 13 2 
8 28 0.2 0.1 0.1 0.16 9 0 11 2 0.2 10 2 
16 29 0.2 0.1 0.1 0.16 9 0 11 5 0.2 16 2 
30* 30 0.2 0.1 0.1 0.08 0.2 0 10 2 2.5 16 3.5 
31* 31 0.2 10 0.1 0.08 5 0.5 10 10 0.1 16 2 
32* 32 2 0.1 1.5 8 5 0 0.2 10 2.5 16 2 
33* 33 0.2 0.1 0.1 0.08 9 0 8 3 0.2 22.5 2 
34* 34 0.2 0.1 0.1 0.08 9 0 19 3 0.2 10 2 
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Experiment 
Nr. 
Run 
order 
Culture time (1) 
(d) 
Xylose consumed 
(C-mol/L) 
Biomass yield (2) 
(C-mol/C-mol) 
Succinic acid yield 
(mC-mol/C-mol) 
1 1 11.0 1.37 0.28 0.11 
35(3) 2 13.9 1.66 0.35 1.81 
32 3 13.9 1.66 0.31 1.92 
9 4 13.9 1.66 0.19 0.28 
33(3) 5 13.9 1.66 0.33 1.84 
7 6 13.9 1.66 0.44 2.03 
11 7 11.0 1.66 0.34 3.15 
12 8 13.9 1.58 0.35 4.09 
10 9 11.0 1.66 0.34 2.57 
23 10 13.9 1.50 0.22 4.37 
4 11 13.9 1.57 0.36 15.46 
19 12 13.9 1.66 0.34 6.25 
26 13 13.9 1.64 0.35 4.12 
31 14 11.0 1.66 0.47 1.28 
25 15 13.9 1.63 0.38 5.01 
21 16 13.9 1.39 0.35 5.79 
5 17 11.0 1.66 0.57 2.38 
18 18 11.0 1.66 0.75 2.30 
2 19 13.9 1.55 0.39 2.68 
16 20 11.0 1.66 0.50 1.16 
24 21 13.9 1.16 0.35 2.47 
8 22 13.9 1.35 0.36 0.11 
15 23 13.9 1.66 0.32 3.35 
29 24 13.9 1.19 0.27 2.59 
14 25 11.0 1.59 0.47 1.72 
27 26 13.9 1.59 0.31 2.38 
20 27 13.9 1.66 0.45 2.63 
13 28 13.9 1.57 0.37 3.90 
30 29 11.0 1.66 0.40 1.31 
28 30 13.9 1.57 0.40 5.91 
17 31 13.9 1.50 0.31 3.30 
34(3) 32 13.9 1.66 0.35 4.76 
6 33 11.0 1.66 0.38 3.36 
3 34 13.9 1.45 0.28 3.80 
22 35 13.9 1.39 0.28 4.73 
 
(1) Yields are calculated before a significant decrease of biomass (1g/L) and when xylose concentration 
is below 2 g/L. 
(2) Yields in biomass calculated with the following formula of the biomass: CH1.72O0.55N0.17P0.005 
(3) These results are the centre points 
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Experiment 
Nr. 
Run 
order 
Culture time (1) 
(d) 
Xylose consumed 
(C-mol/L) 
Biomass yield (2) 
(C-mol/C-mol) 
Succinic acid yield 
(mC-mol/C-mol) 
17 1 13.7 0.90 0.30 0.79 
8 2 10.9 1.66 0.33 2.54 
2 3 13.7 1.66 0.42 1.77 
16 4 10.9 1.66 0.38 1.81 
9 5 10.9 1.66 0.46 2.73 
11 6 10.9 1.66 0.47 1.76 
26(3) 7 13.7 1.65 0.46 1.56 
15 8 7.9 1.66 0.39 4.06 
25(3) 9 13.7 1.66 0.43 2.24 
20 10 11.1 1.66 0.38 2.41 
10 11 13.7 1.66 0.40 1.71 
23 12 13.7 1.62 0.49 2.12 
1 13 13.7 1.63 0.44 2.93 
4 14 13.7 1.66 0.44 2.78 
12 15 13.7 1.66 0.46 1.54 
3 16 13.7 1.63 0.43 1.73 
18 17 13.7 0.94 0.28 0.93 
22 18 13.7 1.60 0.43 1.14 
6 19 7.9 1.66 0.30 4.14 
5 20 13.7 1.14 0.32 0.33 
27(3) 21 13.7 1.65 0.44 1.18 
13 22 13.7 0.92 0.41 0.83 
7 23 13.7 0.94 0.32 0.72 
19 24 10.9 1.66 0.41 0.85 
21 25 13.7 1.66 0.42 1.89 
14 26 13.72 1.12 0.39 0.93 
24 27 13.72 1.66 0.67 1.93 
 
(1) Yields are calculated before a significant decrease of biomass (1g/L) and when xylose concentration 
is below 2 g/L. 
(2) Yields in biomass calculated with the following formula of the biomass: CH1.72O0.55N0.17P0.005 
(3) These results are the centre points 
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Experiment 
Nr. 
Run 
order 
Culture time (1)      
(d) 
Xylose consumed 
(C-mol/L) 
Biomass yield (2) 
(C-mol/C-mol) 
Succinic acid yield    
(C-mol/C-mol) 
11 1 7.8 1.66 0.29 0.31 
26 2 7.8 1.66 0.29 0.36 
1 3 10.6 1.66 0.26 1.43 
3 4 10.6 1.66 0.40 1.18 
27(3) 5 10.6 1.66 0.21 0.75 
23 6 10.6 1.66 0.25 4.12 
15 7 7.8 1.63 0.35 1.27 
9 8 10.6 1.66 0.31 6.77 
2 9 7.8 1.63 0.34 0.27 
7 10 10.6 1.66 0.36 3.38 
29(3) 11 7.8 1.66 0.30 0.27 
13 12 10.6 1.66 0.30 2.07 
17 13 7.8 1.64 0.28 1.05 
21 14 7.8 1.66 0.25 0.00 
18 15 7.8 1.66 0.29 0.20 
28(3) 16 7.8 1.63 0.30 0.55 
22 17 7.8 1.66 0.26 0.25 
24 18 7.8 1.66 0.26 0.39 
6 19 7.8 1.62 0.26 0.23 
10 20 7.8 1.64 0.32 0.75 
14 21 7.8 1.66 0.24 0.09 
5 22 10.6 1.66 0.30 0.62 
25 23 no results no results no results no results 
12 24 7.8 1.66 0.24 0.24 
4 25 10.6 1.66 0.25 3.39 
20 26 7.8 1.66 0.29 0.29 
19 27 7.8 1.66 0.31 0.37 
8 28 7.8 1.65 0.26 0.33 
16 29 7.8 1.66 0.24 0.20 
30* 30 10.6 1.66 0.23 2.26 
31* 31 10.6 1.66 0.32 0.89 
32* 32 10.6 1.66 0.35 0.73 
33* 33 7.8 1.66 0.27 0.50 
34* 34 10.6 1.67 0.26 2.68 
 
(1)   Yields are calculated before a significant decrease of biomass (1g/L) and when xylose concentration 
is below 2 g/L. 
(2)   Yields in biomass calculated with the following formula of the biomass: CH1.72O0.55N0.17P0.005 
(3)   These results are the centre points 
* These experiments do not belong to the CCF design but are the replicates for the checking experiment 
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Chapter 5  
Physiological characterisation of xylose metabolism in 
Aspergillus niger under oxygen limited conditions 
Meijer S., Panagiotou G., Olsson L. and Nielsen J. 
Biocentrum-DTU, Center for Microbial Biotechnology, Denmark 
 
Biotechnology and Bioengineering (2007) 98 (2):462-475 
 
 
5.1 Abstract 
The physiology of Aspergillus niger was studied under different aeration conditions. Five different 
aeration rates were investigated in batch cultivations of A. niger grown on xylose. Biomass, intra- 
and extra-cellular metabolites profiles were determined and ten different enzyme activities in the 
central carbon metabolism were assessed. The focus was on organic acid production with a 
special interest in succinate production. The fermentations revealed that oxygen limitation 
significantly changes the physiology of the micro-organism. Changes in extra cellular metabolite 
profiles were observed, i.e there was a drastic increase in polyol production (erythritol, xylitol, 
glycerol, arabitol and mannitol) and to a lesser extent in the production of reduced acids (malate 
and succinate). The intracellular metabolite profiles indicated changes in fluxes, since several 
primary metabolites, like the intermediates of the TCA cycle accumulated during oxygen limitation 
(on average 3 fold increase). Also the enzyme activities showed changes between the exponential 
growth phase and the oxygen limitation phase. In general, the oxygen availability has a significant 
impact on the physiology of this fungus causing dramatic alterations in the central carbon 
metabolism that should be taken into account in the design of A. niger as a succinate cell factory. 
 
Keywords: Aspergillus niger, organic acids, oxygen limitation, metabolome profiling 
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5.2 Introduction  
The filamentous fungus Aspergillus niger is widely used in industry for the production of citric acid 
and many different enzymes. In nature this fungus is found in soils, where it plays a central role in 
the global carbon cycle (Lewis et al. 1994). The natural ability to break down lignocellulose from 
plants, by production of hydrolytic and oxidative extracellular enzymes, makes it an interesting 
micro-organism for creating high sugar syrups (Pedersen et al. 1999). However, its ability to 
efficiently produce citric acid (Kubicek et al. 1986), makes it an obvious candidate for development 
of an efficient cell factory for the production of other organic acids. In particular its ability to use 
complex feedstocks as nutrients, allows this organism to be used for production of chemicals from 
biomass. These products can be further processed for use as plastic monomers, solvents, 
detergents, pharmaceuticals or fuels (Potera 2005), reducing the dependence on petroleum that 
constitutes the traditional source for synthesis of chemical building blocks used in these products.  
 
The US DOE Office of Energy Efficiency and Renewable Energy has started a Biomass Program, 
in which they aim for developing biorefineries producing multiple biobased products, including 
higher-value chemicals as well as fuels and power. The program has identified the top ten value-
added chemicals from biomass that would economically and technically support the production of 
fuels and power in an integrated biorefinery (Werpy and Petersen 2004). One of these chemicals is 
the four-carbon dicarboxylic acid succinate (Potera 2005; Zeikus et al. 1999). Several production 
micro-organisms for succinate production are already under investigation.  
 
There are some naturally producing organisms like Mannheimia succiniciproducens and 
Actinobacillus succinogenes that produce large amounts of this acid (Lee et al. 2006). However, 
they are cultivated at pH values around 6, and the product is therefore the succinic acid salt, and 
obtaining the free acid adds costs to the downstream processing. Several research groups have 
also metabolically engineered E.coli to produce succinic acid (Lee et al. 2005; Lin et al. 2005; 
Millard et al. 1996; Sanchez et al. 2005; Vemuri et al. 2002), but the productivities obtained do still 
not allow to compete with the chemical process, and an E. coli based process will also only enable 
production of the succinate salt. The highest productivity obtained with E. coli is around 1.8 g/L/h, 
but it has been estimated that this needs to be increased to 2.5 g/L/h to become compatible with 
the chemical process (Lee et al. 2006; Werpy and Petersen 2004).   
 
In the present study we wanted to evaluate the use of A. niger as production organism for organic 
acids, including succinic acid. The advantage of using this organism is that it can grow at low pH, 
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thereby producing succinic acid instead of its salt. It also has been shown that A. niger is able to 
produce high yields and final titers of organic acids especially in the form of citric acid (Kubicek et 
al. 1986). However, contrary to how much is known about the fermentation process for citric acid 
production, relatively little is known about the molecular mechanisms controlling the metabolism of 
A. niger (Karaffa et al. 2001). The effects of various environmental factors on suppressing or 
triggering the export of various biomass degrading enzymes, molecular mechanisms critical to 
fermentation process development, and mechanisms involved in the control of fungal morphology, 
have been studied (Papagianni 2004; Grimm et al. 2005). Nevertheless, a thorough understanding 
of the molecular mechanisms controlling carbon flux in this fungus is still lacking. The creation of a 
stoichiometric metabolic model of A. niger (David et al. 2003) has contributed to a better 
understanding of the central carbon metabolism and even more insight will be gained from the 
study of the A. niger genome. As more fungal genomes are sequenced, scientists will even be able 
to use comparative genomics to find commonalities and differences in the molecular circuits that 
control carbon flux in fungi (Archer and Dyer 2004; Nielsen and Olsson 2002). All these data can 
be integrated with metabolite profiling and finally with transcriptome data to retrieve a 
comprehensible system approach for engineering A. niger (Jewett et al. 2006). 
 
Here we investigated the effect of oxygen limitation on the phenotype of A.niger and the metabolic 
profiles in the central carbon metabolism. Oxygen limitation, occurring in industrial processes, has 
been shown to result in reduced productivity of citric acid and has a significant influence on the 
morphology of A. niger (Kubicek et al. 1980). Furthermore, it has an effect on the redox and energy 
state of the micro-organism. Simulation of the oxygen limitation with a stoichiometric model 
indicated that carbon fluxes were redirected towards different metabolic pathways, resulting in a 
changed metabolic profile (David et al. 2003).  We therefore focused on micro-aerobic cultivation 
conditions, since in micro-organisms that naturally produce succinate, this acid is produced most 
efficiently under anaerobic conditions, probably due to the use of the reductive part of the TCA-
cycle to balance the redox state within the cell (also referred to as fumarate respiration). A. niger is 
an aerobic organism, but we approached anaerobic conditions by limiting the oxygen supply and 
studied the physiological response of A. niger to these micro-aerobic conditions and especially the 
effects on succinate production.  
 
The cultivations were performed on xylose, the second most abundant carbon source in nature, 
that is fermented relatively easy by A. niger. Xylose enters the metabolism in the reductive part of 
the Pentose Phosphate Pathway (PPP) and it is therefore necessary that there is a flux back to 
glucose-6-phosphate in order to ensure use of the oxidative part of the PPP for NADPH production 
(Diano et al. 2006).  
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As nitrogen source we used nitrate, as nitrate consumption results in an increase in the reducing 
power that supports cellular metabolism during oxygen limited conditions. Nitrate uptake and 
conversion releases NADP that delivers extra reducing power to the cells especially under oxygen 
limited condition where the NAD(P)H/NAD(P) ratio is high and cellular reducing power is low. 
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5.3 Materials and Methods 
5.3.1 Strain 
The laboratory strain Aspergillus niger N402 was used in this study. This strain is also known as 
A733 at the fungal genetics stock center and is a short-conidiophore derivative (cspA1 mutation) of 
the N400 strain which is an Aspergillus niger wild type strain. 
5.3.2 Media 
A minimal medium adjusted to pH 6.5 was used for the pre-culture. Spores were propagated on 
agar plates containing 10 g/L D-glucose, 50 ml salt solution, 1 ml trace element solution 1 and 18 
g/L agar. The salt solution consisted of 120 g/L NaNO3, 10.4 g/L KCl, 10.4 g/L MgSO4 ⋅ 7 H2O and 
30.4 g/L KH2PO4. The trace element solution 1 consisted of 22 g/L ZnSO4 ⋅ 7 H2O, 11 g/L H3BO3, 5 
g/L MnCl2 ⋅ 2 H2O, 5 g/L FeSO4 ⋅ 7 H2O, 1.7 g/L CoCl2 ⋅ 6 H2O, 1.6 g/L CuSO4 ⋅ 5 H2O, 1.5 g/L 
Na2MoO4 ⋅ 2 H2O and 50 g/L Na4EDTA. 
 
A chemically defined medium adjusted to pH 2.5 was used for the batch cultivations containing 50 
g/L xylose, 10 g/L NaNO3, 1.5 g/L KH2PO4, 1 g/L MgSO4 ⋅ 7 H2O, 2 g/L NaCl, 0.1 g/L CaCl2 ⋅ 2H2O, 
0.5 ml/L antifoam (sb2121) and 1 ml/L trace element solution 2. The trace element solution 2 
consisted of 0.4 g/L ZnSO4 ⋅ 7 H2O, 5 g/L CuSO4 ⋅ 5 H2O, 0.25 g/L NiCl2 ⋅ 6 H2O, 35 g/L MnCl2 ⋅ 2 
H2O and 30 g/L FeSO4 ⋅ 7 H2O. 
5.3.3 Cultivation conditions 
During the pre-culture spores were propagated on agar plates at 37 ºC for 4-7 days and harvested 
with 0.01% Tween-80.  
 
The batch cultivations were inoculated with a volume of spore solution to yield a spore 
concentration of 109 spores/L bioreactor. These cultivations were carried out in 3 L-Braun 
fermenters with a working volume of 2 L. The bioreactors were equipped with temperature control, 
pH control and two Rushton four-blade disc turbines. No baffles were incorporated in the reactors, 
thereby reducing the surface area available for wall growth. Air was used for sparging and the 
concentrations of oxygen and carbon dioxide in the exhaust gas were monitored by an acoustic 
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gas analyser (Brüel & Kjær, Nærum, Denmark). The dissolved oxygen tension (DOT) was 
measured with an oxygen probe (Mettler Toledo sensors). During the cultivation the temperature 
was maintained at 30 ºC. The pH was controlled by automatic addition of 2 M NaOH and 2 M HCl. 
The pH was initially set to 2.5 to prevent spore aggregation and was gradually increased to 3.5 as 
soon as spore germination started. After inoculation the agitation was shortly (10 s) increased to 
1000 rpm to avoid spore aggregation and thereafter kept at 150 rpm until the spores started to 
germinate. The agitation was in two steps increased to 700 rpm as soon as the spores started to 
germinate. Five different aeration levels, 0.01, 0.02, 0.05, 0.1 and 1 vvm, respectively, were 
applied to simulate oxygen-limited and aerobic conditions. The mass flow controller is sufficiently 
precise to enable differentiation between the different flow rates. 
5.3.4 Sampling 
For the quantification of cell dry weight a known cell culture volume was filtered through a pre-
weighed nitrocellulose filter (pore size 45 μm, Pall Corporation). The filtrate was frozen 
immediately and later used for the determination of substrate and extracellular metabolites. The 
filter was washed with 0.9% w/v NaCl, dried for 15 min in a microwave oven at 150 W and weighed 
again to determine the biomass concentration. 
 
For the quantification of intracellular metabolites 10 mL of cell culture was immediately quenched 
in 20 mL of cold 72% methanol (- 40 ºC). After quenching the cells were separated from the 
quenching solution by centrifugation at 10000g for 20 min at -20 ºC and the intracellular 
metabolites were extracted as described by Koning et al (1992). Finally, the samples were 
lyophilised and stored at - 80 ºC until further analysis. 
 
For determination of in vitro enzyme activities the samples were filtered through a nitrocellulose 
filter (pore size 45 μm, Pall Corporation), washed with 0.9% w/v NaCl and the filter cake (± 1 g) 
was immediately frozen in liquid nitrogen and stored at -80 ºC. 
5.3.5 Quantification of substrate and extracellular metabolites 
The concentrations of sugars, organic acids and polyols in the extracellular environment were 
determined by using high-performance liquid chromatography. Xylose, acetate, pyruvate, citrate, 
ethanol, succinate, fumarate, malate, glycerol, and oxalate concentrations were measured on an 
Aminex HPX-87H cationic exchange column (BioRad, Hercules, California), eluted at 60 ºC with 5 
mM H2SO4 at a flow rate of 0.6 mL/min. Metabolites were detected with both a refractive index 
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detector and a UV detector. The polyols arabitol, erythritol, glycerol, mannitol and xylitol were 
analysed using a CarboPac MA1 anionic exchange column (Dionex, Rødovre, Denmark) that was 
eluted at 60 ºC with 612 mM NaOH at a flow rate of 0.4 mL/min and an electrochemical detector 
(ED 40) was employed.  
5.3.6 Determination of intracellular metabolites 
The lyophilised samples were derivatised using methyl chloroformate as described by Villas-Boas 
et al. (2003). The resulting dry organic solutions were transferred to silanised GC vials and 
analysed. The GC-MS analysis of amino and non-amino organic acids was performed with a 
Hewlett–Packard system HP 6890 gas chromatograph coupled to a HP 5973 quadrupole mass 
selective detector (EI) operated at 70 eV. The column used for all analysis was a J&W1701 
(Folsom, CA) 30 m long; 250 μm inner diameter; 0.10 μm film thickness. The MS was operated in 
scan mode (start after 5 min, mass range 38–550 atomic mass unit at 2.88 s/scan) (Villas-Boas et 
al. 2003). 
5.3.7 Preparation of cell extracts 
The frozen samples were thawed on ice and 0.5 g was suspended in 2 mL of 0.1 M sodium 
phosphate (pH 7.4), 5 mM MgCl2, 1 mM EDTA and 2.6 mM dithiothreitol buffer. This solution was 
transferred to 2-mL FastPrep tubes containing 0.5 mL glass beads (0.75-1 mm). The FastPrep 
tubes were processed 3 times 10 s on a FastPrep FP120 Instrument (Savant Instruments, 
Holbrook, NY), at speed setting 5, with cooling on ice in between. After disruption, samples were 
centrifuged at 13,000 g at 4 ºC for 10-20 min, and the supernatants were analysed for enzyme 
activity. 
5.3.8 Analysis of in vitro enzyme activities 
Enzyme assays were performed at 30°C with a HP8453 UV-visible light spectrophotometer. In 
order to test the linearity of the assays, the reactions were performed with 2-3 different dilutions of 
cell extract. For succinate dehydrogenase and pyruvate carboxylase the activity measurements 
were, however, determined only once. The specific enzyme activities are expressed as micromoles 
minute-1 milligram-1 (U/mg). The amount of protein was determined by the Bradford method 
(Bradford 1979) with bovine serum albumin as the standard. 
 
The enzymes measured and reaction mixtures used are listed in Table 5.1. All the assays were 
tested with pure enzyme before quantification of the enzyme activities in the cell extracts, but for 
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succinate dehydrogenase, malic enzyme and pyruvate carboxylase no pure enzymes were 
available. 
 
Table 5.1 Enzyme assay methods 
 
 
Enzyme 
 
 
Reaction mixture 
 
Ref. 
Glucose-6P dehydrogenase  
(EC 1.1.1.49) 
 
50 mM Tris-HCl (pH 8.2), 2 mM D-glucose 6-phosphate, 0.67 mM ß-nicotinamide adenine 
dinucleotide phosphate, 10 mM magnesium chloride and cell extract. (340 nm; ε = 6.22 mM-1 
cm-1) 
 
1(m) 
Malic dehydrogenase  
(EC 1.1.1.37) 
 
100 mM potassium phosphate (pH 7.5), 0.13 mM ß-nicotinamide adenine dinucleotide (reduced 
form), 0.25 mM oxalacetic acid and cell extract. (340 nm; ε = 6.22 mM-1 cm-1) 
 
1 
Malic enzyme  
(EC 1.1.1.40) 
 
67 mM Tris-HCl (pH 7.4), 3.3 mM L-malic acid, 0.3 mM β-nicotinamide adenine dinucleotide 
phosphate, 5.0 mM manganese chloride and cell extract. (340 nm; ε = 6.22 mM-1 cm-1) 
 
1 
Pyruvate decarboxylase  
(EC 4.1.1.1) 
 
187 mM citric acid (pH 6), 33 mM sodium pyruvate, 0.11 mM ß-nicotinamide adenine 
dinucleotide (reduced form), 10 units alcohol dehydrogenase, and cell extract. (340 nm; ε = 6.22 
mM-1 cm-1) 
 
1 
Pyruvate carboxylase 
(EC 6.4.1.1) 
 
134 mM Tris-HCl (pH 7.8), 5 mM magnesium sulfate, 7 mM pyruvic acid, 0.12% (w/v) bovine 
serum albumin, 0.23 mM β-nicotinamide adenine dinucleotide  (reduced form), 0.05 mM acetyl 
coenzyme A, 2.63 units malic dehydrogenase, 1 mM adenosine 5'-triphosphate, 15 mM 
potassium bicarbonate and cell extract. (340 nm; ε = 6.22 mM-1 cm-1) 
 
 
1(m) 
Pyruvate dehydrogenase 
(EC 1.2.4.1) 
 
51 mM Tris-HCl (pH 7.4), 0.20 mM magnesium chloride, 0.01 mM calcium chloride, 0.30 mM 
Thiamine pyrophosphate, 0.12 mM coenzyme A, 2.0 mM β-NAD, 2.64 mM L-cysteine 
hydrochloride, 20.4 mM pyruvate and cell extract. (340 nm; ε = 6.22 mM-1 cm-1) 
 
1(m) 
Citrate synthase 
(EC 2.3.3.1) 
 
46 mM Tris (pH 8), 0.42 mM Acetyl-CoA, 1 mM OAA, 5.3 mM KCl, 0.6 mM DTNB and cell 
extract. (412 nm; ε = 13.6 mM-1 cm-1) 
 
1(m) 
Isocitrate lyase  
(EC 4.1.3.1) 
 
30 mM Tris-HCl (pH 6.8), 5 mM magnesium chloride, 1 mM ethylenediaminetetraacetic acid, 4 
mM phenylhydrazine, 1 mM DL-isocitric acid, and cell extract. (324 nm; ε = 16.8 mM-1 cm-1) 
 
1(m) 
Succinate dehydrogenase 
(EC 1.3.99.1) 
 
0.8 M Tris-HCl (pH 7.6), 0.15 M sucrose, 0.4 M succinate, 8 mM sodium azide,  6.4 mM INT and 
cell extract. (458 nm; ε = 22 mM-1 cm-1)  
 
2 
Fumarase 
(EC 4.2.1.2) 
 
96.7 mM potassium phosphate (pH 7.6), 48.3 mM L-malic acid and cell extract. (240 nm; ε = 
2.44 mM-1 cm-1) 
 
1 
 
1. http://www.sigmaaldrich.com/Area_of_Interest/Biochemicals/Enzyme_Explorer/Key_Resources/Assa
y_Library/Assays _by_En zyme_Name_III (06-10-2006) 
2. Green and Narahara (1980). 
m. modified assay  
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5.4 Results and discussion 
5.4.1 Physiology  
The fermentation performance of A. niger was studied under different aeration conditions. Five 
batch cultivations were performed using different levels of aeration (0.01, 0.02, 0.05, 0.1 and 1 
vvm) and the effects of oxygen limitation on the specific growth rate, biomass and product yields, 
and enzyme activities were determined. The carbon source used in all fermentations was xylose, 
which was supplied at a high concentration (50 g/L) at the beginning of the cultivation to ensure a 
high glycolytic flux needed for organic acid production (Kubicek et al. 1986). This high sugar 
concentration is likely to cause carbon catabolite repression in the beginning of the fermentation. 
This carbon catabolite repression is mainly via the CreA transcription factor (Kelly 1994; Drysdale 
et al. 1993). In all our fermentations we performed analyses at approximately the same sugar 
concentration, and any possible effects of CreA repression are therefore likely to be the same in 
the fermentations, and this issue was not considered any further. Nitrate was used as nitrogen 
source, as this enables better growth conditions under oxygen limitation by supplying more 
reducing power (Takasaki et al. 2004).  All batch fermentations were characterised by a lag phase, 
an exponential growth phase and an oxygen limitation phase. An extended lag phase was 
observed when less oxygen was supplied during the cultivation. However, this was not reflected in 
the specific growth rate (Table 5.2). When the cells reached the exponential growth phase the 
specific growth rate was found to be independent of the oxygen supply and ranged between 0.13 
and 0.15 h-1. A log plot of the biomass profiles (Figure 5.1) shows a clear distinction between the 
exponential growth phase and the oxygen limitation phase. From the growth curves we could also 
conclude that at lower airflow the oxygen limitation sets in slightly sooner.  
 
Changes in the carbon uptake rate were followed and it increased with increasing aeration from 3.4 
to 13.0 mmol/L/h. The xylose was completely consumed in all fermentations, except for the 
fermentation with the lowest aeration (0.01 vvm), where only 46% of the initial amount was 
consumed. The biomass yields were fairly constant, indicating more by-product formation at higher 
aeration. By-product formation could be detected already in the exponential growth phase and 
continued in the oxygen limitation phase. The main by-products produced were polyols (glycerol, 
erythritol, xylitol) and some organic acids (succinate and malate).  
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Figure 5.2 gives a typical profile of the extracellular metabolites being produced. It is obvious that 
the polyol production drastically increases when the oxygen limitation sets in. At the end of the 
fermentation, when the carbon source is exhausted, these polyols are consumed again. This 
activation of polyol consumption pathways provides the cells with more carbon for metabolism. 
 
 
Figure 5.1 Logarithmic plot of the biomass profiles under different aeration levels. ■: 1 vvm; ▲: 0.1 vvm; •: 
0.05vvm; ◊: 0.02 vvm; □: 0.01 vvm. The gray area is where the transition from exponential growth phase to 
oxygen limitation phase occurs. 
5.4.2 Extracellular metabolites 
The yields of both polyol and organic acid production on consumed substrate increased as the 
oxygen supply decreased (Figure 5.2). It was observed that erythritol and glycerol were the first 
polyols being produced (20-25 hours), followed by xylitol (25-30 hours). Furthermore, the erythritol 
and glycerol production stopped before the production of xylitol. Arabitol and mannitol production 
started later in all cultivations, but the production stopped approximately at the same time as for 
the other polyols. The arabitol production was higher than the mannitol production (0.08 g/L and 
0.01g/L, respectively) and the total amount of these polyols decreased with an increasing airflow. 
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Figure 5.2 A typical batch production profile (0.1 vvm) with a clear increase in acid and in polyol during the 
oxygen limitation phase. A) ♦: xylose; •: biomass; ▲: malate; ■: succinate; ◊: fumarate; □: oxalate. B) ◊: 
mannitol; □: xylitol; ■: arabitol; ▲: erythritol; •: glycerol. The gray area is where the transition from 
exponential growth phase to oxygen limitation phase occurs. 
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Polyols are known to be involved in carbohydrate reserves, osmoregulation, storing reducing 
power and translocation processes in the metabolism of A. niger (Witteveen and Visser 1995; 
Beever and Laracy 1986). Due to the use of xylose as carbon source, significant amounts of xylitol 
were produced during all cultivations (Table 5.2). Xylitol production is known to be regulated by the 
NADH levels in the cell. Under oxygen limited conditions the NADH pool increases, thereby limiting 
the NAD dependent xylitol dehydrogenase, xylitol production will increase under these conditions 
(Jeffries et al. 2004).  In fungi xylose is metabolised via xylitol to xylulose and further to xylulose-5-
phosphate from where it enters the reductive part of the PPP. Xylitol production requires the 
cofactor NADPH and this demand is satisfied by a backflux from the reductive part of the PPP to 
the oxidative part of the PPP (Diano and Nielsen 2006). 
 
With nitrate as nitrogen source, we further increase the NADPH requirement leading to a high flux 
through the PPP (Ruijter et al. 2005). This was also reflected by high activity of the G6PDH and 
high production of erythritol (Table 5.2 and Table 5.3). Also arabitol is produced from the PPP, but 
the production was not as high as erythritol (0.08 g/L and 0.48 g/L, respectively). Furthermore, the 
results obtained in this study are in agreement with Poulsen et al. (2005), who showed that by 
using nitrate as nitrogen source enzymes in the PPP were upregulated, leading to a PPP overflow, 
resulting in erythritol production. The high flux through the PPP results in a reduced flux through 
the EMP pathway and this leads to less glycerol production (Table 5.2). At aeration conditions 
allowing a high oxygen availability we observe oxalate production, which is a well known product 
produced by A. niger under certain conditions (Ruijter and Visser 1999). With lower aeration a 
drastic decrease in oxalate production (from 0.4 g/L to 0) is measured and a small increase in the 
production of succinate and malate (0.07 and 0.05 g/L, respectively) is found. These results 
indicate that more reduced organic acids are being produced when the oxygen availability is lower 
and could be an indication that the reductive part of the TCA cycle is slightly active under oxygen 
limited conditions. This is in contradiction with the results of Diano et al. (2006), who observed a 
significant succinate production under the same cultivation conditions, namely when A. niger was 
grown on xylose and nitrate and oxygen limitation was posed on the system. The reason for this is 
not clear, but could be explained by strain differences (Diano et al. used an industrial strain). In 
another filamentous fungus, Fusarium oxysporum, an increase in ethanol and acetate was 
observed at anaerobic growth conditions when xylose was the carbon source, indicating that there 
are differences in the by-product spectrum in different fungi and even different strains (Panagiotou 
and Christakopoulos 2004). 
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5.4.3 Intracellular metabolites 
Since metabolites represent the reactants of the metabolic network, quantification of metabolite 
concentrations offers a direct access to the identification of the intracellular kinetics of metabolism 
(Buchholz et al. 2002; Jewett et al. 2006). Intracellular metabolite profiles give new insights in how 
the cellular metabolism and regulation change in response to growth conditions, thereby providing 
a greater comprehension of flux dynamics and metabolic control. 
 
Table 5.4 Intracellular metabolite profiles determined during both the exponential growth phase and the 
oxygen limitation phase in all cultivations. The values are expressed in relative area normalised by 
dryweight.  
 
             0.01 vvm              0.02 vvm              0.05 vvm               0.1 vvm                1 vvm
Metabolite growth O2-limitation growth O2-limitation growth O2-limitation growth O2-limitation growth O2-limitation
Pyruvate metabolism
pyruvate 37 205 12 44 37 51 0 3 7 0
lactate 24 350 38 162 311 122 0 46 27 1
2-oxovalerate 1 9 2 3 4 8 0 0 0 0
2-isopropylmalate 7 20 0 5 17 9 0 0 8 0
TCA cycle
citrate 967 7816 1839 3698 844 2798 379 1403 1030 1993
2-oxoglutarate 24 142 71 29 50 93 0 31 19 12
cis-aconitate 6 117 8 44 14 26 8 9 14 26
succinate 77 435 67 167 112 297 18 14 33 3
malate/fumarate 233 1713 292 398 718 687 0 32 54 15
2-aminobutyrate 2 34 32 25 38 20 0 10 33 12
4-amino-n-butyrate (GABA) 0 73 4 209 22 631 0 28 15 6
Amino acid metabolism
histidine 0 0 4 43 0 9 0 42 25 187
glutamate 857 1831 5873 4057 2745 1524 1842 1734 9213 2000
glutamine 0 0 9 37 0 0 0 3 21 61
pyroglutamate 54 248 916 305 796 245 0 213 636 324
asparagine 55 118 166 146 37 97 38 183 183 742
aspartate 235 773 1561 757 1193 185 501 902 3070 1998
threonine 0 0 125 133 36 48 0 57 102 175
lysine 6 109 208 150 36 71 0 307 90 925
proline 132 2469 181 432 430 657 43 390 178 817
D-2-amino adipate 0 4 13 17 19 8 0 15 27 17
ornithine 34 215 161 238 102 288 126 263 268 190
phenylalanine 1 86 53 88 33 71 0 124 55 225
tyrosine 0 38 5 27 4 14 0 69 11 76
alanine 1839 9262 6889 7042 9395 9325 626 1707 4931 427
leucine 69 568 121 363 143 153 30 243 136 326
valine 52 633 280 894 340 551 63 329 430 298
methionine 0 9 20 48 18 13 0 21 23 89
glycine 0 244 107 142 121 117 16 33 58 93
serine 0 0 9 7 4 5 0 15 12 26
Other metabolites
citramalate 11 48 18 9 15 34 0 2 6 1
malonate 0 0 1 5 0 2 0 0 0 0
myristate 0 0 10 3 0 0 0 0 7 7  
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Figure 5.3 Intracellular metabolites levels in the oxygen limitation phase measured under the different 
cultivation conditions (0.01 vvm, 0.02 vvm, 0.05 vvm, 0.1 vvm and 1 vvm). Malate and fumarate could not be 
separated by the applied method. All values are expressed as relative area normalised by dryweight. 
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In the present study, the profile of intracellular amino and non-amino organic acids was expressed 
as peak areas normalised by the biomass concentration both during the exponential growth phase 
and in the oxygen limitation phase. By using an in house metabolite library, consisting of 74 
metabolites, 49% of these metabolites could be detected during the GC-MS analysis. High levels 
of alanine, leucine, valine, proline, ornithine, aspartate, glutamate and citrate were measured in 
both the exponential growth phase and the oxygen limitation phase (Table 5.4). A number of 
compounds were detected that had higher levels in the oxygen limitation phase compared to the 
exponential growth phase. Amino acids in this category are: glycine, valine, leucine, threonine, 
proline, asparagine, methionine, phenylalanine, ornithine, tyrosine and lysine (Table 5.4). Also 
histidine showed the same profile, but for this amino acid the level was found to increase with the 
aeration level in the fermentations, which is opposite as observed for the other amino acids.  
 
Analysis of organic acids showed that citrate, pyruvate, lactate, malate, fumarate and succinate 
had increased levels in the oxygen limitation phase and we also observed that the levels increased 
when the aeration level in the fermentations decreased (Table 5.4). Furthermore, cis-aconitate and 
4-amino-n-butyrate were present in higher levels during oxygen limitation than during exponential 
growth (Table 5.4). These results indicate that metabolites of the TCA cycle accumulate during 
oxygen limitation. Furthermore, amino acids directly derived from TCA cycle intermediates show 
the same trend, e.g. asparagine, threonine, isoleucine, proline and lysine (Table 5.4). The 
accumulation of TCA cycle intermediates is accompanied with accumulation of upstream 
metabolites, e.g. pyruvate, lactate, tyrosine and alanine (Table 5.4). This further points to 
difficulties in oxidation of NADH resulting in accumulation of pathway intermediates. Figure 5.3 
gives a schematic overview of how a selection of intracellular metabolites varies in the 
fermentations.  
 
A few unusual metabolites were also detected (Table 5.4). The detection of pyroglutamate 
(Panagiotou et al. 2005), for example, is an indication of active glutathione metabolism, which 
seems to be more active in the growth phase compared to the oxygen limitation phase. The 
metabolite citramalate was also measured, but in very low amounts at all aeration levels. This 
metabolite has been found in several micro-organisms, for example in the filamentous fungus 
Fusarium oxysporum (Panagiotou et al. 2005), but also in bacteria like the Rhodobacter 
sphaeroides (Filatova et al. 2005a). Citramalate can be formed by condensation of acetyl-CoA and 
pyruvate or via the itaconate pathway. The first pathway is only identified in bacteria and is called 
the citramalate pathway (Filatova et al. 2005a), whereas the second pathway is also found in fungi 
(Bonnarme et al. 1995). The citramalate pathway (CM) is thought to be an alternative to the 
glyoxylate cycle (Filatova et al. 2005b). The CM pathway converts the citramalate formed, via 
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several intermediate products, to glyoxylate and propionyl-CoA. The glyoxylate can then enter the 
TCA cycle again by malate synthase creating malate. Citramalic acid is chemically related to the 
TCA cycle compound malic acid. Presumably, citramalate may interfere with the production of 
malic acid in the TCA cycle (http://www.gpl4u.com/test1comp2.html). However, further 
characterisation of citramalate production is necessary to reveal the biochemical pathway and 
functional properties of this pathway in filamentous fungi. Especially its competitive nature with the 
glyoxylate pathway is interesting in relation to succinate production. In our study no clear 
conclusion could be made on the activity of the glyoxylate pathway, as the intracellular glyoxylate 
measurements were contradicting the activity of the isocitrate lyase.  
 
We also detected 4-amino-n-bytyric acid (GABA) and glutamate. These compounds are 
intermediates of the GABA shunt, a pathway that bypasses certain steps in the TCA cycle (Balazs 
et al. 1970). In this alternative pathway, 2-ketoglutarate is aminated to form glutamate instead of 
being oxidatively decarboxylated to succinate like in the TCA cycle. The glutamate is subsequently 
decarboxylated to GABA, by glutamate decarboxylase. GABA is then irreversibly transaminated to 
succinic semialdehyde by 4-aminobutyrate transaminase. Finally, the TCA cycle is entered again 
by oxidation of succinic semialdehyde to succinate by NAD(P)H dependent succinic semialdehyde 
dehydrogenase. The activation of this GABA shunt is mainly caused by the NADH/NAD+ ratio, that 
has been shown to regulate the 2-ketoglutarate dehydrogenase complex (Streeter and Salminen 
1990). Therefore, under oxygen limited conditions a redox imbalance could be expected, leading to 
activation of the GABA shunt and indeed we observed an increase in the GABA levels under 
oxygen limitation. GABA can also be produced by catabolism of ornithine and lysine and in our 
study we measured elevated levels of ornithine and lysine (Kumar et al. 2000). The exact function 
of the GABA shunt has not yet been unravelled, but the intermediate conversion towards succinate 
is interesting. Other filamentous fungi like Neurospora crassa, Aspergillus nidulans and Fusarium 
oxysporum are also known to produce GABA as an intracellular metabolite (Kumar and Punekar 
1997; Schmit and Brody 1975; Panagiotou et al. 2005). In Neurospora crassa it is thought to be 
involved in spore germination (Schmit and Brody 1975). In Aspergillus niger an unusual 
accumulation of GABA during acidogenesis has been documented (Kubicek et al. 1979), showing 
that the GABA levels increased in parallel with citric acid accumulation, while under normal 
conditions it was virtually undetectable. What kind of function GABA performs under oxygen 
limitation, after being activated by the high NADH/NAD+ ratio, is still unclear. 
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5.4.4 Enzyme assays 
Ten enzymes related to the xylose to succinate flux were investigated in the different 
fermentations, both in the exponential growth phase and in the oxygen limitation phase. We 
measured glucose-6P dehydrogenase, pyruvate dehydrogenase, pyruvate decarboxylase, 
pyruvate carboxylase, malic enzyme, malic dehydrogenase, fumarase, succinate dehydrogenase, 
isocitrate lyase and citrate synthase. No activity could be detected for two of these enzymes, 
pyruvate dehydrogenase (PDH) and pyruvate decarboxylase (PDC). The activities of the other 
eight enzymes, expressed in Units per mg of protein, are shown in Table 5.3 together with the 
reactions they catalyse. As a general trend we observed that the activity of the enzymes decreased 
during the oxygen limitation phase compared to the exponential growth phase (Figure 5.4). This is 
probably due to a general reduction in metabolic activity caused by a decrease in substrate uptake 
and specific growth rate. 
5.4.4.1 Glucose-6-P dehydrogenase 
All cultivations have been performed using a high concentration of xylose as carbon source. The 
detection of glucose-6-phosphate dehydrogenase indicates a backflux of carbon from the reductive 
part of the pentose phosphate pathway via the glycolysis to the oxidative part of the pentose 
phosphate pathway. This is necessary for replenishing NADPH required for biosynthesis and also 
for uptake of xylose and nitrate. The conversion of xylose to xylitol by the xylose reductase is 
NADPH dependent thereby increasing the cellular demand for NADPH. This NADPH requirement 
is elevated by the consumption of nitrate, the nitrogen source used in the cultivations. The uptake 
of one mole of nitrate requires another 2 moles of NADPH. The G6PDH activity correlated with the 
xylose consumption rate at all levels of aeration.  A clear increase in G6PDH activity is detected 
with increasing aeration (Figure 5.4). Therefore, if more oxygen is available more sugar can be 
consumed and more NADPH should be available requiring a higher G6PDH activity. 
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Figure 5.4 Enzyme activities measured under the different cultivation conditions (0.01 vvm, 0.02 vvm, 0.05 
vvm, 0.1 vvm and 1 vvm). Light grey bars are the enzyme measurements in the exponential growth phase. 
Black bars are the enzyme activities measured in the oxygen limitation phase. No PDH and PCD activity 
could be detected. GDH: Glucose-6-P dehydrogenase, PYC: pyruvate carboxylase, PDH: pyruvate 
dehydrogenase, PDC: pyruvate decarboxylase, PDH: pyruvate dehydrogenase, PDC: pyruvate 
decarboxylase, ME: malic enzyme, ICL: isocitrate lyase, CIT: citrate synthase, MDH: malic dehydrogenase, 
FUM: fumarase and SDH: succinate dehydrogenase. 
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5.4.4.2 Pyruvate carboxylase, pyruvate decarboxylase and pyruvate dehydrogenase 
The pyruvate branchpoint is an important point of regulation in the metabolism of micro-organisms 
and plays and important role in succinate production. Recently, Lee et al. (2005) showed in silico 
that the metabolic flux to pyruvate is crucial for an efficient succinate production in E. coli. 
However, in high succinate producing micro-organisms the phosphoenolpyruvate carboxylase 
plays a fundamental role in succinic acid production. In yeast, the pyruvate node has been 
extensively studied as well as the interplay between pyruvate dehydrogenase, pyruvate 
decarboxylase and pyruvate carboxylase (Pronk et al. 1996). It is an important junction between 
assimilatory and dissimilatory reactions. However, this pathway may not be active in A. niger, since 
no activity could be measured and only seldom small quantities of acetate or ethanol are produced. 
This indicates that this fungus is not as efficient as other fungi in producing ethanol or other 
metabolites for redox balancing and this may also explain why this fungus cannot grow 
anaerobically.  
 
Thus, A. niger seems to be dependent on the energetically more favourable respiratory pathway, 
which is coupled to the TCA cycle. The TCA cycle has both a dissimilatory and an assimilatory 
function for energy and redox balancing, and for producing biosynthetic precursors, respectively. 
Pyruvate can enter the TCA cycle in two ways. One is as a 2-carbon metabolite by oxidative 
decarboxylation of pyruvate to acetyl-CoA by pyruvate dehydrogenase. The other one is by CO2 
fixation producing oxaloacetate from pyruvate by pyruvate carboxylase. We have measured activity 
of pyruvate carboxylase in our cell extracts but could not measure pyruvate dehydrogenase activity 
(Table 5.3). Since there is a requirement for both acetyl-CoA and oxaloacetate to have a functional 
TCA cycle, it is believed that there must be an in vivo pyruvate dehydrogenase activity. However, 
this enzyme consists of a multimeric complex that is difficult to measure in crude cell extracts due 
to proteolytic degradation and interference with other enzymes. Localisation and substrate affinity 
of the three enzymes competing for pyruvate is also an important issue considering the competitive 
nature they share for the same substrate. Jaklitsch et al. (1991) have done extensive studies to 
determine the localisation of these enzymes and they observed that in A. niger the pyruvate 
dehydrogenase is located in the mitochondria, thereby requiring transport of pyruvate from the 
cytosol to the mitochondria by an unknown transport process. Pyruvate decarboxylase on the other 
hand is only located in the cytosol, while pyruvate carboxylase is present in both the mitochondria 
and the cytosol. Unfortunately, no kinetic data are available for Aspergillus species restricting a 
reasonable model for competition between these three enzymes for the substrate pyruvate. There 
is also not a clear trend visible in the pyruvate carboxylase activity measured in all cultivations at 
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different aeration rates. The activity does, however, follow the general trend of being less active 
during the oxygen limitation than in the exponential growth phase.   
5.4.4.3 Isocitrate lyase and malic enzyme 
Isocitrate lyase is part of the glyoxylate cycle. The primary function of the glyoxylate cycle is to 
permit growth when C2 compounds, such as ethanol and acetate, are the only sources of carbon 
(Kornberg et al. 1966a+b). The glyoxylate cycle consists of two steps. In the first, isocitrate is 
hydrolysed to succinate and glyoxylate by isocitrate lyase. In the second step, acetyl-CoA is 
condensed with glyoxylate to produce malate by malate synthase. Malate is an intermediate of the 
TCA cycle and can be metabolised further. The activity of the glyoxylate cycle has been shown to 
be under carbon catabolite repression (Stemple et al. 1998; Prathumpai et al. 2004). However, 
recently Panagiotou et al. (2006) detected glyoxylate intracellularly during xylose fermentations 
using Fusarium oxysporum, and 13C-labelling experiments verified that the pathway was active 
under anaerobic conditions. We initially hypothesized that isocitrate lyase was inactive using high 
xylose concentrations in the cultivations. However, in this study we measured activity of isocitrate 
lyase, indicating that the carbon catabolite repression can somehow be overcome (Table 5.3). The 
activity of isocitrate lyase increased with increasing aeration indicating that the glyoxylate cycle 
was more active at higher aeration (Figure 5.4). Since we did not detect any two-carbon 
metabolites, nor did we detect any intracellular glyoxylate, the physiological significance of this 
enzyme is not clear. Because succinate is produced via the glyoxylate cycle, a very active cycle 
would likely increase succinate production.  
 
Malic enzyme is known for its function in fatty acid biosynthesis (Wynn et al. 1999). However, malic 
enzyme can also be a part of the gluconeogenesis together with isocitrate lyase. This might be the 
reason why isocitrate lyase and malic enzyme show similar enzyme profiles in the exponential 
phase (Figure 5.4). It is hard to explain the increase in activity, since gluconeogenesis is normally 
repressed by the high concentrations of xylose used is this study. We would expect an increasing 
glycolytic flux with increasing air supply resulting in an inhibition of the gluconeogenesis pathways. 
In the oxygen limitation phase the enzyme seems to be constitutively expressed without any 
changes in the activity between the different aeration levels.   
5.4.4.4 TCA cycle enzymes 
The citrate synthase showed an opposite activity profile compared to fumarase in the growth phase 
(Figure 5.4). Citrate is known to be the main product produced in fully aerated cultivations at low 
pH. The decrease in citrate synthase and increase in fumarase might attribute to the increase in 
extracellular oxalate being produced at high aeration conditions. The lack of citrate excretion is 
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probably due to the selected medium, which contains manganese that is known to drastically 
inhibit citrate production by a yet unknown mechanism (Kubicek et al. 1979). Therefore, it seems 
that under the studied conditions oxalate production is preferred at higher aeration rates.  
 
Under oxygen limited conditions, the citrate synthase activity was always lower than in the 
exponential growth phase and showed a decreasing trend with increasing aeration (Table 5.3). 
From literature we know that oxygen is crucial for citrate production (Horitzu and Clark 1966; 
Kubicek et al. 1980). If oxygen is limited this can have major influences on the citrate synthase 
activity, but the molecular mechanism of how oxygen limitation negatively influences citrate 
production is not known.   
 
A general trend in the activities of malic dehydrogenase and succinate dehydrogenase was not 
found (Figure 5.4). Oxygen therefore seems to have no effect on their activity level.  
 
From the enzyme activity measurements it is difficult to conclude on whether there is a relationship 
between the gluconeonenesis pathways and the TCA cycle during the exponential growth phase. 
Thus, our analysis points to that both malic enzyme and isocitrate lyase are active at the same 
time as pyruvate carboxylase. This indicates that both the gluconeogenesis and the TCA are 
upregulated at the same time. Co-operation of these pathways has also been found in yeast based 
on transcriptome analysis (Regenberg et al. 2006).  
 
Under oxygen limitation the increase in TCA cycle intermediates (and derivatives hereof) suggests 
a lower TCA activity, which can also be seen by the enzyme activities of the citrate synthase and 
fumarase.  This is probably caused by the higher NADH/NAD+ ratio occurring at oxygen limitation. 
The extracellular metabolite profiles together with the intracellular metabolite profiles could also 
indicate a low activity of the reductive TCA cycle, which might be regulated by the NADH/NAD+ 
ratio.   
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5.5 Conclusion 
In this study we have investigated the effect of different oxygen levels on A. niger metabolism. The 
aim was to study micro-aerobic growth conditions and the effect on organic acid production, with a 
special interest in succinic acid. Poor production of organic acids was found, which is in agreement 
with A. niger's absolute aerobic nature, suggesting a poor performance of the reductive TCA cycle. 
Nevertheless, a slight increase in organic acid production, mostly fumarate and malate, was 
measured at oxygen limited conditions. However, the largest changes were depicted in polyol 
production, indicating a redox imbalance in the cell due to the lack of oxygen. The oxygen level has 
less effect on the specific growth rate, but influences the substrate uptake rate drastically.  
 
Additionally, intracellular metabolite profiles were determined, giving some indications of which 
pathways might be activated or deactivated at different oxygen levels. For example citramalate, 
GABA and pyroglutathione were measured (mainly under oxygen limited conditions) indicating 
activity of the citramalate pathway, GABA shunt and glutathione metabolism, respectively. Also in 
the central carbon metabolism (TCA cycle intermediates) different metabolite levels were 
determined, indicating a shift in the flux pattern. The enzymes measured, showed a lower activity 
of the TCA cycle under oxygen limited conditions, which is consistent with earlier findings. 
Furthermore, the G6PDH showed higher activities when more oxygen was available indicating a 
higher glycolytic flux, which is also consistent with earlier studies.    
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6.1 Abstract 
With the availability of the genome sequence of the filamentous fungus Aspergillus niger, the 
use of targeted genetic modifications has become easier. This makes this fungus an 
attractive micro-organism for creating a cell factory platform for production of chemicals. 
Using different molecular biology techniques, this study focused on metabolic engineering of 
A. niger to improve its organic acid production in the direction of succinic acid. Two gene 
targets were determined for complete gene deletion, ATP-citrate lyase (acl) and succinate 
dehydrogenase (sdh). It was attempted to delete these genes using several bi-partite gene 
targeting methods. Only the acl gene was successfully deleted and was characterised in 
batch cultivations. It was found that the succinic acid yield was threefold improved by 
deleting the acl gene. Additionally, the total amount of organic acids produced in this strain 
was significantly increased. The fact that the sdh gene could not be deleted might be due to 
poor transformation performance or the possibility that sdh is an essential gene. 
 
 
 
Keywords: Aspergillus niger, organic acids, ATP: citrate lyase, succinate dehydrogenase 
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6.2 Introduction 
The release of the genomic sequence of Aspergillus niger in 2006 has opened a window of 
opportunities in the field of biotechnology (Baker 2006; Pel et al. 2007). However, while a 
genomic sequence can yield a great deal of information, genome sequencing is only the first 
step towards understanding a microbe’s biological capability. It is still a challenge how 
genomic information can be transferred to information on the functions of genes and further 
to the role of the individual genes on overall cellular function. Due to several sequencing 
projects and intensive annotating programs we are now able to compare genomes among 
different species. The comparison helps us in identifying genes and additionally make it 
possible to assign putative function to genes. With the genome sequence available for A. 
niger it has also become possible to perform target deletion of genes, which is often the key 
to redirect fluxes towards desirable pathways.  
 
Tools for predicting the effect of a gene deletion in silico have already been developed for A. 
niger. David et al. (2003) created a detailed stoichiometric metabolic model of the central 
carbon metabolism. They used the model to identify metabolic engineering targets for 
increased succinate production. Hereby they predicted that it should be possible to obtain an 
increased succinate yield in a double deletion mutant (pyruvate decarboxylase and 
ATP:citrate lyase) when grown under oxygen limiting conditions. Although this stoichiometric 
model does not contain any regulatory information, it has shown to give us a good indication 
of metabolic changes in the cell (Ideker et al. 2001; Stephanopoulos et al. 2004; Price et al. 
2003; Patil et al. 2004). However, model predictions still need to be verified experimentally, 
which may lead to a revision of the model. In the present study, an attempt was made to 
replicate the results from the stoichiometric model prediction. Because the molecular biology 
tools in A. niger are not as reliable as in e.g. E. coli, mainly due poor homologous 
recombination in this filamentous fungus, an altered strategy was used. In a previous study 
(Meijer et al. 2007) it was shown that the pyruvate decarboxylase (PDC) enzyme was not 
active under oxygen limiting conditions. Therefore, instead of making a double deletion, only 
a single deletion mutant was created in which ATP:citrate lyase (ACL) was knocked out.  
 
Because an improvement in the organic acid yield of succinate has already been attempted 
in several other micro-organisms (Lee et al 2006; Lin et al. 2005a; Vermuri et al. 2002; 
Arikawa et al. 1999), also a rational approach was undertaken in the present study. This 
would allow a comparison of this approach with the model predicted strategy. In different 
microbial cell factories, evaluated for succinate production it has been found that an 
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important gene involved in improving succinate production is the gene encoding succinate 
dehydrogenase (sdh). This gene encodes an enzyme that is part of the TCA cycle and is 
catalysing the conversion of succinate to fumarate. If this gene is deleted, the TCA cycle is 
interrupted and 3 pathways remain that can form succinate as the end product (the oxidative 
and the reductive TCA cycle and the glyoxylate pathway). We therefore also deleted the sdh 
gene in A. niger. However, the impact of this gene deletion on the overall metabolism of A. 
niger is not known. In other micro-organisms, like E. coli, the stoichiometric model already 
predicted that sdh deletion would improve the succinate yield. This is not the case for the A. 
niger model. SDH is an enzyme that is part of the respiratory chain and uses as cofactor 
FADH2 (David et al. 2003). Due to a lack of detailed knowledge about the possible active 
FADH2 contributing pathways in A. niger, the deletion of this gene might have a major impact 
on the redox balance of FAD/FADH2 in the cell. Another concern is the fact that A. niger is 
unable to grow anaerobically in contrast to the other micro-organisms in which sdh has been 
deleted. These species use the reductive TCA cycle (fumarate respiration) as the main 
pathway for redox balancing and produces succinate via this route during anaerobic 
conditions.  
 
In order to construct the two deletion strains (Δacl and Δsdh), the bipartite gene targeting 
method was used (Nielsen et al. 2006). Since homologous recombination is a rare event 
compared to non-homologous end joining in A. niger, this fragmented marker method 
reduces the background signal (ectopic integrations of the marker) during transformations. 
As stated above genetic targeting techniques in A. niger are challenging and therefore 
several strategies concerning the deletion were performed simultaneously. For example, the 
bipartite method with and without pop-out possibilities was used and also the transient 
marker system developed by Nielsen et al. (2007) was evaluated. The latter method 
incorporates the marker gene in its native locus in the genome, thereby not disturbing any 
other gene expression levels except for the targeted gene. In case of the normal bipartite 
gene targeting method a strain stays either auxotrophic for the marker gene or has the 
marker gene inserted in the genome locus of the deleted target gene. This may result in a 
changed expression level of the marker gene and influence the metabolic state of the cells.    
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6.3 Materials and Methods 
6.3.1 Strains 
The Aspergillus strains used in this study were: 
- A742 derived from strain N402 containing a mutation in pyrA5. 
- AB4.1 derived from strain N402 containing a mutation in pyrG1 (van Hartingsveldt et 
al. 1987).  
- pyrG-tr constructed by Nielsen et al. (2007) containing a transient pyrG mutation 
(IBT28739. IBT Culture Collection at BioCentrum-DTU, Lyngby. Denmark).  
- As reference the N402 strain (cspA1 mutation) was used (A733 at the fungal genetics 
stock center).  
6.3.2 Deletion strategies 
The first deletion strategy (D1) tested was the deletion of the target genes (sdh and acl, 
respectively) in the A742 strain, where pyr4 from Neurospora crassa is used as marker gene 
(Ballance et al. 1983). Protoplasting and gene targeting procedures for A. niger were used as 
described previously for A. nidulans (Nielsen et al. 2006). A schematic overview of the gene 
targeting method is shown in Figure 6.1  
 
Figure 6.1 Schematic representation of the bipartite gene targeting method. We used different ACL and 
SDH gene fragments for up and downstream homologous sequences. As marker gene we used the pyr4
gene from N. crassa and we performed transformations with and without direct repeats (DR).  
Gene X
Marker gene
Up DR Marker g
ker gene DR Down
Up Down 
DR DR Down Up
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The deletion strains were constructed using PCR generated bipartite gene targeting 
substrates. Each part of the bipartite substrate consists of a targeting fragment and a marker 
fragment, which are individually amplified by PCR using the primer pairs presented in Table 
6.1.  
 
In order to achieve adequate sequence overlap to favour homologous recombination,1.5 kb 
flanking regions were used, flanking both sites of the coding region. The upstream region of 
the gene was fused to the pyr4 upstream marker fragment and the downstream region of the 
gene to the downstream part of pyr4. The pyr4 fragments were made with and without direct 
repeats (see primers Table 6.1). The fusion is facilitated by using oligonucleotides that have 
fusion tags (adaptamers) (Erdeniz et al. 1997; Nielsen et al. 2006). 2 – 3 μg of each purified 
fusion PCR fragment was used for the transformation in 100 μL protoplast solution of A. 
niger. The transformation was performed as described by Nielsen et al. (2005). Selection of 
transformants was done on minimal medium plates (MM).  
 
As a second strategy (D2) the flanking regions were elongated (2.5 kb) and the AB4.1 was 
used for transformation. We performed this transformation, like the first strategy, both with 
and without direct repeats.  
 
At the same time the transient marker system was used for transformation of the marker 
gene (with direct repeats) into the pyrG-tr strain (Nielsen et al. 2007).  
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a) Pyr_F2 and pyr_R are the primers used when no direct repeats are wanted in the 
transformation. 
b) The capital letters are the homologous regions with the target DNA, the small letters are the 
adaptamer sequences used for the fusion PCR.  
c) D1 = transformation in the A742 strain, D2 = transformation in the AB4.1 strain, D3 = 
transformation in the pyrG-tr strain. 
 
 
 
 
 
 
Table 6.1 Primers used for bipartite PCR fragments 
Primer name (a) Sequence (b) D1 (c) D2 (c) D3 (c)
pDEL1-pyr4
Upst-pDEL1-F-Ad cat ggc aat tcc cgg gga tc TGG ATA ACC GTA TTA CCG CC x x x
Dst-pDEL1-R-Ad cat ggt ggt cag ctg gaa tt TGC CAA GCT TAA CGC GTA CC x x x
pyr4-IF GTT GTC TGC TTG CGC TTC TTC x x x
pyr4-IR CCA GAA GCA GTA CAC GGC x x x
pyr_F2 cat ggc aat tcc cgg gga tc GCC GGC AAT TCT TTT T x x
pyr_R cat ggt ggt cag ctg gaa tt CCT CCG CCA TTT CTT A x x
SDH
SDH_fl_F TGT TCT TCT ATG CGG GCG A x
SDH_fl_R CCG TGA ACT TTT GGT CTT CC x
SDH_edge_F aat tcc agc tga cca cca tg AGA TAC TAA TGC CAT AGC CGC x x x
SDH_edge_R2 gat ccc cgg gaa ttg cca tgCAA GAG ATA GTG AGA GGC TG x x x
SDH_fl_F3 GGT GCA TGG AAG CGA GAT AC x x
SDH_Fl_R3 CCA ATG AAC CAA GTT GCC GC x x
ACL
ACL2_fl_F GCA TCA GCA CAG AAA CCC AA x
ACL2_fl_R CCG ATG ATG TAA TGG GTT GG x
ACL2_edge_R*  aat tcc agc tga cca cca tg GCC TGT TTT CTT TTC ACC CA x x x
ACL2_edge_F2* gat ccc cgg gaa ttg cca tgGGC TGA ATA CTC TGT GAA TCG x x x
ACL_fl_F3 CGG GAA GTC AAC CTA CTG CA x x
ACL_fl_R3 GAA TCG ACT TGG CGG ACA TG x x
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6.3.3 Southern blot analysis of transformants 
For each strain, approximately 2 μg of genomic DNA was isolated and digested with 
appropriate restriction enzymes. Sequence information for restriction digest of the target loci 
(acl or sdh) were obtained from the A. niger ATCC 1015 genome sequence from the US 
Department of Energy Joint Genome Institute (http://genome.jgi-psf.org/Aspni1/). Blotting 
was done according to the method described by Sambrook and Russell (2001) and using 
RapidHyb™  hybridisation buffer (Amersham Pharmacia) for probing. The target locus was 
detected by probing with the labelled upstream target gene PCR fragment. The probes were 
radioactively labelled with α-32P-dCTP by random priming using Rediprime II™  kit (GE 
Healthcare). 
6.3.4 Characterisation of deletion mutant 
The deletion strain was tested in batch fermentations with 50 g/L glucose and 50 g/L xylose, 
respectively, as initial carbon concentrations and compared to the wild type strain N402. The 
medium composition used was the same as described in Meijer et al. (2007) and was also 
used for the pre-culture.  
 
Before inoculation of the batch fermentors, spores were harvested with 0.01% Tween-80 
from pre-culture plates that were incubated for 4-7 days at 30 ºC. Subsequently, 109 spores/L 
were added to the bioreactors. All strains were cultivated under oxygen limitation (0.1 vvm) in 
5 L in-house manufactured bioreactors with a working volume of 4 L. The bioreactors were 
equipped with two disk turbine impellers rotating at 700 rpm. The initial pH was set at 2.5 and 
after 16 hours increased to 5 with NaCO3. The temperature was maintained constant at 30 
ºC and the pH was controlled by automatic addition of 1 M NaCO3 and 2 M HCl. 
6.3.5 Cell dry weight determination 
The cell mass concentration on a dry weight basis was determined by the use of 
nitrocellulose filters with a pore size of 0.45 μm (Osmonics, Minnetonka, MN). Initially, the 
filters were pre-dried in a microwave oven at 150 W for 10 minutes, and then weighed. A 
known weight of cell culture was filtered, and the residue was washed with distilled water. 
Finally, the filter was dried in the microwave at 150 W for 15 minutes and the dry weight was 
determined. 
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6.3.6 Extracellular metabolite quantification 
For determination of the extracellular metabolites, a culture sample was taken and 
immediately filtered through a 0.45 μm-pore-size nitrocellulose filter (Osmonics, Minnetonka, 
MN). The filtrate was frozen and kept at -20°C until analysis. Glucose, acetate, pyruvate, 
citrate, ethanol, succinate, fumarate, malate, glycerol, and oxalate concentrations were 
determined on an Aminex HPX-87H cationic exchange column (BioRad, Hercules, California) 
eluted at 60 ºC with 5 mM H2SO4 at a flow rate of 0.6 mL/min. Metabolites were detected with 
both a refractive index detector and a UV detector. 
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6.4 Results and Discussion 
To divert carbon fluxes into the direction of succinate, several metabolic engineering 
strategies were tested in this study. Two different gene loci were targeted for complete gene 
deletion in order to divert the fluxes of the primary metabolism towards succinate. 
6.4.1 Strain construction 
In an attempt to redirect fluxes towards C4 precursor compounds two different gene deletion 
strategies were designed. One of the strategies is based on an in silico model prediction, that 
has shown an increase in succinate production when both pdc and acl were deleted (David 
et al. 2003). In a previous study it has been shown that PDC has no detectable activity under 
the cultivation conditions posed on the system, so it was decided to delete only acl (Meijer et 
al. 2007).  
The second target for deletion is sdh. This is based on a rational understanding of the carbon 
metabolism. Deletion of this target has demonstrated higher C4 organic acid levels in other 
micro-organisms like E. coli (Lin et al. 2005b).   
  
The methods used for deleting these genes (acl and sdh) were similar, with the only 
differences being in the primers and flanking regions used during the transformation. In the 
first transformation design the PCR fragments were directly transformed in the A742 strain 
(D1). This transformation was performed with and without direct repeats. When direct 
repeats are involved a second selection step is required, and this complicates the already 
difficult transformation protocol. With direct repeats the unstable marker replacement needs 
to be popped out. Selection of transformants was done on minimal medium plates (MM), 
since transformants should have lost their auxotrophic behaviour. The auxotrophic A742 
strain on the other hand needs 10 mM of both uracil and uridine for survival. This strain is 
used as negative control as it is unable to grow on MM. 
The results of this transformation were surprising. On the Southern blots both the WT and 
the transformed band sizes could be detected (Figure 6.2 A and B). This indicates that 
multiple chromosomes are present in the transformants. A heterokaryon could be an 
explanation for this observation. However, heterokaryons are believed to occur only in 
mycelia and not in spores. Spores are believed to be haploid. Since these transformants 
were purified by streaking (4x), it was suggested that we might deal with a diploid strain. 
However, diploidity in A. niger strains was never mentioned in the literature.  
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To ensure that two transformants were not co-purified accidentally, single spores were 
picked and analysed on Southern blots. In Figure 6.2 the results of these single spore picked 
transformants are displayed. Even the differences between transformations with and without 
direct repeats can be detected on these blots. A 600 bp size difference was seen between 
the two transformations (Figure 6.2 A). Again, this is an indication that the band really is the 
band from the correct target locus and not a random background band. Another remarkable 
observation is that this phenomenon is seen in both genomic target regions (both for acl and 
sdh genome locus). It can be concluded that the A742 strain has multiple copies of the 
chromosomes and is not a good strain for doing deletions. The chances of homologous 
recombination in A. niger are already very small (1:106). If the gene has to be deleted on 2 
different chromosomes to achieve a complete deletion, the chances are even smaller.  
 
It was not possible to show that the strain was diploid by using benomyl as haplodizing 
agent. Benomyl is a microtubule destabilizing agent that will generate haploid cells out of 
diploid cells (Yu et al. 1999). Diploid cells are very sensitive to benomyl and are not able to 
survive in this medium. However, the haploidization effect of benomyl is extremely 
concentration dependent. The correct concentration could not be determined.  
 
Instead, another pyr negative strain, AB4.1, was used that is also related to the N402 wild-
type strain (see deletion strategy D2). The AB4.1 strain has been used for multiple 
transformations and is believed to be a haploid strain (Ram et al. 2004; Denherder et al. 
1992). The flanking regions were increased in these transformations from 1.5 kb to 2.5 kb in 
order to improve the homologous recombination efficiency. Again, the transformations were 
performed with and without direct repeats. The recovery of transformants was high in these 
transformations, but only 1 correct deletion mutant could be retrieved (over 400 were 
checked). The Southern blot (Figure 6.3) clearly shows that the acl gene is replaced by the 
marker. This mutant was transformed without direct repeats so we were unable to pop-out 
the heterologous pyr4 marker. The other transformants that were retrieved from these 
transformations still showed a high number of ectopic integrations of the bipartite fragments, 
resulting in several bands on the Southern blots (data not shown).  
 
Although it was tried to delete the acl and sdh in the pyrG-tr strain as well (see deletion 
stratege D3), this strategy was unsuccessful. It contains the most elaborate transformation 
protocol used in this study and when successful, it would result in the most reliable deletion 
strain with the native marker gene located at its original place in the genome. 
The transformation efficiency in A. niger is very poor and a synthetic marker selection on 
hygromycin (used in D3) complicates the method. Hygromycin selection is not as efficient as 
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auxotrophic selection, thereby causing a lot of background noise in the form of non-specific 
transformants. This background noise can be decreased by using sorbitol as osmotic 
stabilizing agent instead of sucrose. Even though this turned out to be a major improvement, 
no desired deletions could be retrieved with this method.  
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Figure 6.2 On the left side the restricted genomic regions, their length and the restriction enzymes 
used in the different strains are presented. On the right side the Southern blots are shown. A are the 
deletion results from acl deletion in the A742 strain. B shows the deletion results for sdh deletion in the 
A742 strain. WT = wild-type, TR = transformant,* = with direct repeats. 
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The fact that many different deletion strategies have been tried and only one transformant 
was successfully deleted in the target locus, indicates that the transformation protocols in A. 
niger are far from optimal. Efforts towards deleting the non-homologous end joining pathways 
are being made (Meyer et al. 2007). This might give promising new strategies for deleting 
target specific genes in the future. When the transformation efficiency has been improved, 
the deletion of sdh should be tested again. It is still possible that sdh is an essential gene, but 
the poor transformation results in this study may imply that the transformation method failed. 
 
6.4.2 Strain characterisation 
The acl deletion strain was compared to the wild-type N402 strain in 2 different batch set-
ups. The carbon sources tested were glucose and xylose and the cultivations were run under 
oxygen limiting conditions. An overview of the batch profiles of the different fermentations is 
shown in Figure 6.4. The first observation during the fermentation was that the ∆acl strain 
consumed two times more base compared to the wild-type on both glucose and xylose. This 
indicated that more acids were being produced. The increased acid production could be 
verified by the HPLC method analysing several extracellular acids. Table 6.2 shows the acids 
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Figure 6.3 On the left side the genomic region of the target locus, its length and the restriction enzymes 
used for Southern blot analysis, is shown before and after the deletion. No direct repeats are used in this 
deletion. On the right hand side the Southern blot is presented with the first lane containing the WT band 
and the second lane containing the deletion band. 
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measured in the different fermentations. It was observed that the ratio between the different 
acids changed when the carbon source has been changed.   
 
Table 6.2 Organic acid yields in C-mmol/C-mol carbon source. 
 
Succinate Acetate Glycerol Citrate Fumarate Oxalate Pyruvate
WT xylose n.a. n.a. 14 1 0.18 27 1.1
∆acl  xylose n.a. n.a. 16 5 0.74 24 2.3
WT glucose 2.1 n.a. 12 25 0.40 26 n.a.
∆acl  glucose 7.1 51 11 40 0.30 29 n.a.  
 
n.a. means not analysed.   
 
 
Additionally, the total amount of acid being produced differed between the different strains. 
Looking at the total amount of organic acid produced, it was observed that on xylose the Δacl 
strain produced slightly more acids compared to the wild-type (48 and 43 C-mmol, 
respectively). On glucose the difference was more pronounced. Here a total acid production 
of about 66 C-mmol was seen in the wild-type compared to 138 C-mmol in the Δacl strain. 
Thus, glucose as carbon source increased the acid production in the deletion strain more 
than two-fold. With glucose as C-source no pyruvate could be detected, indicating that there 
is no bottleneck at this point in the glycolysis, which might have resulted in the production of 
organic acids. One of the organic acids produced was citrate, which is known to be 
preferably produced during growth on glucose. The acl deletion seemed to stimulate citrate 
production also on xylose, but the yield was significantly lower than the yields achieved on 
glucose. During growth on xylose, pyruvate could be measured indicating that there is flux 
control at the entry into the TCA cycle, and this may explain the reduced amount of total 
organic acid production compared to cultivation on glucose. 
 
It was observed that succinate was not produced when xylose was used as carbon source. 
On the other hand, using glucose as C-source resulted in production of small amounts of 
succinate (0.10 – 0.25 g/L). The deletion of acl increased the succinate yield more than 3 
times, supporting the stoichiometric model prediction. Even though the model predicted a 
double deletion and not a single acl deletion, the experimental finding of an inactive PDC 
enzyme (Meijer et al. 2007) combined with this single deletion strain seems to confirm the 
model predictions quite well. The succinate yield was significantly increased, but it did not 
reach the maximum yields (>0.7 g/g) predicted by the model. An explanation might be that 
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some reactions are under-estimated and that regulatory effects influence the metabolic state, 
which is not incorporated in the stoichiometric model. Modelling is therefore an iterative 
process, i.e. the model needs to be adjusted to the obtained experimental results in order to 
get a more realistic view on cellular function.  
 
Finally, during growth on xylose the fumarate yield increased significantly in the deletion 
strain compared to the wild-type strain, which was not observed on glucose. This is an 
unexpected result, since in other cases (E. coli or M. succiniciproducens) succinate and 
fumarate production are closely related. If succinate is produced through the reductive TCA 
cycle, fumarate must be produced before succinate. In this study it is observed that fumarate 
and succinate production are not correlated at all, indicating that A. niger does not use the 
reductive TCA cycle for succinate production. More likely it will use the oxidative TCA cycle 
or the glyoxylate shunt. Fumarate production is possibly obtained by the reductive pathway. 
The fumarate reductase is most likely missing or not active in A. niger, making it impossible 
to produce succinate via the reductive pathway under these experimental conditions. No 
large differences in glycerol and oxalate yield were observed between the different carbon 
sources and strains. The most prominent change seems to occur in the TCA cycle and not in 
other pathways. The flux has clearly been redirected by deleting acl. The stoichiometric 
model needs to be fine tuned by incorporating these experimental results. New simulations 
should be performed in order to define a new strategy for further optimising succinate 
production in A. niger. 
Figure 6.4 Batch profiles of carbon source consumption, biomass and organic acid production.  
A. ♦ = xylose consumption, ▲ = biomass production, ■ = fumarate production. B. ♦ = glucose 
consumption, ▲ = biomass production, ■ = succinate production  
0
WT glucose                                          acl glucoseΔ
WT xylose Δacl xylose
B
A
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6.5 Conclusion 
Two deletion strategies were tested in an attempt to increase the succinate production in A. 
niger. One strategy (acl deletion) is based on stoichiometric metabolic model predictions 
under oxygen limited conditions. The other strategy (sdh deletion) was chosen as it has been 
successfully used in other micro-organisms. Several approaches were tested to achieve 
complete gene deletions of these two target genes. However, the different gene targeting 
methods used in this study did not result in a high deletion success rate. Only one of the two 
target genes was successfully deleted. There is still an urgent need for improved gene 
targeting methods in A. niger.  
 
In the acl deletion strain there was an increased organic acid production on both glucose and 
xylose as carbon-sources. On glucose a three-fold higher succinate yield was detected in the 
deletion strain. This might indicate that the stoichiometric model is a good tool for defining 
target genes.  
 
Although A. niger can be used as a cell factory for succinate production, further optimisation 
is needed in order to reach levels of industrial relevance. Additionally, there is still a lack of 
physiological knowledge, which complicates the optimisation process. This can only be 
overcome by more research on the metabolism of A. niger. 
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Chapter 7  
Physiological characterisation of acuB deletion in 
Aspergillus niger 
Meijer S., Jongh de W.A., Olsson L. and Nielsen J. 
Biocentrum-DTU, Center for Microbial Biotechnology, Denmark 
 
Aimed at Journal of Biotechnology 
7.1 Abstract 
The acuB gene of A. niger is an autolog of facB in A. nidulans. It encodes a positively acting 
regulatory protein, which is involved in acetate induction of ACS (acuA), ICL (acuD) and MS 
(acuE). Mutants lacking AcuB function are unable to grow on acetate as sole carbon source. 
AcuB is also known to be directly repressed by CreA. Under carbon repression conditions 
acuB is repressed, thereby preventing acetate metabolism as long as the repressing carbon 
source is present. Even though acuB is reported to be repressed directly by the main glucose 
repression gene creA, it is believed that there is a basic level of AcuB activity under glucose 
repressive conditions. 
 
 In the present study the effect of the deletion of the acuB gene on the physiology of A. niger 
was assessed. The differences in organic acid and acetate production, enzyme activities and 
extracellular amino and non-amino organic acid production were determined under glucose 
repressing and derepressing conditions. Furthermore, the consumption of alternative carbon 
sources (e.g. xylose, citrate, lactate and succinate) was investigated.  
 
It was shown that AcuB has pleiotropic effects on the physiology of A. niger. The results 
indicate that metabolic pathways, that are not directly involved in acetate metabolism, are 
influenced by acuB deletion. Clear differences in organic acid consumption and production 
were detected between the ΔacuB and reference strain. However, the hypothesis that AcuB 
is responsible for some basic acuA activity necessary for activation of the acetate metabolic 
pathways, even during growth on glucose, could not be confirmed. 
 
Keywords: AcuB deletion, signal transduction pathways, organic acids, acetate 
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7.2 Introduction 
The biochemically versatile fungus Aspergillus niger produces a wide array of acids and 
degradative enzymes to support its absorptive life style. This metabolic diversity and its 
capability to use a large amount of different carbon sources, makes A. niger a valuable cell 
factory for use in many different industrial processes (Bennett 1997). The diverse carbon 
catabolism of A. niger is, like many other micro-organisms, regulated by several mechanisms 
providing adaptation to prevailing conditions. One of these regulatory processes is carbon 
catabolite repression, ensuring that readily metabolisable carbohydrates repress the 
synthesis of enzymes related to the catabolism of alternative carbon sources. This 
preferential utilization of the most favoured carbon source is beneficial for two reasons. 
Firstly, the energetically easiest metabolisable carbon source is used first, and secondly, no 
energy is wasted on the synthesis of other catabolic systems (Ruijter and Visser 1997a).  
 
Carbon repression in Aspergilli has been the focus of several studies, in particular for the 
model organism A. nidulans (for review see Arst 1977; Kelly and Hynes 1982; Ruijter and 
Visser 1997b; Scazzocchio et al. 1995). The major regulatory gene controlling carbon 
repression is creA (Agger et al. 2002; Ruijter et al. 1997b; Shroff et al. 1997). The carbon 
repression regulated by the CreA protein can be divided into three groups based on their 
metabolic function. The first and main group consists of genes encoding enzymes that 
catabolize less preferred carbon sources (Prathumpai et al. 2004). The second group 
comprises genes that are involved in secondary metabolism (Espeso and Penalva 1992). 
The third group includes genes encoding gluconeogenic and glyoxylate cycle enzymes 
(Sandeman and Hynes 1989; Bowyer et al. 1994; Kelly and Hynes 1981; David et al. 2005). 
The regulatory impact of CreA on metabolism is complex and encompasses a diverse range 
of signal transduction pathways (Veen et al. 1995; Dowzer and Kelly 1991). 
 
AcuB, the focus of this study, is a global regulator in acetate metabolism and is directly 
repressed by CreA (Katz and Hynes 1989). Under carbon repression conditions acuB is 
repressed, thereby preventing induction of acetate metabolism as long as the repressing 
carbon source is present. However, it is believed that AcuB has a basic level of activity under 
carbon repressing conditions, since the glyoxylate bypass genes induced by AcuB, showed a 
low level of expression under glucose repressive conditions (Ruijter et al. 1999). Also the 
lack of acetate formation during oxalate production, formed by the enzymatic cleavage of 
oxaloacetate (OAA) to oxalate and acetate in medium with a high glucose concentration, has 
been thought to be caused by basic level activity of AcuB. These data led to the hypothesis 
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that acetyl CoA synthetase (ACS) is induced by AcuB, and metabolises all acetate formed. It 
has already been shown that ACS has detectable enzyme activity levels under glucose 
repressing conditions in A. niger, but not in A. nidulans (Sealy-Lewis and Fairhurst 1998). 
 
The acuB gene of A. niger is an autolog of facB in A. nidulans (Papadopoulou and Sealy-
Lewis 1999). It encodes a positively acting regulatory protein, which is involved in acetate 
induction of acetyl-CoA synthase (AcuA), isocitrate lyase (AcuD), malate synthase (AcuE) 
and NADP-specific isocitrate dehydrogenase (IDH) (Hynes 1977; Todd et al. 1997a; Kelly 
1980). In A. nidulans FacB also induces acetamidase (AmdS). AcuB can take over this 
function but, in contrast to A. nidulans, amdS is not a natural occurring gene in A. niger 
(Sealy-lewis and Fairhurst 1998; Todd et al. 1998). AcuB contains a Zn(II)2Cys6 DNA-
binding motif that shows high similarity to the Cat8 and Sip4 proteins in S. cerevisiae (Todd 
et al. 1997b). Cat8 is thought to be the central regulator of gluconeogenesis (Hedges et al. 
1995), while Sip4 is involved in regulation of carbon metabolism via its interaction with Snf1 
(Lesage et al. 1996).  
 
Mutants lacking AcuB function have been shown to be unable to grow on acetate as the sole 
carbon source (Sealy-Lewis and Fairhurst 1998). The two-carbon compound acetate is 
capable to function as sole carbon source for many micro-organisms. In eukaryotes, acetate 
utilisation occurs in three different subcellular localisations (Stemple et al. 1998). First the 
acetate is activated to acetyl-CoA in the cytosol by acetyl-CoA synthase (ACS). Acetyl-CoA 
is subsequently transported by the acetylcarnitine shuttle to the mitochondria, where it is 
metabolised via the TCA cycle. Such a shuttle also transfers the acetyl-CoA from the cytosol 
to the glyoxysomes, where acetyl-CoA is metabolised via the glyoxylate pathway (Kornberg 
1966). However, when growing on acetate, gluconeogenesis is required for energetic and 
structural cell viability. Gluconeogenesis leads to depletion of the citric acid cycle (TCA) 
intermediates, that are replenished via the glyoxylate pathway. The glyoxylate pathway 
consists of two reactions producing the TCA cycle intermediates malate and succinate from 
isocitrate and acetyl-CoA. The two enzymes catalysing these reactions are isocitrate lyase 
(ICL) and malate synthase (MS), which are both under AcuB regulation. The AcuB mediated 
induction of these enzymes is regulated at two levels: induction of acuB levels and increased 
activity of AcuB caused by acetate itself (Todd et al. 1997a; Katz and Hynes 1989).  
 
In this study the effect of complete deletion of the acuB gene on the physiology of A. niger 
was characterised. The differences in organic acid production and extracellular amino acid 
secretion under glucose repressing and derepressing conditions were determined. 
Furthermore, the consumption of alternative carbon sources in solid state and submerged 
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cultures was investigated and the enzyme activities of four key enzymes in the TCA cycle 
and glyxoylate pathway were determined. 
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7.3 Material and Methods 
7.3.1 Strains 
As reference strain (WT) the laboratory strain N402 of Aspergillus niger was used. This strain 
is also known as A733 at the fungal genetics stock center and is a short-condiophore 
derivative of the N400 strain. The N402 strain is closely related to the ATCC1015 strain that 
is sequenced by DOE (Department of Energy, USA) (http://genome.jgi-
psf.org/Aspni1/Aspni1.home.html, Sept 2007). 
 
The other strain used was a ΔacuB strain in which the complete coding region of acuB has 
been deleted from the N402 strain by using the reversible auxotrophic marker strategy 
decribed in Nielsen et al. (2007). 
7.3.2 Cultivation media 
For the pre-culture a defined medium was used, containing 10 g/L D-glucose, 50 mL/L salt 
solution, 1 mL trace element solution 1 and 18 g/L agar. The salt solution consisted of 120 
g/L NaNO3, 10.4 g/L KCl, 10.4 g/L MgSO4 ⋅ 7 H2O and 30.4 g/L KH2PO4. The trace element 
solution 1 consisted of 22 g/L ZnSO4 ⋅ 7 H2O, 11 g/L H3BO3, 5 g/L MnCl2 ⋅ 2 H2O, 5 g/L 
FeSO4 ⋅ 7 H2O, 1.7 g/L CoCl2 ⋅ 6 H2O, 1.6 g/L CuSO4 ⋅ 5 H2O, 1.5 g/L Na2MoO4 ⋅ 2 H2O and 
50 g/L Na4EDTA. Spores were propagated on plates containing this medium at pH 6.5.  
 
The growth phenotype of the ΔacuB strain on different carbon sources was compared to the 
reference strain N402 on agar plates containing the same medium as described above. As 
carbon source were used glucose (10 g/L), fumarate (10 g/L), citrate (10 g/L), succinate (10 
g/L), acetate (10 g/L), propionate (4 %, 0.1 % glucose) and propionate (1.6 %, 0.1 % 
glucose), respectively. 
 
The batch cultivations were carried out in a chemically defined medium adjusted to pH 2.5 
containing 0.5 g/L NaNO3, 3 g/L KH2PO4, 2 g/L MgSO4 ⋅ 7 H2O, 2 g/L NaCl, 0.2 g/L CaCl2 ⋅ 
2H2O, 0.5 ml/L antifoam (sb2121) and 1 ml/L trace element solution 2. The trace element 
solution 2 consisted of 14.3 g/L ZnSO4 ⋅ 7 H2O, 2.5 g/L CuSO4 ⋅ 5 H2O, 0.5 g/L NiCl2 ⋅ 6 H2O, 
7 g/L MnCl2 ⋅ 2 H2O and 13.8 g/L FeSO4 ⋅ 7 H2O. The carbon sources were varied in these 
cultivations and are listed in Table 7.1. 
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Table 7.1 Carbon sources and concentrations used in the batch fermentations of both WT and ΔacuB 
strains. 
Carbon source Concentration
Glucose 100 g/L 
Glucose 50 g/L
Glucose 10 g/L
Xylose 10 g/L
Glucose - succinate 10 g/L - 10 g/L
Glucose - citrate 10 g/L - 10 g/L
Glucose - lactate 10 g/L - 10 g/L  
 
7.3.3 Cultivation conditions 
The pre-culture plates were incubated for 4-7 days at 30 ºC after which the spores were 
harvested with 0.01 % w/w Tween-80. For the phenotypic growth characterisation the agar 
plates were incubated at 30 ºC and checked regularly to assess the growth differences.  
 
All batch cultivations were carried out in 3 L Braun bioreactors with a working volume of 2 L. 
The temperature was maintained constant at 30 ºC and the pH was controlled by automatic 
addition of 2 M NaOH and 2 M HCl. Two Rushton four-blade disc turbines were used for 
homogeneous mixing. No baffles were incorporated in the reactors, thereby reducing the 
surface area available for biofilm formation. All cultivations were inoculated with spores to an 
initial concentration of 5*108 spores/L. The initial aeration rate, agitation and pH were 0.2 
vvm, 200 rpm and pH 2.5, respectively. These were gradually increased after germination 
(approx. 15 hours) to 1 vvm, 700 rpm and pH 5 respectively, after which these parameters 
were kept constant throughout the rest of the cultivation. Air was used for sparging and the 
concentrations of oxygen and carbon dioxide in the exhaust gas were monitored by an 
acoustic gas analyser (Brüel & Kjær, Denmark). The dissolved oxygen tension (DOT) was 
measured with an oxygen probe (Mettler Toledo sensors). 
7.3.4 Sampling 
Biomass samples were taken manually from the reactor. For dry weight measurements, a 
known cell culture volume was filtered through a pre-weighed nitrocellulose filter (pore size 
45 μm, Pall Corporation). The filtrate was frozen immediately and later used for 
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determination of substrate and extracellular metabolites. The filter was washed with 0.9 % 
w/v NaCl, dried for 15 min in a microwave oven at 150 W and weighed again to determine 
the biomass concentration. 
 
For determination of in vitro enzyme activities biomass samples were filtered through a 
nitrocellulose filter (pore size 45 μm, Pall Corporation) and washed with 0.9 % w/v NaCl. 
Thereafter, the filter cake (± 1 g) was immediately frozen in liquid nitrogen and stored at -80 
ºC. 
7.3.5 Substrate and extracellular metabolite quantification 
High-performance liquid chromatography (Dionex, Rødovre, Denmark) was used for 
quantification of extracellular sugars and organic acids. Glucose, xylose, acetate, pyruvate, 
citrate, ethanol, succinate, fumarate, malate, glycerol, lactate and oxalate concentrations 
were measured on an Aminex HPX-87H cationic exchange column (BioRad, Hercules, 
California) eluted at 60 ºC with 5 mM H2SO4 at a flow rate of 0.6 mL/min. Metabolites were 
detected with both a refractive index detector and a UV detector. We calculated the 
maximum obtained yields for all these organic acids based on their substrate consumption. 
 
Extracellular amino and non-amino organic acids were analysed using GC-MS analysis. The 
filtrate (1 mL) was lyophilised and derivatised using methyl chloroformate as decribed by 
Vilas-Boas et al. (2003). The resulting dry organic solutions were transferred to silanised GC 
vials and analysed with a Hewlett–Packard system HP 6890 gas chromatograph coupled to a 
HP 5973 quadrupole mass selective detector (EI) operated at 70 eV. The column used for all 
analyses was a J&W1701 (Folsom, CA) 30 m long; 250 μm inner diameter; 0.10 μm film 
thickness. The MS was operated in scan mode (start after 5 min, mass range 38–550 atomic 
mass unit at 2.88 s/scan) (Villas-Boas et al. 2003). Principal component analysis (PCA) was 
performed on the extracellular amino and non-amino organic acids in order to better visualise 
the differences between the two strains and their cultivation conditions. 
7.3.6 Analysis of in vitro enzyme activities 
The frozen samples were crushed in liquid nitrogen with a mortar. The crushed biomass (0.5 
g) was solved in 2 ml of extraction buffer containing 25 mM MES-NaOH, 0.1 mM EDTA, 0.1 
mM DTT, 0.1 mM phenylmethylsulfonyl fluoride, 0.1 mM NaN3. This solution was transferred 
to 2-mL FastPrep tubes containing 0.5 mL glass beads (0.75-1 mm). The FastPrep tubes 
were processed 3 times 10 s on a FastPrep FP120 Instrument (Savant Instruments, New 
York), at speed setting 5, with cooling on ice in between. After disruption, samples were 
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centrifuged at 13000 g at 4 ºC for 10-20 min, and the supernatants were analysed for 
enzyme activity. 
 
Enzyme assays were performed at 30 °C using a HP8453 UV-visible light spectrophotometer 
for detection of respective reactions. In order to test the linearity of the assays, the reactions 
were performed with 2-3 different dilutions of cell extract. The specific enzyme activities are 
expressed as micromoles minute-1 substrate consumed milligram-1 protein (U/mg). The 
amount of protein was determined by the Bradford method (Bradford 1976) with bovine 
serum albumin as the standard. We measured four different enzyme activities in the 
exponential growth phase: citrate synthase (CIT), malate dehydrogenase (MDH), isocitrate 
lyase (ICL) and malate synthase (MS) (Meijer et al. 2007; 
http://www.sigmaaldrich.com/sigma/enzyme%20assay/malatesynthase.pdf). 
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7.4 Results and Discussion 
Since AcuB has been shown to have a wide regulatory role, we performed a detailed 
physiological characterisation of the ΔacuB strain constructed by Nielsen et al. (2007). The 
phenotypic behaviour of the ΔacuB strain was compared to the wild-type A.niger strain 
(N402). The focus of our study was on determining the influence of the acuB gene in the 
utilisation of certain di- and tricarboxylic acids and its effect on carbon repression. 
7.4.1 Solid state growth characterisation 
As a first screening test the solid state growth performance of both WT and ΔacuB on 
different carbon sources, as well as on the toxic compound propionate, were compared 
(Table 7.2). Results from literature have illustrated that mutants, that are hampered in their 
acetate metabolism, are able to grow on propionate concentrations at which the WT cannot 
(Sealy-Lewis 1994). The results of this screening experiment show that both strains can grow 
equally well on glucose, as on the organic acids fumarate, citrate and succinate. At these 
growth conditions deletion of the acuB gene has no detectable influence on the growth 
phenotype. Apparently, the role of AcuB on the physiology was more subtle and a more 
detailed characterisation is needed for identifying the physiological state of the strains.   
 
On the other hand, we observed that the solid state growth of the ΔacuB strain was affected 
in its acetate metabolism and that it was more resistant to the toxic compound propionate. 
These last two observation correlate well with the literature showing that AcuB is responsible 
for regulating acetate uptake and metabolism (Hynes 1977; Todd et al. 1997a; Kelly 1980). 
An unknown mechanism makes the ΔacuB strain less susceptible to propionate. This 
resistance is most likely caused by the inability of the ΔacuB strain to metabolise certain 
compounds and thereby incapable to produce certain toxic intermediates like propionyl-CoA 
and methylisocitrate that are formed from propionate (Brock and Buckel 2004). This plate 
screening test is, however, a rough method for comparing strains. On other carbon sources 
like citrate, succinate and fumarate the differences between the ΔacuB and the WT strains 
were minimal. 
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Table 7.2 Growth phenotype of the ΔacuB strain on different carbon sources compared to the WT. 
Tested by point inoculating spores of the WT and ΔacuB onto MM plates with the indicated carbon 
source. 
 
Carbon source Growth of ΔacuB Growth of the WT
Glucose +++ +++
Fumarate +++ +++
Citrate +++ +++
Succinate +++ +++
Acetate --- +
Propionate 4%, 0.1 
% glucose -- 0
Propionate 1.6%, 
0.1 % glucose - ---  
 
+++ Normal growth 
+ Slower growth 
- Slow growth. altered morphology. delayed sporulation. Faun coloured spores 
-- Very slow growth. altered morphology. delayed sporulation. Faun coloured spores 
--- Very slow growth. altered morphology. no sporulation observed. 
0 No growth 
 
7.4.2 Uptake and specific growth rates  
To get more insight into the role of AcuB, controlled batch cultivations of ΔacuB and WT were 
performed. Growth on several different carbon sources was tested (see Table 7.1), and also 
the effect of high sugar concentrations, since acuB expression is known to be influenced by 
carbon repression. Additionally, an attempt was made to grow the strains on acids as the 
sole carbon source. Several different intermediates of the TCA cycle were tested as carbon 
source to determine what effect acuB deletion has on these compounds and their 
gluconeogenesis pathways. An additional carbon source (lactate) was tested in these batch 
cultivations, since in S. cerevisiae it has been shown that deletion of an acuB homologue 
restricts lactate usage (Bojunga et al. 1998; Soares et al. 2004). It was found that in 
submerged cultures both strains were unable to germinate on media containing organic acids 
as the sole carbon source. This is in contrast with the observations on solid media. 
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Therefore, it was decided to add glucose to the medium allowing germination and initial 
growth, after which the micro-organism could switch to metabolising the alternative carbon 
source.  
 
An illustration of these batch fermentations is shown in Figure 7.1. The volumetric carbon 
uptake rates of all carbon sources are presented in Table 7.3, together with the specific 
growth rates. These values show that the glucose uptake rate was slightly lower when a 
second carbon source was present. In the exponential phase (phase 1) the uptake rate of the 
second carbon source was less than the uptake rate in the glucose depleted phase (phase 2) 
for all substrates. For both strains lactate was the least favourable carbon source, and the 
∆acuB strain was clearly more impaired in lactate uptake than the WT strain. The lactate 
uptake rates were 0.43 and 0.13 mmol/L/h, respectively. This is consistent with observations 
made in C. albicans and S. cerevisiae, where a cat8 deletion (the homolog of acuB in C. 
albicans and S. cerevisiae) restricts the micro-organisms to consume lactate (Bojunga et al. 
1998; Soares et al. 2004). Lactate is a non-fermentable carbon source, whose consumption 
is regulated by carbon repression. When cat8 is deleted, the lactate permease jen1 is 
expressed at a low level, leading to reduced lactate uptake.  
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Figure 7.1 Typical carbon consumption profile for both the WT and ΔacuB strain when 2 carbon sources are 
present in the medium. Phase 1 is the exponential phase in which the glucose (most favourable carbon 
source) is consumed. In phase 2 the glucose is depleted and the second carbon source is consumed.  
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It should also be noted that uptake of citrate is almost absent in both strains when glucose is 
present in the medium (0.04 – 0.10 mmol/L/h), while succinate is consumed at similar rates 
by the WT strain in the presence and absence of glucose (0.70 versus 0.77 mmol/L/h). A 
clear difference is observed between the succinate uptake rate in the exponential phase in 
the ∆acuB and WT strains, with the uptake rate being lower in the mutant (0.21 versus 0.70 
mmol/L/h). In contrast, the succinate uptake rate is similar in the ∆acuB strain and the WT 
strain when glucose is exhausted. The lower succinate uptake rate of the mutant in the 
exponential phase is surprising, since the acuB gene is known to be under carbon 
repression. Katz and Hynes (1989) showed that in an A. nidulans strain, carrying a creA 
mutation, facB induction was alleviated compared to the wild-type strain. Papadopoulou and 
Sealy-Lewis (1999) showed that facB is the homolog of acuB and that their functions could 
be interchanged. Although AcuB is not known to regulate the succinate uptake system 
directly, it could have an influence under carbon repressing conditions. It seems that carbon 
repression does not have a major impact on succinate consumption in the WT strain. On the 
contrary, a carbon repression effect can be postulated in the ∆acuB strain. However, this 
regulation will be influenced by a regulatory circuit that is not influenced by AcuB. It is 
possible that a basic level of acuB expression relieves the carbon repressive effect on 
succinate consumption in the WT strain, suggesting a new regulatory role for AcuB.  
 
Another interesting observation is that, when glucose is depleted, the ∆acuB strain has a 
higher citrate consumption rate compared to the WT. There is no clear explanation for this 
observation. Possibly, when acuB is deleted a plethora of regulatory circuits are affected that 
stimulate organic acid uptake systems. Another possibility is that AcuB limits the transport 
systems of organic acids.  
 
Table 7.3 illustrates that when more carbon source is added to the culture medium the 
volumetric carbon uptake rate increases, which correlates well to the higher biomass 
concentrations in the reactor. The specific growth rates are fairly constant at the different 
conditions, except for a few outliers (Table 7.3). This indicates that the available carbon 
concentration regulates the carbon uptake rates, but does not affect the specific growth rates 
of the micro-organism. 
7.4.3 Enzyme activities  
AcuB is known to be a regulatory protein that induces several enzymes (such as ICL, MS, 
ACS) and acuB is in itself again regulated by the global carbon repression gene creA. 
Because of both the carbon regulation and the enzyme regulation, the effect of acuB deletion 
on the activity of four different enzymes was determined (CIT, MDH, ICL and MS). ICL and 
CHAPTER 7. Physiological characterisation of ∆acuB 
 
  147
MS are known to be directly regulated by AcuB (Sealy-Lewis and Fairhurst 1998), while 
deletion of acuB might have an indirect effect on CIT and MDH. 
 
Table 7.3: Carbon uptake rate and specific growth rate for all different cultivation conditions in both 
WT and ∆acuB strains. 
 
WT ∆acuB  
qs 
1. phase 
qs 
2. phase 
μ qs 
1. phase 
qs 
2. phase 
μ 
Single carbon source 
Glucose 
Glucose (50) 
Glucose (100) 
Xylose 
Glucose+Citrate 
Glucose 
Citrate 
Glucose+Lactate 
Glucose 
Lactate 
Glucose+Succinate 
Glucose 
Succinate 
 
4.18 
7.90 
14.11 
5.56 
 
2.50 
0.04 
 
2.07 
0.27 
 
3.24 
0.70 
 
 
 
 
 
 
 
0.79 
 
 
0.43 
 
 
0.77 
 
0.12 
0.13 
0.17 
0.13 
0.14 
 
 
0.16 
 
 
0.15 
 
4.31 
8.89 
12.21 
4.37 
 
2.86 
0.10 
 
2.95 
0.17 
 
4.09 
0.21 
 
 
 
 
 
 
 
2.38 
 
 
0.13 
 
 
1.85 
 
0.10 
0.17 
0.14 
0.12 
0.16 
 
 
0.16 
 
 
0.21 
 
qs is expressed in mmol/L/h and μ in h-1.   
(50) and (100) means 50 and 100 g/L, respectively, when nothing is stated the concentration is 10 g/L 
 
 
It was also tested which effect acuB deletion had on the physiology, when the sugar 
concentrations in the batch fermentations were changed (10, 50 and 100 g/L). Figure 7.2 
shows the enzyme activities measured (U/mg protein). Comparing the three different sugar 
concentrations it appears that CIT and ICL show an increasing activity level with increasing 
sugar concentration (Pearson correlation of 0.95 and 0.99, respectively), while MDH and MS 
activity levels do not show much change. For CIT this increase is found for both ∆acuB and 
WT, while for ICL the increase in activity in ∆acuB is significantly higher than for WT. This is 
peculiar because literature states that acuB is not induced under carbon repression, resulting 
in un-induced glyoxylate enzymes like ICL and MS (Hynes 1977: Katz and Hynes 1989). This 
favours the hypothesis of a basic level of AcuB under glucose repressing conditions. ICL 
clearly shows the opposite profile, suggesting that more regulating systems are influencing 
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ICL under carbon repressing conditions or that AcuB might have an inhibiting effect on ICL 
activity. The MS profile indicates a decrease in activity in the ∆acuB strain. This profile could 
be expected due to carbon repression in the WT strain, but it should not be present in the 
∆acuB strain.  
 
 
 
Figure 7.2 Enzyme activities are expressed in U/mg protein. The WT activities are expressed in the 
dark grey bars and the enzyme activities of ΔacuB in the light grey bars. Levels 1 till 7 express the 
different fermentation conditions used in the fermentation. 1) glucose 10 g/L, 2) glucose 50 g/L, 3) 
glucose 100 g/L, 4) xylose 10 g/L, 5) glucose 10 g/L + citrate 10 g/L, 6) glucose 10 g/L + lactate 10 g/L 
and 7) glucose 10 g/L + succinate 10 g/L. All enzyme activities were determined in the exponential 
growth phase. 
 
 
The inconsistencies between the enzyme activity measured and the current knowledge 
suggest that more regulatory pathways influence the enzyme activities in A. niger. The 
enzyme activities are not completely repressed by high sugar concentrations, which has 
been shown earlier for ICL (Meijer et al. 2007; Ruijter et al. 1999).  
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7.4.4 Organic acid production 
The yields of excreted organic acids for the 7 different cultivation conditions of both strains 
are illustrated in Table 7.4 and Figure 7.3. The organic acid produced at the highest level in 
all fermentations is oxalate (0.7 – 4.7 g/L). Oxalate is one of the organic acids known to be 
produced in A. niger under certain conditions (Ruijter et al. 1999). The formation of organic 
acids is dependent on the pH of the medium. At pH < 3 the major acid produced is citrate, 
while at a pH between 3 - 6 mainly oxalate is produced (Kubicek and Rohr 1986; Ruijter et al. 
1999). When pH values reach 5.5 or higher gluconate production may occur (Rohr et al. 
1983).  
 
 
 
It should also be noted that, under all growth conditions, no acetate was detected in neither 
of the strains. This indicates that, although acuB is deleted, the cells are still able to 
metabolise acetate that may be formed. Ruijter et al. (1999) have demonstrated that an 
equimolar acetate / oxalate yield was achieved upon cleavage of oxaloacetate by a partially 
purified oxaloacetate hydrolase (OAH). The lack of acetate production by A. niger during 
oxalate production was explained by the fact that a ∆acuA (no acetylCoA synthase) strain did 
transiently produce acetate. Sealy-Lewis and Fairhurst (1998) discovered that AcuB is the 
regulatory enzyme that induces acuA. Lacking this induction would lead to acetate 
production, as there would be no acetylCoA synthase (ACS) activity. Sealy-Lewis and 
Fairhurst (1998) also demonstrated that ACS is not completely repressed by glucose, even 
though CreA has been shown to repress it directly. It seems that under glucose derepressed 
conditions acuA is induced by AcuB. When acuB is deleted, there is still a basic level of 
activity of ACS, as is found during glucose repressing conditions. Other pathways are likely 
to take over the regulation of AcuB and/or the enzymes that are normally induced by AcuB. 
These alternative pathways will then lead to a basic level of ACS activity. This basic level of 
activity seems to be sufficient to ensure that the acetate, produced by the oxaloacetate 
hydrolase, is metabolised.  
Table 7.4 Maximal product yields in mmol/mol substrate for the different fermentation conditions and both 
WT and ΔacuB strains.  
         Biomass          Succinate             Citrate           Fumarate          Oxalate           Pyruvate           Glycerol
WT ∆acuB WT ∆acuB WT ∆acuB WT ∆acuB WT ∆acuB WT ∆acuB WT ∆acuB
glucose 10 g/L 1.9 1.9 3.5 0.0 14.7 19.8 0.0 0.2 251 203 18.0 2.5 22.8 8.2
glucose 50 g/L 1.6 1.7 6.0 0.9 15.7 3.0 0.8 0.1 153 103 5.3 10.9 26.4 4.8
glucose 100 g/L 1.4 1.3 2.1 1.4 43.2 39.5 1.5 1.3 130 89 0.0 0.0 52.7 38.4
xylose 2.2 2.2 1.0 1.4 3.5 4.2 1.1 0.6 199 142 0.3 0.6 1.1 0.9
gluc + cit 4.5 5.0 5.3 0.0 0.0 0.0 0.8 0.8 226 239 0.0 2.6 13.1 36.7
gluc + lac 4.2 4.5 46.1 46.7 60.7 70.4 0.6 1.2 219 210 1.8 16.8 22.6 25.9
gluc + succ 4.1 4.3 0.0 0.0 57.9 42.0 4.1 2.8 206 178 3.1 1.0 18.9 13.5
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Figure 7.3 Comparison of maximal product yields for succinate, citrate, fumarate, oxalate, pyruvate 
and glycerol normalised to the highest yield. The top graph represents the yields for the WT, while the 
bottom graph respresents the ΔacuB yields. The colours of the bars represent the fermentation 
conditions used as presented directly under the graph. The values shown underneath both figures 
indicate the highest maximal yields to which the other yields are normalised.  
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Additionally, slightly higher citrate production was detected in fermentations with high sugar 
concentration compared to lower sugar concentration in both the WT and ∆acuB strain 
(average of WT and ∆acuB is 17 mM and 41 mM, respectively). This has been extensively 
documented in literature and is known as the overflow metabolism of A. niger that starts 
producing citrate at glucose concentrations of 50 g/L and higher (Papagianni 2007). 
Moreover, in fermentations where a second carbon source (lactate and succinate) is used, 
the production of citrate is even higher (average of WT and ∆acuB 65 mM for lactate or 49 
mM for succinate). When lactate is used as a second carbon source also a significant 
amount of succinate is produced, while when succinate is used as second carbon source a 
lot of fumarate is produced, indicating a change in TCA cycle kinetics (Table 7.4). Glycerol is 
mainly produced in fermentations with high sugar concentrations (38-52 mM). For the ∆acuB 
strain there is also higher production of glycerol when citrate is used as second carbon 
source (37 and 13 mM in the ∆acuB and WT, respectively). It seems that the balance 
between oxalate and glycerol changes when the sugar concentration increases (decrease in 
oxalate production and increase in glycerol production). This might be caused by the fact that 
in cultivations with high sugar concentrations, the flux switches from the pentose phosphate 
pathway towards glycolysis (Legisa and Mattey 2007). When a second carbon source is 
added the product profile seems to become dependent on the source of the second 
compound (citrate, lactate or succinate). 
7.4.5 Amino and non-amino organic acids 
Looking at the extracellular amino and non-amino organic acid profiles we were not able to 
separate the ∆acuB strain from the WT strain by PCA analysis (data not shown). It appears 
that the fermentation conditions have a higher influence on the extracellular metabolite 
profiles than the effect of the gene deletion. The sugar concentration in particular has a large 
impact on the secretion pattern. The PCA plot (Figure 7.4) clearly shows that at high sugar 
concentrations (100 g/L glucose), more organic acids are produced compared to the low 
sugar concentration (10 g/L). At the intermediate sugar concentration (50 g/L) a higher 
production of amino acids is detected. These results correspond well to other investigations, 
which indicate that high sugar concentrations lead to an overflow metabolism producing high 
titers of organic acids. Karaffa and Kubicek (2003) showed that high amounts of citric acid 
are produced when the sugar concentration is high. At lower concentration glucose is mainly 
used for biomass production (Karaffa and Kubicek 2003; Ruijter and Visser 1997b). 
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Figure 7.4 PCA analysis of ΔacuB and WT using 10, 50, 100 g/L glucose, respectively. The PCA is 
based on the extracellular amino and non-amino organic acids. 
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7.5 Conclusion 
We conclude that the ∆acuB strain was limited in its acetate metabolism. This is clearly 
observed during the growth on solid media. The increased resistance of ∆acuB to propionate 
was confirmed in our experiments. In the submerged batch cultivations the differences 
between ∆acuB and WT were more subtle than expected. Especially under carbon 
repressing conditions we did not see the expected effect of ∆acuB on the enzyme activities 
that, in A. nidulans, are known to be regulated by AcuB (ICL and MS). Therefore, it seems 
that A. niger possesses more regulatory systems that ensure robustness in terms of 
metabolism of different carbon sources compared with A. nidulans. Thus, ∆acuB had an 
altered consumption and production of organic acids, but its effect is likely to be limited due 
to the presence of other processes involved in controlling the general state of metabolism in 
A. niger. 
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Chapter 8  
Overexpression of Isocitrate lyase – Glyoxylate bypass 
influence on metabolism in Aspergillus niger 
 
Meijer S., Otero J., Olivares R., Andersen MR., Olsson L. and Nielsen J. 
Biocentrum-DTU, Center for Microbial Biotechnology, Denmark 
 
Aimed at Metabolic Engineering 
8.1 Abstract 
In order to improve the production of succinate and malate by the filamentous fungus 
Aspergillus niger the activity of the glyoxylate bypass pathway was increased by over-
expression of the isocitrate lyase (icl) gene. The hypothesis was that when isocitrate lyase 
was up-regulated the flux towards glyoxylate would increase, leading to excess formation of 
malate and succinate compared to the wild-type. However, metabolic network analysis 
showed that an increased icl expression did not result in an increased glyoxylate bypass flux. 
The analysis did show a global response with respect to gene expression, leading to an 
increased flux through the oxidative part of the TCA cycle. Instead of an increased 
production of succinate and malate, a major increase in fumarate production was observed.  
The effect of malonate, a competitive inhibitor of succinate dehydrogenase (SDH), on the 
physiological behaviour of the cells was investigated. Inhibition of SDH was expected to lead 
to succinate production, but this was not observed. There was an increase in citrate and 
oxalate production in the wild-type strain. Furthermore, in the strain with over-expression of 
icl the organic acid production shifted from fumarate towards malate production when 
malonate was added to the cultivation medium.  
Overall, the icl over-expression and malonate addition had a significant impact on 
metabolism and on organic acid production profiles. Although the expected succinate and 
malate formation was not observed, a distinct and interesting production of fumarate and 
malate was found.   
 
 
Keywords: isocitrate lyase over-expression, glyoxylate bypass, reduced organic acids, 
Metabolic Network Analysis, gene expression. 
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8.2 Introduction 
For decades microbial citric acid production has been an important industrial process. The 
main source for citric acid production is the filamentous fungus Aspergillus niger.  Medium 
composition and technical parameters have been extensively characterised and adapted to 
create an optimal production process (Kristiansen et al. 1999; Papagianni 2007). With 
advances in molecular biology and functional genomics during the last years it has become 
possible to study metabolism at a global level. One important breakthrough has been the 
sequencing of the A. niger genome (Baker 2006; Pel et al. 2007) and the subsequent design 
of DNA microarrays (Andersen et al. 2008). Another important and powerful method is 
metabolic network analysis, which has proven to be an important tool for analysis of the 
metabolic network and cellular physiology. This method has been developed by Christensen 
and Nielsen (1999) and others (Schmidt et al. 1997; Zupke and Stephanopoulos 1994). For 
quantifying metabolic fluxes, measurements of the amino acid labelling patterns by GC-MS 
or NMR are required, using 13C- labelled carbon sources. Quantification of the fluxes 
provides a direct measure of the degree of engagement of various pathways on the overall 
cellular function. 
 
Using DNA microarrays and flux analysis it is possible to get an in-depth knowledge about 
which molecular and biochemical pathways play a key role in product formation. Especially, 
in the quest to develop generic cell factories used for the production of a wide range of 
products, it is necessary to obtain detailed knowledge of the working mechanism of 
metabolic networks. The main focus of the present study is on the central carbon metabolism 
and the organic acid production in A. niger. With the ability of this fungus to produce high 
amounts of citric acid, it represents an attractive cell factory for the production of other 
organic acids like malic, fumaric and succinic acid. They are all considered valuable for the 
chemical industry (Werpy and Petersen 2004). For the production of these four-carbon 
organic acids it is quite natural to study the role of the glyoxylate pathway, as this pathway 
leads to malic acid and succinic acid production. Therefore, it was attempted to redirect 
fluxes towards the glyoxylate pathway by over-expressing the isocitrate lyase (ICL). Isocitrate 
lyase is the first enzyme of the glyoxylate pathway, with malate synthase being the second 
enzyme. The effect of adding malonic acid to the medium was also investigated. Malonic 
acid is known to be an inhibitor of succinate dehydrogenase (SDH). By disrupting the TCA 
cycle we tried to produce more organic acids in the form of succinic acid and malic acid.  
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The influence of icl over-expression and malonic acid addition on cellular performance was 
determined by transcript levels using DNA microarrays and metabolic flux analysis. 
Additionally, activities of key enzymes in the pathways leading to organic acids, as well as 
extracellular metabolite levels were measured. Our goal was to link the different information 
levels (genome, transcriptome, enzyme activities, metabolome and fluxome) to obtain a 
system-level understanding of the effect of icl over-expression on the cellular physiology. 
This provided us with new insights into the metabolism that can be used for improving the 
organic acid production of succinate and malate in the filamentous fungus A. niger. 
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8.3 Materials and Methods  
8.3.1 Strains 
As reference strain the laboratory strain N402 of Aspergillus niger was used. The icl over-
expression was made in the pyrA- strain AB4.1, which is auxotrophic for uridine and uracil. 
The icl gene was put on a high copy number plasmid. The vector used was pCR2.1-AfpyrG 
(kindly provided by Axel Brakhage), which carries pyrG from A. fumigatus (Vanhartingsveldt 
et al. 1987). Icl was fused to the A. nidulans gpdA promoter using fusion PCR. PCR was 
performed using the Expand High Fidelity PCR kit (Roche) according to the manufacturer’s 
recommendations. The primers used are shown in Table 8.1. The fusion PCR product of 
gpdA and icl was cut with SbfI, and the pCR2.1-AfpyrG vector was cut with PsiI. Both these 
enzymes are blunt-end cutting restriction enzymes and therefore the pCR2.1-AfpyrG vector 
and icl fusion gene product can be ligated using T4 DNA ligase. The ICL over-expression 
plasmid pCR2.1-AfpyrG_ICL was transformed into the AB4.1 strain using the protoplast and 
transformation procedures for A. niger as described previously for A. nidulans (Nielsen et al. 
2006).  
 
 Table 8.1 Primers used for fusion PCR to over-express icl in A. niger 
Primer name Sequence
GpdA_up AATAT CCTGCAGG GCT GAT TCT GGA GTG ACC CAG AG 
GpdA_down CTT CTT CTT CAA AGG AAG CCA T ACA CCG GGC GGA CAG ACG 
ICL_up         ATG GCT TCC TTT GAA GAA GAA G
ICL_down ATTA CCTGCAGG ATT CCC CTC CAT TCC CAT GC  
The underlined letters are the overlapping genetic elements used for fusion PCR. The bold letters 
code for the restriction enzyme Sbf1 that is used for restriction of the fusion PCR product, before 
insertion in the pCR2.1-AfpyrG plasmid.  
8.3.2 Cultivation media 
For the pre-culture a defined medium was used containing 10 g/L D-glucose, 50 ml salt 
solution, 1 ml trace element solution 1 and 18 g/L agar. The salt solution contained 120 g/L 
NaNO3, 10.4 g/L KCl, 10.4 g/L MgSO4 ⋅ 7 H2O and 30.4 g/L KH2PO4. The trace element 
solution 1 contained 22 g/L ZnSO4 ⋅ 7 H2O, 11 g/L H3BO3, 5 g/L MnCl2 ⋅ 2 H2O, 5 g/L FeSO4 ⋅ 
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7 H2O, 1.7 g/L CoCl2 ⋅ 6 H2O, 1.6 g/L CuSO4 ⋅ 5 H2O, 1.5 g/L Na2MoO4 ⋅ 2 H2O and 50 g/L 
Na4EDTA. Spores were propagated on agar plates containing this medium at pH 6.5.  
 
The batch cultivations were carried out in a chemically defined medium adjusted to pH 2.5 
containing 10 g/L glucose, 10 g/L NaNO3, 3 g/L KH2PO4, 2 g/L MgSO4 ⋅ 7 H2O, 2 g/L NaCl, 
0.2 g/L CaCl2 ⋅ 2H2O, 0.5 ml/L antifoam (sb2121) and 1 ml/L trace element solution 2. The 
trace element solution 2 contained 14.3 g/L ZnSO4 ⋅ 7 H2O, 2.5 g/L CuSO4 ⋅ 5 H2O, 0.5 g/L 
NiCl2 ⋅ 6 H2O, 7 g/L MnCl2 ⋅ 2 H2O and 13.8 g/L FeSO4 ⋅ 7 H2O.  
 
For the flux experiments 5 g/L of 1-13C glucose was used as sole carbon source. The rest of 
the medium components were the same as described above. The same reactor was used in 
all other experiments, only the working volume was reduced to 200 mL for the flux 
experiment.  
8.3.3 Cultivation conditions 
Before spore harvesting with 0.01% w/w Tween-80 the pre-culture plates were incubated for 
4-7 days at 30 ºC. Subsequently, 109 spores were inoculated in 3 L Braun bioreactors with a 
working volume of 2 L. The temperature was maintained constant at 30 ºC and the pH was 
controlled by automatic addition of 1 M NaCO3 or 2 M HCl. Two Rushton four-blade disc 
turbines were used for homogeneous mixing. No baffles were used in the reactors thereby 
reducing the surface area available for biofilm formation. The initial aeration rate, agitation 
and pH were 0.2 vvm, 200 rpm and pH 2.5, respectively. They were gradually changed after 
germination (that takes place after approximately 15 hours) to 0.02 vvm, 700 rpm and pH 5, 
respectively. These parameters were kept constant throughout the rest of the batch 
cultivation.  Air was used for sparging and the concentrations of oxygen and carbon dioxide 
in the exhaust gas were monitored by an acoustic gas analyser (Brüel & Kjær, Nærum, 
Denmark). The dissolved oxygen tension (DOT) was measured with an oxygen probe 
(Mettler Toledo sensors). 
8.3.4 Sampling 
Biomass samples were taken manually from the reactor. For dry weight measurements, a 
known cell culture volume was filtered through a pre-weighed nitrocellulose filter (pore size 
45 μm, Pall Corporation). The filtrate was frozen immediately and later used for the 
determination of the concentrations of substrate and extracellular metabolites. The filter was 
washed with 0.9 % w/v NaCl, dried for 15 min in a microwave oven at 150 W and weighed 
again to determine the biomass concentration. 
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For determination of in vitro enzyme activities, flux analysis and microarray analysis, biomass 
samples were filtered through a nitrocellulose filter (pore size 45 μm, Pall Corporation) and 
washed with 0.9% w/v NaCl. The filter cake (± 1 g) was immediately frozen in liquid nitrogen 
and stored at -80 ºC. 
8.3.5 Substrate and extracellular metabolite quantification 
High-performance liquid chromatography was used for the quantification of extracellular 
sugars and organic acids. Glucose, acetate, pyruvate, citrate, ethanol, succinate, fumarate, 
malate, glycerol and oxalate concentrations were measured on an Aminex HPX-87H cationic 
exchange column (BioRad, Hercules, California) eluted at 60 ºC with 5 mM H2SO4 at a flow 
rate of 0.6 mL/min. Metabolites were detected with both a refractive index detector and a UV 
detector. 
8.3.6 Analysis of in vitro enzyme activities 
The frozen samples were crushed on liquid nitrogen with a mortar. The crushed biomass (0.5 
g) was solved in 2 ml of extraction buffer containing 25 mM MES-NaOH, 0.1 mM EDTA, 0.1 
mM DTT, 0.1 mM phenylmethylsulfonyl fluoride and 0.1 mM NaN3. This solution was 
transferred to 2 mL FastPrep tubes containing 0.5 mL glass beads (0.75-1 mm). The 
FastPrep tubes were processed 3 times 10 s on a FastPrep FP120 Instrument (Savant 
Instruments, New York), at speed setting 5, with cooling on ice in between. After disruption, 
samples were centrifuged at 13,000 g at 4 ºC for 10-20 min, and the supernatants were 
analysed for enzyme activity. 
 
Enzyme assays were performed at 30 °C using a HP8453 UV-visible light 
spectrophotometer. In order to test the linearity of the assays, the reactions were performed 
with 2-3 different dilutions of cell extract. The specific enzyme activities were expressed in 
micromoles minute-1 milligram-1 (U/mg). The amount of protein was determined by the 
Bradford method with bovine serum albumin as the standard (Bradford 1976). Four different 
enzyme activities were measured: citrate synthase (CIT), malate dehydrogenase (MDH), 
isocitrate lyase (ICL) and pyruvate carboxylase (PYC) as described by Meijer et al. (2007).    
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8.3.7 Determination of intracellular flux distribution 
8.3.7.1 Sample preparation and derivatisation for flux analysis  
35-50 mg of biomass was dissolved in 600 μl 6M HCl and kept overnight at 105 ºC for 
hydrolysis. The hydrolysate was then centrifuged for 5 minutes at 15,000 rpm and the 
supernatant was transferred into new vials. The supernatant was dried for 3 hours at 105 ºC 
and dissolved in 200 μl milliQ water.  
 
In the mean time, the resin bed for solid phase extraction was prepared by weighing 1 g of 
Dowex cation exchange resin and mixed with 15 mL of 50 % w/w glycerol. One mL of resin 
solution was added to a syringe containing a frit on a SPE workstation. When the resin was 
settled at the bottom of the syringe, the excess of glycerol was drained and a second frit was 
added on top of the resin. Two mL of biomass hydrolysate was added on the SPE column. 
After the biomass had trickled through the column, 1 mL of 50 % v/v ethanol solution was 
added followed by 200 μl 1M NaOH solution, which washed the remaining unbound 
compounds off the column. Finally, the amino acids were eluted with 1 mL of solution 
containing 1 % v/v NaOH in saline (0.9 % w/v NaCl), ethanol and pyridine in a ratio of 9:5:1, 
respectively. The eluted amino acids were derivatised by two separate methods.  
1) ethylchloroformate (ECF) derivatisation  
2) dimethylformamide dimethylacetal (DMF/DMA) derivatisation  
 
In the ECF derivatisation 50 μl ECF was added to 500 μl amino acid solution and mixed in 
two sequential rounds of 30 s. Next, 200 μl propylacetate was added and finally 50 μl 1M 
HCl. The upper organic layer was removed and analysed by GC-MS. 
 
The DMF/DMA derivatisation required the addition of 300 μl 1M HCl to 500 μl amino acid 
solution followed by a 2-4 hours drying period at 105 ºC. 200 μl DMF/DMA and 200 μl 
acetonitrile were then added to dissolve the dried substance and mixed well for 30 s. This 
solution was kept at 100 ºC for 20 minutes and was subsequently transferred to -20 ºC for 10 
minutes to ensure proper derivatisation. This solution was finally analysed by the GC-MS. 
8.3.7.2 GC-MS analysis 
GC-MS analysis was performed on an Agilent (Palo Alto, CA, USA) HP 6890 gas 
chromatograph coupled to a HP 5973 quadrupole mass selective detector in positive electron 
impact ionization (EI+) operated at an electron energy of 70 eV. The GC was equipped with a 
4.0 mm i.d. Siltek gooseneck splitless deactivated liner (Restek, Bellefonte, PA, USA), and a 
Supelco (Bellefonte, PA, US) SLB-5 MS column, 15 m, 0.25 mm i.d., 0.25 µm film. Helium of 
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a purity of 99.999% was used as carrier gas at a constant linear gas velocity of 35 cm/s. 
Transfer line temperature was 280 ºC, quadrupole temperature 150 ºC and MS source 200 
ºC. The GC-MS system was controlled from Agilent MSD Chemstation v. D.01.02.16. For 
both methods (ECF and DMF/DMA) 1 µL sample was injected in the splitless (30 sec, split 
1:20) mode at 200 ºC using a hot needle. The MS scan range was m/z 40-400 with 2.88 
s/scan. To avoid sample carry-over the syringe was cleaned using five times 5 µL acetone, 
then five times 5 µL dichloromethane and finally 3 times rinsing with 3 µL sample.  
8.3.7.2.1 ECF derivatives  
The oven temperature was initially held at 75 °C for one min. Hereafter, the temperature was 
raised with a gradient of 40 °C/min until 165 °C, after which the temperature increase was 4 
°C/min until 190 °C and followed by an increase of 40 °C/min up to 240 °C. Finally, the 
temperature was increased to 260 °C with a gradient of 4 °C/min and held constant for 4 
minutes. The flow through the column was held constant at 1.3 mL He/min. The temperature 
of the inlet was 200 °C, of the interface 280 °C and of the quadrupole 105 °C.  
8.3.7.2.2 DMF/DMA derivatives 
Initially, the oven temperature was held at 60 °C for one min. Hereafter, the temperature was 
raised with a gradient of 20 °C/min until 130 °C, after which the temperature increase was 4 
°C/min until 150 °C and followed by an increase of 40 °C/min up to 260°C. Next, this the 
temperature was held constant for 4.25 minutes. The flow through the column was held 
constant at 1 mL He/min. The temperature of the inlet was 230 °C, of the interface 270 °C 
and of the quadrupole 105 °C. 
8.3.7.3 Metabolic network analysis 
The flux analysis was based on the labelling patterns of derivatives of glucose and amino 
acids obtained from acid hydrolysis of the biomass. The mass spectra obtained from the GC-
MS were converted into summed fractional labelling (SFL) patterns with the aid of the XCMS 
library operating within the R programming language environment (Smith et al. 2006). The 
SFL of a molecule or a fragment is identical to the sum of the fractional labelling of the 
carbon atoms contained in the molecule or fragment.  
 
The metabolic network consisted of 52 reactions, 6 of them are reversible and 25 balanced 
metabolites (see supplementary material S2). The fluxes were determined using an in-house 
program code in Matlab V 7.0.4 (Grotkjær et al. 2005), which implements the metabolic 
network analysis framework from Wiechert (2001). The algorithm minimises the differences 
between measured fluxes and calculated fluxes by least square minimisation, as well as 
measured and calculated SFL using the non-linear Levenberg-Marqueartd algorithm. 
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Measured fluxes were weighed with a standard deviation of 10 %. Multiple initial guesses 
were generated with a genetic algorithm to verify the existence of a global minimum. A 
sensitivity analysis was done by adding 10 % of Gaussian noise to the measured SFL data in 
50 simulations followed by calculating the standard deviation of the estimated fluxes. 
8.3.8 Analysis of transcription data 
8.3.8.1 Total RNA extraction 
Total RNA was extracted from 40-50 mg frozen mycelia. The mycelia were transferred to 
pre-cooled 2 ml Eppendorf tubes containing steel balls (2x  ∅2mm, 1x ∅5mm) and shaken in 
a Mixer Mill for 10 minutes at 4 °C. The resulting powder was used for total RNA extraction 
using the Qiagen RNA easy kit, according to the protocol for isolation of total RNA from plant 
and fungi.  
The quality of the extracted total RNA of each sample was analysed using the Bioanalyser 
2100 (Agilent technologies Inc., Santa Clara, CA, USA) and the quantity of the extracted total 
RNA was determined spectrophotometrically (Amersham Pharmacia Biotech, GE Healthcare 
Biosciences AB, Uppsala, Sweden). The total RNA was stored at -80 °C until further 
processing.  
8.3.8.2 Biotin labelled cRNA and microarray processing 
5 μg of total RNA was used for making 15 μg of fragmented biotin labelled cRNA that was 
hybridised to the 3AspergDTU gene chip (Affymetrix) according to the Affymetrix GeneChip 
Expression Analysis Technical Manual (Affymetrix 2007). The cRNA quality and quantity 
were analysed in the same way as the total RNA described above. A GeneChip fluidics 
Station FS-400 and a GeneChip scanner were used for hybridisation and scanning of the 
microarrays. The scanned probe array images were converted to .CEL files using the 
GeneChip Operating Software (Affymetrix). Affymetrix CEL-data files were pre-processed 
using the statistical language and environment R (R Development Core Team 2007). The 
probe intensities were normalised for background using the robust multiarray average (RMA) 
method (Irizarry et al. 2003) only using perfect match (PM) probes. Subsequently, 
normalisation was performed using the quantiles algorithm (Bolstad et al. 2003). Gene 
expression values were calculated from the PM probes with the medianpolish summary 
method (Irizarry et al. 2003). All statistical pre-processing methods were used by invoking 
them through the Affymetrix package (Gautier et al. 2004). 
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Statistical analysis was applied to determine genes subject to differential transcriptional 
regulation. The limma package (Smyth 2004) was used for all statistical analyses. Moderated 
t-tests between the sets of experiments were used for pair-wise comparisons. Empirical 
Bayesian statistics were used to moderate the standard errors within each gene and 
Benjamini-Hochberg’s method (Benjamini and Hochberg 1995) was used to adjust for multi-
testing. A cut-off value of adjusted p<0.05 was used for statistical significance. The 
significantly expressed genes can be found in supplementary material S1. 
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8.4 Results and Discussion  
Because most living cells are capable of using a large variety of compounds as carbon, 
energy and nitrogen sources, they contain complementary pathways that serve similar 
functions when they operate at the same time. The glyoxylate bypass can be seen as a 
bypass pathway of the TCA cycle, because the two pathways share a number of similar 
reactions. In prokaryotes these two pathways are both present in the cytosol, while in 
eukaryotes compartmentalisation separates them. The TCA cycle is located in the 
mitochondria, in contrast to the glyoxylate bypass that operates either in the cytosol or in 
microbodies. Although these pathways follow the same reactions they serve very different 
purposes. The TCA cycle serves as an oxidizing pathway where pyruvate is converted to 
carbon dioxide, whereas the glyoxylate bypass has the purpose of synthesizing precursor 
metabolites anaplerotically, e.g. net production of oxaloacetate from acetyl-CoA. The 
glyoxylate bypass basically consists of only two enzymes: isocitrate lyase (ICL, EC 4.1.3.1) 
and malate synthase (MS, EC 2.3.3.9) (Kornberg and Krebs 1957). ICL catalyses the 
cleavage of isocitrate to succinate and glyoxylate and hence, isocitrate is a branch point 
metabolite between the TCA cycle and the glyoxylate bypass. MS catalyses the 
condensation of acetyl-CoA and glyoxylate to form malate. This anaplerotic reaction enables 
a net synthesis of C4 carboxylic acids from a carbon source of C2 compounds like acetate or 
fatty acid derived acetyl-CoA (Kornberg 1966).  In the present study the icl gene was over-
expressed in order to stimulate the glyoxylate bypass flux and thereby produce more 
succinate and malate in A. niger.   
8.4.1 Comparison WT and ICL over-expression strains 
The wild-type strain and the ICL over-expression mutant were grown in batch cultures with 
glucose as carbon source. Metabolic fluxes were determined, as well as the global 
transcription response using DNA microarrays. Based on the data, 1,511 significantly 
changed genes were identified using a moderated t-test. The list of significantly changed 
genes is given in supplementary material S1.  
 
The metabolic flux analysis showed that in the ICL over-expression strain the flux towards 
the PPP is reduced (Figure 8.1). The total flux through the glycolysis was increased. At the 
branch point towards serine synthesis a higher flux towards serine was measured in the ICL 
over-expression strain compared to the WT strain. Figure 8.1 is a simplified representation of 
the stoichiometric metabolic model. The complete model can be found in supplementary 
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material S2. The microarray data support the decreased flux in the PPP since the genes in 
the PPP were significantly down-regulated. Furthermore, genes encoding glycolytic enzymes 
were up-regulated whereas gluconeogenic genes were down-regulated, supporting the 
increased glycolytic flux (Figure 8.1). Glycolysis is known to be important for citrate 
production since most of the citrate is produced via this pathway (Cleland and Johnsen 1954; 
Martin and Wilsen 1951; Legisa and Mattey 1986). Only a slight increase in citrate yield was 
found in the ICL over-expression strain (0.05 C-mol/C-mol glucose in the WT and 0.14 C-
mol/C-mol glucose in the ICL over-expression strain), indicating that the over-expression 
changed the flux distribution (Table 8.2). Looking at the fermentation profiles a higher citrate 
concentration was measured during the exponential growth phase (Figure 8.2). 
 
Table 8.2 Biomass and organic acid yields expressed in C-mol/C-mol glucose consumed 
 
Biomass Citric acid Oxalic acid Succinic acid Pyruvic acid Glycerol Fumaric acid
WT 0.37 0.05 0.016 0.003 0.0012 0.0032 0
WT + mal 0.23 0.08 0.030 0 0 0.0032 0
ICL 0.22 0.14 0.000 0 0.0033 0 0.058
ICL+mal 0.58 0.09 0.000 0 0.0025 0.0059 0.003  
 
WT = wild-type N402 strain, WT + mal = N402 strain with addition of 50 mM malonate, ICL = isocitrate 
lyase over-expression in the AB4.1 strain, ICL + mal = isocitrate lyase over-expression in the AB4.1 
strain with addition of 50 mM malonate 
 
For the TCA cycle a similar positive correlation between transcription and flux was not found. 
The flux through the TCA cycle was lower in the ICL over-expression strain compared to the 
wild-type strain, while expression of several of the TCA cycle genes was up-regulated. Over-
expression of the icl was not confirmed by the gene expression data. The expression levels 
of icl and ms were unchanged (fold change is 1.1). This is likely to be an artefact as a higher 
ICL enzyme activity was observed in the over-expression strain (Table 8.3).  
 
The fumarate reductase was found to be down-regulated, but nevertheless no succinate 
production was observed in the ICL over-expression strain (Table 8.2). Succinate production 
could result from up-regulation of the oxidative part of the TCA cycle and down-regulation of 
the gene encoding fumarate reductase. However, instead of producing succinate and malate, 
the estimated fluxes and measurements of the extracellular metabolite concentrations 
indicated that fumarate was over-produced. This suggests that instead of up-regulating the 
glyoxylate bypass by over-expressing the icl gene, the oxidative part of the TCA cycle is up-
regulated, creating a bottleneck in the TCA cycle, leading to fumarate production. 
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Figure 8.1 A simplified flux distribution model of the N402 and ICL over-expression strain (complete 
model see S2). The first number is the flux in the N402 strain and the second number (italic) is the flux 
in the ICL over-expression strain. G6P = glucose 6-phosphate, F6P = fructose 6-phosphate, GOL = 
glycerol, G3P = glyceraldehyde 3-phosphate, PEP = phosphoenolpyruvate, PYRcyt = cytosolic 
pyruvate, SER = serine, GLY = glycine, THR = threonine, OAAcyt = cytosolic oxaloacetate, CIT = 
citrate, ACCoAcyt = cytosolic acetyl-CoA, OXAcyt = cytosolic oxalate, ACCoAmit = mitochondrial 
acetyl-CoA, OAAcyt = mitochondrial oxaloacetate, AkGT = alfa-keto-glutarate, SUC = succinate, FUM 
= fumarate, MAL = malate. 
■ = up-regulation of gene expression levels, □ = down-regulation of gene expression levels. Unmarked 
reactions did not have any significant change in gene expression. 
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In comparison to the WT, the ICL over-expression strain produced more fumarate and 
pyruvate, and less oxalate and glycerol (Figure 8.1 and Table 8.2) indicating a clear shift of 
flux distribution in the TCA cycle.  
 
The in vitro enzyme activities measured in the ICL over-expression strain differed from the 
WT (Table 8.3). First, measurement of the ICL activity confirmed that the gene was over-
expressed in the ICL strain as the activity was higher. Although the MDH activity was 
reduced, no malate or succinate was produced. The PYC activity was increased in the ICL 
over-expression strain, which corresponds with the increased gene expression and elevated 
flux through this pathway. The expression of the gene encoding pyruvate dehydrogenase 
was also up-regulated, but this reaction showed a decreased flux in the ICL over-expression 
strain. Comparing the pyruvate carboxylase and pyruvate dehydrogenase flux at the 
pyruvate branch point in the ICL over-expression strain showed that the pyruvate 
dehydrogenase flux was higher than the carboxylase flux. Compared to the WT strain the 
ratio between dehydrogenase and carboxylase flux was found to be changed, but the 
dehydrogenase flux was still most dominant. This suggests that the oxidative TCA cycle is 
active, as this pathway requires both oxaloacetate and acetyl-CoA. The reduced flux through 
the TCA cycle in the ICL over-expression strain may be caused by a feedback regulation 
mechanism exerted at the level of the fumarase reaction that converts fumarate to malate. 
 
A slightly higher citrate production in the ICL over-expression strain is likely to be caused by 
an increased formation of oxaloacetate. The rate of the reaction catalysed by citrate 
synthase is controlled in vivo by the oxaloacetate concentration. Oxaloacetate first binds to 
the enzyme, followed by binding of acetyl-CoA (Kubicek and Rohr 1980; Papagianni 2007). 
Therefore, if more oxaloacetate is produced the production of citrate will also increase.  
 
The measured gene expression data between the WT and ICL over-expression strain 
showed also pathway regulations outside the central carbon metabolism. The gene 
expression changes were mapped against the stoichiometric model developed by Andersen 
et al. (2008). These analyses showed that the protein degradation pathway was significantly 
down-regulated, whereas the purine and pyrimidine pathways were up-regulated in the ICL 
over-expression strain. Purines and pyrimidines make up the two groups of nitrogenous 
bases, that are a crucial part of both deoxyribonucleotides and ribonucleotides. Aside from 
DNA and RNA, purines are biochemically significant components in a number of other 
important cellular metabolites such as ATP, GTP, cyclic AMP, NADH, and coenzyme A.  
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Since major changes were detected in the PPP and TCA cycle, which are pathways that are 
highly linked to redox reactions, it seems that the redox balance has been changed in the 
ICL over-expression strain. Fuhrer et al. (1980) showed that a remarkable constancy was 
found in the catabolic reduction charge (NADH/ (NADH + NAD)) and the anabolic reduction 
charge (NADPH/ (NADPH + NADP)) in A. niger grown at non-limited growth conditions. 
Furthermore, they observed that the ratio (NAD + NADH)/( NADP + NADPH) was constant 
over the whole culture time. In the growth phase of A. niger, the catabolic reduction charge 
has been found to be relatively high (0.10) and during citric acid accumulation this value was 
even higher. This may reflect the metabolic situation of growth-restricting conditions 
necessary for acidogenesis (Kubicek and Rohr 1977). Excessive NADH production under 
acidogenic conditions also requires high alternative oxidase activity (AOX) to maintain the 
redox balance and to limit the amount of ATP produced (Ruijter et al. 2002). Since a shift in 
organic acid production was detected in the ICL over-expression strain, a shift in the 
Figure 8.2 Fermentation profiles of the wild-type N402 strain and ICL over-expression strain with 
and without 50 mM malonate addition in glucose batches. ♦ = glucose, ■ = biomass, • = citrate, 
▲ = glycerol, ○ = oxalate 
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catabolic reduction charge is expected. This shift may result in an up-regulation of the purine 
and pyrimidine pathways. It has been proven that the levels of pyridine nucleotides are highly 
interdependent and their well-balanced ratios are necessary for optimal operation of the 
metabolic pathways (Fuhrer et al. 1980), indicating that in the ICL over-expression strain a 
new physiological state was achieved. It was also observed that the expression levels of 
genes involved in nitrogen metabolism were up-regulated, which can be linked to the need of 
nitrogen incorporation in the pyridine nucleotides. Also gene expression levels of other 
pathways requiring nitrogen were up-regulated like pathways leading to several amino acids 
and vitamins, e.g. the biotin pathway. These pathways mainly lead to biomass formation, 
however, in our experiments the biomass yield was not increased in the ICL over-expression 
strain. This indicates that up-regulation does not result in increased fluxes through these 
pathways.  
 
Table 8.3 Enzyme activities in U/mg measured in different A. niger strains 
 
ICL MDH CIT PYC
WT 0.26 0.016 0.10 0.013
WT + mal 0.1 0.012 0.07 0.031
ICL 0.38 0.009 0.14 0.023
ICL+ mal 0.47 0.003 0.06 0.029  
 
WT = wild-type N402 strain, WT + mal = N402 strain with addition of 50 mM malonate, ICL = isocitrate 
lyase over-expression in the AB4.1 strain, ICL + mal = isocitrate lyase over-expression in the AB4.1 
strain with addition of 50 mM malonate. 
ICL = isocitrate lyase, MDH = malate dehydrogenase, CIT = citrate synthase, PYC = pyruvate 
carboxylase 
8.4.2 Effect of malonate addition for SDH inhibition 
Malonate is known to be a competitive inhibitor of the succinate dehydrogenase. In rat and 
mammalian cells its inhibitory characteristics have been demonstrated (Ki values of 0.68 and 
0.018 mM, respectively) (Armson et al. 1995; Hatefi and Stiggall 1976). Since the enzyme 
assay for SDH was not sufficiently sensitive for analysis in the cell extracts of A. niger (most 
likely due to instability of the co-factor FAD) the inhibition constant of malonate on SDH could 
not be determined. Instead several concentrations of malonate were tested and the effect of 
malonate on growth was assessed (data not shown). The fact that A. niger is unable to grow 
anaerobically suggests that SDH is an essential enzyme required for cellular propagation. 
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Figure 8.3 A simplified flux distribution model of the wild-type N402 strain with and without 50 mM 
malonate addition (complete model see S2). The first number is the flux in the N402 strain and the 
second number (italic) is the flux in the N402 strain with 50 mM malonate added. G6P = glucose 6-
phosphate, F6P = fructose 6-phosphate, GOL = glycerol, G3P = glyceraldehyde 3-phosphate, PEP = 
phosphoenolpyruvate, PYRcyt = cytosolic pyruvate, SER = serine, GLY = glycine, THR = threonine, 
OAAcyt = cytosolic oxaloacetate, CIT = citrate, ACCoAcyt = cytosolic acetyl-CoA, OXAcyt = cytosolic 
oxalate, ACCoAmit = mitochondrial acetyl-CoA, OAAcyt = mitochondrial oxaloacetate, AkGT = alfa-keto-
glutarate, SUC = succinate, FUM = fumarate, MAL = malate. 
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Figure 8.4 A simplified flux distribution model of the ICL over-expression strain with and without 50 
mM malonate addition (complete model see S2). The first number is the flux in the ICL over-
expression strain and the second number (italic) is the flux in the ICL over-expression strain with 50 
mM malonate added. G6P = glucose 6-phosphate, F6P = fructose 6-phosphate, GOL = glycerol, G3P 
= glyceraldehyde 3-phosphate, PEP = phosphoenolpyruvate, PYRcyt = cytosolic pyruvate, SER = 
serine, GLY = glycine, THR = threonine, OAAcyt = cytosolic oxaloacetate, CIT = citrate, ACCoAcyt = 
cytosolic acetyl-CoA, OXAcyt = cytosolic oxalate, ACCoAmit = mitochondrial acetyl-CoA, OAAcyt = 
mitochondrial oxaloacetate, AkGT = alfa-keto-glutarate, SUC = succinate, FUM = fumarate, MAL = 
malate. 
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It was expected that inhibiting the SDH with malonate would inhibit the growth of A. niger. 
Indeed, it was observed that with increasing malonate concentrations the growth was limited. 
A malonate concentration of 50 mM was found to be suitable for partial inhibition of SDH 
without having a considerable effect on the growth of A. niger. This concentration is much 
higher than the Ki values in rat and mammals, suggesting that there is some inhibition of the 
SDH enzyme. In order to be sure that malonate was reaching the SDH inside the cell, the 
uptake of malonate was verified by measurement of the intracellular levels of malonate. 
Hereby the effect of inhibition of SDH in the WT and the ICL over-expression strain could be 
evaluated. The effect between the strains was found to differ significantly. 
 
Malonate addition affected the fluxes in the PPP and the fluxes towards amino acids (Figure 
8.3 and 8.4). When malonate was added in the WT strain the flux through the PPP was 
reduced and the flux towards amino acids was unchanged. In the ICL over-expression strain 
malonate addition caused an increase in the PPP flux. It was remarkable that in the ICL over-
expression strain the flux towards amino acids was already higher compared to the WT 
strain. This flux increased even more when malonate was added. This increase in amino acid 
synthesis and PPP flux was accompanied by a significantly higher biomass yield of 0.58 C-
mol biomass/C-mol glucose in the ICL over-expression strain when malonate was added, 
compared to 0.22 if no malonate was added (Table 8.2).  
 
When malonate was added, the flux towards glycerol was increased while the extracellular 
pyruvate flux was decreased in both the WT and the ICL over-expression strain. This 
indicates that malonate addition regulates cell metabolism not only in the TCA cycle, but also 
in glycolysis.  
 
At the pyruvate node, the flux ratio between pyruvate carboxylase (PYC) and pyruvate 
dehydrogenase (PDH) was changed. When malonate was added the flux through pyruvate 
carboxylase increased, and the flux ratio of PDH over PYC changed from 18 to 0.8 in the WT 
strain and from 3 to 0.2 in the ICL over-expression strain. This may indicate an increase in 
flux towards the reductive TCA cycle.  
 
In the WT strain, the flux through the TCA was not significantly changed by adding malonate 
and the extracellular organic acid profiles were also not significantly changed, except for 
citrate and oxalate (Figure 8.3 and Table 8.2). The increase in citrate flux upon addition of 
malonate did not relate to the 1.5 fold decrease in enzyme activity (Figure 8.3 and Table 8.3).  
In the ICL over-expression strain, the malonate addition did not lead to an increased flux 
towards citrate, rather a decreased flux (Figure 8.4). When icl was over-expressed an almost 
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20 times increase in fumarate yield was detected (Table 8.2). This might be caused by a 
limitation in the conversion from fumarate to malate. When malonate was added, the flux 
control was shifted due to inhibition of the SDH activity. Therefore, instead of fumarate more 
malate was produced. The malate was most likely produced in the cytosol before it was 
shuttled towards the extracellular medium or towards the mitochondria in exchange for 
citrate. Since the citrate production was reduced the capacity of shuttling malate towards the 
mitochondria was decreased leading to more malate excretion into the medium.  
 
The difference between the effect of malonate on the WT strain and ICL over-expression 
strain may be caused by a shift in flux control found in the metabolism. A strong flux control 
at the level of fumarase in the TCA cycle, caused by icl over-expression, was not present in 
the WT strain. The effect of SDH inhibition by malonate in the WT strain was therefore not 
effecting the fumarate and malate production, but instead increased the citrate and oxalate 
production. 
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8.5 Conclusion 
Over-expression of the icl gene was hypothesised to up-regulate the glyoxylate bypass 
resulting in production of more succinate and malate. The glyoxylate bypass is known to be a 
parallel pathway to the TCA cycle and by up-regulation of the glyoxylate bypass the flux 
through the TCA cycle was expected to decrease. Even though flux analysis showed a 
decreased flux through the TCA cycle, more fumarate was produced instead of malate and 
succinate. This change in organic acid profiles was caused by regulation within the TCA 
cycle and not by the glyoxylate bypass.  
 
A second method for stimulating the glyoxylate bypass was investigated. Malonate inhibits 
the SDH, which should lead to succinate production. The addition of malonate showed 
different cellular effects in both the WT and ICL over-expression strain. In the WT, the 
malonate addition resulted in more citrate and oxalate production, while in the ICL over-
expression strain more malate was produced.  
 
The combination of flux, gene expression, enzyme activity and metabolite production data 
gave a better understanding of the physiological behaviour of the cells and resulted in some 
unexpected outcomes. The hypothesized increase in glyoxylate bypass by over-expression 
of icl and its influence of succinate and malate showed distinct results. This shows that there 
is a coordinated regulation of fluxes through the glycolysis, the TCA cycle and different 
anapleorotic reactions, and redirection of the carbon fluxes therefore requires building better 
models for the overall regulation in these pathways.  
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Chapter 9  
Creation of a cytosolic reductive TCA cycle in Aspergillus 
niger – Heterologous gene insertion of fumarase and fumarate 
reductase 
 
Meijer S., Otero J., Olivares R., Andersen MR., Olsson L. and Nielsen J. 
Biocentrum-DTU, Center for Microbial Biotechnology, Denmark 
 
Aimed at Biotechnology and Bioengineering 
 
9.1 Abstract 
Metabolic engineering strategies were applied to shift the metabolism of A. niger towards more 
reduced organic acids like malate, fumarate and succinate instead of the citrate that is natively 
produced. The wild-type strain N402 and a strain unable to produce gluconic acid and oxalic acid 
(NW185) were compared. Additionally, the effect of the insertion of fumarase (fum) and fumarate 
reductase (frds) in the cytosol of both the N402 and NW185 strain was determined.  
Although a major shift in glycolysis between the strains N402 and NW185 has been detected 
earlier, in this study only minor differences were observed in the organic acid profiles, whereas the 
main difference was found in anabolism, showing clear differences in energy and redox 
requirements. 
The insertion of fum and frds in the cytosol of both strains led to major changes in the flux 
distribution and a significant increase in more reduced organic acids like malate, fumarate and 
succinate.  
 
Keywords: NW185 strain, fumarase, fumarate reductase, redox state, organic acids 
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9.2 Introduction 
Organic acids are valuable compounds that are widely used in the industry. They form important 
precursor molecules from which a lot of chemical compounds may be produced (Werpy and 
Petersen 2004). Some organic acids are used directly, e.g. in the food industry. In the last decades 
there has been a need to produce these organic acids more efficiently and environmentally 
friendly. With the increasing oil prices there is an increasing focus on developing sustainable 
biotech processes that can compete with traditional chemical synthesis. An example of an organic 
acid produced by a biological system is citrate, which is produced by fermentation of the 
filamentous fungus Aspergillus niger. This is an ancient production process that reaches high final 
product titers and yields, even competing with the natural extraction of citrate from lemons. More 
than 75 % of the citrate production is produced by biotechnological means (Kristiansen et al. 
1998).  
 
An economic forecast from 2004 predicted that also other organic acids like malic acid, fumaric 
acid and succinic acid are compounds that have high potential for biological production (Werpy and 
Petersen 2004). Ever since, there has been an interest in developing good hosts for production of 
these organic acids. Most attempts have been made in the model organism E. coli as E. coli is 
genetically easy to manipulate (Millard et al. 1996; Vermuri et al. 2002; Lin et al. 2005). Several 
groups have tried to design new production strategies in yeast and filamentous fungi. Arikawa et al. 
(1999) have studied the effect of single and multiple TCA cycle gene deletions on succinate 
production in S. cerevisiae. They observed that succinate was mainly formed by the cytosolic 
reactions of pyruvate carboxylase and malate dehydrogenase and the mitochondrial reactions of 
fumarase and fumarate reductase (reductive TCA cycle). In a medium optimisation study for 
improved succinate yields, it has been found that P. simplisicum has an organic acid transporter 
that favours succinate transport (Gallmetzer et al. 2002). This transporter is similar to the citrate 
transporter in A. niger, both resulting in an energy spilling process. A. flavus also produces 
succinate as a by-product in the malate production process, but due to its mycotoxin formation it is 
unsuitable for industrial applications.  
 
In the present study, the focus was on organic acid production in the filamentous fungus A. niger. 
The proposed strategy was to test several strains under defined conditions and to assess the effect 
of different genetic changes on the transcript profiles and flux patterns in relation to organic acid 
production. We investigated a wild-type (WT) strain and a strain that is unable to produce gluconic 
acid and oxalic acid (NW185). A second strategy was to insert two genes, fumarate reductase from 
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S. cerevisiae (frds) and fumarase from R. oryzae (fum), for cytosol expression in A. niger (Enomoto 
et al. 2002; Friedberg et al. 1995). These genes are believed to form a reductive TCA cycle in the 
cytosol that should be able to produce cytosolic fumarate and succinate. In the native genome 
these enzymes are expressed in the mitochondria (Andersen et al. 2008). Our physiological 
studies have not indicated an active reductive TCA pathway.  
 
A. niger has evolved to produce citrate. Firstly, malate is produced in the cytosol and then 
exchanged for mitochondrial citrate through an antiport mechanism over the mitochondrial 
membrane (Kubicek et al. 1988; Karaffa and Kubicek 2003). This observation, and the fact that A. 
niger is not able to grow anaerobically, made us believe that the reductive part of the TCA cycle is 
underdeveloped in this micro-organism. By a heterologous insertion of the reductive TCA cycle 
enzymes frds and fum in the WT and NW185 strain we aimed at diverting the flux towards these 
organic acids (malate, fumarate and succinate).  
 
The frds gene from S. cerevisiae has been shown to irreversibly convert cytosolic fumarate to 
succinate. A possible problem of using this enzyme in the present study is that it uses non-
covalently bound FAD as co-factor (Muratsubaki and Katsume 1985) and there is still a lack of 
knowledge of the FAD redox balance in A. niger. Additionally, it has been reported that FAD is 
oxygen sensitive, which might lead to a lack of this co-factor during aerobic fermentations. In this 
study, we did not insert the fumarase gene from S. cerevisiae since the kinetics of this enzyme 
favour the reaction from fumarate to malate (Peleg et al. 1990; Pines et al. 1997). Instead, the 
fumarase gene from R. oryzae was inserted, as this enzyme favours the reverse reaction. Because 
fumarase is normally a mitochondrial enzyme, the first 15 basepairs coding for the mitochondrial 
target sequence in R. oryzae were deleted (Friedberg et al. 1995). We supposed that oxygen 
limiting conditions will adequately mimic anaerobic fermentation conditions to stimulate the inserted 
reductive part of the TCA cycle and to stabilize the FAD+ availability in the cells. NaCO3 was used 
as base control, in order to stimulate carboxylation reactions. This has been shown to have an 
effect in other organic acid production processes like malate production in A. flavus, A. paraciticus 
and A. oryzae (Abe et al. 1962; Peleg et al. 1988). The consequence of adding NaCO3 is that we 
have to run the fermentation at higher pH for the carbonate to be dissolved. At higher pH A. niger 
is likely to produce gluconic acid and, therefore, we included the NW185 strain that is unable to 
produce gluconic acid and oxalic acid in the study.  
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9.3 Material and Methods 
9.3.1 Strains 
As a reference strain the laboratory strain N402 (cspA1 mutation) of Aspergillus niger was used. 
The NW185 strain (cspA1, fwnA1, goxC17, prtF28 mutation) was kindly donated by Peter Schaap 
(Wageningen University, Holland). This strain is deficient in gluconic and oxalic acid production 
(Ruijter et al. 1999). 
 
The fumarate reductase from S. cerevisiae (frds) and fumarase from R. oryzae (fum) were both 
fused to the A. nidulans gpdA promoter using fusion PCR. PCR was performed using the Expand 
High Fidelity PCR kit (Roche) according to the manufacturer’s recommendations. The primers 
used are shown in Table 9.1.  
 
Table 9.1 Primers used for fusion PCR of genes to be inserted in the cytosolic A. niger fraction 
Primer name Sequence
FumRs_up CGT CTG TCC GCC CGG TGT AAC AAC TCT CCT CGT CTT TTC AG
FumRs_down TTT AAT CCT TGG CAG AGA TCA TAT CTT C
FRDS_down2 TAT AGG ATC CGT TAC TTG CGG TCA    
FRDS_up CGT CTG TCC GCC CGG TGT ATG TCT CTC TCT CCC GTT GT
GpdA_up_ICL GCT GAT TCT GGA GTG ACC CAG AG
GpdA_down_ICL  ACA CCG GGC GGA CAG ACG  
The underlined letters are the overlapping genetic elements used for fusion PCR. The other letters are the 
actual primer sequences. 
 
All PCR products were purified from agarose gels using illustra™ DNA and Gel band purification kit 
(GE Healthcare). 2-3 μg of the purified fusion PCR fragments were used to co-transform both 
genes, applying the protoplast and transformation procedures for A. niger as described previously 
for A. nidulans (Nielsen et al. 2006). In order to confirm gene insertion and expression a semi-
quantitave reverse transcriptase PCR reaction was performed using the SuperScript III OneStep 
RT-PCR kit (Invitrogen) following the manufacturer’s protocol. The primers used were GpdA_up 
and FumRs_down for the fumarase detection and GpdA_up and FRDS_down2 for the fumarate 
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reductase detection (Table 9.1). Both genes were shown to be expressed based on this RT-PCR 
reaction.  
9.3.2 Cultivation conditions 
Before spore harvesting with 0.01 % w/w Tween-80, the pre-culture plates were incubated for 4-7 
days at 30 ºC. These culture plates consisted of a defined medium containing 10 g/L D-glucose, 50 
ml salt solution, 1 ml trace element solution 1 and 18 g/L agar. Salt solution contained the 
following: 120 g/L NaNO3, 10.4 g/L KCl, 10.4 g/L MgSO4 ⋅ 7 H2O and 30.4 g/L KH2PO4. Trace 
element solution 1 contained the following: 22 g/L ZnSO4 ⋅ 7 H2O, 11 g/L H3BO3, 5 g/L MnCl2 ⋅ 2 
H2O, 5 g/L FeSO4 ⋅ 7 H2O, 1.7 g/L CoCl2 ⋅ 6 H2O, 1.6 g/L CuSO4 ⋅ 5 H2O, 1.5 g/L Na2MoO4 ⋅ 2 H2O 
and 50 g/L Na4EDTA. The spores were propagated on these culture plates at pH 6.5  
 
Subsequently 109 spores were inoculated in 3 L Braun bioreactors with a working volume of 2L. 
The batch cultivations were carried out in a chemically defined medium adjusted initially to pH 2.5 
containing 10 g/L glucose, 10 g/L NaNO3, 3 g/L KH2PO4, 2 g/L MgSO4 ⋅ 7 H2O, 2 g/L NaCl, 0.2 g/L 
CaCl2 ⋅ 2H2O, 0.5 ml/L antifoam (sb2121) and 1 ml/L trace element solution 2. Trace element 
solution 2 contained the following: 14.3 g/L ZnSO4 ⋅ 7 H2O, 2.5 g/L CuSO4 ⋅ 5 H2O, 0.5 g/L NiCl2 ⋅ 6 
H2O, 7 g/L MnCl2 ⋅ 2 H2O and 13.8 g/L FeSO4 ⋅ 7 H2O.  
 
For the flux experiments the same cultivation conditions were used as in the other batch 
cultivations. The only changes in these cultivations were that 5 g/L 1-13C glucose labelled substrate 
was used in a total volume of 200 mL.  
 
In all cultivations the temperature was maintained constant at 30 ºC and the pH was controlled by 
automatic addition of 1 M NaCO3 and 2 M HCl. Two Rushton four-blade disc turbines were used 
for homogeneous mixing. No baffles were used in the reactors thereby reducing the surface area 
available for biofilm formation. The initial aeration rate, agitation and pH were 0.2 vvm, 200 rpm 
and pH 2.5, respectively. They were gradually changed after germination (that takes place after 
approximately 15 hours) to 0.02 vvm, 700 rpm and pH 5, respectively. These parameters were 
kept constant throughout the rest of the batch cultivation.  Air was used for sparging and the 
concentrations of oxygen and carbon dioxide in the exhaust gas were monitored by an acoustic 
gas analyser (Brüel & Kjær, Nærum, Denmark). The dissolved oxygen tension (DOT) was 
measured with an oxygen probe (Mettler Toledo sensors). 
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9.3.3 Sampling 
Biomass samples were taken manually from the reactor. For dry weight measurements, a known 
cell culture volume was filtered through a pre-weighed nitrocellulose filter (pore size 45 μm, Pall 
Corporation). The filtrate was frozen immediately and later used for the determination of the 
concentrations of substrate and extracellular metabolites. The filter was washed with 0.9 % w/v 
NaCl, dried for 15 min in a microwave oven at 150 W and weighed again to determine the biomass 
concentration. 
 
For determination of in vitro enzyme activities, flux analysis and microarray analysis, biomass 
samples were filtered through a nitrocellulose filter (pore size 45 μm, Pall Corporation) and washed 
with 0.9 % w/v NaCl. The filter cake (± 1 g) was immediately frozen in liquid nitrogen and stored at 
-80 ºC. 
9.3.4 Substrate and extracellular metabolite quantification 
High-performance liquid chromatography was used for the quantification of extracellular sugars 
and organic acids. Glucose, acetate, pyruvate, citrate, ethanol, succinate, fumarate, malate, 
glycerol and oxalate concentrations were measured on an Aminex HPX-87H cationic exchange 
column (BioRad, Hercules, California) eluted at 60 ºC with 5 mM H2SO4 at a flow rate of 0.6 
mL/min. Metabolites were detected with both a refractive index detector and a UV detector. 
9.3.5 Analysis of in vitro enzyme activities 
The frozen samples were crushed on liquid nitrogen with a mortar. The crushed biomass (0.5 g) 
was solved in 2 ml of extraction buffer containing 25 mM MES-NaOH, 0.1 mM EDTA, 0.1 mM DTT, 
0.1 mM phenylmethylsulfonyl fluoride and 0.1 mM NaN3. This solution was transferred to 2 mL 
FastPrep tubes containing 0.5 mL glass beads (0.75-1 mm). The FastPrep tubes were processed 3 
times 10 s on a FastPrep FP120 Instrument (Savant Instruments, New York), at speed setting 5, 
with cooling on ice in between each cycle. After disruption, the samples were centrifuged at 13,000 
g at 4 ºC for 10-20 min, and the supernatants were analysed for enzyme activity. 
 
Enzyme assays were performed at 30 °C using a HP8453 UV-visible light spectrophotometer. In 
order to test the linearity of the assays, the reactions were performed with 2-3 different dilutions of 
cell extract. The specific enzyme activities were expressed in micromoles minute-1 milligram-1 
(U/mg). The amount of protein was determined by the Bradford method with bovine serum albumin 
as the standard (Bradford 1976). Four different enzyme activities were measured: citrate synthase 
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(CIT), malate dehydrogenase (MDH), isocitrate lyase (ICL) and pyruvate carboxylase (PYC) as 
described by Meijer et al. (2007).    
9.3.6 Determination of intracellular flux distribution 
9.3.6.1 Sample preparation and derivatisation for flux analysis  
35-50 mg of biomass was dissolved in 600 μl 6M HCl and kept overnight at 105 ºC for hydrolysis. 
The hydrolysate was then centrifuged for 5 minutes at 15,000 rpm and the supernatant was 
transferred into new vials. The supernatant was dried for 3 hours at 105 ºC and dissolved in 200 μl 
milliQ water.  
 
In the mean time, the resin bed for solid phase extraction was prepared by weighing 1 g of Dowex 
cation exchange resin and mixed it with 15 mL of 50 % w/w glycerol. One mL of resin solution was 
added to a syringe containing a frit on a SPE workstation. When the resin was settled at the bottom 
of the syringe, the excess of glycerol was drained and a second frit was added on top of the resin. 
Two mL of biomass hydrolysate was added on the SPE column. After the biomass had trickled 
through the column, 1 mL of 50 % v/v ethanol solution was added followed by 200 μl 1M NaOH 
solution, which washed the remaining unbound compounds off the column. Finally, the amino acids 
were eluted with 1 mL of solution containing 1 % w/v NaOH in saline (0.9 % w/v NaCl), ethanol and 
pyridine in a ratio of 9:5:1, respectively. The eluted amino acids were derivatised by 
ethylchloroformate (ECF) derivatisation and dimethylformamide dimethylacetal (DMF/DMA) 
derivatisation, respectively.  
 
In the ECF derivatisation, 50 μl ECF was added to 500 μl amino acid solution and mixed in two 
sequential rounds of 30 s. Next, 200 μl propylacetate was added and finally 50 μl 1 M HCl. The 
upper organic layer was removed and analysed by GC-MS. 
 
The DMF/DMA derivatisation required the addition of 300 μl 1M HCl to 500 μl amino acid solution 
followed by a 2-4 hours drying period at 105 ºC. 200 μl DMF/DMA and 200 μl acetonitrile were 
then added to dissolve the dried substance and mixed well for 30 s. This solution was kept at 100 
ºC for 20 minutes and was subsequently transferred to -20 ºC for 10 minutes to ensure proper 
derivatisation. This solution was finally analysed by the GC-MS. 
9.3.6.2 GC-MS analysis 
GC-MS analysis was performed on an Agilent (Palo Alto, CA, USA) HP 6890 gas chromatograph 
coupled to a HP 5973 quadrupole mass selective detector in positive electron impact ionization 
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(EI+) operated at an electron energy of 70 eV. The GC was equipped with a 4.0 mm i.d. Siltek 
gooseneck splitless deactivated liner (Restek, Bellefonte, PA, USA), and a Supelco (Bellefonte, 
PA, US) SLB-5 MS column, 15 m, 0.25 mm i.d., 0.25 µm film. Helium of a purity of 99.999 % was 
used as carrier gas at a constant linear gas velocity of 35 cm/s. Transfer line temperature was 280 
ºC, quadrupole temperature 150 ºC and MS source 200 ºC. The GC-MS system was controlled 
from Agilent MSD Chemstation v. D.01.02.16. For both methods (ECF and DMF/DMA) 1 µL 
sample was injected in the splitless (30 sec, split 1:20) mode at 200 ºC using a hot needle. The MS 
scan range was m/z 40-400 with 2.88 s/scan. To avoid sample carry-over the syringe was cleaned 
using five times 5 µL acetone, then five times 5 µL dichloromethane and finally 3 times rinsing with 
3 µL sample.  
9.3.6.2.1 ECF derivatives  
The oven temperature was initially held at 75 °C for one min. Hereafter, the temperature was 
raised with a gradient of 40 °C/min until 165 °C, after which the temperature increase was 4 °C/min 
until 190 °C and 40 °C/min up to 240 °C. Finally, the temperature was increased to 260 °C with a 
gradient of 4 °C/min and held constant for 4 minutes. The flow through the column was held 
constant at 1.3 mL He/min. The temperature of the inlet was 200 °C, of the interface 280 °C and of 
the quadrupole 105 °C.  
9.3.6.2.2 DMF/DMA derivatives 
Initially the oven temperature was held at 60 °C for one min. Hereafter, the temperature was raised 
with a gradient of 20 °C/min until 130 °C, after which the temperature increase was 4 °C/min until 
150 °C and  40 °C/min up to 260 °C. Next, the temperature was held constant for 4.25 minutes. 
The flow through the column was held constant at 1 mL He/min. The temperature of the inlet was 
230 °C, of the interface 270 °C and of the quadrupole 105 °C. 
9.3.6.3 Metabolic network analysis 
The flux analysis was based on the labelling patterns of derivatives of glucose and amino acids 
obtained from acid hydrolysis of the biomass. The mass spectra obtained from the GC-MS were 
converted into summed fractional labelling (SFL) patterns with the aid of the XCMS library 
operating within the R programming language environment (Smith et al. 2006). The SFL of a 
molecule or a fragment is identical to the sum of the fractional labelling of the carbon atoms 
contained in the molecule or fragment.  
 
The metabolic network consisted of 52 reactions, 6 of them are reversible and 25 are balanced 
metabolites (Supplementary materials S2). The fluxes were determined using an in-house program 
code in Matlab V 7.0.4 (Grotkjær et al. 2005), which implements the metabolic network analysis 
framework from Wiechert (2001). The algorithm minimises the differences between measured 
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fluxes and calculated fluxes by least square minimisation, as well as measured and calculated SFL 
using the non-linear Levenberg-Marqueartd algorithm. Measured fluxes were weighed with a 
standard deviation of 10%. Multiple initial guesses were generated with a genetic algorithm to 
verify the existence of a global minimum. A sensitivity analysis was done by adding 10% of 
Gaussian noise to the measured SFL data in 50 simulations followed by calculating the standard 
deviation of the estimated fluxes. 
9.3.7 Analysis of transcription data 
9.3.7.1 Total RNA extraction 
Total RNA was extracted from 40-50 mg frozen mycelia. The mycelia were transferred to pre-
cooled 2 ml Eppendorf tubes containing steel balls (2x  ∅2mm, 1x ∅5mm) and shaken in a Mixer 
Mill for 10 minutes at 4 °C. The resulting powder was used for total RNA extraction using the 
Qiagen RNA easy kit, according to the protocol for isolation of total RNA from plant and fungi.  
The quality of the extracted total RNA of each sample was analysed using the Bioanalyser 2100 
(Agilent technologies Inc., Santa Clara, CA, USA) and the quantity of the extracted total RNA was 
determined spectrophotometrically (Amersham Pharmacia Biotech, GE Healthcare Biosciences 
AB, Uppsala, Sweden). The total RNA was stored at -80 °C until further processing.  
9.3.7.2 Biotin labelled cRNA and microarray processing 
5 μg of total RNA was used for making 15 μg of fragmented biotin labelled cRNA that was 
hybridised to the 3AspergDTU gene chip (Affymetrix) according to the Affymetrix GeneChip 
Expression Analysis Technical Manual (Affymetrix 2007). The cRNA quality and quantity were 
analysed in the same way as the total RNA described above. A GeneChip fluidics Station FS-400 
and a GeneChip scanner were used for hybridisation and scanning of the microarrays. The 
scanned probe array images were converted to .CEL files using the GeneChip Operating Software 
(Affymetrix). Affymetrix CEL-data files were pre-processed using the statistical language and 
environment R (R Development Core Team 2007). The probe intensities were normalised for 
background using the robust multiarray average (RMA) method (Irizarry et al. 2003) only using 
perfect match (PM) probes. Subsequently normalisation was performed using the quantiles 
algorithm (Bolstad et al. 2003). Gene expression values were calculated from the PM probes with 
the medianpolish summary method (Irizarry et al. 2003). All statistical pre-processing methods 
were used by invoking them through the Affymetrix package (Gautier et al. 2004). 
 
Statistical analysis was applied to determine genes subject to differential transcriptional regulation. 
The limma package (Smyth 2004) was used for all statistical analysis. Moderated t-tests between 
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the sets of experiments were used for pairwise comparisons. A 2x2 ANOVA design was used to 
assess the effects of the strain, the insertion of the fumarate pathway and an additive effect. For all 
analyses, empirical Bayesian statistics were used to moderate the standard errors within each 
gene and Benjamini-Hochberg’s method (Benjamini and Hochberg 1995) to adjust for multi-testing. 
A cut-off value of adjusted p<0.05 was for statistical significance. The complete list of significant 
genes is given as Supplementary materials S3. 
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9.4 Results and discussion 
A physiological characterisation was made in order to map possible shift in metabolic behaviour 
towards production of more reduced organic acids comparing four different strains. The 
physiological state of these strains, fermented under the same conditions, was determined at 
different levels. Gene expression levels were compared to enzyme activities, metabolite 
concentrations and metabolic fluxes. The two strains compared in this study were the wild-type 
N402 strain and the mutated strain NW185 (unable to produce oxalate and gluconate). 
Furthermore, the effect of inserting two genes (fum and frds) on organic acid production was 
evaluated.  
9.4.1 Comparison between N402 and NW185 
The physiological state of N402 was significantly altered compared to NW185. Figure 9.1 gives an 
overview of the flux and gene expression changes in the central carbon metabolism of both strains. 
This figure is only a simplified representation of the stoichiometric metabolic model used for flux 
simulations. The complete model can be found in the supplementary material S2. The fluxes 
showed a correlation with the expression data in the upper part of the central carbon metabolism 
(PPP and upper part of glycolysis). Deviations were mainly found in the lower part of the glycolysis, 
where the flux is reduced in NW185 compared to N402. In line with the flux analysis, expression of 
genes involved in the lower part of the glycolysis and the oxidative part of the TCA cycle was 
significantly down-regulated in the NW185 strain (Figure 9.1). 
 
At the pyruvate node a more pronounced change in flux pattern was detected between the two 
strains. The N402 strain obviously favoured flux through the pyruvate dehydrogenase (145.9 in the 
N402 strain and 17.0 in the NW185 strain), in contrast to the NW185 strain, which preferred the 
pyruvate carboxylase (8.2 in the N402 strain and 106.5 in the NW185 strain) (Figure 9.1). Looking 
at the enzyme activity of the pyruvate carboxylase (PYC), no difference could be detected in 
activity between the two strains (Table 9.2). Also the gene expression level was not significantly 
changed for this enzyme. Therefore, if the flux through PYC in NW185 was indeed higher 
compared to N402, post-translational modifications or metabolic regulation must be responsible for 
this increase. In case of a higher flux through this pathway would result in more oxaloacetate being 
formed. In the NW185 strain, this excess of oxaloacetate cannot be converted to oxalate, since this 
strain is unable to produce oxalate and therefore the oxaloacetate needs to be converted to other 
compounds. Since A. niger is well known for its organic acid production, it was expected that other 
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organic acids would be overproduced (Kubicek et al. 1989). However, none of the other TCA 
organic acids were produced significantly higher compared to the N402 strain (Table 9.3).  
 
Table 9.2 Enzyme activities in U/mg measured in different A. niger strains 
 
ICL MDH CIT PYC
WT 0.26 0.016 0.100 0.013
NW185 0.83 0.005 0.160 0.011
WT + FF 0.16 0.015 0.047 0.023
NW185 + FF 0.50 0.020 0.043 0.025  
 
WT = wild-type N402 strain, NW185 = NW185 strain unable to produce gluconate and oxalate,  
WT + FF = wild-type N402 strain with cytosolic fumarase and fumarate reductase genes inserted, NW185 + 
FF = NW185 strain with  cytosolic fumarase and fumarate reductase genes inserted. 
ICL = isocitrate lyase, MDH = malate dehydrogenase, CIT = citrate synthase, PYC = pyruvate carboxylase 
 
The production profiles of organic acids derived from the TCA cycle differed only slightly  between 
the two strains. The NW185 strain produced small amounts of fumarate (5 mg/L), while the N402 
strain produced more citrate (1.2 g/L) (Figure 9.1 and Table 9.3). An increase in pyruvate excretion 
could be observed in the NW185 strain (0.2 g/L) (Table 9.3). This suggests that accumulation of 
intracellular pyruvate might occur, promoting the secretion of pyruvate. Another significant 
difference between the two strains was observed in the flux towards glycerol. The measured 
extracellular glycerol concentration was three times higher in the NW185 strain. The increase in 
both pyruvate and glycerol production indicates a metabolic limitation in the glycolysis leading to a 
higher excretion of these metabolites in the NW185 strain. 
 
Looking at the enzyme activities, it was observed that the ICL activity was much higher in the 
NW185 strain than in the N402 strain (Table 9.2). Unfortunately, the flux through the glyoxylate 
cycle could not be determined with the method used. Therefore, it could not be verified if the higher 
enzyme activity was associated with a higher flux. However, a higher enzyme activity would 
suggest a higher flux through this pathway. Additionally, the expression data confirmed that ICL 
was up-regulated, giving an indication that the glyoxylate pathway was more active in the NW185 
strain. All significantly expressed genes were plotted in the stoichiometric metabolic model from 
Andersen et al. (2008), which also showed an elevated ICL gene expression levels. The MDH 
activity was significantly lower in the NW185 strain. This does not seem to have an obvious effect 
on the flux through this enzyme, and moreover, the lower enzyme activity was not confirmed by the 
expression data (Table 9.2 and 9.3).   
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Table 9.3 Biomass and organic acid yields expressed in C-mol/C-mol glucose consumed 
Biomass Citric acid Oxalic acid Succinic acid Pyruvic acid Glycerol Fumaric acid
WT 0.37 0.14 0.0157 0.0029 0.0012 0.0032 0
NW185 0.49 0.08 0.0000 0.0024 0.0047 0.0096 0.001
WT + FF 0.29 0.10 0.0024 0.0096 0 0.0041 0.008
NW185 + FF 0.41 0.01 0.0000 0.0061 0.0042 0 0.020  
 
WT = wild-type N402 strain, NW185 = NW185 strain unable to produce gluconate and oxalate, WT + FF = 
wild-type N402 strain with cytosolic fumarase and fumarate reductase genes inserted, NW185 + FF = 
NW185 strain with  cytosolic fumarase and fumarate reductase genes inserted 
 
It was found that over 1000 genes were significantly changed comparing the expression levels in 
N402 and NW185 (in S3, the 1000 most significantly changed genes are listed). Using the 
microarray data, pathway changes outside the central carbon metabolism could be detected. The 
surprisingly good correlation between the flux and microarray data in the central carbon 
metabolism, also seen in other micro-organisms (Cakir et al. 2007; Schilling et al. 2007), provided 
a good basis for elaborating on other parts of the metabolism based on the expression data. The 
significantly expressed genes were plotted in the stoichiometric model of Andersen et al. (2008) 
and showed that other parts of the metabolism were significantly changed as well (data not 
shown). For example the protein degradation pathway in the NW185 strain was up-regulated. The 
pyrimidine and purine synthesis together with amino acid pathways were down-regulated. At the 
same time down-regulation of RNA synthesis genes and ribosomal genes was detected in the 
NW185 strain. Also mitochondrial carriers were down-regulated. The combination of these gene 
expression changes indicate that the metabolic activity and, therefore, also the total energy 
requirement in the NW185 strain was reduced. This reduced energy requirement can again be 
correlated to the down-regulation of the TCA cycle that is coupled to the electron transport chain. 
The electron transport chain is the main regeneration pathway of redox equivalents, since A. niger 
is an absolute aerobic micro-organism needing its respiratory chain for survival. This reduced need 
for regeneration of redox equivalents is an indication that the redox balance was less disturbed in 
the NW185 or, that the NW185 strain needs less redox equivalents for maintaining its cellular 
state. This could have led to an increased biomass yield. The NW185 strain reached a biomass 
yield of 0.49 C-mol biomass / C-mol glucose, while the N402 strain reached only 0.37 C-mol 
biomass / C-mol glucose. 
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Figure 9.1 A simplified flux distribution model of the N402 and NW185 (complete model see S2). The first 
number is the flux in the N402 strain and the second number (italic) is the flux in the NW185 strain. G6P = 
glucose 6-phosphate, F6P = fructose 6-phosphate, GOL = glycerol, G3P = glyceraldehyde 3-phosphate, 
PEP = phosphoenolpyruvate, PYRcyt = cytosolic pyruvate, SER = serine, GLY = glycine, THR = threonine, 
OAAcyt = cytosolic oxaloacetate, CIT = citrate, ACCoAcyt = cytosolic acetyl-CoA, OXAcyt = cytosolic 
oxalate, ACCoAmit = mitochondrial acetyl-CoA, OAAcyt = mitochondrial oxaloacetate, AkGT = alfa-keto-
glutarate, SUC = succinate, FUM = fumarate, MAL = malate. 
■ = up-regulation of gene expression levels, □ = down-regulation of gene expression levels. Unmarked 
reactions did not have any significant change in gene expression. 
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9.4.2 Comparison of N402 with and without gene insertions 
The fumarate reductase from S. cerevisiae and the fumarase from R. oryzae were inserted into the 
genome of A. niger N402. The gene insertions significantly changed the expression profiles of 965 
genes (see S3). These insertions created a cytosolic pathway towards succinate in the cytosol of 
A. niger. Insertion of the genes resulted in a decreased flux towards the PPP and an increased flux 
through the glycolysis (Figure 9.2). The PPP is an essential pathway for NADPH regeneration, 
which is an important redox equivalent necessary for biomass production (Poulsen et al. 2005). 
Due to the reduction in the PPP flux the biomass yield in the strain with the genes inserted was 
reduced. For the strain without and with heterologous genes, respectively, the biomass yields were 
0.37 and 0.29 C-mol biomass / C-mol glucose, respectively (Table 9.3). Furthermore, in the strain 
with the heterologous genes inserted there were increased fluxes from 3-phosphoglycerate 
towards serine biosynthesis (Figure 9.2). This resulted in a decreased flux through the lower part of 
the glycolysis. At the pyruvate node the pyruvate carboxylase reaction was clearly preferred when 
the two genes were inserted, probably the gene insertion provided a pathway where the 
carboxylated pyruvate could be further converted to malate, fumarate and succinate in the cytosol. 
Thus, the expression of frds and fum allowed for further conversion of malate to fumarate and 
succinate, instead of transporting malate into the mitochondria. Due to a drain of pyruvate into the 
new pathway, the flux towards extracellular pyruvate was decreased. As a response the malate 
transporter, transporting malate from the cytosol to the mitochondria, was up-regulated. 
Additionally, an increased expression level of the succinate thiokinase was observed, which also 
may have contributed to an increased succinate production. 
 
Overall, the metabolic changes led to a three times increase in extracellular succinate levels. It was 
not determined if the majority of the succinate was built inside the mitochondria due to a shuttling 
of malate into the mitochondria and a higher expressed succinate thiokinase, or whether it was 
formed by the cytosolic pathway. Unfortunately, the enzyme activities of the inserted genes could 
not be determined due to unstable cofactors and separation difficulties between native and 
heterologous enzyme activity and kinetic properties. The overall production of reduced organic 
acids like fumarate and succinate was significantly increased in the strain with the gene insertions. 
This is in contradiction with the results obtained by Jongh (2006), who found more citrate and 
oxalate production when these genes were inserted. Even though the same strain was used, an 
explanation for the difference in results could be the substantial difference in cultivation conditions 
between the present study and the one by de Jongh. We used a more complete medium compared 
to the medium used by Jongh (2006). In our medium the pH was set to 5 instead of 3.5 and 
controlled with NaCO3 instead of NaOH.  
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Figure 9.2 A simplified flux distribution model of the N402 and N402 with heterologous fum and frds 
inserted.(complete model see S2). The first number is the flux in N402 and the second number (italic) is the 
flux in N402 with heterologous fum and frds inserted. G6P = glucose 6-phosphate, F6P = fructose 6-
phosphate, GOL = glycerol, G3P = glyceraldehyde 3-phosphate, PEP = phosphoenolpyruvate, PYRcyt = 
cytosolic pyruvate, SER = serine, GLY = glycine, THR = threonine, OAAcyt = cytosolic oxaloacetate, CIT = 
citrate, ACCoAcyt = cytosolic acetyl-CoA, OXAcyt = cytosolic oxalate, ACCoAmit = mitochondrial acetyl-
CoA, OAAcyt = mitochondrial oxaloacetate, AkGT = alfa-keto-glutarate, SUC = succinate, FUM = fumarate, 
MAL = malate. 
■ = up-regulation of gene expression levels, □ = down-regulation of gene expression levels. Unmarked 
reactions did not have any significant change in gene expression. 
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Also the aeration was lower in our study. We can conclude that the medium composition and 
fermentation conditions have a major influence on the physiological behaviour during the 
cultivations. 
 
In this study the extracellular citrate concentration was not increased in the strains harbouring gene 
insertions (Table 9.3). Also the enzyme activity of CIT was not increased in comparison with the 
N402 strain (Table 9.2). Only an increased pyruvate carboxylase activity could be detected (0.013 
and 0.023 U/mg protein, respectively). Therefore, we assume that malate was mainly converted 
towards fumarate and succinate in the cytosol and not transported into the mitochondria. This was 
confirmed by the increase in extracellular concentrations of these two compounds (Table 9.3), 
since the transport of malate into mitochondria would most likely produce more citrate (Jongh 
2006).  
9.4.3 Comparison of NW185 with and without gene insertions 
The same genes as inserted in the N402 strain were inserted in the NW185 strain. The gene 
insertions had only a small effect on the gene expression levels of NW185. Only 5 genes were 
significantly changed in their expression level (see S3). These genes were not located in one 
specific part of the metabolism. In contrast, the fluxes were significantly changed, as well as the 
enzyme activities and extracellular metabolite concentrations. 
The flux through the PPP was significantly decreased when the two heterologous genes were 
inserted in the genome of the NW185 strain. As a consequence the flux in the glycolysis was 
increased. Furthermore, insertion of the two heterologous genes led to an increased flux towards 
serine biosynthesis and a small decrease in flux through the pyruvate carboxylase reaction (Figure 
9.3). 
 
The pyruvate carboxylase enzyme activity measured in both NW185 strains was comparable and 
the gene expression of this enzyme was not found to be changed (Table 9.2 and Figure 9.3). 
Considering these results and the extracellular metabolite profiles, it is believed that the flux 
through this pathway was not decreased, but rather similar to the flux in the NW185 strain without 
gene insertions. 
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Figure 9.3 A simplified flux distribution model of the N402 and N402 with heterologous fum and frds 
inserted.(complete model see S2). The first number is the flux in N402 and the second number (italic) is the 
flux in N402 with heterologous fum and frds inserted. G6P = glucose 6-phosphate, F6P = fructose 6-
phosphate, GOL = glycerol, G3P = glyceraldehyde 3-phosphate, PEP = phosphoenolpyruvate, PYRcyt = 
cytosolic pyruvate, SER = serine, GLY = glycine, THR = threonine, OAAcyt = cytosolic oxaloacetate, CIT = 
citrate, ACCoAcyt = cytosolic acetyl-CoA, OXAcyt = cytosolic oxalate, ACCoAmit = mitochondrial acetyl-
CoA, OAAcyt = mitochondrial oxaloacetate, AkGT = alfa-keto-glutarate, SUC = succinate, FUM = fumarate, 
MAL = malate. 
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 Looking at trends in the other enzyme activities measured, a large difference in MDH and CIT 
activity was observed (Figure 9.4). The MDH activity was significantly increased in the strain with 
the two heterologous genes. This higher activity leads to a larger flux towards extracellular malate, 
25.1 compared to 0 (Figure 9.3). Also a significant change in the CIT activity was measured. The 
CIT activity was almost 4 times lower with gene insertions (Table 9.2). The extracellular flux 
towards citrate was estimated to be 0 for both strains, but a slightly lower extra-cellular citrate 
concentration was measured in the strain with the two genes inserted, correlating with the 
decreased enzyme activity. This indicates that the reductive TCA cycle is probably stimulated, 
resulting in a decrease in citrate production. In both NW185 strains (with and without genes 
inserted) the fluxes are mainly diverted towards malate and fumarate. Although no fluxes towards 
succinate could be estimated, the strain with the heterologous genes inserted showed a 3 times 
higher succinate yield based on the extracellular concentrations (Table 9.3), demonstrating an 
active reductive TCA cycle.  
 
Figure 9.4 Relative enzyme activities and their standard deviations. ■ = WT N402, ■ = NW185, □ = N402 
with the heterologous gene insertions of fum and frds, ■ = NW185 with the heterologous gene insertions of 
fum and frds. ICL = isocitrate lyase, MDH = malate dehydrogenase, CIT = citrate synthase, PYC = pyruvate 
carboxylase 
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9.4.4 Effect of gene insertions in both strains 
The insertions of the two heterologous genes in both the N402 strain and the NW185 strain 
showed some resemblance but also some differences. In both the N402 and the NW185 strain the 
PPP was down-regulated as a consequence of the insertion of fum and frds. Furthermore, the flux 
towards serine biosynthesis was increased in both strains upon addition of the genes. The 
succinate yield was improved in both strains when the reductive part of the TCA cycle was 
expressed in the cytosol, indicating that both strains had a functional reductive TCA cycle pathway. 
However, the pyruvate carboxylase reaction was increased in the N402 strain upon addition of the 
genes, which was not observed in the NW185 strain. It was also observed that the citrate 
production in the “NW185 strains” was lower than in the “N402 strains”. 
 
Overall, malate, fumarate and succinate production was higher in the strains with the genes 
inserted. This together with the fact that less citrate was produced in the NW185 strain with the two 
genes inserted indicates that significantly more reduced organic acids are produced. The insertion 
of the fumarate reductase and fumarase in the cytosol of A. niger has obviously diverted the flux 
towards the reductive part of the TCA cycle, thereby producing more reduced organic acids.    
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9.5 Conclusion 
Major strain differences between N402 and NW185 (unable to produce gluconate and oxalate) 
were observed. The reduced need for regeneration of redox equivalents in the NW185 was a 
remarkable observation, but it did not result in more organic acid production. On the other hand, 
the insertion of the two heterologous genes (fumarate reductase and fumarase) shifted the 
metabolism towards organic acid production in the reductive part of the TCA cycle in both the 
NW185 strain and N402. Overall, a threefold higher succinate yield was achieved. A comparison 
between the four strains showed that the NW185 strain with the genes inserted was the best 
combination regarding malate, fumarate and succinate production. The metabolism was obviously 
redirected towards more reduced organic acids. It is believed that most of these acids are 
produced in the cytosol and not in the mitochondria. 
 
The system level approach used in this study showed that a better cell factory for reduced organic 
acid production was created. The integration of the measurements at different cellular levels has 
contributed to defining and comparing the physiological states of the four strains. The correlation 
between expression data and flux data was evident in the primary metabolism, but more elaborate 
experiments are necessary for determining if this correlation also holds outside the primary 
metabolism. 
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Chapter 10  
Summary and future prospects 
The overall objective of this study was to improve the organic acid production platform by 
Aspergillus niger. At first a shake flask medium optimization study was performed using a 
Design of Experiment set up (Chapter 4). The fractional factorial optimization could not 
define an optimum medium compostion due to large experimental variations. The hypothesis 
was that varying amounts of oxygen limitation caused these deviations. Therefore, a second 
study was performed analyzing the oxygen limitation effect on the physiology of A. niger 
(Chapter 5). This study showed that oxygen limitation affected the polyol production. This 
change in polyol profiles indicated that the redox balance was changed and that cells 
encountered a state of cellular stress. Only minor changes in organic acid profiles were 
detected. Intracellular metabolite analysis showed that some pathways were activated under 
oxygen limited conditions. This gave information about possible flux distributions and 
metabolic targets that might be interesting.  
 
After these two physiological characterisation studies five different metabolic engineering 
strategies were pursued, aimed at increasing organic acid production with focus on succinic 
acid.  
 
The first strategy was a complete deletion of the gene encoding succinate dehydrogenase 
(Chapter 6), but unfortunately no knock-out mutant could be obtained. It is possible that SDH 
is an essential gene, prohibiting growth when deleted. Another possibility is that the poor 
gene targeting performance obscured the results.  
 
The second metabolic engineering strategy aimed at complete deletion of ATP: citrate lyase 
(Chapter 6). This enzyme was identified as a target by in silico stoichiometric metabolic 
model predictions in combination with pyruvate decarboxylase (PDC) and oxygen limitation. 
Because the physiological study on oxygen limitation showed no PDC activity under oxygen 
limitation, only ACL was deleted. This deletion resulted in a three-fold increase in succinate 
production on glucose, and the model predictioncs was hereby verified. 
 
As a third strategy the regulatory enzyme AcuB was deleted and characterized in solid state 
and submerged fermentations (Chapter 7). AcuB is responsible for acetate metabolism 
through the glyoxylate pathway leading to succinate and malate. AcuB regulates the 
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enzymes involved in the glyoxylate pathway and was therefore thought to have an effect on 
organic acid production. However, the organic acid profiles were not significantly changed by 
acuB deletion. This indicates that deletion of this regulatory enzyme was not as effective as 
deleting acl, which is directly involved in the central carbon metabolism. It is believed that 
evolution resulted in a complex regulatory mechanism, where functions can be replaced by 
other regulatory pathways ensuring system robustness. This does not hold for enzymes in 
the central carbon metabolism, since these enzymes are conserved.    
 
Over-expression of isocitrate lyase (ICL) was the fourth metabolic engineering strategy 
studied in this dissertation (Chapter 8). In contrast to AcuB, ICL has a direct influence on the 
glyoxylate pathway. ICL and malate synthase (MS) are the two enzyme that constitute this 
pathway. Instead of producing more succinate and malate, the fumarate production was 
significantly increase by icl over-expression. This change in organic acid profiles is thought to 
be caused by regulation within the TCA cycle and not by the glyoxylate bypass. For 
additional stimulation of the glyoxylate pathway malonate was added to the cultivations. 
Malonate inhibits the SDH, thereby interrupting the TCA cycle. The addition of malonate 
showed different cellular effects in both wild-type and icl over-expression strain. In the WT, 
the malonate addition resulted in more citrate and oxalate production, while in the ICL over-
expression strain more malate was produced.  
 
The fifth metabolic engineering strategy was the insertion of fumarase (fum) and fumarate 
reductase (frds) in the cytosol of both the wild-type and NW185 strain (Chapter 9). These two 
insertions created a reductive TCA cycle route towards succinate in the cytosol of A. niger. In 
both strain a three times higher succinate yield was achieved upon insertion of the genes. 
The combination of the NW185 strain and gene insertions led to a significant increase in 
malate, fumarate and succinate production. Therefore, the metabolism was redirected 
towards more reduced organic acids and it is believed that most of these acids were 
produced in the cytosol and not in the mitochondria.  
 
The different metabolic engineering strategies tested in this dissertation have resulted in 
significant changes in the organic acid production profiles and show potential for using A. 
niger as production platform for formation of several organic acids. The system level 
approach used to characterize the strains has given us valuable new information. It was 
possible to link data retrieved from DNA microarrays, flux analyses, enzyme analyses and 
metabolite quantification methods. The integration of these results has given us a better 
understanding of the cellular mechanisms involved in organic acid production and has led to 
the discovery of new metabolic engineering targets. 
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Stoichiometric metabolic models were shown to be a useful tool for defining new targets. It is 
therefore believed that integration of the experimental results obtained by these studies will 
reveal new strategies redirecting carbon flux towards desired products. Probably, the 
simulations will predict multiple manipulations. Because the gene targeting methods are not 
very efficient in A. niger, more development is needed in this area. Strategies aimed at 
avoiding non-homologous end-joining must be investigated.  
 
Transport mechanisms are another important aspect in unravelling the metabolic regulation 
of organic acid production. With the current sequencing projects more genes will be 
annotated and possible transporters might be identified. Transport of organic acids from 
mitochondria towards cytosol and vice versa will be a key element in understanding organic 
acid production. Localization of compounds must be verified in these studies, which poses a 
new challenge in separation technology for separating cellular compartments. Finally, the 
redox state and energy balance will be important for understanding the transport 
mechanisms and the general metabolic state of the cell. Further studies on this topic will 
improve our understanding of metabolism, leading to new metabolic engineering strategies 
and enhanced organic acid production.  
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Sammenfatning på dansk 
Formålet med denne PhD afhandling var at forbedre organisk syreproduktion i Aspergillus 
niger. Indledningsvis blev et rystekolbeoptimeringsstudie udført. ”Fractional factorial 
optimization” gav ikke de ønskede resultater, da iltbegrænsningen forårsagede store 
eksperimentelle variationer. Den næste undersøgelse blev derfor koncentreret om 
iltbegrænsning i forbindelse med A. niger fysiologi. Denne undersøgelse påviste, at 
iltbegrænsning påvirker polyol produktion, mens den organiske syreproduktion var næsten 
upåvirket.  
 
Efter disse to fysiologiske studier, blev teorier indenfor metabolic engineering anvendt til at 
undersøge mulighederne for at fremme ravsyreproduktion. Den første strategi var at fjerne 
hele succinate dehydrogenase (SDH) genet. Desværre viste det sig umuligt at konstruere 
denne deletions mutant.  
 
Den næste strategi fokuserede på at fjerne al ATP: citrate lyase (ACL). Denne undersøgelse 
har resulteret i en tre gang større ravsyreproduktion på glukose. Det kan derfor konkluderes, 
at brugen af støkiometriske metabolome modeller er et godt værktøj til identificering af gener 
der kan fremme organisk syreproduktion.  
 
I den tredje strategi blev det regulatoriske enzym AcuB slettet. Dette påvirkede desværre 
ikke i tilstrækkelig grad den organiske syreproduktion. Dette beviser, at fjernelse af dette 
regulatoriske enzym ikke var så effektiv som fjernelse af acl, som er direkte involveret i en 
central kulstofmetabolisme.  
 
Over-udtryk af isocitrat lyase (ICL) var den fjerde metabolic engineering strategi som blev 
brugt i denne afhandling. I modsætning til AcuB, har ICL direkte indflydelse på glyoxylate 
syntesevejen. ICL og malat synthase (MS) er de to enzymer som opbygger denne 
syntesevej. I stedet for at fremme succinat- og malatproduktion, blev fumaratproduktionen 
betydeligt øget med icl over-udtryk. Med henblik på at stimulere glyoxylat syntesevejen, blev 
malonat tilføjet kultiveringen. Malonate inhiberer SDH, og bryder dermed Tricarboxylsyre 
(TCA) cyklussen. Hos wild-typen (WT) øger dette citrate and oxalate produktion, mens mere 
malat blev produceret i ICL stammen.  
 
Den femte strategi var at tilføre fumarase (fum) og fumarate reduktase (frds) i cytosolen hos 
både WT og NW185 stammerne. Dette resulterede i en reduceret TCA cyklus mod succinate 
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i A. niger cytosol. Et tre gang så stort succinat afkast blev observeret i begge stammer. I 
NW185 stammen resulterede genindsætningen i øget malat, fumarat og succinat produktion. 
 
De forskellige metabolic engineering strategier, der blev testede i denne afhandling har 
resulteret i signifikante ændringer i organisk syreproduktion og viser potentialet af A. niger til 
produktion af forskellige organiske syrer. Det var muligt at forbinde DNA microarray data, flux 
analyse, enzym analyse and metabolite kvantificeringsmetoder. Integrering af disse 
resultater har givet os bedre forståelse af cellular mekanismer involveret i organisk 
syreproduktion, samt indblik i nye metabolic engineering strategier.  
 
Støkiometriske metabolome modeller har viste sig at være et brugbart værktøj til at finde nye 
mål. Desuden kan integrering af eksperimentelle resultater, som beskrevet i denne 
afhandling, bruges til at finde strategier til om-dirigering af kulstof fluxen væk fra uønskede 
produkter. Gen targeting metoderne er desværre ikke så effektive i A. niger, og yderligere 
forskning er derfor nødvendig indenfor dette område.  
 
Transport mekanismer er endnu et vigtigt aspekt forbundet med metabolisk regulering af 
organisk syreproduktion. Med de nuværende sekventeringsprojekter vil flere gener blive 
annoterede og nye transportproteiner muligvis blive identificerede. Organisk syretransport fra 
mitochondria til cytosol og vice versa kan blive et bærende element i forståelsen af 
syreproduktion. Sidst men ikke mindst, vil redox niveau og energi balance være vigtige 
områder til forståelse af transport mekanismer, men også for den generelle metabolome 
tilstand i cellen. Dette åbner døre til forskellige muligheder, som vil forbedre vores forståelse 
for metabolisme og øge organisk syreproduktion ved hjælp af nye metabolic engineering 
strategier.         
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S1: Significantly expressed genes in Chapter 8 
 
Identification of the significantly expressed genes, fold change in log2 ration between WT 
and ICL over-expression strain (positive number then expression level in ICL over-
expression strain higher), p. value < 0.05, the general description is taken from the JGI 
annotation database. 
 
JGI_ID Fold change p. value General description 
198539 21.8 5.3E-04 - 
209252 -4.5 5.7E-04 Autophagy related protein, involved in membrane trafficking 
45946 7.9 7.9E-04 - 
213703 -5.3 9.9E-04 - 
189002 -102.1 1.1E-03 - 
46621 -4.5 1.1E-03 Hypothetical amylo-alpha-1,6-glucosidase. Glycogen 
debranching 
213014 -4.5 1.2E-03 Flavin-containing monooxygenase 
38103 -2.9 1.3E-03 Hypothetical Damage-specific DNA binding protein 
170627 -5.0 1.4E-03 - 
196377 3.2 1.4E-03 Mitochondrial/chloroplast ribosomal protein L2 
52705 4.2 1.7E-03 Predicted protein shares amino acid sequence identity with 
the Saccharomyces cerevisiae TUF1 gene product; 
mitochondrial translation elongation factor Tu. 
208272 -2.0 1.7E-03 Ubiquitin-like protein 
57285 24.4 1.8E-03 Major facilitator superfamily 
212412 6.1 1.8E-03 - 
131354 -5.3 1.9E-03 - 
53717 -2.5 1.9E-03 AAA ATPase 
209058 5.6 1.9E-03 ATP sulfurylase  
53518 -6.2 2.0E-03 Phosphoribosyltransferase 
44868 -3.3 2.1E-03 - 
170612 -2.5 2.1E-03 - 
57159 -2.5 2.1E-03 - 
136000 1.4 2.2E-03 - 
184507 -2.1 2.2E-03 - 
205766 -5.9 2.2E-03 Sugar (ANd other) transporter 
213950 -2.3 2.3E-03 Peptidase M28 
200887 4.7 2.3E-03 Hypothetical S-adenosylmethionine-dependent 
methyltransferase activity 
184678 -4.8 2.3E-03 - 
55052 -3.1 2.3E-03 Fungal specific transcription factor 
210556 -2.6 2.4E-03 - 
128721 -3.6 2.4E-03 - 
209032 -7.3 2.5E-03 - 
208048 105.1 2.5E-03 Nitrate reductase 
210558 4.1 2.5E-03 Thiamine pyrophosphate-requiring enzyme 
208078 5.6 2.6E-03 - 
205484 -6.3 2.6E-03 - 
210295 -3.2 2.6E-03 SNARE protein TLG1/Syntaxin 6 
123074 2.3 2.7E-03 - 
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206645 -3.0 2.7E-03 Related to phosphatidylinositol/phosphatidylglycerol transfer 
protein 
54541 -116.7 2.8E-03 Candidate oxidoreductase, Short-chain 
dehydrogenase/reductase 
127436 -7.7 2.8E-03 Carbohydrate kinase 
57039 3.3 2.9E-03 Aspartyl-tRNA synthetase, mitochondrial 
208387 2.4 3.0E-03 RNA-binding protein LARP/SRO9 and related La domain 
proteins 
136140 -5.6 3.0E-03 - 
190740 3.6 3.1E-03 - 
37080 -2.7 3.2E-03 pepE, extracellular aspartic protease 
209660 3.6 3.2E-03 SWI-SNF chromatin-remodelling complex protein 
50350 -7.3 3.3E-03 Hypothetical Fungal transcriptional regulatory protein, N-
terminal 
52970 -2.6 3.3E-03 - 
54838 -74.1 3.3E-03 Major facilitator superfamily 
49674 -4.9 3.3E-03 - 
37678 -3.6 3.3E-03 - 
202315 -2.3 3.3E-03 - 
39215 3.0 3.4E-03 Ribosomal protein L6 
120185 -1.7 3.4E-03 Hypothetical protein. May be a transcription factor due to a 
Zn-finger domain. 
137527 3.1 3.5E-03 - 
209255 3.6 3.5E-03 Mitochondrial substrate carrier 
55785 3.8 3.5E-03 Protein kinase 
42152 -13.6 3.5E-03 - 
51685 21.5 3.5E-03 Related to Schizosaccharomyces pombe asparaginase (EC 
3.5.1.1) 
207376 2.1 3.6E-03 Predicted protein shares amino acid sequence identity to the 
Saccharomyces cerevisiae TIF34 gene product; subunit of 
the core complex of translation initiation factor 3(eIF3), which 
is essential for translation. 
131516 -3.7 3.7E-03 - 
203401 6.3 3.7E-03 Amidase 
46405 -3.2 3.7E-03 - 
142364 3.2 3.8E-03 - 
55805 -2.6 3.8E-03 Hypothetical catalytic protein 
41505 -9.7 3.8E-03 Permease of the major facilitator superfamily 
46346 -5.4 3.8E-03 - 
176433 -10.6 3.9E-03 - 
129773 10.8 3.9E-03 - 
55741 2.4 3.9E-03 Protein import receptor MAS20 
54145 3.7 3.9E-03 - 
133160 -2.5 4.0E-03 Beta subunit of farnesyltransferase 
201957 -2.0 4.0E-03 Synaptobrevin/VAMP-like protein 
205959 2.0 4.0E-03 - 
38274 -3.9 4.0E-03 - 
178744 -7.2 4.1E-03 Hypothetical Metal-dependent phosphohydrolase, HD region 
120353 2.6 4.2E-03 Hypothetical protein with PPR repeat 
55707 -2.4 4.2E-03 Nucleotide-sugar transporter 
211162 -3.7 4.2E-03 Hypothetical 1,4-alpha-glucan branching enzyme 
124156 -28.6 4.3E-03 Candidate NAD dependent formate dehydrogenase 
200589 8.8 4.4E-03 8-amino-7-oxononanoate synthase (biotin synthesis) 
54926 -3.8 4.5E-03 - 
56366 -2.2 4.5E-03 - 
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188168 -2.8 4.5E-03 - 
39625 -6.4 4.7E-03 - 
42619 -2.9 4.7E-03 DSBA oxidoreductase 
55980 4.5 4.7E-03 - 
194595 -2.5 4.7E-03 Flavonol reductase/cinnamoyl-CoA reductase 
55261 -2.4 4.8E-03 - 
52996 2.7 4.9E-03 Related to ubiquinone biosynthesis methyltransferase COQ5 
(S. cerevisiae) 
208535 -3.0 4.9E-03 - 
52668 -2.0 4.9E-03 (trpC) Anthranilate synthase. Trifunctional enzyme bearing 
the Gln amidotransferase (GATase) domain of anthranilate 
synthase, indole-glycerolphosphate synthase, and 
phosphoribosylanthranilate isomerase activities 
205291 -2.5 4.9E-03 Isocitrate and isopropylmalate dehydrogenases 
38286 3.4 5.0E-03 FOG: RRM domain 
53978 -2.4 0.01 (mstA) high affinity monosaccharide transporter 
133197 -5.6 0.01 Transcriptional coactivator 
209315 4.4 0.01 - 
56629 -2.1 0.01 Cullin 4 type protein 
201918 1.9 0.01 Synaptic vesicle protein Synapsin 
208898 7.6 0.01 NADP/FAD dependent oxidoreductase 
56782 -27.3 0.01 Glycosyl hydrolase family 3 C terminal domain 
37333 4.9 0.01 - 
56635 2.9 0.01 Ribonucleotide reductase 
182442 4.5 0.01 - 
49490 2.2 0.01 - 
208835 -2.6 0.01 Serine/threonine protein kinase Chk2 and related proteins 
57101 2.0 0.01 - 
197860 -2.7 0.01 - 
196077 3.2 0.01 - 
206447 2.3 0.01 Hypothetical Aminotransferase 
203758 15.3 0.01 - 
206414 7.6 0.01 - 
42171 -5.3 0.01 Hypothetical isocitrate lyase and phosphorylmutase 
193981 -8.5 0.01 Putative pyruvate decarboxylase joined with TPR repeat 
containing protein 
40734 -15.3 0.01 Hypothetical aldehyde dehydrogenase. Specificity towards 
NAD or NADP is not deducible from sequence data 
195172 -2.3 0.01 Hypothetical. N-acetyltransferase activity 
199051 -2.2 0.01 Sugar transporter superfamily 
200430 1.7 0.01 Sterol desaturase 
211137 -2.0 0.01 GHMP kinase 
56275 3.1 0.01 acnA, Homoaconitase (EC 4.2.1.36) 
40329 -2.5 0.01 - 
40484 -2.5 0.01 Peptidase M, neutral zinc metallopeptidases, zinc-binding site
39180 3.1 0.01 - 
214665 -3.0 0.01 Hypothetical protease 
51820 -1.9 0.01 Related to S. cerevisiae phosphatidyl serine synthase 
209436 1.6 0.01 Putative cell polarity protein 
175251 -5.5 0.01 - 
44156 6.1 0.01 Related to mitochondrial translation elongation factor 
41926 -2.3 0.01 Hypothetical G-protein with WD-40 repeat 
52140 -2.6 0.01 Serine/threonine protein kinase 
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39360 -1.8 0.01 Zinc-binding oxidoreductase 
198023 1.6 0.01 Actin/actin-like 
46999 1.9 0.01 Related to prephenate dehydrogenase of Candida albicans 
56195 2.1 0.01 Carbohydrate kinase, FGGY 
39893 -2.9 0.01 Synaptic vesicle transporter SVOP 
124912 -3.0 0.01 Choline kinase 
211094 3.2 0.01 - 
132154 2.5 0.01 Cytochrome P450 
56202 1.6 0.01 - 
127627 2.3 0.01 Candidate ribosomal protein S18 
171442 -7.0 0.01 - 
52586 -10.0 0.01 Hypothetical protein with TPR-like domain 
48688 4.8 0.01 Adenosylmethionine-8-amino-7-oxononanoate transaminase 
198685 2.0 0.01 - 
51731 1.9 0.01 Molecular chaperones GRP170/SIL1, HSP70 superfamily 
42523 3.5 0.01 Hypothetical Inositol monophosphatase 
44347 2.3 0.01 Ribosomal protein L3 
52717 1.9 0.01 Shares limited amino acid sequence identity with ribosomal 
protein L15, bacterial form. 
208043 54.7 0.01 Nitrogen transporter 
198660 2.1 0.01 Hypothetical translocase of outer mitochondrial membrane 
complex 
53574 4.8 0.01 Candidate carbamoyl-phosphate synthase 
55742 -3.7 0.01 aldA Aldehyde dehydrogenase (aldA) (EC 1.2.1.3) 
48502 1.6 0.01 Hypothetical septin B-like protein 
48505 -2.0 0.01 - 
212582 3.6 0.01 - 
40867 2.2 0.01 - 
39679 5.8 0.01 Oxidoreductase, molybdopterin binding 
184314 -2.7 0.01 - 
40924 -2.7 0.01 - 
40917 3.4 0.01 Predicted mechanosensitive ion channel 
52919 4.2 0.01 Hypothetical. Intrpro: AMP-dependent synthetase and ligase 
56336 -17.0 0.01 - 
206719 2.0 0.01 Hypothetical protein with Zn-finger, Tim10/DDP type 
200187 -3.1 0.01 pepC. Subtilisin like serine protease 
119993 -2.1 0.01 Hypothetical Mg2+ transporter protein, CorA-like 
55956 -2.2 0.01 Hypothetical subunit of the 26S proteasome regulatory 
complex 
54662 2.1 0.01 Hypothetical SNF5/SMARCB1/INI1 protein - a key 
component of SWI/SNF-class complexes; KOG Class: 
Chromatin structure and dynamics; KOG Id: 1649; KOG 
Description: SWI-SNF chromatin remodelling complex, Snf5 
subunit 
196832 2.3 0.01 Hypothetical pseudouridylate synthase 
201712 -1.9 0.01 - 
125418 -2.6 0.01 Short-chain dehydrogenase/reductase SDR 
124206 4.4 0.01 - 
38222 2.7 0.01 - 
211068 -9.5 0.01 - 
54784 2.4 0.01 - 
211595 1.5 0.01 Related to extracellular GH family 61 endo-1,4-beta-
glucanase of Trichoderma reesei 
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53049 -1.7 0.01 Ras-related small GTPase, Rho type 
209327 -4.0 0.01 Fungal transcriptional regulatory protein, N-terminal 
54217 -2.4 0.01 Conserved Zn-finger protein 
41983 -2.4 0.01 Amidohydrolase 2 
52725 -3.9 0.01 Flavin-containing monooxygenase 
52603 -3.0 0.01 Related to carboxypeptidase Y 
42282 2.7 0.01 - 
191636 -9.2 0.01 Hypothetical protein. Electronic annotation suggests pyridine 
nucleotide-disulphide oxidoreductase 
202783 -2.2 0.01 Ras small GTPase, 
188662 2.3 0.01 Nuclear transport factor 2 
199618 -2.5 0.01 - 
209093 2.5 0.01 - 
192093 -10.7 0.01 Major facilitator superfamily 
130834 -2.6 0.01 Fungal specific transcription factor 
40968 1.6 0.01 - 
55391 3.3 0.01 - 
53297 3.6 0.01 - 
38135 1.6 0.01 Esterase/lipase/thioesterase 
36895 2.8 0.01 SAM-dependent methyltransferases 
210297 -2.3 0.01 Signal transduction 
54083 2.4 0.01 Hypothetical. Related to GCN5-related N-acetyltransferase 
189635 -7.1 0.01 Monodehydroascorbate/ferredoxin reductase 
120659 1.4 0.01 - 
204514 -2.2 0.01 Nucleotide excision repair factor NEF2, RAD23 component 
54071 -4.8 0.01 - 
187475 -2.6 0.01 - 
209263 5.2 0.01 - 
171058 -2.7 0.01 - 
54095 -44.5 0.01 Sugar (ANd other) transporter 
41935 -5.8 0.01 - 
210783 -4.0 0.01 Hypothetical. Probable peroxisomal membrane. Interpro 
suggests alkylhydroperoxide reductase 
53357 3.0 0.01 Related to aldehyde dehydrogenase (EC 1.2.1.3). Sequence 
similarity to ALD2 of C. albicans 
198287 -1.7 0.01 Ubiquitin-like protein 
210274 4.8 0.01 NADP-dependent flavoprotein reductase 
46341 -2.0 0.01 - 
209597 -2.0 0.01 Protein kinase 
44118 1.3 0.01 - 
52629 2.4 0.01 - 
176010 -5.8 0.01 Predicted esterase of the alpha-beta hydrolase superfamily 
51482 -17.3 0.01 Major facilitator superfamily 
54966 1.7 0.01 - 
56031 -7.2 0.01 Fungal transcriptional regulatory protein 
56788 -3.1 0.01 Hypothetical protease that contains peptidase M28 domain 
39626 1.3 0.01 Hypothetical protein 
56305 2.8 0.01 Aldehyde dehydrogenase family 
56871 2.6 0.01 Mitochondrial carrier proteins 
55027 -2.2 0.01 - 
213288 -3.2 0.01 - 
209231 -3.9 0.01 Aldo/keto reductase 
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200680 2.4 0.01 Eukaryotic translation initiation factor 3, subunit 7 
190311 -9.8 0.01 2-nitropropane dioxygenase 
187784 -3.8 0.01 Hypothetical. Monocarboxylate transporter  like 
56628 -12.1 0.01 Dak kinase 
190051 -1.7 0.01 Fungal specific transcription factor 
51725 -4.0 0.01 - 
207660 1.6 0.01 Glycosyl transferase, family 48 
178568 -2.5 0.01 - 
205836 -4.3 0.01 - 
184073 7.2 0.01 Related to NADPH-dependent alcohol dehydrogenase, Zinc 
containing 
135849 -2.2 0.01 - 
212140 -2.6 0.01 hypotetical cAMP-dependent protein kinase catalytic subunit 
38226 -7.0 0.01 Related to Geranylgeranyl pyrophosphate synthase 
35655 6.9 0.01 - 
213851 -30.6 0.01 GTP cyclohydrolase II 
49586 5.2 0.01 - 
207636 -4.2 0.01 Hypothetical non-ribosomal peptide synthetase 
140888 -3.0 0.01 Glutathione S-transferase 
49737 -4.4 0.01 Hypothetical protein 
201503 10.0 0.01 NAD-cytochrome b5 reductase 
186114 3.9 0.01 - 
38995 -5.3 0.01 Hypothetical, AAA+-type ATPase domain 
55759 -2.1 0.01 - 
57277 -1.6 0.01 yop1 (A. fumigatus), Protein involved in membrane traffic 
(YOP1/TB2/DP1/HVA22 family) 
210041 2.8 0.01 ABC (ATP binding cassette) 1 protein 
55510 2.8 0.01 Pyruvate dehydrogenase E1 B-subunit 
53338 2.6 0.01 Related to dihydrolipoamide acetyltransferase, EC 2.3.1.12 
212098 6.2 0.01 Hypothetical CAP20-like protein 
210672 -10.7 0.01 Short-chain dehydrogenase/reductase SDR 
50882 9.4 0.01 Hypothetical glucose-methanol-choline oxidoreductase (EC 
1.99.1.1) 
36035 -3.1 0.01 - 
54817 26.2 0.01 Hypothetical oligopeptide transporter 
170261 -11.4 0.01 Permease of the major facilitator superfamily 
57355 -4.5 0.01 - 
43721 -2.5 0.01 - 
42720 2.4 0.01 - 
188037 3.2 0.01 Lipoate-protein ligase A 
52123 1.8 0.01 Mitochondrial import inner membrane translocase, subunit 
TIM23 
212337 -9.7 0.01 Hypothetical protein. Contains four putative transmembrane 
helices 
43123 2.3 0.01 Ferredoxin 
129632 -2.3 0.01 - 
190580 -1.7 0.01 Hypothetical protein prenyltransferase, alpha subunit 
185619 1.4 0.01 Ribosomal protein 
205518 5.6 0.01 NADH-dehydrogenase (ubiquinone) 
47491 -2.2 0.01 - 
174228 3.5 0.01 - 
40771 2.0 0.01 Putative GroEL-like chaperone, ATPase 
50042 2.5 0.01 - 
206931 1.9 0.01 FOG: RCC1 domain 
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137851 -1.5 0.01 - 
199601 2.2 0.01 - 
48803 -2.6 0.01 - 
170638 -1.9 0.01 - 
198936 1.8 0.01 Hypothetical protein with PPR repeat 
53423 -3.0 0.01 Related to 2-methylcitrate dehydratase of E. coli 
54896 4.0 0.01 - 
207572 -40.5 0.01 General substrate transporter 
211078 1.5 0.01 Actin/actin-like 
136845 2.4 0.01 Ribosomal protein 
189135 10.7 0.01 Hypothetical carboxylesterase 
55296 1.9 0.01 Hypothetical threonyl-tRNA synthetase kinase. HMMPfam 
indicates Threonyl-tRNA synthetase kinase activity 
40740 -2.5 0.01 Hypothetical Short-chain dehydrogenase 
170148 -4.5 0.01 Putative GH family 18 endo-chitinase 
201122 -3.6 0.01 - 
143749 -5.0 0.01 - 
35440 1.5 0.01 Hypothetical phosphatidylserine decarboxylase (EC 4.1.1.65) 
55947 4.6 0.01 Related to cytochrome P450 
208150 3.3 0.01 FAD-dependent pyridine nucleotide-disulphide 
oxidoreductase 
175519 -1.9 0.01 Hypothetical Cobalamin synthesis protein  
197381 -2.7 0.01 GTPase Rab5/YPT51 and related small G protein 
superfamily GTPases 
210798 3.5 0.01 Dienelactone hydrolase 
198250 -9.3 0.01 2-enoyl-CoA hydratase/3-hydroxyacyl-CoA 
dehydrogenase/Peroxisomal 3-ketoacyl-CoA-thiolase, sterol-
binding domain and related enzymes 
51829 -1.6 0.01 Clathrin-associated protein medium chain 
174759 -3.0 0.01 Cation efflux family 
39630 1.6 0.01 Ribosomal protein S4 
209875 3.6 0.01 - 
55604 -19.9 0.01 - 
204276 4.7 0.01 Zinc-containing alcohol dehydrogenase 
210871 -8.7 0.01 3-hydroxyacyl-CoA dehydrogenase 
203335 -2.1 0.01 - 
212581 3.6 0.01 Acetohydroxy acid isomeroreductase 
181179 -10.5 0.01 Catechol dioxygenase, N-terminal 
209956 -3.5 0.01 - 
55918 -2.6 0.01 Serine/threonine-specific protein phosphatase 
48713 -5.3 0.01 DNA-binding SAP 
209842 2.8 0.01 Phosphoribosyl pyrophosphate synthetase 
183116 1.8 0.01 - 
39912 1.9 0.01 DMQ mono-oxygenase 
202289 1.5 0.01 - 
55981 1.9 0.01 Cytochrome b5 
190566 3.6 0.01 Predicted endoplasmic reticulum membrane protein Lec35 
37420 2.7 0.01 - 
137661 1.8 0.01 - 
175118 -2.1 0.01 Mob1/phocein family 
45363 3.5 0.01 - 
56736 3.1 0.01 Haloacid dehalogenase-like hydrolase 
56298 2.3 0.01 Putative mannosyl-oligosaccharide glucosidase, GH family 
63 
209768 3.4 0.01 Hypothetical protein of the  Ribonuclease III supefamily 
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180792 2.8 0.01 Glutathione S-transferase 
46100 1.9 0.01 - 
197567 -1.6 0.01 Candidate vacuolar H+-transporting two-sector ATPase, C 
subunit 
50833 -2.2 0.01 - 
120372 -2.9 0.01 Phosphoinositide-specific phospholipase C (PLC) 
42186 -5.7 0.01 - 
50154 -6.1 0.01 Hypothetical ribulose-phosphate 3-epimerase 
143917 -4.2 0.01 Upstream transcription factor 
53053 13.2 0.01 Uroporphyrin III methyltransferase 
52986 2.6 0.01 Lipoprotein 
136397 -3.0 0.01 - 
48817 -3.2 0.01 Transcription initiation factor IIA, gamma subunit 
138063 2.2 0.01 - 
136883 -1.8 0.01 - 
206611 -2.3 0.01 Hypothetical Acyl-CoA-binding protein 
40937 2.2 0.01 Hypothetical phosphoglycerate mutase; EC 5.4.2.1 
37999 2.1 0.01 - 
52796 2.6 0.01 Mitochondrial import inner membrane translocase, subunit 
Tim44 
56137 3.1 0.01 - 
41118 1.4 0.01 - 
142899 1.5 0.01 - 
143893 4.3 0.01 - 
213656 -2.4 0.01 C2 domain 
209919 -1.6 0.01 Tryptophanyl-tRNA synthetase 
36379 2.1 0.01 Calcium-binding EF-hand 
207169 -2.6 0.01 Receptor-activated Ca2+-permeable cation channels 
208321 -3.7 0.01 Peroxisomal membrane protein MPV17 and related proteins 
47444 2.3 0.01 - 
176127 2.1 0.01 Predicted hydrolase related to dienelactone hydrolase 
53082 -2.5 0.01 Related to histone 1 protein, H1, with a predicted H1/H5 
domain, histone linker N- terminal, and winged helix DNA 
binding. The protein is essential for chromatin stucture and 
links nucleosomes in higher order structures; KOG Class: 
Chromatin structure and dynamics; KOG Id: 4012; KOG 
Description: Histone H1 
39105 -3.5 0.01 - 
213757 -3.0 0.01 Gamma-glutamyltranspeptidase 
177781 -1.7 0.01 GCN5-related N-acetyltransferase 
209754 -13.8 0.01 2-nitropropane dioxygenase 
35897 -2.0 0.01 COP9 signalosome, subunit CSN7 
211774 3.9 0.01 Amino acid/polyamine transporter I 
56530 -3.8 0.01 Fungal specific transcription factor 
52517 2.6 0.01 Peptidase S10, serine carboxypeptidase 
189708 -5.2 0.01 - 
172399 2.2 0.01 - 
190892 2.2 0.01 Predicted sugar transporter 
44184 -2.3 0.01 - 
196275 2.2 0.01 - 
52219 2.3 0.01 Glycoside hydrolase, family 28 
57271 2.8 0.01 - 
38426 1.9 0.01 Short-chain dehydrogenase/reductase 
184312 -10.4 0.01 Glutathione S-transferase 
52269 4.8 0.01 - 
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40514 -1.7 0.01 - 
180337 2.7 0.01 Hypothetical. KOG suggests transcription regulation/DEAD 
box 
203198 -3.9 0.01 - 
197415 -5.1 0.01 Putative extracellular proteins sharing 38% amino acid 
sequence identity with Aspergillus oryzae glutaminase A 
(PMID: 10952006) 
210048 -2.1 0.01 - 
197883 3.2 0.01 Plasma membrane H+-transporting ATPase  
198312 1.8 0.01 Reticulon-like protein 
206339 -8.4 0.01 Haem peroxidase, plant/fungal/bacterial 
42805 -4.3 0.01 - 
46852 -2.1 0.01 Tyrosine specific protein phosphatase 
171357 1.4 0.01 - 
212792 1.8 0.01 - 
209960 1.8 0.01 Porin, eukaryotic type 
54125 -2.4 0.01 - 
183782 1.7 0.01 Deduced protein shares amino acid sequence identity with 
Saccharomyces cerevisiae GCD10 gene product comprising 
a subunit of tRNA (1-methyladenosine) methyltransferase 
with Gcd14p; required for the modification of the adenine at 
position 58 in tRNAs, especially tRNAi-Met. 
52947 -1.7 0.01 Peptidase C19 
54056 2.6 0.01 Hypothetical protein kinase 
183937 2.9 0.01 Hypothetical biphenyl-2,3-diol 1,2-dioxygenase III-related 
protein. Glyoxalase/Bleomycin resistance protein 
183900 -5.1 0.01 - 
49486 2.5 0.01 - 
55365 -3.5 0.01 - 
185461 -31.5 0.01 - 
39573 -2.4 0.01 - 
170262 -1.8 0.01 Aldo/keto reductase family proteins 
192940 1.8 0.01 - 
212230 -2.0 0.01 AAA ATPase 
36773 -7.5 0.01 Hypothetical enoyl-CoA hydratase. (EC 4.2.1.17) HMM 
predicts secretion. 
191260 -3.4 0.01 - 
55511 4.3 0.01 Beta-ketoacyl synthase 
193196 1.7 0.01 - 
214565 -1.3 0.01 Mitochondrial F1F0-ATP synthase 
44450 -5.2 0.01 - 
210989 3.8 0.01 Amino acid/polyamine transporter I 
190603 -1.8 0.01 4-hydroxyphenylpyruvate dioxygenase (Phenylalanin 
degradation) 
201697 -2.5 0.01 Signal transduction protein with FHA domain 
206203 -2.1 0.01 Zinc-containing alcohol dehydrogenase 
201858 -2.0 0.01 H+-transporting two-sector ATPase 
53706 3.3 0.01 Related to C-4 methylsterol monooxygenase 
44367 -2.3 0.01 - 
50189 2.1 0.01 Hypothetical protein, Contains WD40 repeat 
54633 -2.8 0.01 Hypothetical protein containing Zn-finger, C2H2 type domain 
128477 2.3 0.01 - 
208631 -5.7 0.01 Predicted pyroglutamyl peptidase 
191505 -3.0 0.01 Possible hexose transporter 
55524 -2.5 0.01 Hypothetical transmembrane protein 
56247 -2.8 0.01 Phospholipase D. Active site motif 
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46523 1.6 0.01 - 
171996 -2.0 0.01 beta-1,6-N-acetylglucosaminyltransferase, contains WSC 
domain 
127717 1.5 0.01 - 
213629 -2.0 0.01 Drebrins and related actin binding proteins 
210450 -1.5 0.01 AMP-dependent synthetase and ligase 
127683 -2.1 0.01 Flavoprotein 
208493 -2.0 0.01 - 
56872 1.7 0.01 - 
53446 2.5 0.01 - 
182426 2.0 0.01 Hypothetical, ABC transporter 
47821 -1.7 0.01 Ras small GTPase, Ras type 
56395 -8.8 0.01 2-nitropropane dioxygenase 
54814 9.7 0.01 D-xylulose 5-phosphate/D-fructose 6-phosphate 
phosphoketolase 
46760 3.3 0.01 - 
52139 -10.3 0.01 Peripheral-type benzodiazepine receptor 
190721 1.5 0.01 Putative transcription factor 
57366 2.3 0.01 - 
55723 4.9 0.01 - 
44808 -10.0 0.01 Acetyl-CoA acetyltransferase 
55177 -1.5 0.01 - 
173033 -9.6 0.01 Translation initiation factor 4F 
52216 2.0 0.01 - 
190197 5.1 0.01 (apsC) aminopeptidase C. 
127495 4.3 0.01 - 
176378 -5.4 0.01 Short-chain dehydrogenase/reductase 
37809 -2.3 0.01 - 
213466 -3.8 0.01 Peptidase 
56753 7.4 0.01 Aromatic-ring hydroxylase 
202202 -1.8 0.01 Hypothetical. Ca2+-binding actin-bundling protein 
(fimbrin/plastin) 
207067 -6.9 0.01 HAD-superfamily hydrolase, 
184327 11.4 0.01 Hypothetical cytochrome P450. Sequence similarity to an 
Aspergillus flavus cytochrome P450 
197162 15.3 0.01 Sugar (ANd other) transporter 
57253 -2.4 0.01 Ubiquitin-conjugating enzyme 
203868 5.6 0.01 Aromatic-ring hydroxylase 
210935 2.4 0.01 Candidate eukaryotic translation initiation factor 3 
48625 1.9 0.01 - 
56462 2.7 0.01 Candidate serine hydroxymethyltransferase (EC 2.1.2.1) 
210213 15.2 0.01 Major facilitator superfamily 
214748 2.2 0.01 Acyl-CoA synthetase 
42464 -4.0 0.01 Candidate Peptidyl-prolyl cis-trans isomerase 
142826 3.8 0.01 Ribosomal protein L27 
210065 2.7 0.01 Transmembrane protein 
47520 -5.3 0.01 Hypothetical protein 
203483 2.0 0.01 - 
44186 -7.3 0.01 Hypothetical protein. HMMPfam predicts short-chain 
dehydrogenase/reductase activity, but no similarity to 
proteins with confirmed activities are found. Signalp predicts 
secretion. 
191512 3.2 0.02 Hypothetical enoyl-CoA hydratase (EC 4.2.1.17) 
51852 -4.1 0.02 Phox-like 
36316 7.1 0.02 - 
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57173 2.0 0.02 Hypothetical fungal transcription factor 
143379 -11.8 0.02 Candidate mismatched base pair and cruciform DNA 
recognition protein 
56523 -3.3 0.02 Related to leucine aminopeptidase  
214265 -2.8 0.02 Putative polyubiquitin 
56966 9.4 0.02 - 
198624 2.4 0.02 Ribosomal protein S6 
56739 2.9 0.02 Ornithine-N5-oxygenase 
46429 -6.8 0.02 Glycosyl hydrolases family 35 
35601 -2.1 0.02 - 
55356 -1.5 0.02 Glucose-repressible alcohol dehydrogenase transcriptional 
effector CCR4 and related proteins 
208447 1.7 0.02 Translation initiation factor 3 
190964 1.7 0.02 Predicted member of the intramitochondrial sorting protein 
family 
55609 3.5 0.02 - 
138144 5.0 0.02 Ribosomal L32p protein 
199912 -2.2 0.02 Oxysterol-binding protein 
42357 -2.4 0.02 - 
40460 -3.7 0.02 FAD-dependent oxidoreductase 
177616 -2.3 0.02 Sugar transporter superfamily 
209716 -1.9 0.02 Cu2+/Zn2+ superoxide dismutase SOD1 
47416 3.2 0.02 Hypothetical protein, contains DENN domain 
54451 -2.1 0.02 Hypothetical. Interpro: UTP-glucose-1-phosphate 
uridylyltransferase 
42051 -1.7 0.02 - 
210666 2.3 0.02 - 
172548 -2.1 0.02 - 
136082 -3.9 0.02 - 
54354 2.4 0.02 - 
177282 -3.4 0.02 - 
191243 -2.4 0.02 Candidate amidase B (EC 3.5.1.4) 
52343 -1.4 0.02 Hypothetical transcription factor TFIIB 
43300 -3.5 0.02 Hypothetical dehydrogenase 
183410 -1.8 0.02 - 
213557 -2.7 0.02 Short-chain dehydrogenase/reductase 
55055 -1.9 0.02 Hypothetical protein containing Zn-finger, C2H2 type domain 
35857 2.6 0.02 - 
44470 -1.9 0.02 Fungal specific transcription factor 
52374 2.2 0.02 Hypothetical protein with ankyrin and DNA-binding domains 
202252 -6.6 0.02 Putative extracellular tannase and feruloyl esterase 
53232 1.6 0.02 Related to dihydrolipoamide dehydrogenase of 
Schizosaccharomyces pombe; EC 1.8.1.4 
44662 2.6 0.02 - 
54378 3.8 0.02 Related to alpha-1,3-glucan synthase 
55566 11.3 0.02 Hydroxymethylglutaryl-coenzyme A synthase 
52868 1.5 0.02 Hypothetical protein transporter of the TRAM (translocating 
chain-associating membrane) superfamily 
141873 4.5 0.02 Carbon-nitrogen hydrolase 
40088 1.6 0.02 Hypothetical protein with predicted Structure-specific 
recognition protein (SSRP) domain 
202206 -1.6 0.02 Gamma-glutamyl phosphate reductase 
213093 -2.0 0.02 Proteasome/cyclosome, regulatory subunit 
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177406 -4.9 0.02 - 
211915 2.2 0.02 Ribosomal protein L23 
170709 -5.5 0.02 Aldehyde dehydrogenase 
202139 -3.1 0.02 Ubiquitin-like protein 
187304 3.6 0.02 Ergosterol biosynthesis ERG4/ERG24 family 
127809 1.3 0.02 Hypothetical extracellular thaumatin domain protein 
47870 -1.8 0.02 - 
205810 1.8 0.02 Calnexin 
177851 2.0 0.02 FOG: WD40 repeat 
191821 -1.9 0.02 Hypothetical. Predicted transporter (major facilitator 
superfamily 
41928 1.5 0.02 - 
128744 -2.9 0.02 - 
173139 -11.7 0.02 Methionine synthase, vitamin-B12 independent 
212637 -2.6 0.02 Hypothetical protein containing fungal specific transcription 
factor and fungal transcriptional regulatory protein domains. 
41950 2.2 0.02 - 
207638 -2.0 0.02 Golgi-associated protein/Nedd4 WW domain-binding protein 
37382 3.4 0.02 Mitochondrial/chloroplast ribosomal protein L54/L37 
49427 -2.0 0.02 - 
119946 -1.7 0.02 AAA ATPase 
130735 -2.4 0.02 - 
39372 -4.6 0.02 - 
209145 -3.8 0.02 Interferon-related protein PC4 like 
55534 1.6 0.02 - 
189874 2.0 0.02 Short-chain dehydrogenase/reductase 
54140 2.3 0.02 Hypothetical myosin assembly protein/sexual cycle protein in 
A. niger 
51779 4.2 0.02 - 
46666 1.6 0.02 Pyridoxal/pyridoxine/pyridoxamine kinase 
55693 -2.4 0.02 - 
197817 3.3 0.02 E3 binding 
49258 -3.8 0.02 Hypothetical aldehyde dehydrogenase. May be a succinate-
semialdehyde dehydrogenase 
211385 -1.8 0.02 - 
51257 2.2 0.02 Deduced translation product shares amino acid sequence 
identity with the Saccharomyces cerevisiae NOP14 gene 
product; a aucleolar protein that forms a complex with Noc4p 
and mediates maturation and nuclear export of 40S 
ribosomal subunits; also present in the small subunit 
processome complex, which is required for processing of pre-
18S rRNA. 
53140 -2.0 0.02 FMN-dependent dehydrogenase 
173978 1.5 0.02 - 
206560 1.3 0.02 Microtubule-associated protein 
178051 -1.6 0.02 Related to A. nidulans CreC 
42034 31.0 0.02 Formate/nitrite transporter 
56606 2.5 0.02 Mitochondrial/chloroplast ribosomal protein 
195925 2.1 0.02 Transcription factor containing homeobox and Zn-finger 
53893 3.4 0.02 Phosphatidylethanolamine binding protein 
199928 -4.9 0.02 Predicted hydrolase 
198862 2.8 0.02 Ribosomal protein S11 
120939 4.0 0.02 - 
201294 1.6 0.02 - 
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119891 -1.5 0.02 Inorganic pyrophosphatase 
206461 -2.1 0.02 - 
52861 -2.0 0.02 Uncharacterised conserved protein XAP-5 
195095 2.5 0.02 Related to zink transporter of A. fumigatus 
125824 -2.8 0.02 - 
52387 -1.8 0.02 Hypothetical H+-transporting two-sector ATPase 
127816 -2.4 0.02 SNARE protein 
56053 4.0 0.02 - 
133626 2.0 0.02 Hypothetical DnaJ domain protein 
206779 -1.9 0.02 Core histone H2A/H2B/H3/H4 
53381 2.4 0.02 Cytochrome b5 domain 
208917 -6.5 0.02 - 
209830 12.5 0.02 Hypothetical FAD/FMN-containing dehydrogenase 
211145 2.7 0.02 - 
173724 2.5 0.02 - 
189339 1.2 0.02 - 
51267 2.9 0.02 Oligosaccharyltransferase subunit 
205553 2.0 0.02 Insulinase-like 
128153 2.5 0.02 Hypothetical Sec61 protein translocation complex, beta 
subunit 
52574 1.5 0.02 - 
39772 1.7 0.02 Kinesin-like protein 
171583 -2.2 0.02 - 
45789 1.3 0.02 Hypothetical copper amine oxidase 
188782 -1.8 0.02 Amino acid transporters 
46527 1.5 0.02 - 
125912 -2.9 0.02 - 
211906 -1.7 0.02 - 
52105 -25.2 0.02 Amidohydrolase 
134406 -2.8 0.02 - 
51717 2.3 0.02 Hypothetical Mitochondrial phosphate carrier protein 
211641 -1.9 0.02 - 
41530 3.8 0.02 Hypothetical glycosylphosphatidylinositol anchor synthesis 
protein 
200274 1.9 0.02 TATA-binding protein 
189204 -3.2 0.02 Hypothetical DNA repair protein (RAD4 like) 
54719 -1.9 0.02 Protein kinase 
202514 -2.2 0.02 - 
200255 1.4 0.02 Hypothetical cation efflux protein 
190212 -1.8 0.02 Splicing coactivator SRm160/300, subunit SRm300 
44253 -1.9 0.02 - 
191350 2.3 0.02 - 
205431 -2.0 0.02 Molecular chaperones HSP70/HSC70, HSP70 superfamily 
55041 2.8 0.02 - 
208113 -1.6 0.02 Mitochondrial substrate carrier 
209236 1.9 0.02 Ribonuclease HII 
210981 -2.6 0.02 Putative extracellular GH family 3 beta-glucosiadse 
212641 -2.5 0.02 Hypothetical protein with esterase/lipase/thioesterase and 
signal peptide motifs 
36108 -1.7 0.02 Protein kinase PCTAIRE and related kinases 
55190 -1.5 0.02 - 
54651 -10.4 0.02 Hypothetical 3-ketoacyl-CoA-thiolase 
181863 1.7 0.02 - 
50560 -3.3 0.02 Predicted ubiquitin regulatory protein 
37318 1.5 0.02 - 
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46776 -2.7 0.02 TatD-related DNase 
184246 2.9 0.02 - 
124989 1.4 0.02 U4/U6 small nuclear ribonucleoprotein Prp4 (contains WD40 
repeats) 
56853 1.6 0.02 Deduced translation product shares amino acid sequence 
identity with the Saccharomyces cerevisiae PNO1 gene 
product; an essential nucleolar protein required for pre-18S 
rRNA processing; in yeast Pno1p interacts with Dim1p, an 
18S rRNA dimethyltransferase, and also with Nob1p, which is 
involved in proteasome biogenesis; contains a KH domain. 
179558 -1.7 0.02 - 
205670 -14.8 0.02 Glycoside hydrolase, family 3 
126807 1.6 0.02 Preprotein translocase subunit 
212837 2.3 0.02 UTP--glucose-1-phosphate uridylyltransferase 
192694 -3.1 0.02 Zinc-containing alcohol dehydrogenase 
204313 1.5 0.02 - 
122081 -4.6 0.02 - 
191038 -1.6 0.02 Amino acid/polyamine transporter 
45504 -2.1 0.02 - 
39277 -9.2 0.02 - 
203770 1.8 0.02 Protein kinase 
173727 -2.1 0.02 - 
53188 -1.9 0.02 - 
211011 -3.3 0.02 - 
203739 2.0 0.02 Hypothetical ubiquinol cytochrome c reductase, subunit 
QCR7 
206266 3.1 0.02 Cytochrome P450 
179623 2.3 0.02 WD40 repeat protein 
197132 2.7 0.02 - 
189398 -2.9 0.02 Protein of unknown function UPF0075 
38830 2.5 0.02 - 
119858 -4.4 0.02 Related to alpha-glucosidase; glycoside hydrolase, family 31 
213343 2.3 0.02 Predicted 3-hydroxy-3-methylglutaryl-CoA (HMG-CoA) 
reductase 
205376 1.4 0.02 - 
214072 -2.6 0.02 SCF ubiquitin ligase, Skp1 component 
212646 2.3 0.02 - 
55164 -7.0 0.02 - 
209397 -2.9 0.02 - 
128007 -2.6 0.02 Membrane protein involved in organellar division 
206911 -1.9 0.02 Hypothetical protein tyrosine phosphatase  
206304 2.5 0.02 Hypothetical RAS GTPase 
36238 -2.2 0.02 Hypothetical protein; KOG Class: Chromatin structure and 
dynamics; KOG Id: 4191; KOG Description: Histone 
acetyltransferases PCAF/SAGA/ADA, subunit 
TADA3L/NGG1 
210029 2.0 0.02 Candidate translational cofactor elongation factor-1 gamma 
119390 -1.8 0.02 Hypothetical vacuolar assembly/sorting protein PEP5/VPS11 
57172 -6.3 0.02 - 
50015 -2.5 0.02 Hypothetical, DNA-binding 
40813 2.0 0.02 Hypothetical protein containing basic-leucine zipper 
transcription factor domain 
213414 1.8 0.02 Predicted transporter (ABC superfamily) 
52503 -1.9 0.02 Peptidase C19 
119363 1.4 0.02 - 
44905 1.8 0.02 - 
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186735 3.3 0.02 - 
206990 -2.1 0.02 HMG box-containing protein 
53675 -2.0 0.02 Predicted protein shares amino acid sequence identity with 
the Saccharomyces cerevisiae SKI3 gene product; a protein 
involved in exosome mediated 3' to 5' mRNA degradation and 
translation inhibition of non-poly(A) mRNAs; forms complex 
with Ski2p and Ski8p; required for repressing propagation of 
dsRNA viruses. 
196788 -1.7 0.02 Hypothetical CCAAT-binding factor; KOG Class: 
Transcription; KOG Id: 0869; KOG description: CCAAT-
binding factor, subunit A (HAP3) 
55573 7.8 0.02 Candidate pyruvate decarboxylase 
54391 3.2 0.02 Hypothetical homoserine O-acetyltransferase (EC 2.3.1.31). 
212490 2.1 0.02 Cell division/GTP binding protein 
38375 -19.2 0.02 Major facilitator superfamily 
49162 1.5 0.02 Major facilitator superfamily 
206713 -2.1 0.02 - 
213947 -2.0 0.02 Hypothetical protein with RRM domain 
207006 -1.6 0.02 - 
57261 -1.5 0.02 Hypothetical Chaperone DnaJ 
207705 -1.8 0.02 Hypothetical 26S proteasome, regulatory subunit 
213834 -1.5 0.02 Permease for cytosine/purines 
127896 -1.9 0.02 - 
54934 1.7 0.02 - 
143899 -2.0 0.02 - 
214608 1.6 0.02 Candidate endo-1,4-beta-glucanase; glucan 1,4-beta-
glucosidase; glycoside hydrolase, family 5; cellulose-binding 
region, fungal 
203604 1.8 0.02 Aminoacyl-tRNA synthetase 
55758 -1.5 0.02 Zn-finger, AN1-like 
198565 1.9 0.02 - 
193227 1.7 0.02 - 
188256 -4.9 0.02 Hypothetical. Interpro: eukaryotic cysteine peptidase active 
site 
206723 -3.4 0.02 - 
54707 -2.4 0.02 Involved in autophagocytosis 
53390 1.5 0.02 - 
56133 -3.0 0.02 ABC superfamily 
51896 1.4 0.02 Hypothetical. KOG suggests role in cell division 
170127 3.2 0.02 - 
179224 -2.0 0.02 TIP120 family protein, Cullin-associated NEDD8-dissociated 
protein 
55560 -5.8 0.02 mannitol-1-phosphate 5-dehydrogenase 
121874 -1.5 0.02 Putative extracellular carboxylesterase, type B 
193894 -2.7 0.02 - 
190578 -1.8 0.02 - 
209184 -2.4 0.02 Oxysterol-binding protein 
173461 -2.1 0.02 - 
54957 1.7 0.02 Putative GroEL-like chaperone, ATPase 
134540 1.5 0.02 Fungal transcriptional regulatory protein, N-terminal 
36938 -1.2 0.02 Hypothetical. KOG: Collagens (type IV and type XIII) 
122116 -4.7 0.02 Metacaspase involved in regulation of apoptosis 
185119 -1.5 0.02 Hypothetical protein , contains FHA domain 
56454 3.0 0.02 - 
52740 2.7 0.02 Myosin class II heavy chain 
193151 2.1 0.02 - 
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208463 1.9 0.02 - 
44729 -26.1 0.02 Zinc-containing alcohol dehydrogenase superfamily 
180728 -1.9 0.02 - 
50898 3.8 0.02 Hypothetical permease. 10 predicted transmembrane 
domains. May have Xanthine/uracil transporter activity 
181975 1.6 0.02 Hypothetical Alkaline phytoceramidase 
45871 2.0 0.02 - 
183812 2.0 0.02 Major facilitator superfamily 
45900 -1.7 0.02 Hypothetical. KOG suggests Carbonic anhydrase. Simil 
suggests DNA polymerase subunit 
54557 -2.2 0.02 - 
176547 1.5 0.02 RNA recognition motif (RRM) 
181231 -1.8 0.02 - 
210131 1.7 0.02 - 
35976 4.5 0.02 Major facilitator superfamily 
133729 2.8 0.02 RNA-binding protein 
177953 -1.6 0.02 Hypothetical Zn finger protein with RING domain 
213441 5.7 0.02 Squalene monooxygenase   
179884 -1.9 0.02 Protein kinase 
56378 -2.2 0.02 - 
36700 2.1 0.02 AAA ATPase 
184522 2.0 0.02 Hypothetical DNA polymerase 
204610 3.1 0.02 Ribosomal protein L7/L12 
180715 1.7 0.02 Hypothetical ubiquitin-dependent hydrolase 
52571 1.5 0.02 Ribosomal protein S17 
45769 -2.3 0.02 Hypothetical FAD/FMN-containing dehydrogenase with signal 
peptide motif 
47307 -3.0 0.02 Methyltransferases 
185138 -1.5 0.02 Candidate GCN5-related histone actyltransferase (GNAT) 
214611 1.9 0.02 Candidate multidrug resistance ABC transporter 
213627 1.9 0.02 Dynamin GTPase effector 
56568 -5.1 0.02 Hypothetical aldehyde dehydrogenase (EC 1.2.1.3). 
47390 -2.6 0.02 - 
207831 -8.1 0.02 Glucose-methanol-choline oxidoreductase 
180069 -8.5 0.02 Major facilitator superfamily 
45394 1.5 0.02 - 
170610 -1.4 0.02 Cytochrome P450 
47683 -2.0 0.02 - 
54097 9.4 0.02 Flavohemoglobon 
134658 -1.7 0.02 Hypothetical 3-methyladenine DNA glycosidase 
184977 3.1 0.02 Mitochondrial substrate carrier 
50449 1.6 0.02 Hypothetical RNA procesing protein 
52803 2.8 0.02 Mitochondrial substrate carrier 
201822 6.0 0.02 Methylmalonate semialdehyde dehydrogenase 
41315 2.4 0.02 Hypothetical Protein involved in inorganic phosphate 
transport   
173004 -1.2 0.02 Predicted hydrolase related to dienelactone hydrolase 
203924 2.1 0.02 Putative protein transport protein SEC61 subunit alpha. 
Probable endoplasmic reticulum 
122948 -1.5 0.02 - 
53084 -1.9 0.02 Ubiquitin-conjugating enzymes, 16 kDa 
46152 1.6 0.02 - 
212507 -4.0 0.02 - 
52653 -2.9 0.02 Phosphotyrosyl phosphatase activator 
211901 3.2 0.02 - 
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199159 -3.9 0.02 - 
52344 -7.2 0.02 - 
46991 1.8 0.02 Peptidase S16, lon protease 
132806 -5.0 0.02 - 
197549 -21.4 0.02 Sugar (ANd other) transporter 
40043 3.1 0.02 - 
52874 -3.3 0.02 Serine/threonine protein kinase 
125779 4.0 0.02 - 
120053 -4.8 0.02 Fungal specific transcription factor 
39998 1.9 0.02 Hypothetical subunit of oligosaccharyltransferase 
180255 -2.6 0.02 neutral zinc metallopeptidases 
54972 1.9 0.02 FAD binding domain 
44695 2.4 0.02 - 
56235 1.9 0.02 Peptidase C50, separase 
43265 -72.1 0.02 - 
54021 1.5 0.02 - 
51373 -4.5 0.02 - 
175181 -3.2 0.02 Phox-like 
39760 -1.5 0.02 - 
36048 -1.3 0.02 - 
212162 1.6 0.02 - 
175900 2.4 0.02 GCN5-related N-acetyltransferase 
51738 -1.4 0.02 - 
54080 4.0 0.02 - 
44000 3.6 0.02 Hypothetical Isochorismatase hydrolase 
49063 -6.0 0.02 Hypothetical fatty acid omega-hydroxylase 
193955 -1.6 0.02 beta-1,6-N-acetylglucosaminyltransferase, contains WSC 
domain 
51069 1.6 0.03 Hypothetical protein with predicted SET, AWS & WW 
domains; KOG Class: Intracellular trafficking, secretion, and 
vesicular transport; KOG Id: 4442; KOG description: Clathrin 
coat binding  
196638 1.6 0.03 60S acidic ribosomal protein P0 
42079 -2.8 0.03 - 
178656 1.6 0.03 - 
53856 -2.3 0.03 Protein phosphatase 
52108 2.5 0.03 - 
42733 2.9 0.03 Dihydroxy-acid dehydratase 
209138 1.6 0.03 Transcription elongation factor 
180771 -1.5 0.03 - 
210632 1.4 0.03 tRNA synthetase anti-codon binding domain 
186860 -7.2 0.03 Aminotransferase class-III 
213042 -7.8 0.03 MOSC N-terminal beta barrel domain 
211200 -2.6 0.03 Snf7 family protein 
55287 -2.3 0.03 Metallophosphoesterase 
55463 -1.3 0.03 - 
175686 2.2 0.03 Myosin class II heavy chain 
48373 2.2 0.03 Uncharacterised conserved protein similar to ATP/GTP-
binding protein 
180608 -5.9 0.03 - 
120524 1.3 0.03 Fungal specific transcription factor 
53788 4.4 0.03 Nucleoside phosphatase 
128495 -3.0 0.03 - 
48357 -1.8 0.03 - 
140924 1.7 0.03 - 
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184532 -2.1 0.03 - 
196241 1.7 0.03 - 
140013 3.6 0.03 - 
208365 -2.5 0.03 Hypothetical. KOG: aldo/keto reductase  
38566 -1.8 0.03 Hypothetical. RNA splicing. Related to S. cerev.TRL, tRNA 
ligase, required for tRNA splicing 
174315 -4.1 0.03 - 
193828 -1.4 0.03 - 
203350 1.5 0.03 - 
37976 3.2 0.03 - 
121695 -5.1 0.03 AMP-dependent synthetase and ligase 
207741 -1.4 0.03 Hypothetical transcription initiation factor TFIIE, beta subunit 
35810 1.7 0.03 DEAD/DEAH box helicase 
180548 -4.1 0.03 - 
200652 1.6 0.03 C-3 sterol dehydrogenase/3-beta-hydroxysteroid 
dehydrogenase and related dehydrogenases 
42784 6.5 0.03 - 
189430 -2.6 0.03 Hypothetical 2-nitropropane dioxygenase. (EC 1.13.11.32) 
195992 -2.5 0.03 Hypothetical cyclic-AMP phosphodiesterase 
57150 -2.2 0.03 - 
48279 1.6 0.03 - 
186792 -4.5 0.03 - 
44995 1.3 0.03 Hypothetical protein with Zn-finger, Tim10/DDP type 
53811 -1.7 0.03 Related to profilin an actin bindin protein involved in 
cytoskeleton dynamics 
196559 -2.1 0.03 - 
43654 -1.8 0.03 - 
206734 1.3 0.03 Hypothetical. Interpro: H+-transporting two-sector ATPase 
125918 2.1 0.03 RNA-binding proteins 
54733 2.0 0.03 Eukaryotic transcription factor with helix-loop-helix DNA-
binding domain 
36622 -1.3 0.03 Hypothetical protein with predicted SET domain & TPR 
repeat; KOG Class: Chromatin structure and dynamics; KOG 
Id: 2084; KOG Description: Predicted histone tail methylase 
containing SET domain 
56243 -1.6 0.03 Electron transfer flavoprotein 
212044 1.3 0.03 Mitochondrial ADP/ATP carrier proteins 
201534 -2.2 0.03 - 
128714 -2.8 0.03 Candidate Rad54 homolog (first part); Related to Vac14 
homolog (second part) 
55273 4.1 0.03 ABC transporter protein. Induced at low pH (2.5). 
120468 -2.0 0.03 Fungal specific transcription factor 
212036 -1.5 0.03 Tyrosine specific protein phosphatase and dual specificity 
protein phosphatase 
206143 -4.5 0.03 - 
186006 -5.5 0.03 - 
52348 -1.8 0.03 - 
56941 1.3 0.03 - 
136905 -2.3 0.03 - 
180730 1.9 0.03 - 
208826 -2.6 0.03 - 
214216 -1.6 0.03 Calmodulin 
43767 1.5 0.03 - 
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46856 2.0 0.03 DEAD/DEAH box helicase 
206496 1.7 0.03 Molecular chaperone of the GrpE family 
40531 1.3 0.03 Citron-like 
200874 8.7 0.03 Transmembrane amino acid transporter protein 
194814 -2.1 0.03 - 
122135 -2.3 0.03 - 
196625 1.8 0.03 Hypothetical. KOG: putative COPII vesicle protein 
35666 1.8 0.03 FAD linked oxidase 
44921 -1.9 0.03 - 
174413 -4.9 0.03 Candidate galactose-1-phosphate uridyl transferase 
47364 -4.2 0.03 Candidate catalase 
179989 -2.4 0.03 - 
203210 1.9 0.03 - 
212525 2.0 0.03 Candidate DNA replication licensing factor 
45992 3.7 0.03 (chsC) Class-III chitin synthase C 
46311 -1.5 0.03 Members of tubulin/FtsZ family 
44596 1.6 0.03 GCN5-related N-acetyltransferase 
53008 2.5 0.03 Hypothetical aminopeptidase 
186010 1.6 0.03 - 
52361 2.8 0.03 - 
200845 -3.6 0.03 Phospholipase D/Transphosphatidylase 
56548 3.6 0.03 Generic methyltransferase 
174264 1.6 0.03 - 
53636 2.5 0.03 DNA-directed DNA polymerase B 
53686 1.3 0.03 Aldo/keto reductase family proteins 
48843 3.0 0.03 rRNA processing protein 
42089 1.5 0.03 Predicted translation product shares amino acid sequence 
identity with the Saccharomyces cerevisiae SEN1 gene 
product; a nuclear protein, putative helicase required for 
processing of tRNAs, rRNAs, and small nuclear RNAs; 
potential Cdc28p substrate. 
204742 1.6 0.03 Hypothetical protein involved in chromatin remodelling 
143435 1.5 0.03 - 
38788 -3.2 0.03 Amino acid/polyamine transporter 
173677 -14.5 0.03 Hypothetical. Ketopantoate reductase pyrimidin base 
metabolism 
206783 11.4 0.03 - 
213169 2.1 0.03 GHMP kinase 
51832 2.8 0.03 - 
35583 1.9 0.03 Deduced amino acid sequence shares identity with the 
Saccharomyces cerevisiae NCL1 gene product; an S-
adenosyl-L-methionine-dependent tRNA: m5C-
methyltransferase; methylates cytosine to m5C at several 
positions in tRNAs and intron-containing pre-tRNAs. 
170910 -2.1 0.03 Glucose/ribitol dehydrogenase 
183972 1.4 0.03 Major facilitator superfamily 
191568 -9.5 0.03 Predicted glutathione S-transferase 
177836 1.5 0.03 - 
128905 2.9 0.03 Protein kinase 
50147 1.5 0.03 Hypothetical Amino acid/polyamine transporter II  
207105 1.5 0.03 - 
53033 1.5 0.03 Related to beta-1,3-glucanosyltransferase 
40602 1.5 0.03 - 
211789 15.7 0.03 - 
200493 5.5 0.03 Imidazoleglycerol-phosphate dehydratase 
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37023 -1.5 0.03 - 
178686 -1.9 0.03 Fungal transcriptional regulatory protein 
208354 1.7 0.03 - 
49311 -10.2 0.03 Hypothetical, similarities to sialidase superfamily 
53473 -3.7 0.03 - 
56299 -1.5 0.03 - 
53696 1.6 0.03 Major facilitator superfamily 
39857 1.4 0.03 - 
119945 1.7 0.03 - 
205426 -2.4 0.03 Peptidase 
202677 2.3 0.03 - 
205095 -6.5 0.03 Short-chain dehydrogenase/reductase 
120073 2.3 0.03 Serine/threonine protein kinase 
181938 -1.9 0.03 Ypt/Rab-specific GTPase-activating protein GYP7 and 
related proteins 
196738 2.6 0.03 Signaling protein 
172823 1.7 0.03 Related to zink transporter of A. fumigatus. Seven putative 
transmembrane domains and PFam domains for zink 
transport. 
51930 -1.6 0.03 Gen A8; hypothetical Cyanovirin-N protein 
121710 -2.2 0.03 Amidases 
46980 1.8 0.03 ABC transporter 
208679 1.5 0.03 - 
135865 1.3 0.03 - 
214413 -2.0 0.03 Vacuolar protein sorting-associated protein 
56457 -2.8 0.03 (cmkB) calcium/calmodulin dependent protein kinase B - high 
homology to cmkB in A. nidulans 
205452 1.6 0.03 Hypothetical translation initiation factor 4F 
44892 1.4 0.03 - 
138876 1.4 0.03 beta-mannosidase A 
193056 -2.0 0.03 - 
201912 -1.7 0.03 - 
128279 1.9 0.03 - 
191935 1.5 0.03 - 
176923 2.1 0.03 - 
41302 1.4 0.03 - 
206219 4.6 0.03 ERG2 and sigma1 receptor-like protein 
184233 1.6 0.03 - 
185018 -1.9 0.03 - 
187701 -4.1 0.03 Electron transporter activity 
180923 -10.4 0.03 Major facilitator superfamily 
47908 2.2 0.03 Short-chain dehydrogenase/reductase SDR 
211941 2.9 0.03 Predicted protein shares amino acid sequence identity with 
the Saccharomyces cerevisiae TRM2 gene product; a tRNA 
methyltransferase, 5-methylates the uridine residue at 
position 54 of tRNAs and may also have a role in tRNA 
stabilization or maturation; previously thought to be an endo-
exonuclease. 
196499 -8.3 0.03 Major facilitator superfamily 
51836 1.4 0.03 Zn-finger, CCHC type 
56841 2.5 0.03 Putative transmembrane GH family 47 mannosyl-
oligosaccharide 1,2-alpha-mannosidase 
49344 2.6 0.03 Putative GH family 76 endo-1,6-alpha-mannanase 
47312 1.6 0.03 Kinesin-like protein 
129990 2.3 0.03 FOG: PPR repeat 
195339 1.3 0.03 - 
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213924 -1.8 0.03 - 
172886 -2.0 0.03 - 
39962 -2.1 0.03 Phosphoinositide 3-kinase, C2 
195119 1.2 0.03 Esterase/lipase/thioesterase 
198750 21.0 0.03 Ammonium transporter 
52406 3.3 0.03 Beta-ketoacyl synthase 
40477 -2.2 0.03 Hypothetical. Some similarity to alkylhydroperoxidase 
45821 2.1 0.03 (pelB) extracellular pectin lyase B 
49775 -1.4 0.03 - 
54127 1.3 0.03 - 
119842 1.4 0.03 Zn-finger-like, PHD finger 
39899 1.4 0.03 Hypothetical Signal recognition particle, subunit Srp68 
136326 -2.7 0.03 - 
205686 1.5 0.03 - 
130307 -3.1 0.03 RNA-binding protein required for biogenesis of the ribosomal 
60S subunit 
44628 -2.3 0.03 - 
188766 1.3 0.03 - 
55655 1.8 0.03 - 
124929 -1.6 0.03 Metallophosphoesterase 
55493 3.0 0.03 Related to serine protease  
49158 -2.2 0.03 Hypothetical NADH:flavin oxidoreductase/NADH oxidase-like 
protein 
127656 -1.9 0.03 Calcium-binding EF-hand 
180223 2.6 0.03 Mitochondrial substrate carrier 
211361 -2.9 0.03 - 
40805 1.6 0.03 - 
209060 1.3 0.03 - 
190584 -1.5 0.03 - 
176070 -6.9 0.03 ATP-dependent DNA ligase 
52362 1.8 0.03 Candidate 40S ribosomal protein S0. 
48684 -3.6 0.03 - 
171513 -1.5 0.03 GCN5-related N-acetyltransferase 
205428 -60.4 0.03 - 
36654 1.5 0.03 Hypothetical. Initiation factor 2B domain and NUDIX 
hydrolase domain 
185751 -1.6 0.03 Hypothetical lysophospholipase 
125201 -4.2 0.03 Esterase/lipase/thioesterase 
50844 -3.5 0.03 Hypothetical Fungal specific transcription factor  
197123 -2.0 0.03 Rab GDI protein 
178195 2.0 0.03 Hypothetical protein with an ARM repeat fold 
205572 -2.0 0.03 Hypothetical protein containing Zn-finger, C2H2 type and U1-
like domains 
190030 -3.9 0.03 Aldo/keto reductase family proteins 
47488 1.7 0.03 DEAD/DEAH box helicase 
53339 2.8 0.03 Malate dehydrogenase 
180990 -4.3 0.03 Zinc-binding oxidoreductase 
35726 3.7 0.03 - 
52713 -1.7 0.03 Glucosamine 6-phosphate synthetases, contain 
amidotransferase and phosphosugar isomerase domains 
189779 6.1 0.03 - 
137999 -2.1 0.03 Predicted coiled-coil protein 
44558 -2.3 0.03 - 
205450 -2.0 0.03 - 
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52275 -3.8 0.03 - 
46302 2.9 0.03 Serine/threonine protein kinase 
189606 2.6 0.03 Fungal specific transcription factor 
44704 2.0 0.03 Predicted translation product shares amino acid sequence 
identity with the Saccharomyces cerevisiae PAP2 gene 
product; the catalytic subunit of TRAMP (Trf4/Pap2p-Mtr4p-
Air1p/2p), a nuclear poly (A) polymerase complex involved in 
RNA quality control; catalyses polyadenylation of unmodified 
tRNAs, and snoRNA and rRNA precursors; disputed role as a 
DNA polymerase (yeast). 
38790 1.4 0.03 Hypothetical protein. 
54742 1.8 0.03 - 
176572 1.6 0.03 - 
214187 -5.3 0.03 - 
205005 -4.4 0.03 Putative soluble Fumarate reductase/succinate 
dehydrogenase flavoprotein, N-terminal 
55487 -2.2 0.03 - 
178864 4.0 0.03 Protein involved in ubiquinone biosynthesis 
186794 2.0 0.03 Related to pseudouridine synthase. 
183189 1.6 0.03 - 
197120 1.7 0.03 Ribosomal protein L29 
38223 1.3 0.03 - 
202801 2.1 0.03 citA citrate synthase 
40316 1.5 0.03 AAA ATPase 
199085 -2.1 0.03 Putative GH family 16 GPI-glucanosyltransferase 
38822 1.3 0.03 Predicted gene product shares amino acid sequence identity 
with the Saccharomyces cerevisiae UTP20 gene product; a 
component of the small-subunit (SSU) processome, which is 
involved in the biogenesis of the 18S rRNA. 
54428 1.5 0.03 - 
205944 -1.8 0.03 - 
197539 -1.1 0.03 Transcription factor of the Forkhead/HNF3 family 
49138 2.0 0.03 AAA ATPase 
211648 1.6 0.03 ATP-dependent RNA helicase 
175987 -4.1 0.03 Carbon-nitrogen hydrolase 
56228 -3.7 0.03 - 
200777 -1.7 0.03 Hypothetical mitotic spindle checkpoint protein 
52614 -4.6 0.03 FAD-binding protein DIMINUTO 
210170 -1.3 0.03 - 
36739 4.2 0.03 - 
55790 -1.5 0.03 Putative allergen produced in response to stress or pathogen 
infection 
132415 1.4 0.03 WD40 protein 
56242 -1.4 0.03 - 
213815 -12.7 0.03 Cytoskeletal protein A 
55611 1.6 0.03 Putative eIF2 alpha subunit, similar to Gcn3p of S. cerevisiae. 
possibly involved in translation initiation and protein 
biosynthesis. 
136603 -2.0 0.03 Hypothetical transcription initiation factor. A putative YEATS 
domain is present in the sequence 
56633 -3.2 0.03 - 
129862 -1.6 0.03 Glycosyl transferase, family 25 
194528 -1.9 0.03 - 
139340 2.9 0.03 - 
47046 2.1 0.03 Hypothetical Ras GTPase 
41998 -3.5 0.03 - 
190360 1.8 0.03 - 
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208486 -1.6 0.03 Peptidase S10 
48500 1.8 0.03 - 
46099 4.9 0.03 - 
39964 2.5 0.03 Conserved ATP/GTP binding protein 
174983 1.6 0.03 Predicted methyltransferase 
176363 -11.3 0.03 - 
50062 1.3 0.03 Hypothetical TGc (transglutaminase/protease-like) domain-
containing protein involved in cytokinesis 
57417 -1.9 0.03 - 
201412 -3.9 0.03 - 
185301 -2.5 0.03 Hypothetical carboxylesterase 
47141 1.5 0.03 - 
45817 2.3 0.03 beta-1,6-N-acetylglucosaminyltransferase, contains WSC 
domain 
40956 2.7 0.03 - 
130150 -1.4 0.03 Serine/threonine protein kinase 
193903 1.5 0.03 Predicted nucleolar protein involved in ribosome biogenesis 
182597 -1.5 0.03 Zn-finger transcription factor 
42045 -2.0 0.03 Ankyrin repeat 
48560 -2.0 0.03 Glutathione S-transferase 
206802 2.8 0.03 Serine/threonine protein kinase 
56664 -8.0 0.03 Exoinulinase 
211484 -2.1 0.04 TATA box binding protein (TBP)-associated factor, RNA 
polymerase II 
212420 2.1 0.04 Hypothetical ribosomal protein 
172476 -2.6 0.04 - 
190129 3.2 0.04 - 
39748 1.6 0.04 - 
43857 -2.3 0.04 Amino acid permease 
173527 1.4 0.04 Related to the extracellular pectin lyase C 
54860 35.8 0.04 Purine nucleoside permease 
196801 -2.2 0.04 Seems like two proteins have been combined in one model 
38920 -2.5 0.04 - 
48810 1.8 0.04 - 
121960 -1.7 0.04 - 
200605 -37.0 0.04 (abfB) alpha-L-arabinofuranosidase B 
191214 3.9 0.04 Hypothetical. Helicase domain 
211010 -1.9 0.04 Protein kinase 
52239 -2.6 0.04 - 
37575 -2.2 0.04 - 
49003 2.7 0.04 - 
36779 1.5 0.04 Hypothetical dihydroorotate dehydrogenase (EC 1.3.3.1) 
187898 -1.6 0.04 Predicted glycosyltransferase 
211766 -15.7 0.04 SAM (and some other nucleotide) binding motif 
40151 1.5 0.04 Caspase-1, p20 
180211 -10.0 0.04 Alpha/beta hydrolase 
178365 -6.0 0.04 Hypothetical aspartic protea 
197786 -1.5 0.04 (dapB) dipeptidylpeptidase 
40078 1.8 0.04 Predicted metalloprotease with chaperone activity 
187366 -4.3 0.04 AMP-binding enzyme 
183511 -5.6 0.04 Fungal transcriptional regulatory protein 
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196062 2.5 0.04 Deduced translation product shares amino acid sequence 
identity with the Saccharomyces cerevisiae NOP1 gene 
product; a nucleolar protein, component of the small subunit 
processome complex, which is required for processing of pre-
18S rRNA; has similarity to mammalian fibrillarin. 
194861 1.2 0.04 Hypothetical shikimate/quinate 5-dehydrogenase 
35846 1.5 0.04 - 
172596 -2.1 0.04 - 
56429 1.3 0.04 - 
186797 -1.4 0.04 - 
53994 1.8 0.04 - 
207173 -2.1 0.04 FYVE finger-containing protein 
211899 -2.4 0.04 Protein kinase 
46407 2.4 0.04 DEAD/DEAH box helicase 
47735 -2.9 0.04 Uncharacterised conserved protein predicted to be involved 
in protein sorting 
196160 -2.8 0.04 - 
51602 -2.3 0.04 - 
170573 2.2 0.04 - 
191708 2.2 0.04 - 
206020 3.5 0.04 Hypothetical. involved in rRNA processing. associates with 
trans-acting ribosome biogenesis factors (yeast); similar to 
beta-transducin superfamily. 
54073 12.0 0.04 - 
188553 -18.1 0.04 Acyl-CoA dehydrogenase 
36331 -6.9 0.04 - 
192427 -2.0 0.04 - 
179151 1.2 0.04 Aminotransferase 
210597 -1.4 0.04 cAMP-dependent protein kinase 
184098 1.6 0.04 - 
210994 1.6 0.04 - 
119438 -1.4 0.04 Phosphoprotein involved in cytosol to vacuolar targeting and 
autophagocytosis 
212289 1.9 0.04 Candidate 6,7-dimethyl-8-ribityllumazine synthase 
55704 -3.1 0.04 (tpsA) trehalose-6-phosphate synthase A 
54208 -1.8 0.04 AAA ATPase 
211598 -3.7 0.04 - 
39109 -2.5 0.04 - 
48067 1.8 0.04 Hydroxyindole-O-methyltransferase and related SAM-
dependent methyltransferases 
123950 -2.0 0.04 Protein phosphatase 2C-like 
199609 -2.4 0.04 Fungal transcriptional regulatory protein 
54575 1.6 0.04 - 
53463 3.5 0.04 Cation efflux family 
121846 1.6 0.04 - 
176596 1.9 0.04 Cytochrome P450 
52961 1.4 0.04 PolyC-binding proteins alphaCP-1 and related KH domain 
proteins 
56345 -2.8 0.04 Major facilitator superfamily 
181821 -1.7 0.04 - 
55077 1.5 0.04 DNA-binding protein of the nucleobindin family 
133804 2.0 0.04 Microfibrillar-associated protein 
207217 -5.7 0.04 Glycogen synthase 
51264 2.5 0.04 - 
187486 -20.7 0.04 - 
55640 -1.4 0.04 - 
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193639 1.9 0.04 - 
184760 1.6 0.04 - 
47578 4.0 0.04 Nucleolar GTPase/ATPase p130 
57028 -2.4 0.04 Aldehyde dehydrogenase 
55090 -1.8 0.04 This subunit of TFIIF is required for recruitment of RNA 
polymerase onto the promoter; this gene is known as "TFG2" 
in S.cerevisiae 
40461 -3.0 0.04 - 
187803 1.6 0.04 Hypothetical ribosomal protein 
141681 -4.1 0.04 - 
47983 2.4 0.04 - 
50979 2.5 0.04 Related to alpha-L-arabinofuranosidase 
37025 -1.5 0.04 Predicted K+/H+-antiporter 
139686 -1.7 0.04 - 
123216 1.8 0.04 FAD linked oxidase, N-terminal 
207131 2.1 0.04 Nucleolar GTPase/ATPase p130 
173825 3.1 0.04 Candidate Alpha-1,2 glucosyltransferase alg10 
52207 -3.2 0.04 - 
51140 1.8 0.04 Hypothetical Signal recognition particle, subunit Srp72 
39373 -1.8 0.04 - 
55773 -2.6 0.04 - 
210957 -7.2 0.04 - 
57395 1.3 0.04 Glycosyl transferase, family 39 
213531 1.8 0.04 Mitochondrial import translocase, subunit Tom70 
55193 -2.4 0.04 - 
35745 1.7 0.04 - 
192901 -1.3 0.04 - 
135590 -6.6 0.04 Predicted RNA binding protein 
196122 1.5 0.04 Putative extracellular GH family 16 cell wall glucanse 
136122 2.3 0.04 Hypothetical Ubiquinol cytochrome c reductase assembly 
protein CBP3 
49039 1.9 0.04 Hypothetical protein containing Sec23/Sec24 domains 
involved in vesicle coating 
193610 -23.5 0.04 Carboxylesterases 
179383 -2.1 0.04 - 
38116 1.8 0.04 Related to ATP-dependent RNA helicases of the DEAD-box 
protein family.  
200271 -1.3 0.04 Zn-finger-like, PHD finger 
177364 -1.3 0.04 Mitochondrial substrate carrier 
136009 -3.1 0.04 - 
120082 -1.6 0.04 Predicted hydrolase involved in interstrand cross-link repair 
50698 1.5 0.04 Hypothetical. Calcium/actin binding 
48814 -12.1 0.04 - 
179991 -2.8 0.04 - 
56607 -2.3 0.04 Armadillo/beta-catenin-like repeats 
184012 1.8 0.04 Amino acid transporters 
40780 -2.6 0.04 - 
141890 1.5 0.04 - 
174055 5.9 0.04 Putative tRNA acetyltransferase, 
136205 3.5 0.04 - 
208174 -1.4 0.04 - 
212069 1.5 0.04 - 
37700 -1.6 0.04 - 
177700 1.5 0.04 Inner centromere protein (INCENP), C-terminal domain 
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180578 1.7 0.04 - 
197463 1.8 0.04 Mitochondrial large ribosomal subunit 
138508 1.4 0.04 Hypothetical Cytochrome c oxidase assembly protein/Cu2+ 
chaperone COX17 
210766 2.2 0.04 - 
44033 -1.6 0.04 (apsA) Peptidase M1 
53274 1.9 0.04 - 
52489 1.7 0.04 Putative extracellular protein 
35368 1.3 0.04 Isopenicillin N synthase 
204359 1.2 0.04 - 
52186 3.3 0.04 Hypothetical beta-keto-reductase 
194765 1.3 0.04 Putative GH family 61 endo-1,4-beta-glucanase 
182877 1.6 0.04 - 
207193 3.7 0.04 Amino acid/polyamine transporter 
42949 1.7 0.04 - 
56203 1.5 0.04 Cell division/GTP binding protein 
35401 1.4 0.04 3-hydroxyacyl-CoA dehydrogenase, NAD-binding 
42764 1.4 0.04 - 
39069 1.5 0.04 - 
205537 -1.5 0.04 Hypothetical. Sequence identity with S. cerevisiae LSM7 
gene; involved in mRNA decay; possibly involved in 
processing tRNA, snoRNA, and rRNA. 
36528 1.5 0.04 - 
180635 3.2 0.04 - 
182245 1.4 0.04 Hypothetical protein. PFam identifies short-chain 
dehydrogenase activity. 
190444 1.4 0.04 - 
54488 -1.8 0.04 - 
211979 -1.7 0.04 - 
124451 -4.8 0.04 Esterase/lipase/thioesterase 
48629 1.8 0.04 - 
208677 4.5 0.04 - 
210217 6.4 0.04 large beta-ketoacyl synthase probably involved in polyketide 
synthesis (aurasperone??) 
183335 -2.9 0.04 Hypothetical. Glutathione-dependent formaldehyde-
activating, GFA domain (Interpro) 
171186 1.7 0.04 - 
207758 -3.2 0.04 26S proteasome regulatory complex, subunit PSMD9 
51164 1.6 0.04 - 
180846 1.9 0.04 beta-1,6-N-acetylglucosaminyltransferase, contains WSC 
domain 
48389 18.5 0.04 Predicted transporter (major facilitator superfamily 
213733 -2.5 0.04 Predicted ubiquitin regulatory protein, contains UAS and UBX 
domains 
182927 3.2 0.04 H+/oligopeptide symporter 
40392 2.3 0.04 Hypothetical protein sharing amino acid sequence identity 
with the Saccharomyces cerevisiae ECM16 gene encoding 
an essential DEAH-box ATP-dependent RNA helicase 
specific to the U3 snoRNP; predominantly nucleolar in 
distribution; required for 18S rRNA synthesis. 
213937 -2.0 0.04 26S proteasome subunit 
200308 2.1 0.04 - 
56906 1.7 0.04 Predicted translation product shares amino acid sequence 
identity with the Saccharomyces cerevisiae PWP2 gene 
product; conserved 90S pre-ribosomal component essential 
for proper endonucleolytic cleavage of the 35 S rRNA 
precursor at A0, A1, and A2 sites; contains eight WD-repeats.
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187248 -1.5 0.04 - 
128935 1.4 0.04 Major facilitator superfamily 
55598 2.5 0.04 - 
185038 1.3 0.04 - 
143030 1.5 0.04 Haloacid dehalogenase-like hydrolase 
45757 -3.3 0.04 - 
186597 1.6 0.04 - 
172198 2.8 0.04 Putative cytochrome P450 monooxygenase 
203777 -2.7 0.04 Hypothetical mitochondrial substrate carrie 
214112 3.0 0.04 - 
46653 -2.6 0.04 - 
212771 -35.4 0.04 - 
45282 -3.3 0.04 - 
171903 1.9 0.04 ABC transporter 
45867 2.6 0.04 - 
38997 1.6 0.04 - 
54229 1.7 0.04 - 
184932 1.6 0.04 Hypothetical protein containing ferric reductase-like 
transmembrane component and helix-turn-helix, Fis-type 
domain components. 
185630 3.0 0.04 Helicase, C-terminal 
190033 -2.0 0.04 Putative proline racemase 
121523 -2.1 0.04 - 
205564 2.0 0.04 Candidate. DNA-directed RNA polymerase 
210481 -8.5 0.04 Predicted dehydrogenase 
209129 -1.8 0.04 - 
42052 2.1 0.04 - 
188780 -2.7 0.04 - 
57403 -4.2 0.04 - 
57296 -1.9 0.04 Nuclear protein ES2 
206692 2.3 0.04 Adenylosuccinate lyase 
119606 -2.7 0.04 Trehalose-6-phosphate synthase component TPS1 and 
related subunits 
195287 -3.8 0.04 - 
49515 5.4 0.04 - 
47166 -3.2 0.04 - 
42934 -4.0 0.04 - 
55985 -1.6 0.04 Protein synthesis factor 
44492 1.4 0.04 ABC transporter 
194066 1.8 0.04 - 
190335 -2.4 0.04 Protein kinase 
53986 -12.8 0.04 - 
124202 2.7 0.04 tRNA(1-methyladenosine) methyltransferase, subunit GCD14 
187778 -9.7 0.04 Fungal transcriptional regulatory protein, N-terminal 
188704 1.8 0.04 Hypothetical signal peptidase. Signalp predictions suggests 
that it is anchored to a membrane. 
190193 2.3 0.04 - 
194077 1.7 0.04 Valyl-tRNA synthetase 
42132 -1.7 0.04 Hypothetical lipase 
53046 -2.1 0.04 Hypothetical protein containing fungal specific transcription 
factor domain. 
121949 -3.0 0.04 - 
183274 1.7 0.04 TatD-related DNase 
208336 3.0 0.04 Hypothetical. Possible role in carbohydrate metabolism 
38054 -11.8 0.04 Hypothetical Short-chain dehydrogenase/reductase SDR 
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208699 2.0 0.04 Predicted translation product shares amino acid sequence 
identity with the Saccharomyces cerevisiae RSC9 gene 
product; one of 15 subunits of the 'Remodel the Structure of 
Chromatin' (RSC) complex; DNA-binding protein involved in 
the synthesis of rRNA and in transcriptional repression and 
activation of genes regulated by the Target of Rapamycin 
(TOR) pathway. 
41754 1.9 0.04 - 
41165 3.5 0.04 Putative GH family 16 GPI_glucanosyltransferase 
182754 -1.9 0.04 - 
198577 -6.9 0.04 Carnitine O-acyltransferase 
43556 1.8 0.04 - 
214402 -1.4 0.04 Zn-finger, C2H2 type 
170608 -8.2 0.04 Hypothetical PHD zinc finger 
184563 -2.4 0.04 - 
56159 -1.6 0.04 Related to phenylalanine-tRNA ligase of Candida albicans 
192754 1.3 0.04 - 
173081 1.2 0.04 Hypothetical protein. Transport activity is a probable function 
due to 12 predicted transmembrane domains. 
181060 1.6 0.04 Predicted protein shares amino acid sequence identity with 
the Saccharomyces cerevisiae UTP4 gene product; a 
nucleolar protein, component of the small subunit (SSU) 
processome containing the U3 snoRNA that is involved in 
processing of pre-18S rRNA. 
49535 -10.4 0.04 FMN-dependent alpha-hydroxy acid dehydrogenase 
55417 -11.6 0.04 Serine/threonine protein kinase, active site 
205270 3.9 0.04 - 
212893 -5.2 0.04 Glycoside hydrolase 
127054 1.4 0.04 - 
186640 -1.3 0.04 Hypothetical  isoprenylcysteine carboxyl methyltransferase 
56498 -8.8 0.04 Isoflavone reductase 
172670 -1.6 0.04 - 
136791 -2.1 0.04 Predicted short chain-type dehydrogenase 
49404 -1.7 0.04 - 
189824 -1.3 0.04 - 
193777 -2.9 0.04 DEAD/DEAH box helicase 
192050 -2.4 0.04 Na+:Ca2+ antiporter 
214512 1.4 0.04 RNA-binding protein musashi/mRNA cleavage and 
polyadenylation factor I complex 
47411 -1.4 0.04 Short-chain dehydrogenase/reductase 
199734 3.1 0.04 Coproporphyrinogen III oxidase 
38678 -1.3 0.04 - 
37042 1.6 0.04 - 
54890 2.0 0.04 Carbamoyl-phosphate synthase 
189342 -1.8 0.04 Sugar transporter 
39731 -4.3 0.04 - 
50029 -4.1 0.04 - 
209244 -2.9 0.04 Oxidoreductase 
44753 -1.3 0.04 Esterase/lipase/thioesterase 
212567 -3.8 0.04 - 
56350 -2.6 0.04 - 
142990 -1.5 0.04 mRNA splicing factor 
194112 -1.4 0.04 Lipase essential for autophagy 
42932 1.6 0.04 Rhodopsin-like GPCR superfamily 
53697 -1.9 0.04 Hypothetical protein containing Zn-finger protein, C2H2 type 
domain 
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42826 1.5 0.04 Putative growth response protein 
55212 1.5 0.04 (pelD) extracellular pectin lyase D 
178954 1.3 0.04 Fungal transcriptional regulatory protein, N-terminal 
52857 -1.5 0.04 NEDD8-activating complex, APP-BP1/UBA5 component 
52637 -1.3 0.04 Histone H3 
187878 -4.1 0.04 Related to hogA MAP kinase 
52779 1.3 0.04 - 
171548 -2.1 0.04 - 
213237 -2.9 0.04 - 
51412 -3.0 0.04 - 
42787 2.1 0.04 - 
207996 15.2 0.04 Permeases for cytosine/purines, uracil, thiamine, allantoin 
119587 2.0 0.04 Glycosyl hydrolases family 18 
53946 -1.7 0.04 - 
135680 1.6 0.04 Methyltransferases 
48610 1.6 0.04 - 
46101 1.5 0.04 - 
48631 1.3 0.04 - 
52154 1.7 0.04 - 
182017 -1.6 0.04 Short-chain dehydrogenase/reductase 
54982 2.6 0.04 Hypothetical protein with homeobox domain 
176406 1.8 0.04 Deduced amino acid sequence shares identity with the 
Saccharomyces cerevisiae NHP2 gene product; a nuclear 
protein related to mammalian high mobility group (HMG) 
proteins, essential for function of H/ACA-type snoRNPs, 
which are involved in 18S rRNA processing. 
42728 -2.5 0.04 Related to vacuolar ATP synthase subunit D 
210454 3.9 0.04 Molecular chaperones mortalin/PBP74/GRP75, HSP70 
superfamily 
46084 1.2 0.04 - 
212182 -6.4 0.04 - 
127270 1.2 0.04 - 
187819 1.4 0.04 Glucose dehydrogenase/choline 
dehydrogenase/mandelonitrile lyase (GMC oxidoreductase 
family) 
138217 -2.0 0.04 Predicted RNA-binding protein (RRM superfamily) 
54762 1.6 0.04 Adenosine monophosphate deaminase 
37289 -1.5 0.04 Non voltage-gated ion channels (DEG/ENaC family) 
54187 -1.6 0.04 - 
36826 2.3 0.04 - 
54411 -17.9 0.04 Short-chain dehydrogenase/reductase SDR 
187108 1.3 0.04 - 
124393 -3.9 0.04 Peroxisomal NUDIX hydrolase 
210291 -2.9 0.04 - 
55229 -2.7 0.04 Alpha/beta hydrolase 
211589 1.5 0.04 Candidate tif5 gene encoding translation initiation factor eIF5.
143583 -2.9 0.04 - 
37296 1.9 0.04 - 
35473 -4.7 0.04 Protein containing a zinc finger C2H2-type domain; it is 
similar to S.cerevisiae CRZ1 (YNL027W) calcineurin-
responsive transcription factor 
212155 1.7 0.04 Ribosomal protein S2 
188240 -1.8 0.04 - 
47972 -1.2 0.04 - 
36822 -1.3 0.04 Hypothetical regulatory subunit of the 20S preoteasome 
213490 15.3 0.04 - 
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53547 2.5 0.04 - 
47866 1.6 0.04 Putative GroEL-like chaperone, ATPase 
54207 -5.3 0.04 MaoC-like dehydratase 
202416 1.4 0.04 40S ribosomal protein S3 
48964 -1.6 0.04 - 
41820 -2.1 0.04 - 
173769 -2.1 0.04 - 
41756 1.6 0.04 Amidohydrolase 
55526 1.7 0.04 Fungal chitin synthase 
214466 1.5 0.04 Hypothetical. KOG suggests function in ER-Golgi transport 
54960 -1.7 0.04 - 
52676 1.2 0.04 60s ribosomal protein gene RPL5. 
55451 -3.1 0.04 - 
180549 5.6 0.04 - 
43417 2.7 0.04 - 
44401 2.2 0.04 - 
204315 -2.7 0.04 Hypothetical. Interpro suggests Cupin domain. Sugar 
isomerase activity ? 
132036 2.6 0.04 - 
197480 -9.2 0.04 Enoyl-CoA hydratase/isomerase 
51934 1.3 0.04 RuvB-like helicase 2 
47358 2.9 0.04 Predicted protein shares amino acid sequence identity with 
the Saccharomyces cerevisiae UTP10 gene product; a 
nucleolar protein, component of the small subunit (SSU) 
processome containing the U3 snoRNA that is involved in 
processing of pre-18S rRNA. 
129162 1.6 0.04 - 
178237 1.6 0.04 - 
55131 -6.3 0.04 - 
43285 -2.7 0.04 Fungal transcriptional regulatory protein 
184613 1.3 0.04 Fungal transcriptional regulatory protein 
43664 1.3 0.04 Esterase/lipase/thioesterase 
55910 -2.1 0.04 FAD dependent oxidoreductase 
213737 1.5 0.04 - 
52020 1.4 0.04 Ribosomal protein 
46134 -2.2 0.04 FAD-linked oxidase 
171426 -1.6 0.04 Related to aldehyde dehydrogenase (EC 1.2.1.3). Sequence 
similarity to aldH of A. fumigatus 
210182 4.7 0.04 - 
56149 -2.4 0.05 Metallophosphoesterase 
45331 1.4 0.05 - 
130814 -2.8 0.05 - 
180718 -10.9 0.05 AAA+-type ATPase 
201398 -11.5 0.05 - 
194754 -1.7 0.05 - 
206638 2.7 0.05 Aconitate hydratase 
179964 1.5 0.05 Hypothetical ATP-dependent helicase with DEAD/DEAH box 
domain 
52004 1.7 0.05 oxidoreductase 
179508 1.4 0.05 Major facilitator superfamily 
54734 2.3 0.05 Putative extracellular serine carboxypeptidase 
49380 -2.5 0.05 - 
50479 1.4 0.05 - 
204381 -4.0 0.05 Voltage-gated shaker-like K+ channel, subunit beta/KCNAB 
174932 -1.6 0.05 - 
143320 -1.9 0.05 Hypothetical inosine triphosphate pyrophosphatase 
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54717 2.8 0.05 - 
187802 -2.1 0.05 - 
56167 -2.0 0.05 TRIHA 14-3-3 protein homologue, putative kinase regulator 
207503 6.6 0.05 Ammonium Transporter Family 
195335 2.2 0.05 General substrate transporter 
185012 1.5 0.05 Hypothetical WD-40 repeat protein 
45718 1.3 0.05 - 
38610 -1.7 0.05 Possible Translation initiation factor 2B, beta subunit (eIF-
2Bbeta/GCD7) 
186204 1.3 0.05 - 
185165 1.4 0.05 - 
209757 4.2 0.05 - 
191085 -2.5 0.05 - 
128523 2.4 0.05 Mitochondrial ribosomal protein S27 
174948 2.2 0.05 Hypothetical fumarylacetoacetate hydrolase 
46809 2.1 0.05 Amino acid transporters 
53524 2.6 0.05 - 
209439 2.7 0.05 Candidate HMG-CoA reductase 
195098 2.0 0.05 - 
39038 -1.3 0.05 Transcription factor Engrailed, contains HOX domain 
206983 -1.9 0.05 - 
197350 1.6 0.05 Ribosomal protein S9 
172934 -1.7 0.05 ABC transporter 
40884 1.9 0.05 Hypothetical nitric-oxide synthase (EC 1.14.13.39) 
45500 1.3 0.05 G-like protein containing WD-40 repeat 
38759 -1.5 0.05 - 
210938 -1.5 0.05 - 
52945 4.7 0.05 ER chaperone encoding bipA gene, kar2 
53173 -6.1 0.05 - 
55656 2.2 0.05 - 
211990 1.8 0.05 - 
176395 -3.2 0.05 WD40 repeat-containing protein 
189450 1.7 0.05 Heat shock protein DnaJ  
54079 6.3 0.05 - 
40277 1.3 0.05 - 
43469 1.7 0.05 Actin-binding, actinin-type 
131188 2.0 0.05 Glucose dehydrogenase/choline 
dehydrogenase/mandelonitrile lyase (GMC oxidoreductase 
family) 
55738 5.5 0.05 Multifunctional pyrimidine synthesis protein CAD (pyrABCN) 
41616 -1.6 0.05 Proteinase inhibitor I25, cystatin 
178612 -2.0 0.05 - 
52164 2.0 0.05 Putative RNA polymerase II regulator 
171112 1.6 0.05 Hypothetical FAD-dependent pyridine nucleotide-disulphide 
oxidoreductase 
187460 1.5 0.05 - 
205183 -2.0 0.05 AAA+-type ATPase 
189328 -15.6 0.05 - 
136869 2.3 0.05 Hypothetical lysin. Extracellular. Peptidoglycan-binding 
domain and peptidase-like domain 
190389 2.2 0.05 Insulinase-like 
42579 -18.8 0.05 Hypothetical. Related to 15-hydroxyprostaglandin 
dehydrogenase 
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56469 1.4 0.05 Hypothetical protein with WD40-like region 
40039 1.5 0.05 Peptidase, eukaryotic cysteine peptidase active site 
56449 1.9 0.05 - 
192711 1.5 0.05 - 
173430 -11.0 0.05 Major facilitator superfamily 
189424 1.7 0.05 Putative glycosyl transferase 
178649 -2.2 0.05 Nucleolar GTPase/ATPase p130 
37552 -3.8 0.05 - 
199512 -1.8 0.05 Hypothetical proteasome component 
37992 -2.7 0.05 - 
55909 2.8 0.05 GTP binding protein 
208484 -2.3 0.05 Signal transduction 
189666 -2.7 0.05 Aminoacyl-tRNA synthetase 
50657 6.3 0.05 Predicted hydrolases or acyltransferases (alpha/beta 
hydrolase superfamily) 
53726 1.7 0.05 - 
39481 -2.1 0.05 Aldehyde dehydrogenase 
132000 -1.5 0.05 Peptidyl-prolyl cis-trans isomerase 
51992 3.1 0.05 - 
49499 2.5 0.05 - 
54939 4.5 0.05 Amino acid/polyamine transporter 
38493 -2.2 0.05 Candidate V-Snare 
209506 -2.7 0.05 Hypothetical alkaline phosphatase 
133782 1.4 0.05 Hypothetical protein with a MOSC domain 
37300 -11.4 0.05 - 
142108 2.7 0.05 - 
44595 3.9 0.05 Sterol desaturase, methylsterol monooxygenase; C-4 sterol 
methyl oxidase 
207079 2.3 0.05 Zinc-binding oxidoreductase 
43055 -7.9 0.05 - 
52764 2.3 0.05 AAA ATPase 
43993 1.2 0.05 Fungal specific transcription factor 
143389 -2.3 0.05 Serine/threonine protein kinase 
188800 -2.3 0.05 Flavoprotein monooxygenase 
206952 -1.6 0.05 - 
53467 1.8 0.05 - 
40065 -1.9 0.05 - 
51912 2.0 0.05 Argininosuccinate lyase  
53361 -14.9 0.05 - 
192623 -1.6 0.05 Hypothetical DNA helicase 
48618 -2.1 0.05 Esterase/lipase/thioesterase 
39094 -2.2 0.05 Sugar (ANd other) transporter 
52017 -9.1 0.05 - 
38188 -1.6 0.05 N-methyltransferase 
54566 1.7 0.05 Hypothetical tyrosyl-tRNA synthetase. Shows similarity with 
N. crassa tyrosyl-tRNA synthetase 
178117 2.2 0.05 Serine/threonine protein kinase 
57223 1.4 0.05 NRPS 
181710 1.8 0.05 Major facilitator superfamily 
38174 -2.9 0.05 - 
46394 2.1 0.05 Hypothetical methionine aminopeptidase 
211517 5.0 0.05 - 
54806 2.3 0.05 - 
42536 1.4 0.05 - 
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127247 -2.0 0.05 COP9 signalosome, subunit 
141918 2.0 0.05 - 
206105 1.6 0.05 - 
43317 1.9 0.05 - 
123901 -1.5 0.05 - 
173627 -2.4 0.05 HypB/UreG, nucleotide-binding 
45820 9.2 0.05 - 
56689 -2.8 0.05 - 
46226 1.4 0.05 Splicing coactivator SRm160/300, subunit SRm300 
177916 2.0 0.05 - 
124374 1.4 0.05 - 
210373 -28.2 0.05 Cyanate lyase 
52532 -2.3 0.05 - 
203982 -1.9 0.05 - 
46117 3.0 0.05 - 
57034 -21.2 0.05 Short-chain acyl-CoA dehydrogenase 
 
  250
  251
S2: Stoichiometric metabolic model of Aspergillus niger  
 
REACTIONS 
In this section all model reactions are presented and their corresponding carbon atom transitions  
(the order of the metabolites is the same as in the stoichiometry row, e.g. ab + cd <-> bacd). 
The reaction declaration ends with a declaration of net and exchange fluxes. 
 
Glucose uptake 
 
v1: GLC <-> G6P 
abcdef <-> abcdef 
net = 100; exch = 0.0; 
 
EMP-pathway 
 
v2: G6P <-> F6P 
abcdef <-> abcdef 
net 0.0 200.0; 
 
v3: F6P <-> G3P + G3P 
abcdef <-> cba + def 
net 0.0 200.0; exch = 0.0; 
 
v4: G3P <-> 3PG 
abc <-> abc 
net 0.0 200.0; exch = 0.0; 
 
v5: 3PG <-> PEP 
abc <-> abc 
net 0.0 200.0; exch = 0.0; 
 
v6: PEP <-> PYRCYT 
abc <-> abc 
net 0.0 200.0; exch = 0.0; 
PP-pathway 
 
v7: G6P <-> CO + R5P 
abcdef <-> a + bcdef 
net 0.0 300.0; exch = 0.0; 
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v8: R5P + R5P <-> S7P + G3P 
abcde + fghij <-> fgabcde + hij 
net 0.0 300.0; 
 
v9: S7P + G3P <-> F6P + E4P 
abcdefg + hij <-> abchij + defg 
net 0.0 300.0; 
 
v10: R5P + E4P <-> F6P + G3P 
abcde + fghi <-> abfghi + cde 
net 0.0 300.0; 
 
Formation of AcCoA in the cytosol 
 
v11: ICIT <-> ACCOACYT + OAACYT 
abcdef <-> ba + fedc 
net 0.0 200.0; exch = 0.0; 
 
 
Anaplerotic reaction 
 
v12: PYRCYT + CO <-> OAACYT 
abc + d <-> abcd 
net -300.0 300.0; exch = 0.0; 
 
Oxalate formation 
 
v13: OAACYT <-> OXACYT + ACCOACYT 
abcd <-> ab + cd 
net 0.0 200.0; exch = 0.0; 
 
 
 
TCA-cycle 
 
v14: PYRMIT <-> ACCOAMIT + CO  
abc <-> bc + a 
net 0.0 200.0; exch = 0.0; 
 
v15:  OAAMIT + ACCOAMIT <-> ICIT 
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abcd + ef <->  dcabfe 
net 0.0 200.0; exch = 0.0; 
 
v16: ICIT <->  AKGT + CO 
abcdef <-> abcef + d 
net 0.0 200.0; exch = 0.0; 
 
v17: AKGT <-> CO + SUC 
abcde <-> a + bcde 
net 0.0 200.0; exch = 0.0; 
 
v18: SUC <-> FUM 
abcd <-> abcd  
net 0.0 200.0; exch = 0.0; 
 
v19: FUM <-> MAL 
abcd <-> abcd  
net 0.0 200.0; exch = 0.0; 
 
Scrambling in reaction v20 and v21 with variable scrambling fraction 
 
v20: MAL + MAL <-> OAAMIT + OAAMIT 
abcd + efgh <-> abcd + hgfe 
net 0.0 300.0;  
 
Transport reactions Mitochondria-Cytosol 
 
v21: OAACYT <-> OAAMIT 
abcd <-> abcd 
net -200 200.0;  
 
 
v22: ACCOACYT <-> ACCOAMIT 
ab <-> ab 
net 0.0 200.0;exch = 0.0; 
 
v23: PYRCYT <-> PYRMIT 
abc <-> abc  
net 0.0 200.0;exch = 0.0; 
 
Specialties around Glyceraldehyde-3-P 
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v24: 3PG <-> SER 
abc <-> abc 
net 0.0 200.0; exch = 0.0; 
 
v25: SER <-> GLY + C1 
abc <-> ab + c 
net 0.0 200.0; exch = 0.0; 
 
v26: OAACYT <-> GLY + ACCOACYT 
abcde <-> cde + ab 
net 0.0 200.0; exch = 0.0; 
 
v27: OAACYT <-> THR 
abcd <-> abcd 
net 0.0 200.0; exch = 0.0; 
 
v28: THR <-> GLY + ACCOACYT 
abcd <-> ab + cd 
net 0.0 200.0; exch = 0.0; 
 
C1 Metabolism 
 
v29: GLY <-> CO + C1 
ab <-> a + b 
net 0.0 200.0; exch = 0.0; 
 
 
 
 
Polyol Metabolism 
 
v30: G3P <-> GOL 
abc <-> abc 
net 0.0 200.0; exch = 0.0; 
 
Drain of intermediates to BIOMASS 
 
v31: G6P <-> G6POUT 
abcdef <-> abcdef 
net 0.0 200.0; exch = 0.0; 
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v32: F6P <-> F6POUT 
abcdef <-> abcdef  
net 0.0 200.0; exch = 0.0; 
 
v33: R5P <-> R5POUT 
abcde <-> abcde 
net 0.0 200.0; exch = 0.0; 
 
v34: E4P <-> E4POUT 
abcd <-> abcd 
net 0.0 200.0; exch = 0.0; 
 
v35: G3P <-> G3POUT 
abc <-> abc 
net 0.0 200.0; exch = 0.0; 
 
v36: PEP <-> PEPOUT 
abc <-> abc 
net 0.0 200.0; exch = 0.0; 
 
v37: PYRMIT <-> PYRMITOUT 
abc <-> abc 
net 0.0 200.0; exch = 0.0; 
 
v38: PYRCYT <-> PYRCYTOUT 
abc <-> abc 
net 0.0 200.0; exch = 0.0; 
v39: OAACYT <-> OAACYTOUT 
ab <-> ab 
net 0.0 200.0; exch = 0.0; 
 
v40: AKGT <-> AKGTOUT 
abcde <-> abcde 
net 0.0 200.0; exch = 0.0; 
 
v41: ACCOACYT <-> ACCOACYTOUT 
ab <-> ab 
net 0.0 200.0; exch = 0.0 
 
v42: ACCOAMIT <-> ACCOAMITOUT 
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ab <-> ab 
net 0.0 200.0; exch = 0.0 
 
v43: SER <-> SEROUT 
abc <-> abc 
net 0.0 200.0; exch = 0.0; 
 
v44: GLY <-> GLYOUT 
ab <-> ab 
net 0.0 200.0; exch = 0.0; 
 
v45: C1 <-> C1OUT 
a <-> a 
net 0.0 200.0; exch = 0.0; 
 
Secretion to Medium 
 
v46: ICIT <-> ICITOUT   
abcdef <-> abcdef 
net 0.0 200.0; exch = 0.0; 
 
v47: SUC <-> SUCOUT 
abcd <-> abcd 
net 0.0 200.0; exch = 0.0; 
 
 
v48: MAL <-> MALOUT 
abcd <-> abcd 
net 0.0 200.0; exch = 0.0; 
 
v49: FUM <-> FUMOUT 
abcd <-> abcd 
net 0.0 200.0; exch = 0.0; 
 
v50: OXACYT <-> OXACYTOUT 
abcd <-> abcd 
net 0.0 200.0; exch = 0.0; 
 
v51: GOL <-> GOLOUT 
abc <-> abc 
net 0.0 200.0; exch = 0.0; 
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v52: CO <-> COOUT 
a <-> a 
net 0.0 800.0; exch = 0.0; 
 
LABELED METABOLITES 
Here comes a specification of the labeled metabolites and their fractional labelling 
 
GLC: 99.0 1.1 1.1 1.1 1.1 1.1; 
 
EXTERNAL METABOLITES 
Here other metabolites that should not be balanced are stated by their name 
 
G6POUT 
F6POUT 
R5POUT 
E4POUT 
G3POUT 
PEPOUT 
PYRMITOUT 
OAACYTOUT 
AKGTOUT 
ACCOACYTOUT 
ACCOAMITOUT 
SEROUT 
GLYOUT 
C1OUT 
PYRCYTOUT 
ICITOUT 
SUCOUT 
MALOUT 
FUMOUT 
OXACYTOUT 
GOLOUT 
COOUT 
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S3: Significantly expressed genes in Chapter 9 
 
Identification of the first 1000 most significantly expressed genes between WT N402 and 
NW185 strain, fold change in log2 ratio (positive number then expression level in NW185 
strain higher), p. value < 0.05, the general description is taken from the JGI annotation 
database.  
 
JGI_ID Fold change p.value General description 
55604 9.5 3.2E-09 - 
189002 12.6 3.2E-09 - 
208150 -9.7 6.8E-09 FAD-dependent pyridine nucleotide-disulphide 
oxidoreductase 
54541 13.9 1.1E-08 Candidate oxidoreductase, Short-chain 
dehydrogenase/reductase 
52269 -5.1 1.1E-08 - 
209784 -6.5 1.1E-08 Mitochondrial aspartate/glutamate carrier protein 
197162 -8.3 1.1E-08 Sugar (ANd other) transporter 
184012 -6.1 1.1E-08 Amino acid transporters 
171442 6.7 1.1E-08 - 
127436 6.0 1.1E-08 Carbohydrate kinase 
56782 12.2 1.1E-08 Glycosyl hydrolase family 3 C terminal domain 
50981 13.3 1.1E-08 Putative AMP-dependent synthetase and ligase, Acyl-CoA 
synthetase 
44729 10.0 1.1E-08 Zinc-containing alcohol dehydrogenase superfamily 
208043 -11.6 1.1E-08 Nitrogen transporter 
124156 10.9 1.1E-08 Candidate NAD dependent formate dehydrogenase 
54073 -9.5 1.8E-08 - 
42152 8.9 1.8E-08 - 
38375 9.8 1.8E-08 Major facilitator superfamily 
203401 -9.3 1.8E-08 Amidase 
131354 6.6 1.8E-08 - 
176433 7.4 1.9E-08 - 
56336 9.2 2.1E-08 - 
54838 12.6 2.5E-08 Major facilitator superfamily 
209754 8.3 2.5E-08 2-nitropropane dioxygenase 
205428 13.4 2.5E-08 - 
190162 -5.6 2.5E-08 Amino acid transporters 
51685 -8.6 2.8E-08 Related to Schizosaccharomyces pombe asparaginase (EC 
3.5.1.1) 
54095 10.6 2.9E-08 Sugar (ANd other) transporter 
180923 7.4 2.9E-08 Major facilitator superfamily 
56628 8.8 3.6E-08 Dak kinase 
55670 13.4 4.2E-08 Sugar (ANd other) transporter 
198250 8.6 5.2E-08 2-enoyl-CoA hydratase/3-hydroxyacyl-CoA 
dehydrogenase/Peroxisomal 3-ketoacyl-CoA-thiolase, sterol-
binding domain and related enzymes 
186735 -5.9 5.2E-08 - 
205484 5.2 5.6E-08 - 
54717 -5.1 6.2E-08 - 
53338 -4.3 6.2E-08 Related to dihydrolipoamide acetyltransferase, EC 2.3.1.12 
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189779 -7.3 6.2E-08 - 
124797 12.6 6.2E-08 Major facilitator superfamily 
56137 -5.3 6.6E-08 - 
209255 -4.6 6.7E-08 Mitochondrial substrate carrier 
199928 5.3 8.0E-08 Predicted hydrolase 
173139 6.0 8.0E-08 Methionine synthase, vitamin-B12 independent 
53978 5.3 8.2E-08 (mstA) high affinity monosaccharide transporter 
208583 9.8 8.3E-08 - 
177169 8.3 9.0E-08 Hypothetical extracellular gluconolactonase 
37760 -6.1 9.2E-08 - 
208048 -13.6 9.2E-08 Nitrate reductase 
206266 -5.8 9.2E-08 Cytochrome P450 
190311 6.8 9.5E-08 2-nitropropane dioxygenase 
173677 8.5 9.5E-08 Hypothetical. Ketopantoate reductase pyrimidin base 
metabolism 
209058 -6.0 1.1E-07 ATP sulfurylase  
183511 6.0 1.1E-07 Fungal transcriptional regulatory protein 
57285 -13.3 1.2E-07 Major facilitator superfamily 
55566 -8.8 1.2E-07 Hydroxymethylglutaryl-coenzyme A synthase 
43265 11.8 1.2E-07 - 
210213 -10.2 1.2E-07 Major facilitator superfamily 
206339 9.4 1.2E-07 Haem peroxidase, plant/fungal/bacterial 
44808 6.3 1.4E-07 Acetyl-CoA acetyltransferase 
57002 -6.8 1.5E-07 Hypothetical alpha-amylase 
184678 4.8 1.5E-07 - 
182306 -5.7 1.5E-07 - 
54411 8.9 1.6E-07 Short-chain dehydrogenase/reductase SDR 
197480 6.0 1.6E-07 Enoyl-CoA hydratase/isomerase 
52105 7.9 1.7E-07 Amidohydrolase 
207572 12.6 1.8E-07 General substrate transporter 
213014 5.2 1.8E-07 Flavin-containing monooxygenase 
52586 6.1 1.8E-07 Hypothetical protein with TPR-like domain 
200605 13.9 1.8E-07 (abfB) alpha-L-arabinofuranosidase B 
56664 11.2 2.0E-07 Exoinulinase 
210871 6.5 2.0E-07 3-hydroxyacyl-CoA dehydrogenase 
175251 5.6 2.0E-07 - 
54860 -8.3 2.0E-07 Purine nucleoside permease 
54329 11.1 2.0E-07 - 
186207 5.8 2.0E-07 - 
181999 -6.1 2.0E-07 Arylamine N-acetyltransferase 
121987 8.5 2.0E-07 - 
55742 4.4 2.3E-07 aldA Aldehyde dehydrogenase (aldA) (EC 1.2.1.3) 
180718 6.1 2.3E-07 AAA+-type ATPase 
38054 7.8 2.3E-07 Hypothetical Short-chain dehydrogenase/reductase SDR 
212771 9.3 2.3E-07 - 
210730 18.1 2.4E-07 Related to Thermomyces lanuginosus triacylglycerol lipase 
48743 7.6 2.6E-07 Hypothetical enoyl-CoA hydratase 
210108 8.9 2.6E-07 AMP-dependent synthetase and ligase 
207067 6.7 2.6E-07 HAD-superfamily hydrolase, 
45814 -3.8 2.7E-07 - 
56395 9.1 2.7E-07 2-nitropropane dioxygenase 
51813 -6.5 2.7E-07 Amino acid/polyamine transporter 
44156 -5.6 2.7E-07 Related to mitochondrial translation elongation factor 
194529 5.1 2.7E-07 - 
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170891 8.5 2.7E-07 - 
132154 -4.5 2.7E-07 Cytochrome P450 
194335 -6.3 2.8E-07 Amino acid/polyamine transporter 
207831 5.7 2.9E-07 Glucose-methanol-choline oxidoreductase 
46101 -8.7 2.9E-07 - 
42171 5.4 3.0E-07 Hypothetical isocitrate lyase and phosphorylmutase 
53574 -5.9 3.2E-07 Candidate carbamoyl-phosphate synthase 
38226 5.2 3.3E-07 Related to Geranylgeranyl pyrophosphate synthase 
213113 11.2 3.4E-07 Hypothetical cytochrome b5 
184312 7.6 3.4E-07 Glutathione S-transferase 
187304 -3.4 3.5E-07 Ergosterol biosynthesis ERG4/ERG24 family 
42733 -4.6 3.6E-07 Dihydroxy-acid dehydratase 
119858 5.6 3.7E-07 Related to alpha-glucosidase; glycoside hydrolase, family 31
52796 -3.8 3.7E-07 Mitochondrial import inner membrane translocase, subunit 
Tim44 
38000 9.3 3.7E-07 Acetoacetyl-CoA synthase 
201398 9.4 3.7E-07 - 
170261 3.8 3.7E-07 Permease of the major facilitator superfamily 
208631 5.3 3.8E-07 Predicted pyroglutamyl peptidase 
40734 7.0 3.8E-07 Hypothetical aldehyde dehydrogenase. Specificity towards 
NAD or NADP is not deducible from sequence data 
202252 4.3 3.8E-07 Putative extracellular tannase and feruloyl esterase 
48891 -6.5 4.0E-07 Putative extracellular protein 
200874 -6.6 4.0E-07 Transmembrane amino acid transporter protein 
48724 6.0 4.1E-07 Isocitrate lyase 
35965 -5.0 4.1E-07 - 
188553 9.0 4.1E-07 Acyl-CoA dehydrogenase 
47354 9.6 4.1E-07 - 
53518 5.5 4.2E-07 Phosphoribosyltransferase 
190132 -11.4 4.2E-07 Iron/ascorbate family oxidoreductases 
56643 10.3 4.3E-07 Major facilitator superfamily 
49321 5.7 4.3E-07 - 
35778 5.2 4.3E-07 Hypothetical long chain fatty alcohol oxidase 
188168 5.2 4.3E-07 - 
53423 3.2 4.6E-07 Related to 2-methylcitrate dehydratase of E. coli 
57034 10.1 4.8E-07 Short-chain acyl-CoA dehydrogenase 
52919 -5.4 4.8E-07 Hypothetical. Intrpro: AMP-dependent synthetase and ligase 
176294 8.3 4.8E-07 - 
172439 11.3 4.9E-07 - 
55417 7.4 5.3E-07 Serine/threonine protein kinase, active site 
54651 7.8 5.3E-07 Hypothetical 3-ketoacyl-CoA-thiolase 
46405 5.9 5.4E-07 - 
193610 6.3 5.4E-07 Carboxylesterases 
177616 5.7 5.4E-07 Sugar transporter superfamily 
180211 5.3 5.8E-07 Alpha/beta hydrolase 
174330 11.0 6.0E-07 Major facilitator superfamily 
213815 7.6 6.1E-07 Cytoskeletal protein A 
42186 6.6 6.3E-07 - 
210373 10.5 6.3E-07 Cyanate lyase 
206020 -5.1 6.3E-07 Hypothetical. involved in rRNA processing. associates with 
trans-acting ribosome biogenesis factors (yeast); similar to 
beta-transducin superfamily. 
205670 5.2 6.3E-07 Glycoside hydrolase, family 3 
205005 8.1 6.3E-07 Putative soluble Fumarate reductase/succinate 
dehydrogenase flavoprotein, N-terminal 
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211162 4.7 6.4E-07 Hypothetical 1,4-alpha-glucan branching enzyme 
56053 -5.2 6.8E-07 - 
200589 -8.7 6.8E-07 8-amino-7-oxononanoate synthase (biotin synthesis) 
172579 12.5 6.8E-07 - 
203198 4.1 6.9E-07 - 
174228 -5.3 7.2E-07 - 
143749 7.7 7.3E-07 - 
53949 9.0 7.8E-07 Major facilitator superfamily 
43683 -13.8 7.8E-07 Hypothetical argininosuccinate synthase (EC 6.3.4.5) 
44103 6.3 7.8E-07 - 
210981 5.3 7.8E-07 Putative extracellular GH family 3 beta-glucosiadse 
51764 10.8 8.1E-07 Glycosyl hydrolases family 35 
181888 7.6 8.2E-07 Carboxyl transferase 
190129 -5.6 8.3E-07 - 
54145 -4.1 8.4E-07 - 
55052 5.6 8.5E-07 Fungal specific transcription factor 
54207 7.1 8.6E-07 MaoC-like dehydratase 
132806 11.7 8.6E-07 - 
41505 4.9 9.3E-07 Permease of the major facilitator superfamily 
204610 -3.6 9.3E-07 Ribosomal protein L7/L12 
212876 -3.2 9.4E-07 Ribosomal protein S5 
54784 -3.0 9.5E-07 - 
177282 4.1 9.8E-07 - 
53053 -7.0 9.9E-07 Uroporphyrin III methyltransferase 
207996 -6.5 9.9E-07 Permeases for cytosine/purines, uracil, thiamine, allantoin 
38851 11.8 9.9E-07 homogentisate 1,2-dioxygenase 
39400 8.8 1.0E-06 - 
209842 -4.9 1.0E-06 Phosphoribosyl pyrophosphate synthetase 
209327 4.1 1.1E-06 Fungal transcriptional regulatory protein, N-terminal 
47696 4.9 1.1E-06 - 
213793 5.9 1.1E-06 Candidate succinate-semialdehyde dehydrogenase  
205368 6.5 1.1E-06 Peptidase 
44193 5.1 1.1E-06 - 
176070 4.7 1.1E-06 ATP-dependent DNA ligase 
206792 -4.9 1.1E-06 RNA polymerase subunit 
40461 3.0 1.2E-06 - 
53847 13.2 1.2E-06 - 
36331 4.3 1.2E-06 - 
207853 8.2 1.2E-06 Predicted dehydrogenase 
187949 8.7 1.2E-06 Esterase/lipase/thioesterase 
142364 -3.8 1.2E-06 - 
181179 7.2 1.2E-06 Catechol dioxygenase, N-terminal 
197549 7.5 1.2E-06 Sugar (ANd other) transporter 
41762 -4.3 1.2E-06 Hypothetical RNA helicase 
40740 5.6 1.2E-06 Hypothetical Short-chain dehydrogenase 
40460 4.2 1.2E-06 FAD-dependent oxidoreductase 
183812 -2.4 1.2E-06 Major facilitator superfamily 
121695 4.7 1.2E-06 AMP-dependent synthetase and ligase 
205766 7.3 1.2E-06 Sugar (ANd other) transporter 
55437 -3.4 1.3E-06 - 
123450 -3.2 1.4E-06 Hypothetical neutral amino acid permease 
143560 7.4 1.4E-06 Hypothetical, maybe secreted. 
125004 -4.6 1.4E-06 - 
210672 8.1 1.5E-06 Short-chain dehydrogenase/reductase SDR 
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52705 -5.0 1.5E-06 Predicted protein shares amino acid sequence identity with 
the Saccharomyces cerevisiae TUF1 gene product; 
mitochondrial translation elongation factor Tu. 
38924 10.5 1.5E-06 Glycoside hydrolase, family 43 
204381 4.7 1.5E-06 Voltage-gated shaker-like K+ channel, subunit beta/KCNAB 
196275 -3.4 1.5E-06 - 
122081 5.5 1.5E-06 - 
55306 6.6 1.5E-06 Aminotransferase class-III 
205959 -2.6 1.5E-06 - 
55296 -2.6 1.6E-06 Hypothetical threonyl-tRNA synthetase kinase. HMMPfam 
indicates Threonyl-tRNA synthetase kinase activity 
43508 3.7 1.6E-06 - 
44096 4.8 1.6E-06 - 
43929 3.6 1.6E-06 Hypothetical dehydrogenase 
212893 5.3 1.6E-06 Glycoside hydrolase 
208535 3.4 1.6E-06 - 
55205 6.8 1.7E-06 Hypothetical short chain dehydrogenase 
175986 3.4 1.7E-06 - 
55007 8.3 1.8E-06 Related to 3-ketoacyl-CoA thiolase 
55164 6.8 1.8E-06 - 
43953 -5.2 1.8E-06 - 
172390 3.3 1.8E-06 Manganese and iron superoxide dismutase  
205291 5.6 1.8E-06 Isocitrate and isopropylmalate dehydrogenases 
53424 8.1 1.8E-06 - 
44497 -3.2 1.8E-06 - 
40924 2.7 1.8E-06 - 
214881 4.2 1.8E-06 Short-chain dehydrogenase/reductase 
189328 6.2 1.8E-06 - 
170709 5.6 1.8E-06 Aldehyde dehydrogenase 
143580 -3.5 1.8E-06 40s ribosomal protein s10 
209315 -5.4 1.8E-06 - 
57039 -3.1 1.9E-06 Aspartyl-tRNA synthetase, mitochondrial 
198539 -12.0 1.9E-06 - 
55738 -7.1 1.9E-06 Multifunctional pyrimidine synthesis protein CAD (pyrABCN) 
210944 6.4 1.9E-06 Cytochrome P450 
55785 -4.1 2.0E-06 Protein kinase 
55510 -4.3 2.0E-06 Pyruvate dehydrogenase E1 B-subunit 
180570 5.0 2.0E-06 Short-chain dehydrogenase/reductase SDR 
47549 6.0 2.0E-06 - 
49535 6.4 2.0E-06 FMN-dependent alpha-hydroxy acid dehydrogenase 
120053 5.3 2.1E-06 Fungal specific transcription factor 
209244 4.8 2.1E-06 Oxidoreductase 
188426 7.6 2.1E-06 - 
124451 6.7 2.1E-06 Esterase/lipase/thioesterase 
56031 6.5 2.2E-06 Fungal transcriptional regulatory protein 
49576 6.6 2.2E-06 Glucose/ribitol dehydrogenase 
209960 -2.2 2.2E-06 Porin, eukaryotic type 
40569 6.0 2.3E-06 ATPases associated with various cellular activities (AAA) 
42464 4.2 2.3E-06 Candidate Peptidyl-prolyl cis-trans isomerase 
206496 -3.1 2.3E-06 Molecular chaperone of the GrpE family 
55680 6.2 2.4E-06 Coenzyme A transferase 
52415 6.5 2.4E-06 Glycoside hydrolase, family 38 
52239 5.2 2.4E-06 - 
42357 3.3 2.4E-06 - 
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210295 3.6 2.4E-06 SNARE protein TLG1/Syntaxin 6 
124202 -3.3 2.4E-06 tRNA(1-methyladenosine) methyltransferase, subunit 
GCD14 
55131 4.1 2.4E-06 - 
57355 3.4 2.4E-06 - 
49063 6.0 2.4E-06 Hypothetical fatty acid omega-hydroxylase 
209252 5.0 2.4E-06 Autophagy related protein, involved in membrane trafficking 
45688 7.5 2.4E-06 - 
141681 3.5 2.4E-06 - 
43221 -4.5 2.5E-06 Amino acid transporters 
37300 3.8 2.5E-06 - 
180223 -4.0 2.5E-06 Mitochondrial substrate carrier 
44916 6.2 2.5E-06 Candidate extracellular phospholipase C 
53576 -2.7 2.7E-06 Candidate 60s ribosomal protein gene RPP1. 
212044 -2.2 2.7E-06 Mitochondrial ADP/ATP carrier proteins 
42852 -5.6 2.7E-06 Survival protein SurE 
131149 6.8 2.7E-06 - 
48811 4.9 2.7E-06 (xlnR) Transcriptional activator xlnR 
180635 -4.3 2.7E-06 - 
55468 -3.2 2.7E-06 - 
52362 -3.4 2.7E-06 Candidate 40S ribosomal protein S0. 
136397 3.8 2.8E-06 - 
206611 2.5 2.8E-06 Hypothetical Acyl-CoA-binding protein 
206645 3.5 2.8E-06 Related to phosphatidylinositol/phosphatidylglycerol transfer 
protein 
42184 3.9 2.9E-06 pgaX Exopolygalacturonase precursor (ExoPG) (Galacturan 
1,4-alpha-galacturonidase) 
198715 -3.0 2.9E-06 Related to tef1B; elongation factor 1 beta 
197817 -3.9 3.0E-06 E3 binding 
45610 9.9 3.1E-06 Sugar (ANd other) transporter 
187254 6.1 3.1E-06 - 
120939 -4.3 3.1E-06 - 
202416 -2.6 3.1E-06 40S ribosomal protein S3 
128421 4.6 3.1E-06 FOG: WD40 repeat 
47417 6.8 3.2E-06 Short-chain dehydrogenase/reductase 
208677 -4.1 3.2E-06 - 
57101 -2.7 3.2E-06 - 
56339 -7.0 3.2E-06 Related to sulphate permease. Has 11 transmembrane 
domains and several sulphate transporter domains. 
48373 -3.8 3.2E-06 Uncharacterised conserved protein similar to ATP/GTP-
binding protein 
207002 -5.0 3.2E-06 Hypothetical. InterPro suggests role in chromosome 
condensation 
125764 6.7 3.2E-06 - 
53845 9.0 3.2E-06 - 
45887 7.7 3.2E-06 Hypothetical glucose-methanol-choline oxidoreductase (EC 
1.99.1.1) 
39346 3.7 3.2E-06 Hypothetical protein containing Ada, metal-binding and helix-
turn-helix, AraC type domains. 
36596 5.2 3.3E-06 Esterase/lipase/thioesterase 
37678 4.1 3.3E-06 - 
178744 5.6 3.3E-06 Hypothetical Metal-dependent phosphohydrolase, HD region 
55391 -4.6 3.3E-06 - 
206033 6.4 3.3E-06 - 
202059 5.4 3.4E-06 Isochorismatase hydrolase 
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47429 -3.2 3.4E-06 (dphE) Methyltransferase required for synthesis of 
diphthamide, which is a modified histidine residue of 
translation elongation factor 2. 
45208 -3.3 3.4E-06 Hypothetical Ribosome biogenesis protein RPF1, contains 
IMP4 domain 
49737 3.9 3.5E-06 Hypothetical protein 
46100 -5.2 3.5E-06 - 
42787 -3.3 3.5E-06 - 
212337 6.5 3.5E-06 Hypothetical protein. Contains four putative transmembrane 
helices 
181938 2.7 3.5E-06 Ypt/Rab-specific GTPase-activating protein GYP7 and 
related proteins 
172786 7.1 3.5E-06 Major facilitator superfamily 
202490 9.8 3.6E-06 Cellulase (glycosyl hydrolase family 5) 
196077 -4.2 3.6E-06 - 
51482 5.9 3.7E-06 Major facilitator superfamily 
51478 3.1 3.7E-06 (faeB) feruloyl esterase 
135002 -2.7 3.7E-06 - 
48688 -5.3 3.7E-06 Adenosylmethionine-8-amino-7-oxononanoate transaminase
53339 -2.8 3.8E-06 Malate dehydrogenase 
39109 2.4 3.9E-06 - 
187366 5.0 4.0E-06 AMP-binding enzyme 
57271 -3.5 4.0E-06 - 
56498 4.6 4.0E-06 Isoflavone reductase 
56022 4.0 4.0E-06 Cytochrome P450 
47847 -4.2 4.0E-06 Predicted translation product shares amino acid sequence 
identity with the Saccharomyces cerevisiae POL5 gene 
product; a protein with sequence similarity to the human 
MybBP1A and weak sequence similar to B-type DNA 
polymerases, not required for chromosomal DNA replication; 
required for the synthesis of rRNA. 
46429 4.2 4.0E-06 Glycosyl hydrolases family 35 
40929 -5.2 4.0E-06 Fungal transcriptional regulatory protein 
201122 5.3 4.0E-06 - 
198624 -3.6 4.0E-06 Ribosomal protein S6 
194112 3.2 4.0E-06 Lipase essential for autophagy 
183900 3.9 4.0E-06 - 
128988 3.2 4.0E-06 Ankyrin 
180885 6.9 4.0E-06 Fungal transcriptional regulatory protein 
52653 2.9 4.1E-06 Phosphotyrosyl phosphatase activator 
39560 7.2 4.1E-06 - 
206434 12.2 4.1E-06 Related to glucose transporter 
200680 -3.2 4.1E-06 Eukaryotic translation initiation factor 3, subunit 7 
202801 -3.4 4.1E-06 citA citrate synthase 
196819 -2.9 4.1E-06 RNA polymerase 
205686 -2.6 4.2E-06 - 
186114 -6.4 4.2E-06 - 
211094 -4.4 4.3E-06 - 
191636 4.4 4.4E-06 Hypothetical protein. Electronic annotation suggests pyridine 
nucleotide-disulphide oxidoreductase 
46134 2.9 4.4E-06 FAD-linked oxidase 
39788 -2.8 4.4E-06 Permease for cytosine/purines, uracil, thiamine, allantoin 
37080 4.1 4.4E-06 pepE, extracellular aspartic protease 
56553 10.7 4.5E-06 - 
206738 5.1 4.5E-06 Esterase/lipase/thioesterase 
128861 6.6 4.5E-06 Acyl-CoA dehydrogenase 
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45681 7.3 4.5E-06 Short chain dehydrogenase 
54926 3.6 4.5E-06 - 
196147 -3.0 4.5E-06 - 
139340 -4.5 4.5E-06 - 
53893 -4.5 4.7E-06 Phosphatidylethanolamine binding protein 
194300 3.7 4.7E-06 Candidate Ribonuclease III 
209231 5.2 4.7E-06 Aldo/keto reductase 
185434 7.5 4.8E-06 Short chain dehydrogenase 
36779 -2.8 4.9E-06 Hypothetical dihydroorotate dehydrogenase (EC 1.3.3.1) 
51717 -3.8 4.9E-06 Hypothetical Mitochondrial phosphate carrier protein 
212412 -5.6 4.9E-06 - 
170262 2.9 4.9E-06 Aldo/keto reductase family proteins 
49515 -4.1 4.9E-06 - 
129773 -4.3 4.9E-06 - 
53381 -2.8 5.0E-06 Cytochrome b5 domain 
176830 -3.4 5.1E-06 WD40 repeat nucleolar protein putatively involved in 
ribosome biogenesis 
174161 -2.4 5.1E-06 snRNP A' protein 
46760 -4.3 5.1E-06 - 
176483 9.1 5.1E-06 12 kDa heat shock protein 
182005 -4.7 5.1E-06 Amino acid permease 
170612 2.9 5.1E-06 - 
38274 4.4 5.3E-06 - 
203604 -2.3 5.3E-06 Aminoacyl-tRNA synthetase 
47307 3.3 5.4E-06 Methyltransferases 
37420 -4.4 5.4E-06 - 
180608 5.0 5.4E-06 - 
198599 -4.1 5.4E-06 - 
46346 5.7 5.4E-06 - 
172955 2.8 5.5E-06 Hydantoinase/oxoprolinase 
37998 3.5 5.5E-06 Hypothetical protein. Is very likely associated with 
degradation of aromatic compounds based on Pfam and 
protein similarity 
198565 -3.1 5.6E-06 - 
54939 -3.4 5.6E-06 Amino acid/polyamine transporter 
55209 -6.7 5.6E-06 Isocitrate dehydrogenase, alpha subunit 
39803 6.4 5.7E-06 Yippee-type zinc-binding protein 
209263 -7.1 5.7E-06 - 
120073 -3.6 5.7E-06 Serine/threonine protein kinase 
51373 3.5 5.8E-06 - 
56753 -5.0 5.8E-06 Aromatic-ring hydroxylase 
129399 2.5 5.9E-06 Putative pyruvate carboxylase 
52361 -2.5 6.0E-06 - 
43055 5.1 6.0E-06 - 
210297 2.3 6.0E-06 Signal transduction 
41928 -2.8 6.0E-06 - 
184233 -2.7 6.1E-06 - 
193981 4.5 6.1E-06 Putative pyruvate decarboxylase joined with TPR repeat 
containing protein 
170910 3.5 6.1E-06 Glucose/ribitol dehydrogenase 
214665 3.2 6.4E-06 Hypothetical protease 
190106 2.5 6.5E-06 2-nitropropane dioxygenase family 
40771 -3.0 6.7E-06 Putative GroEL-like chaperone, ATPase 
196874 8.9 6.7E-06 Aldehyde dehydrogenase 
181451 6.5 6.8E-06 Hypothetical 3-methylcrotonyl-CoA carboxylase, subunit 
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beta 
56227 11.9 6.8E-06 Major facilitator superfamily 
199462 -2.3 6.9E-06 Related to ribosomal protein RPL26. 
176411 6.3 6.9E-06 Haloacid dehalogenase-like hydrolase 
173997 -5.8 6.9E-06 Deduced translation product shares amino acid sequence 
identity with the Saccharomyces cerevisiae NSR1 gene 
product; a nucleolar protein that binds nuclear localisation 
sequences, required for pre-rRNA processing and ribosome 
biogenesis. 
53910 -4.3 7.0E-06 Fatty acid desaturase 
213414 -2.4 7.0E-06 Predicted transporter (ABC superfamily) 
211531 -6.6 7.0E-06 - 
178256 4.8 7.0E-06 Related to histidine kinase 
213288 3.4 7.0E-06 - 
119939 3.8 7.1E-06 Fungal specific transcription factor 
56770 4.9 7.1E-06 Peptidase S16 
48827 3.7 7.1E-06 - 
208898 -6.8 7.1E-06 NADP/FAD dependent oxidoreductase 
211789 -7.1 7.1E-06 - 
175855 -3.1 7.1E-06 Major facilitator superfamily 
176012 -3.5 7.2E-06 - 
179385 2.6 7.3E-06 Major facilitator superfamily 
210666 -2.5 7.4E-06 - 
185842 5.6 7.5E-06 Cytochrome b5 
209386 -2.6 7.6E-06 Ribosomal protein S17 
51512 4.6 7.7E-06 Cytochrome P450 
211185 -3.4 7.7E-06 - 
206955 4.1 7.7E-06 Transthyretin and related proteins 
48713 3.8 7.7E-06 DNA-binding SAP 
125644 5.1 7.7E-06 Short-chain dehydrogenase/reductase SDR 
127191 -2.4 7.8E-06 - 
197015 -5.7 7.8E-06 Cytochrome c 
205884 -2.3 7.8E-06 - 
52344 4.7 7.8E-06 - 
39459 -4.4 7.8E-06 - 
176378 4.9 7.9E-06 Short-chain dehydrogenase/reductase 
51952 4.7 7.9E-06 - 
204514 1.7 7.9E-06 Nucleotide excision repair factor NEF2, RAD23 component 
53361 7.9 8.0E-06 - 
52571 -2.7 8.0E-06 Ribosomal protein S17 
46099 -7.0 8.1E-06 - 
210454 -4.8 8.1E-06 Molecular chaperones mortalin/PBP74/GRP75, HSP70 
superfamily 
127671 -4.2 8.2E-06 - 
55759 3.3 8.2E-06 - 
212140 3.2 8.3E-06 Hypotetical cAMP-dependent protein kinase catalytic subunit
125201 7.1 8.5E-06 Esterase/lipase/thioesterase 
40356 -4.3 8.6E-06 Predicted DNA-directed RNA polymerase 
213737 -1.9 8.6E-06 - 
129990 -3.3 8.6E-06 FOG: PPR repeat 
123758 5.5 8.6E-06 - 
172596 2.3 8.7E-06 - 
40329 2.0 8.7E-06 - 
39630 -2.2 8.7E-06 Ribosomal protein S4 
186860 5.1 8.7E-06 Aminotransferase class-III 
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57352 -2.7 8.8E-06 Ribosomal protein S6e 
55609 -6.3 8.8E-06 - 
54125 3.5 8.8E-06 - 
201503 -6.1 8.8E-06 NAD-cytochrome b5 reductase 
176363 7.2 8.8E-06 - 
122999 -5.9 8.8E-06 Major facilitator superfamily 
38832 6.2 8.8E-06 Cytochrome P450 
205431 2.4 8.9E-06 Molecular chaperones HSP70/HSC70, HSP70 superfamily 
48629 -2.2 8.9E-06 - 
55305 -3.0 9.0E-06 - 
46090 6.6 9.0E-06 - 
45282 3.6 9.1E-06 - 
179623 -3.4 9.1E-06 WD40 repeat protein 
54294 2.8 9.1E-06 - 
125779 -3.6 9.1E-06 - 
52335 -4.5 9.1E-06 Related to protein arginine N-methyltransferase (E. nidulans)
212567 4.2 9.1E-06 - 
122116 5.4 9.1E-06 Metacaspase involved in regulation of apoptosis 
47866 -3.0 9.2E-06 Putative GroEL-like chaperone, ATPase 
128477 -2.8 9.2E-06 - 
48505 3.0 9.2E-06 - 
197381 2.7 9.2E-06 GTPase Rab5/YPT51 and related small G protein 
superfamily GTPases 
212915 -5.1 9.2E-06 Hypothetical alpha-1,3-glucan synthase 
53668 3.7 9.3E-06 - 
130294 -4.1 9.3E-06 Hypothetical ATP-dependent RNA helicase 
52441 -2.8 9.4E-06 Putative GroEL-like chaperone, ATPase 
49896 6.1 9.4E-06 Mandelate racemase 
48646 6.9 9.4E-06 Hypothetical enoyl-CoA hydratase (EC 4.2.1.17) 
54106 5.9 9.5E-06 - 
189170 8.2 9.6E-06 Related to alpha keto acid dehydrogenase complex of 
Aspergillus fumigatus; EC 2.3.1.12 
188037 -2.7 9.6E-06 Lipoate-protein ligase A 
47380 -2.3 9.7E-06 NRPS 
45820 -6.4 9.7E-06 - 
186253 -2.9 9.7E-06 - 
44666 5.2 9.7E-06 - 
42981 6.3 9.7E-06 Lanthionine synthetase C-like protein 
44770 3.5 9.9E-06 - 
42238 -8.7 9.9E-06 Guanine-specific ribonuclease N1 and T1 
195992 4.6 9.9E-06 Hypothetical cyclic-AMP phosphodiesterase 
54083 -3.2 9.9E-06 Hypothetical. Related to GCN5-related N-acetyltransferase 
47533 -2.2 9.9E-06 Amino acid permease 
40917 -2.7 9.9E-06 Predicted mechanosensitive ion channel 
40260 -3.5 9.9E-06 Major facilitator superfamily 
52996 -3.5 9.9E-06 Related to ubiquinone biosynthesis methyltransferase COQ5 
(S. cerevisiae) 
43123 -3.1 9.9E-06 Ferredoxin 
189635 6.9 9.9E-06 Monodehydroascorbate/ferredoxin reductase 
54174 5.3 9.9E-06 Dihydroxy-acid dehydratase 
137527 -3.3 1.0E-05 - 
210041 -2.3 1.0E-05 ABC (ATP binding cassette) 1 protein 
206469 -2.6 1.0E-05 - 
137752 -2.2 1.0E-05 60S ribosomal protein L18A 
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133810 -2.7 1.1E-05 FAD dependent oxidoreductase 
140924 -3.8 1.1E-05 - 
120955 4.3 1.1E-05 - 
184314 2.6 1.1E-05 - 
206859 -2.5 1.1E-05 40S ribosomal protein S14 
193903 -2.9 1.1E-05 Predicted nucleolar protein involved in ribosome biogenesis 
176127 -7.1 1.1E-05 Predicted hydrolase related to dienelactone hydrolase 
188240 3.7 1.1E-05 - 
50403 -4.5 1.1E-05 Kinesin-like protein 
205848 -5.0 1.1E-05 Sulfate/bicarbonate/oxalate exchanger SAT-1 and related 
transporters (SLC26 family) 
56308 -4.3 1.1E-05 ABC transporter 
44216 -3.9 1.1E-05 - 
128739 2.8 1.1E-05 Hypothetical. RNA binding motif 
37610 -5.0 1.1E-05 - 
54001 -3.6 1.1E-05 Putative Hsp60 
51857 6.7 1.1E-05 - 
50029 5.0 1.1E-05 - 
43594 4.9 1.1E-05 Hypothetical. SignalP suggests secreted 
172823 -2.5 1.1E-05 Related to zink transporter of A. fumigatus. Seven putative 
transmembrane domains and PFam domains for zink 
transport. 
180069 5.6 1.1E-05 Major facilitator superfamily 
55524 2.4 1.1E-05 Hypothetical transmembrane protein 
49311 5.6 1.1E-05 Hypothetical, similarities to sialidase superfamily 
196583 -3.3 1.1E-05 Candidate rpl12 gene, component of the large (60S) 
ribosomal subunit 
55741 -2.4 1.1E-05 Protein import receptor MAS20 
55365 3.6 1.1E-05 - 
140013 -3.4 1.1E-05 - 
176395 5.2 1.1E-05 WD40 repeat-containing protein 
56477 7.3 1.1E-05 Epoxide hydrolase 
54071 3.5 1.1E-05 - 
45992 -3.9 1.1E-05 (chsC) Class-III chitin synthase C 
207169 3.5 1.1E-05 Receptor-activated Ca2+-permeable cation channels 
56462 -4.7 1.1E-05 Candidate serine hydroxymethyltransferase (EC 2.1.2.1) 
208447 -3.5 1.1E-05 Translation initiation factor 3 
48002 6.4 1.2E-05 Amidohydrolase 
36773 4.1 1.2E-05 Hypothetical enoyl-CoA hydratase. (EC 4.2.1.17) HMM 
predicts secretion. 
55451 3.4 1.2E-05 - 
43674 -1.7 1.2E-05 Ribonuclease II 
202202 2.0 1.2E-05 Hypothetical. Ca2+-binding actin-bundling protein 
(fimbrin/plastin) 
194591 5.6 1.2E-05 - 
47358 -5.1 1.2E-05 Predicted protein shares amino acid sequence identity with 
the Saccharomyces cerevisiae UTP10 gene product; a 
nucleolar protein, component of the small subunit (SSU) 
processome containing the U3 snoRNA that is involved in 
processing of pre-18S rRNA. 
43791 -6.0 1.2E-05 Generic methyltransferase 
174644 4.3 1.2E-05 Ubiquitin-conjugating enzymes 
211901 -3.3 1.2E-05 - 
207158 7.2 1.2E-05 Prohibitins and stomatins of the PID superfamily 
209012 8.1 1.2E-05 Proteins containing the FAD binding domain 
53946 3.3 1.2E-05 - 
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185301 4.6 1.2E-05 Hypothetical carboxylesterase 
137631 5.5 1.2E-05 - 
53084 2.2 1.2E-05 Ubiquitin-conjugating enzymes, 16 kDa 
39990 6.7 1.2E-05 Carbamoyl-phosphate synthetase large chain 
56215 -6.7 1.2E-05 Hypothetical Hydroxymethylglutaryl-coenzyme A synthase 
56167 2.4 1.2E-05 TRIHA 14-3-3 protein homologue, putative kinase regulator 
48625 -2.3 1.2E-05 - 
211906 1.9 1.2E-05 - 
207426 -4.9 1.3E-05 - 
120372 4.2 1.3E-05 Phosphoinositide-specific phospholipase C (PLC) 
210989 -4.8 1.3E-05 Amino acid/polyamine transporter I 
194595 2.6 1.3E-05 Flavonol reductase/cinnamoyl-CoA reductase 
189927 -6.1 1.3E-05 Monocarboxylate transporter 
35976 -3.8 1.3E-05 Major facilitator superfamily 
55693 2.4 1.3E-05 - 
190740 -2.8 1.3E-05 - 
172934 3.3 1.3E-05 ABC transporter 
38549 7.2 1.3E-05 - 
48817 2.7 1.3E-05 Transcription initiation factor IIA, gamma subunit 
54957 -2.4 1.3E-05 Putative GroEL-like chaperone, ATPase 
190030 4.0 1.3E-05 Aldo/keto reductase family proteins 
55193 3.0 1.3E-05 - 
56084 3.3 1.3E-05 - 
52186 -2.9 1.3E-05 Hypothetical beta-keto-reductase 
46776 3.0 1.3E-05 TatD-related DNase 
50151 9.1 1.4E-05 Hypothetical Glutathione-dependent formaldehyde-
activating, GFA 
201109 -3.0 1.4E-05 Putative GroEL-like chaperone, ATPase 
37942 7.1 1.4E-05 Hypothetical Cytochrome P450 monooxygenase 
187314 3.3 1.4E-05 - 
45912 6.6 1.4E-05 FMN-dependent alpha-hydroxy acid dehydrogenase 
212502 -4.2 1.4E-05 Hypothetical nucleosome assembly protein 
188497 -4.2 1.4E-05 Fungal specific transcription factor 
172399 -2.7 1.4E-05 - 
55805 3.3 1.4E-05 Hypothetical catalytic protein 
178365 7.0 1.4E-05 Hypothetical aspartic protea 
52783 3.0 1.4E-05 Alternative splicing factor SRp55/B52/SRp75 (RRM 
superfamily) 
197079 -3.2 1.4E-05 - 
36238 1.9 1.4E-05 Hypothetical protein; KOG Class: Chromatin structure and 
dynamics; KOG Id: 4191; KOG Description: Histone 
acetyltransferases PCAF/SAGA/ADA, subunit 
TADA3L/NGG1 
170848 9.4 1.4E-05 - 
203483 -2.3 1.5E-05 - 
207730 -3.3 1.5E-05 60S ribosomal protein L7A 
176010 5.0 1.5E-05 Predicted esterase of the alpha-beta hydrolase superfamily 
39372 4.3 1.5E-05 - 
185692 -2.9 1.5E-05 Mitochondrial substrate carrier 
198577 4.4 1.5E-05 Carnitine O-acyltransferase 
133729 -4.8 1.5E-05 RNA-binding protein 
35657 -3.0 1.5E-05 - 
56966 -5.2 1.5E-05 - 
210935 -3.2 1.5E-05 Candidate eukaryotic translation initiation factor 3 
207710 3.1 1.5E-05 MAP kinase 
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188804 3.8 1.5E-05 - 
208835 3.4 1.5E-05 Serine/threonine protein kinase Chk2 and related proteins 
53446 -3.4 1.5E-05 - 
35307 -2.3 1.5E-05 - 
170148 4.5 1.5E-05 Putative GH family 18 endo-chitinase 
39511 -4.7 1.5E-05 - 
174831 6.1 1.6E-05 Ribonuclease T2 
207217 5.8 1.6E-05 Glycogen synthase 
137560 4.1 1.6E-05 - 
209521 3.9 1.6E-05 - 
192202 6.7 1.6E-05 Transketolase, C-terminal domain 
50189 -2.3 1.6E-05 Hypothetical protein, Contains WD40 repeat 
37620 9.6 1.6E-05 gdhB, NAD dependent glutamate dehydrogenase 
55967 -2.2 1.6E-05 Cytochrome P450 
51887 3.1 1.6E-05 - 
50833 2.0 1.6E-05 - 
49148 -4.9 1.6E-05 - 
208321 3.5 1.6E-05 Peroxisomal membrane protein MPV17 and related proteins 
55560 5.4 1.6E-05 Mannitol-1-phosphate 5-dehydrogenase 
183352 -1.9 1.6E-05 Aromatic-ring hydroxylase 
47227 -6.0 1.6E-05 3-oxoacyl-(acyl-carrier-protein) synthase 
54383 3.7 1.6E-05 Splicing coactivator SRm160/300, subunit SRm300 
57366 -3.3 1.7E-05 - 
37382 -4.0 1.7E-05 Mitochondrial/chloroplast ribosomal protein L54/L37 
52676 -2.4 1.7E-05 60s ribosomal protein gene RPL5. 
214825 -5.2 1.7E-05 Glycosyl transferase, group 1 
214265 4.4 1.7E-05 Putative polyubiquitin 
55501 6.3 1.7E-05 Cytochrome P450 
43264 4.8 1.7E-05 - 
214402 2.5 1.7E-05 Zn-finger, C2H2 type 
43857 2.6 1.7E-05 Amino acid permease 
207193 -5.4 1.7E-05 Amino acid/polyamine transporter 
46473 6.3 1.7E-05 Hypothetical short chain dehydrogenase 
46523 -2.7 1.7E-05 - 
49003 -2.4 1.7E-05 - 
42079 3.5 1.7E-05 - 
128007 2.1 1.8E-05 Membrane protein involved in organellar division 
55161 6.1 1.8E-05 Hypothetical Alpha/beta hydrolase. Involded in aromatic 
compound metabolism 
136049 4.4 1.8E-05 Hypothetical protein with WD-40 and NACHT domain 
45871 -2.7 1.8E-05 - 
175089 5.7 1.8E-05 NAD dependent epimerase 
133888 -3.0 1.8E-05 Putative Zinc transporter ZIP, Zn /Fe 
142826 -4.5 1.8E-05 Ribosomal protein L27 
46272 -4.0 1.8E-05 Putative Ribosomal protein S8  
47586 3.3 1.8E-05 Fungal specific transcription factor 
42344 1.8 1.8E-05 Hypothetical esterase/lipase 
198750 -8.4 1.8E-05 Ammonium transporter 
191806 -2.7 1.8E-05 40S ribosomal protein S28 
44695 -3.6 1.8E-05 - 
127378 3.9 1.8E-05 - 
52603 3.4 1.8E-05 Related to carboxypeptidase Y 
172668 3.5 1.8E-05 Aldehyde dehydrogenase 
35486 6.1 1.8E-05 - 
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55529 -3.6 1.8E-05 Candidate ATP-dependent RNA helicase of the DEAD-box 
protein family 
56078 -3.2 1.8E-05 Deduced protein shares amino acid sequence identity with 
the Saccharomyces cereivisiae YRG054W gene product; 
eukaryotic initiation factor (eIF) 2A; associates specifically 
with both 40S subunits and 80 S ribosomes, and interacts 
genetically with both eIF5b and eIF4E; homologous to 
mammalian eIF2A. 
206982 4.4 1.8E-05 - 
125824 3.6 1.8E-05 - 
56702 -2.4 1.8E-05 Ribosomal protein L7Ae/L30e/S12e/Gadd45 
212718 -5.2 1.9E-05 Hypothetical protein. PFam suggests Oligopeptide 
transporter activity. 12 transmembrane domains are 
predicted 
205095 4.4 1.9E-05 Short-chain dehydrogenase/reductase 
49344 -3.3 1.9E-05 Putative GH family 76 endo-1,6-alpha-mannanase 
177847 5.5 1.9E-05 ABC transporter 
57253 2.2 1.9E-05 Ubiquitin-conjugating enzyme 
210217 -3.7 1.9E-05 Large beta-ketoacyl synthase probably involved in polyketide 
synthesis (aurasperone??) 
214305 3.5 1.9E-05 Hypothetical  Vesicle transport  protein (v-SNARE) 
50457 -3.9 1.9E-05 Nuclear GTP binding protein 
56788 3.5 1.9E-05 Hypothetical protease that contains peptidase M28 domain 
35583 -2.5 1.9E-05 Deduced amino acid sequence shares identity with the 
Saccharomyces cerevisiae NCL1 gene product; an S-
adenosyl-L-methionine-dependent tRNA: m5C-
methyltransferase; methylates cytosine to m5C at several 
positions in tRNAs and intron-containing pre-tRNAs. 
201783 5.5 1.9E-05 - 
127635 3.4 1.9E-05 - 
121949 3.3 1.9E-05 - 
52874 3.8 1.9E-05 Serine/threonine protein kinase 
213185 -3.5 1.9E-05 Pyruvate carboxylase (EC 6.4.1.1) 
44450 3.7 1.9E-05 - 
180548 3.5 1.9E-05 - 
48704 -3.1 1.9E-05 - 
130735 2.7 2.0E-05 - 
211766 8.6 2.0E-05 SAM (and some other nucleotide) binding motif 
209822 -5.7 2.0E-05 Hypothetical ribosomal protein L1 
127816 1.7 2.0E-05 SNARE protein 
54961 10.0 2.0E-05 Hypothetical cysteine dioxygenase (EC 1.13.11.20) 
184073 -6.2 2.0E-05 Related to NADPH-dependent alcohol dehydrogenase, Zinc 
containing 
209685 5.4 2.0E-05 Acyl-CoA dehydrogenase 
199933 -3.0 2.0E-05 Hypothetical Ribosomal protein S21e 
212420 -3.1 2.0E-05 Hypothetical ribosomal protein 
194767 5.0 2.0E-05 - 
170127 -4.0 2.0E-05 - 
55229 2.8 2.0E-05 Alpha/beta hydrolase 
42523 -3.2 2.0E-05 Hypothetical Inositol monophosphatase 
39215 -3.6 2.0E-05 Ribosomal protein L6 
211616 2.4 2.0E-05 Peptidase 
187878 4.0 2.0E-05 Related to hogA MAP kinase 
210558 -3.7 2.0E-05 Thiamine pyrophosphate-requiring enzyme 
183116 -2.5 2.0E-05 - 
180337 -4.5 2.0E-05 Hypothetical. KOG suggests transcription regulation/DEAD 
box 
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190193 -3.3 2.0E-05 - 
53525 -2.6 2.0E-05 Ribosomal protein L32e 
213531 -1.8 2.0E-05 Mitochondrial import translocase, subunit Tom70 
190860 -3.4 2.0E-05 Threonine dehydratase 
56332 -3.9 2.1E-05 Prolyl-4-hydroxylase 
51877 4.5 2.1E-05 Isopenicillin N synthase 
41935 4.5 2.1E-05 - 
40825 5.1 2.1E-05 Geranylgeranyl pyrophosphate synthase/Polyprenyl 
synthetase 
213350 3.1 2.1E-05 - 
44347 -2.4 2.1E-05 Ribosomal protein L3 
197679 -5.5 2.1E-05 Amino acid/polyamine transporter 
196638 -4.1 2.1E-05 60S acidic ribosomal protein P0 
179170 6.6 2.1E-05 - 
50197 7.6 2.1E-05 Hypothetical protein. PFam suggests a Enoyl-CoA 
hydratase/isomerase function 
207027 8.2 2.1E-05 Oxidoreductase, N-terminal 
38275 7.6 2.1E-05 - 
203758 -12.4 2.1E-05 - 
214897 4.1 2.1E-05 - 
36035 4.6 2.1E-05 - 
38174 2.3 2.2E-05 - 
203246 -3.2 2.2E-05 40S ribosomal protein S24 
55190 2.9 2.2E-05 - 
176406 -5.4 2.2E-05 Deduced amino acid sequence shares identity with the 
Saccharomyces cerevisiae NHP2 gene product; a nuclear 
protein related to mammalian high mobility group (HMG) 
proteins, essential for function of H/ACA-type snoRNPs, 
which are involved in 18S rRNA processing. 
55964 6.6 2.2E-05 - 
42808 12.2 2.2E-05 - 
42805 4.4 2.2E-05 - 
39108 2.7 2.2E-05 Predicted NUDIX hydrolase FGF-2 and related proteins 
207638 2.2 2.2E-05 Golgi-associated protein/Nedd4 WW domain-binding protein 
203335 5.1 2.2E-05 - 
120052 -4.7 2.2E-05 Related to SPB1 
207776 3.3 2.2E-05 Voltage-gated shaker-like K+ channe 
43391 8.9 2.2E-05 Dehydrogenase E1 component 
202653 -1.9 2.2E-05 Putative Ribosomal protein 60S 
51124 3.3 2.3E-05 - 
52539 4.9 2.3E-05 - 
208093 -1.9 2.3E-05 - 
193894 2.9 2.3E-05 - 
41702 5.3 2.3E-05 Major facilitator superfamily 
53246 1.6 2.3E-05 - 
206038 5.5 2.3E-05 - 
50499 13.1 2.3E-05 Related to 2-deoxy-D-gluconate 3-dehydrogenase 
42446 3.7 2.3E-05 Zinc transporter ZIP 
208365 3.1 2.3E-05 Hypothetical. KOG: aldo/keto reductase  
199618 3.7 2.3E-05 - 
41761 -2.3 2.3E-05 Predicted RNA-binding protein 
39748 -2.3 2.4E-05 - 
181825 -2.1 2.4E-05 Nuclear cap-binding complex, subunit NCBP1/CBP80 
200208 3.6 2.4E-05 N-methyl-D-aspartate receptor glutamate-binding subunit 
197269 5.8 2.4E-05 - 
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187486 6.8 2.4E-05 - 
54016 -3.4 2.4E-05 Hypothetical high-affinity nickel transport protein 
48843 -5.8 2.4E-05 rRNA processing protein 
193012 2.9 2.4E-05 Ubiquitin-protein ligase 
121560 4.4 2.4E-05 - 
200276 -2.3 2.4E-05 40S ribosomal protein S13 
197559 -3.2 2.4E-05 60S ribosomal protein L22 
206509 4.3 2.4E-05 - 
55252 -2.2 2.4E-05 Ribosomal protein S7 
53232 -1.6 2.4E-05 Related to dihydrolipoamide dehydrogenase of 
Schizosaccharomyces pombe; EC 1.8.1.4 
171186 -6.1 2.4E-05 - 
171113 2.2 2.5E-05 Fatty acid desaturase 
135680 -2.0 2.5E-05 Methyltransferases 
176795 4.1 2.5E-05 Hypothetical phenylalanine ammonia-lyase 
187076 -3.9 2.5E-05 - 
213213 -2.6 2.5E-05 Ribosomal protein L36E 
183718 1.5 2.5E-05 Predicted membrane protein 
173652 -3.8 2.5E-05 - 
38529 4.0 2.5E-05 - 
171440 2.3 2.5E-05 Fungal specific transcription factor 
45363 -3.6 2.5E-05 - 
128721 2.2 2.5E-05 - 
52257 3.1 2.5E-05 Ankyrin repeat 
51992 -5.4 2.5E-05 - 
46653 2.7 2.6E-05 - 
212055 -2.3 2.6E-05 40S ribosomal protein S12 
210632 -1.7 2.6E-05 tRNA synthetase anti-codon binding domain 
200417 -2.5 2.6E-05 60S ribosomal protein L28 
53197 -5.4 2.6E-05 Hypothetical IMP dehydrogenase 
210783 4.1 2.6E-05 Hypothetical. Probable peroxisomal membrane. Interpro 
suggests alkylhydroperoxide reductase 
188662 -2.7 2.6E-05 Nuclear transport factor 2 
176941 -5.6 2.6E-05 RNA polymerase 
188673 5.7 2.6E-05 AMP-dependent synthetase and ligase 
214112 -5.5 2.6E-05 - 
200967 -2.8 2.6E-05 - 
56457 2.4 2.7E-05 (cmkB) calcium/calmodulin dependent protein kinase B - 
high homology to cmkB in A. nidulans 
188691 5.0 2.7E-05 - 
128111 3.2 2.7E-05 - 
206692 -4.2 2.7E-05 Adenylosuccinate lyase 
206105 -2.9 2.7E-05 - 
184977 -3.8 2.7E-05 Mitochondrial substrate carrier 
211004 9.9 2.7E-05 Glycosyl transferase, family 20 
208493 2.6 2.7E-05 - 
192136 -3.0 2.7E-05 Hypothetical protein shares amino acid sequence identity 
with the Saccharomyces cerevisiae RRS1 gene product; an 
essential protein that binds ribosomal protein L11 and is 
required for nuclear export of the 60S pre-ribosomal subunit 
during ribosome biogenesis 
35670 4.5 2.8E-05 GCN5-related N-acetyltransferase 
56033 -2.1 2.8E-05 Prolyl-4-hydroxylase 
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54662 -1.8 2.8E-05 Hypothetical SNF5/SMARCB1/INI1 protein - a key 
component of SWI/SNF-class complexes; KOG Class: 
Chromatin structure and dynamics; KOG Id: 1649; KOG 
Description: SWI-SNF chromatin remodelling complex, Snf5 
subunit 
122321 10.1 2.8E-05 Major facilitator superfamily 
36031 -1.8 2.8E-05 Putative GroEL-like chaperone, ATPase 
53784 2.6 2.8E-05 Ras small GTPase, Rab type 
52118 8.2 2.8E-05 - 
191597 4.8 2.8E-05 Short chain dehydrogenase 
179383 2.3 2.8E-05 - 
56247 2.6 2.8E-05 Phospholipase D. Active site motif 
54557 2.3 2.8E-05 - 
39817 -2.7 2.8E-05 Hypothetical glutathione-dependent formaldehyde-activating 
protein 
36316 -3.7 2.8E-05 - 
197459 -1.9 2.8E-05 Translation initiation factor 
44432 4.9 2.8E-05 Helix loop helix transcription factor EB 
55644 -2.3 2.9E-05 Putative Ribosomal protein S4/9 
198674 -2.5 2.9E-05 60S ribosomal protein L10A 
213042 6.1 2.9E-05 MOSC N-terminal beta barrel domain 
42169 5.9 2.9E-05 - 
35952 3.2 2.9E-05 - 
207376 -3.1 2.9E-05 Predicted protein shares amino acid sequence identity to the 
Saccharomyces cerevisiae TIF34 gene product; subunit of 
the core complex of translation initiation factor 3(eIF3), which 
is essential for translation. 
174968 4.4 2.9E-05 - 
202504 -3.1 2.9E-05 40S ribosomal protein S19 
197350 -3.4 2.9E-05 Ribosomal protein S9 
193991 6.2 2.9E-05 - 
40623 2.9 2.9E-05 - 
213629 2.1 2.9E-05 Drebrins and related actin binding proteins 
211941 -3.0 3.0E-05 Predicted protein shares amino acid sequence identity with 
the Saccharomyces cerevisiae TRM2 gene product; a tRNA 
methyltransferase, 5-methylates the uridine residue at 
position 54 of tRNAs and may also have a role in tRNA 
stabilization or maturation; previously thought to be an endo-
exonuclease. 
175113 4.8 3.0E-05 Predicted Yippee-type zinc-binding protein 
173033 4.9 3.0E-05 Translation initiation factor 4F 
201412 5.2 3.0E-05 - 
211539 3.1 3.0E-05 - 
206447 -3.4 3.0E-05 Hypothetical Aminotransferase 
46218 -2.5 3.0E-05 Predicted kinase 
199510 4.0 3.0E-05 Sugar transporter superfamily 
50782 5.7 3.0E-05 Cytidine deaminase, homotetrameric 
207758 2.4 3.1E-05 26S proteasome regulatory complex, subunit PSMD9 
177222 2.2 3.1E-05 Hypothetical protein. May be involved in protein-protein 
interactions due to a predicted TPR-like domain 
39988 4.6 3.1E-05 - 
188987 3.2 3.1E-05 - 
43297 9.9 3.1E-05 Glyoxylate/hydroxypyruvate reductase (D-isomer-specific 2-
hydroxy acid dehydrogenase superfamily) 
49674 4.7 3.1E-05 - 
43695 3.7 3.1E-05 - 
143899 4.7 3.1E-05 - 
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174332 -2.4 3.2E-05 Zn-finger, C2H2 type 
197786 2.0 3.2E-05 (dapB) dipeptidylpeptidase 
46410 -4.0 3.2E-05 Predicted protein involved in nuclear export of pre-ribosomes
43311 4.5 3.2E-05 Hypothetical carboxylesterase 
213502 -5.6 3.2E-05 Dihydroxy-acid dehydratase 
175410 -3.3 3.2E-05 Peptidase 
171242 -5.3 3.2E-05 - 
133197 2.8 3.2E-05 Transcriptional coactivator 
45864 -5.7 3.2E-05 Deduced gene product shares amino acid sequence identity 
with the Saccharomyces cerevisiae NIP7 gene product; a 
nucleolar protein required for 60S ribosome subunit 
biogenesis, constituent of 66S pre-ribosomal particles. 
207677 -3.0 3.2E-05 Deduced amino acid sequence shares identity with the 
Saccharomyces cerevisiae MRP49 gene product; a 
mitochondrial ribosomal protein of the large subunit. 
186794 -2.2 3.2E-05 Related to pseudouridine synthase. 
173835 2.2 3.2E-05 - 
51810 6.1 3.2E-05 Glutathione S-transferase 
212182 5.4 3.2E-05 - 
212180 -2.3 3.2E-05 Putative GroEL-like chaperone, ATPase 
198936 -1.9 3.2E-05 Hypothetical protein with PPR repeat 
178649 2.3 3.2E-05 Nucleolar GTPase/ATPase p130 
53770 4.4 3.3E-05 Hypothetical GPI anchor protein 
38790 -4.0 3.3E-05 Hypothetical protein. 
136905 2.1 3.3E-05 - 
130434 -4.2 3.3E-05 Protein required for normal rRNA processing 
129632 3.4 3.3E-05 - 
170573 -3.9 3.3E-05 - 
127683 2.1 3.3E-05 Flavoprotein 
212884 2.2 3.3E-05 - 
211361 2.9 3.3E-05 - 
50014 -2.1 3.3E-05 RNA polymerase III (C) subunit 
44753 1.9 3.3E-05 Esterase/lipase/thioesterase 
212637 4.0 3.3E-05 Hypothetical protein containing fungal specific transcription 
factor and fungal transcriptional regulatory protein domains. 
55041 -7.3 3.3E-05 - 
37809 2.3 3.3E-05 - 
50713 2.1 3.4E-05 Putative Zinc-containing alcohol dehydrogenase superfamily 
212646 -2.3 3.4E-05 - 
47390 1.8 3.4E-05 - 
41394 5.3 3.4E-05 - 
54217 3.5 3.4E-05 Conserved Zn-finger protein 
41757 -2.3 3.4E-05 - 
39893 5.2 3.4E-05 Synaptic vesicle transporter SVOP 
209032 4.9 3.4E-05 - 
55723 -4.0 3.4E-05 - 
208354 -2.5 3.4E-05 - 
55936 -4.1 3.4E-05 Related to N. crassa RNA polymerase, beta subunit 
43930 5.9 3.4E-05 - 
190605 -2.6 3.4E-05 - 
183410 1.8 3.4E-05 - 
55895 -2.3 3.5E-05 - 
180348 4.8 3.5E-05 Peptidase S26 
35556 6.1 3.5E-05 Hypothetical amidase (EC 3.5.1.4) 
173461 2.2 3.5E-05 - 
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50898 -5.4 3.5E-05 Hypothetical permease. 10 predicted transmembrane 
domains. May have Xanthine/uracil transporter activity 
206586 1.8 3.5E-05 Vacuolar assembly/sorting protein 
42962 -3.2 3.5E-05 Adenine nucleotide translocator 
38222 -2.2 3.5E-05 - 
40484 4.2 3.5E-05 Peptidase M, neutral zinc metallopeptidases, zinc-binding 
site 
175896 -4.2 3.5E-05 Glucose-6-phosphate/phosphate and 
phosphoenolpyruvate/phosphate antiporter 
52938 3.3 3.5E-05 Esterase/lipase/thioesterase 
46856 -3.2 3.5E-05 DEAD/DEAH box helicase 
133565 3.5 3.5E-05 - 
200493 -5.2 3.5E-05 Imidazoleglycerol-phosphate dehydratase 
176865 2.7 3.5E-05 Hypothetical GPI anchor protein 
211641 1.4 3.6E-05 - 
196377 -3.6 3.6E-05 Mitochondrial/chloroplast ribosomal protein L2 
39551 4.1 3.6E-05 Protein-L-isoaspartate(D-aspartate) O-methyltransferase 
52046 -5.2 3.6E-05 Shares amino acid sequence identity with Saccharomyes 
cerevisiae EBP2 encoding an essential protein required for 
the maturation of 25S rRNA and 60S ribosomal subunit 
assembly; localises to the nucleolus; constituent of 66S pre-
ribosomal particles. 
127627 -2.7 3.6E-05 Candidate ribosomal protein S18 
46999 -2.1 3.6E-05 Related to prephenate dehydrogenase of Candida albicans 
174680 -2.0 3.7E-05 Candidate glucosyltransferase 
206881 -1.8 3.7E-05 40S ribosomal protein S7 
181216 4.1 3.7E-05 Kinesin light chain 
55773 3.0 3.7E-05 - 
52971 3.9 3.7E-05 Protein kinase 
124393 4.5 3.7E-05 Peroxisomal NUDIX hydrolase 
136845 -3.1 3.7E-05 Ribosomal protein 
56736 -3.1 3.8E-05 Haloacid dehalogenase-like hydrolase 
51412 2.2 3.8E-05 - 
185461 8.4 3.8E-05 - 
47290 -3.6 3.8E-05 Mitochondrial substrate carrier 
174284 3.6 3.8E-05 - 
176409 -5.3 3.8E-05 Hypothetical citrate synthase  
209363 3.3 3.8E-05 - 
185262 5.1 3.9E-05 - 
50719 -4.5 3.9E-05 - 
48814 7.6 3.9E-05 - 
129172 1.6 3.9E-05 - 
191450 3.0 3.9E-05 - 
54566 -1.6 3.9E-05 Hypothetical tyrosyl-tRNA synthetase. Shows similarity with 
N. crassa tyrosyl-tRNA synthetase 
54707 2.6 3.9E-05 Involved in autophagocytosis 
54391 -3.5 3.9E-05 Hypothetical homoserine O-acetyltransferase (EC 2.3.1.31). 
46991 -3.8 3.9E-05 Peptidase S16, lon protease 
201439 -6.2 3.9E-05 Related to molecular chaperone DnaJ. 
186614 -2.2 3.9E-05 - 
172145 4.0 3.9E-05 - 
197622 -2.3 3.9E-05 Putative GroEL-like chaperone, ATPase 
137182 -3.0 3.9E-05 60S ribosomal protein L14 
53140 2.7 3.9E-05 FMN-dependent dehydrogenase 
41013 2.3 4.0E-05 - 
52140 3.2 4.0E-05 Serine/threonine protein kinase 
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206235 -2.1 4.0E-05 40S ribosomal protein S8 
40254 -5.0 4.0E-05 Hypothetical glucose oxidase (EC 1.1.3.4) 
134353 3.3 4.0E-05 - 
54483 -2.9 4.0E-05 Related to squalene synthetase (EC 2.5.1.21). Involved in 
lipid biosynthesis. 
39541 -5.3 4.0E-05 Predicted protein shares amino acid sequence identity with 
the Saccharomyces cerevisiae UTP22 gene product; a 
possible U3 snoRNP protein involved in maturation of pre-
18S rRNA, based on computational analysis of large-scale 
protein-protein interaction data. 
48809 -2.9 4.0E-05 - 
38758 3.7 4.0E-05 Fungal specific transcription factor 
201957 2.1 4.0E-05 Synaptobrevin/VAMP-like protein 
55027 1.8 4.1E-05 - 
56776 6.2 4.1E-05 - 
44662 -3.0 4.1E-05 - 
202682 -2.3 4.1E-05 - 
173346 2.4 4.1E-05 DEAD/DEAH box helicase 
54575 -2.3 4.1E-05 - 
40922 4.2 4.1E-05 Predicted dehydrogenase 
35655 -4.2 4.1E-05 - 
52998 -2.3 4.1E-05 Hypothetical protein. Pfam suggests activity similar to the 
SAM-dependent methyltransferase/cell division protein FtsJ 
209716 1.9 4.1E-05 Cu2+/Zn2+ superoxide dismutase SOD1 
211346 3.8 4.2E-05 - 
206831 1.6 4.2E-05 Histone acetyltransferase complex 
196832 -2.7 4.2E-05 Hypothetical pseudouridylate synthase 
51832 -6.0 4.2E-05 - 
43122 -3.2 4.2E-05 Hypothetical. Sequence similarity to S cerevisiae RRP15; 
Nucleolar, constituent of pre-60S ribosomal particles; 
required for processing of the 27S pre-rRNA 
36700 -1.7 4.2E-05 AAA ATPase 
119946 2.4 4.2E-05 AAA ATPase 
136205 -3.4 4.2E-05 - 
56454 -5.6 4.3E-05 - 
54966 -2.0 4.3E-05 - 
125912 4.4 4.3E-05 - 
49486 -3.0 4.4E-05 - 
143917 3.5 4.4E-05 Upstream transcription factor 
52769 -4.6 4.4E-05 - 
52748 -2.4 4.4E-05 Hypothetical. Sequence identity to protein component of the 
large (60S) ribosomal subunit  
45989 -3.5 4.4E-05 Hypothetical UDP-glucose 4-epimerase 
187754 2.1 4.5E-05 - 
52536 3.8 4.5E-05 Ubiquitin-conjugating enzyme 
202623 -1.9 4.5E-05 Hypothetical protein containing a Golgi phosphoprotein 3 
domain 
170610 2.3 4.5E-05 Cytochrome P450 
136267 2.6 4.5E-05 Kinesin light chain 
184532 2.9 4.5E-05 - 
53238 3.1 4.5E-05 Candidate sterol 3-beta-glucosyltransferease 
191568 5.6 4.6E-05 Predicted glutathione S-transferase 
52717 -2.9 4.6E-05 Shares limited amino acid sequence identity with ribosomal 
protein L15, bacterial form. 
47806 -2.1 4.6E-05 - 
207173 2.2 4.6E-05 FYVE finger-containing protein 
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41983 2.6 4.6E-05 Amidohydrolase 2 
139419 -4.8 4.6E-05 KRR1-interacting protein involved in 40S ribosome 
biogenesis 
192151 6.2 4.6E-05 - 
55704 2.6 4.7E-05 (tpsA) trehalose-6-phosphate synthase A 
41591 -2.1 4.7E-05 - 
201401 -2.6 4.7E-05 60S ribosomal protein L7 
183782 -2.1 4.7E-05 Deduced protein shares amino acid sequence identity with 
Saccharomyces cerevisiae GCD10 gene product comprising 
a subunit of tRNA (1-methyladenosine) methyltransferase 
with Gcd14p; required for the modification of the adenine at 
position 58 in tRNAs, especially tRNAi-Met. 
188287 2.4 4.7E-05 Hypothetical silent information regulator protein of the Sir2 
family 
213827 10.2 4.7E-05 Permease of the major facilitator superfamily 
52617 7.6 4.7E-05 Aromatic-ring hydroxylase 
207187 3.5 4.7E-05 Hypothetical protein with predicted Appr-1-p domain; KOG 
Class: Chromatin structure and dynamics; KOG Id: 2633; 
KOG Description: Hismacro and SEC14 domain-containing 
proteins 
51912 -4.2 4.7E-05 Argininosuccinate lyase  
52111 4.9 4.7E-05 Hypothetical beta-galactosidase. extracellular GH family 2  
44202 -3.7 4.7E-05 G-protein containing WD40 repeats 
206812 2.9 4.7E-05 - 
133728 2.9 4.7E-05 - 
212792 -2.6 4.7E-05 - 
39731 3.0 4.7E-05 - 
172733 -3.8 4.8E-05 Predicted membrane protein 
211917 4.6 4.8E-05 Dual specificity phosphatase, catalytic domain 
52969 -5.9 4.8E-05 Importin-beta, N-terminal 
36379 -2.4 4.8E-05 Calcium-binding EF-hand 
41518 3.5 4.8E-05 - 
197959 -4.4 4.8E-05 Hypothetical. Sequence identity with S cerevisiae NOP53 
gene (nuclear); involved in biogenesis of 60S subunit of 
ribosome.  
187288 -2.3 4.8E-05 - 
54041 3.4 4.8E-05 - 
47225 -7.2 4.9E-05 - 
40333 5.4 4.9E-05 - 
39277 4.4 4.9E-05 - 
190177 -4.4 4.9E-05 Predicted protein shares amino acid sequence identity with 
the Saccharomyces cerevisiae UTP13 gene product; a 
nucleolar protein, component of the small subunit (SSU) 
processome containing the U3 snoRNA that is involved in 
processing of pre-18S rRNA. 
40780 3.2 5.0E-05 - 
54128 4.1 5.0E-05 - 
53524 -3.6 5.0E-05 - 
191332 -1.9 5.0E-05 Serine/threonine kinase receptor-associated protein 
55348 4.2 5.1E-05 - 
187802 3.1 5.1E-05 - 
52578 -2.2 5.1E-05 - 
178568 2.3 5.1E-05 - 
180990 4.8 5.2E-05 Zinc-binding oxidoreductase 
143583 3.8 5.2E-05 - 
206219 -4.6 5.2E-05 ERG2 and sigma1 receptor-like protein 
130155 -1.7 5.2E-05 - 
214206 2.6 5.2E-05 Nucleoside transporter 
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Identification of the most significantly expressed genes between N402 and N402 with fum 
and frds inserted, fold change in log2 ratio (positive number then expression level in N402 
strain with gene insertions higher), p. value < 0.05, the general description is taken from the 
JGI annotation database.  
 
JGI_ID Fold change p.value General description 
170261 2.9 1.7E-05 Permease of the major facilitator superfamily 
49576 5.5 3.9E-05 Glucose/ribitol dehydrogenase 
54383 4.0 3.9E-05 Splicing coactivator SRm160/300, subunit SRm300 
180570 4.0 3.9E-05 Short-chain dehydrogenase/reductase SDR 
56336 -3.5 4.5E-05 - 
179170 6.8 4.6E-05 - 
40825 5.2 4.6E-05 Geranylgeranyl pyrophosphate synthase/Polyprenyl 
synthetase 
176795 4.4 4.6E-05 Hypothetical phenylalanine ammonia-lyase 
35307 2.1 7.9E-05 - 
131354 -2.2 8.2E-05 - 
194591 4.7 9.5E-05 - 
41998 3.2 9.5E-05 - 
54080 -2.3 9.5E-05 - 
48762 -4.1 9.5E-05 - 
40740 3.2 1.1E-04 Hypothetical Short-chain dehydrogenase 
41662 1.6 1.1E-04 - 
52586 2.5 2.0E-04 Hypothetical protein with TPR-like domain 
191345 3.1 2.3E-04 Related to carbonic anhydrase, protection against oxidative 
damage 
119587 -2.1 2.3E-04 Glycosyl hydrolases family 18 
194452 6.4 3.2E-04 - 
177169 -2.7 3.5E-04 Hypothetical extracellular gluconolactonase 
198715 1.6 4.5E-04 Related to tef1B; elongation factor 1 beta 
54541 3.0 5.7E-04 Candidate oxidoreductase, Short-chain 
dehydrogenase/reductase 
47386 2.8 5.7E-04 - 
132154 -1.7 5.7E-04 Cytochrome P450 
179001 -1.3 5.8E-04 Dihydroxy-acid dehydratase 
37743 4.3 6.8E-04 - 
127639 2.8 6.8E-04 - 
173139 1.8 6.8E-04 Methionine synthase, vitamin-B12 independent 
189022 4.7 7.8E-04 - 
44428 4.0 7.8E-04 - 
41394 3.8 7.8E-04 - 
43594 3.0 7.8E-04 Hypothetical. SignalP suggests secreted 
213612 -2.5 8.0E-04 Nucleolar GTPase 
189398 1.6 8.2E-04 Protein of unknown function UPF0075 
136267 1.9 8.5E-04 Kinesin light chain 
42291 -1.5 8.6E-04 - 
205291 -2.5 8.6E-04 Isocitrate and isopropylmalate dehydrogenases 
52219 -2.0 9.0E-04 Glycoside hydrolase, family 28 
44546 3.1 9.5E-04 - 
179491 -1.5 1.0E-03 Serine/threonine protein kinase 
52239 -2.3 1.0E-03 - 
192151 4.3 1.2E-03 - 
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179385 -1.4 1.2E-03 Major facilitator superfamily 
140548 -1.5 1.2E-03 Cytochrome P450 
39667 3.0 1.2E-03 - 
127335 -1.8 1.2E-03 - 
35478 -1.3 1.3E-03 - 
136326 -1.3 1.3E-03 - 
55077 -1.4 1.4E-03 DNA-binding protein of the nucleobindin family 
179673 4.2 1.4E-03 Ankyrin 
126670 2.3 1.4E-03 - 
133728 1.9 1.4E-03 - 
42784 -2.4 1.4E-03 - 
52111 -3.3 1.5E-03 Hypothetical beta-galactosidase. extracellular GH family 2  
175401 4.5 1.5E-03 - 
54636 3.0 1.6E-03 - 
140623 -1.2 1.6E-03 Cytochrome P450 
199928 -1.3 1.7E-03 Predicted hydrolase 
54079 -2.6 1.7E-03 - 
207067 -2.0 1.7E-03 HAD-superfamily hydrolase, 
51794 2.9 1.7E-03 Extracellular ribonuclease M 
42602 1.6 1.7E-03 Cytochrome P450 
172476 -1.2 1.7E-03 - 
208150 1.4 1.7E-03 FAD-dependent pyridine nucleotide-disulphide 
oxidoreductase 
45103 5.0 1.7E-03 - 
182162 3.1 1.8E-03 Hypothetical alpha-amylase 
125836 -1.9 1.8E-03 - 
171880 5.5 1.8E-03 Multicopper oxidase 
193010 3.7 1.8E-03 Ferric reductase-like transmembrane component 
43055 2.4 1.8E-03 - 
39856 1.9 1.8E-03 - 
35902 -1.3 1.8E-03 Fungal specific transcription factor 
45042 -1.4 1.8E-03 - 
41171 -1.6 1.8E-03 - 
45928 3.4 1.8E-03 - 
55305 1.4 1.8E-03 - 
210217 -2.0 1.8E-03 Large beta-ketoacyl synthase probably involved in polyketide 
synthesis (aurasperone??) 
202949 3.6 1.8E-03 Hypothetical. Has similarity to beta-1,6-N-
acetylglucosaminyltransferase (KOG), contains WSC domain 
44776 -1.1 1.8E-03 - 
214441 1.0 1.9E-03 Hypothetical. KOG: acetyl-CoA acetyltransferase 
182167 -1.2 1.9E-03 - 
177882 -1.4 1.9E-03 - 
175986 -1.3 1.9E-03 - 
209075 -1.2 2.0E-03 Hypothetical  mannosyltransferase activity 
178804 -1.2 2.0E-03 Putative  2-dehydropantoate 2-reductase activity 
55131 1.6 2.1E-03 - 
52629 -1.2 2.1E-03 - 
56664 -3.0 2.1E-03 Exoinulinase 
55278 -3.5 2.1E-03 Hypothetical protein containing helix-turn-helix, Fis-type 
domain 
54717 1.1 2.1E-03 - 
55208 -2.4 2.1E-03 - 
208525 5.3 2.3E-03 - 
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193984 1.9 2.3E-03 C4-dicarboxylate transporter/malic acid transport protein 
194529 -1.4 2.3E-03 - 
188240 -1.8 2.4E-03 - 
56966 -2.6 2.4E-03 - 
40876 3.4 2.4E-03 - 
55402 -1.2 2.4E-03 - 
209514 -1.7 2.4E-03 Myb, DNA-binding 
133197 1.5 2.6E-03 Transcriptional coactivator 
183352 -0.9 2.6E-03 Aromatic-ring hydroxylase 
53015 4.6 2.7E-03 - 
193767 2.0 2.7E-03 Predicted methyltransferase 
129107 -1.1 2.7E-03 Hypothetical protein. Is likely to be involved in protein-protein 
interaction due to the presence of four TPR repeats. 
53522 -1.1 2.7E-03 Hypothetical microtubule-associated protein essential for 
anaphase spindle elongation 
42357 -1.2 2.7E-03 - 
177244 -1.6 2.8E-03 - 
212618 4.0 3.2E-03 - 
180923 -1.4 3.2E-03 Major facilitator superfamily 
194300 -1.5 3.2E-03 Candidate Ribonuclease III 
176875 -1.1 3.3E-03 Receptor-activated Ca2+-permeable cation channels 
(STRPC family) 
173803 1.9 3.3E-03 - 
120113 1.6 3.3E-03 - 
47364 1.1 3.3E-03 Candidate catalase 
49158 -1.2 3.3E-03 Hypothetical NADH:flavin oxidoreductase/NADH oxidase-like 
protein 
125323 2.9 3.3E-03 - 
174497 -1.0 3.3E-03 - 
40178 1.0 3.4E-03 - 
186554 2.9 3.5E-03 Monooxygenase, FAD-binding 
173689 1.1 3.6E-03 Protein kinase 
37742 1.8 3.6E-03 Rhodopsin-like GPCR superfamily 
37533 -1.7 3.7E-03 Unknown. SignalP predicts Anchor 
186748 -1.8 3.7E-03 - 
136363 -1.5 3.7E-03 - 
54129 -1.2 3.7E-03 Isoflavone reductase 
44405 -1.2 3.7E-03 Hypothetical DNA excision repair protein 
178173 2.6 3.8E-03 - 
195378 -1.0 3.8E-03 RNA polymerase II transcription initiation/nucleotide excision 
repair factor 
206475 -1.3 3.8E-03 - 
213113 -2.9 3.8E-03 Hypothetical cytochrome b5 
195375 3.9 3.9E-03 Multicopper oxidase 
118995 1.6 3.9E-03 WD40 repeat-containing protein 
40885 -1.5 3.9E-03 beta-1,6-N-acetylglucosaminyltransferase, contains WSC 
domain 
56215 -2.9 3.9E-03 Hypothetical Hydroxymethylglutaryl-coenzyme A synthase 
193384 2.9 3.9E-03 - 
140802 1.3 3.9E-03 Monocarboxylate transporter 
207820 -0.7 3.9E-03 Major facilitator superfamily 
202289 -0.9 3.9E-03 - 
210798 -1.9 3.9E-03 Dienelactone hydrolase 
41719 -1.0 4.0E-03 Hypothetical FAD/FMN-containing dehydrogenase 
214466 -1.0 4.0E-03 Hypothetical. KOG suggests function in ER-Golgi transport 
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44401 -1.6 4.0E-03 - 
192821 2.9 4.0E-03 Helicase-like transcription factor HLTF/DNA helicase RAD5, 
DEAD-box superfamily 
192595 2.9 4.1E-03 - 
36284 -1.1 4.1E-03 Hypothetical protein containing cytochrome c heme-binding 
site and Zn-finger, C2H2 type domains 
40478 -2.8 4.1E-03 Aromatic-ring hydroxylase 
183201 -0.7 4.2E-03 - 
144154 -1.1 4.2E-03 - 
189328 2.0 4.2E-03 - 
134478 1.3 4.3E-03 - 
119939 -1.5 4.3E-03 Fungal specific transcription factor 
130000 3.0 4.3E-03 Vacuolar sorting protein VPS1, dynamin, and related proteins 
214038 -0.9 4.3E-03 DEAD/DEAH box helicase 
172955 -1.1 4.3E-03 Hydantoinase/oxoprolinase 
173461 -1.1 4.3E-03 - 
54174 -2.2 4.3E-03 Dihydroxy-acid dehydratase 
192439 1.1 4.3E-03 ATP binding protein 
122060 1.1 4.3E-03 - 
55742 1.0 4.3E-03 aldA Aldehyde dehydrogenase (aldA) (EC 1.2.1.3) 
172823 -1.0 4.4E-03 Related to zink transporter of A. fumigatus. Seven putative 
transmembrane domains and PFam domains for zink 
transport. 
38570 -2.0 4.4E-03 Fibronectin type III domain 
210119 -2.3 4.4E-03 Major facilitator superfamily 
53002 1.1 4.4E-03 - 
54966 -1.0 4.4E-03 - 
180211 1.4 4.6E-03 Alpha/beta hydrolase 
46858 3.0 4.6E-03 Hypothetical alcohol dehydrogenase; EC 1.1.1.1 
45270 -1.2 4.6E-03 - 
56311 -1.7 4.6E-03 Hypothetical Glucose-methanol-choline oxidoreductase 
170984 -1.2 4.7E-03 - 
36316 -1.8 4.7E-03 - 
171113 -1.0 4.7E-03 Fatty acid desaturase 
118832 -1.1 4.7E-03 ABC transporter 
130814 -1.4 4.7E-03 - 
207505 -0.9 4.7E-03 (pmrA) Secretory pathway Ca2+-ATPase 
35683 -1.0 4.7E-03 - 
55781 -1.1 4.8E-03 - 
182202 -1.5 4.8E-03 DUF821 domain protein. Putative lipopolysaccharide-
modifying enzyme; 
52449 -1.3 4.8E-03 Transcription coactivator 
35358 1.3 4.9E-03 CCAAT-binding transcription factor, 
55296 -0.8 4.9E-03 Hypothetical threonyl-tRNA synthetase kinase. HMMPfam 
indicates Threonyl-tRNA synthetase kinase activity 
43788 -1.4 4.9E-03 - 
53945 -1.6 5.0E-03 Haem peroxidase, plant/fungal/bacterial 
53909 -3.9 0.01 - 
40617 -1.3 0.01 - 
212637 -1.9 0.01 Hypothetical protein containing fungal specific transcription 
factor and fungal transcriptional regulatory protein domains. 
134276 3.1 0.01 FOG: RRM domain 
57420 -1.2 0.01 - 
53233 -2.5 0.01 Hypothetical short chain dehydrogenase 
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190964 1.9 0.01 Predicted member of the intramitochondrial sorting protein 
family 
35983 1.2 0.01 Conserved hypothetical ATP binding protein 
186640 1.0 0.01 Hypothetical  isoprenylcysteine carboxyl methyltransferase 
50713 1.0 0.01 Putative Zinc-containing alcohol dehydrogenase superfamily 
39373 0.9 0.01 - 
132378 0.6 0.01 Amino acid transporters 
181601 -0.9 0.01 - 
175222 -1.0 0.01 Cell cycle-associated protein 
128988 -1.1 0.01 Ankyrin 
192367 -1.2 0.01 Uncharacterised conserved protein, contains TBC domain 
44775 -1.3 0.01 - 
210117 -1.4 0.01 - 
182627 -1.6 0.01 - 
38000 -2.2 0.01 Acetoacetyl-CoA synthase 
182754 1.1 0.01 - 
144008 -1.6 0.01 - 
173989 -0.8 0.01 - 
180295 -2.3 0.01 FAD-dependent oxidoreductase 
52459 -1.1 0.01 - 
211641 0.6 0.01 - 
46090 2.5 0.01 - 
190385 1.8 0.01 - 
183718 -0.7 0.01 Predicted membrane protein 
53918 -1.5 0.01 Fungal transcriptional regulatory protein 
49896 -2.3 0.01 Mandelate racemase 
206384 3.9 0.01 Related to aspartic protease 
214715 2.8 0.01 Hypothetical. KOG suggests chitinase. SignalP suggests 
secretion 
55721 2.5 0.01 Sulfatase 
137681 1.6 0.01 Scytalone dehydratase 
204381 -1.3 0.01 Voltage-gated shaker-like K+ channel, subunit beta/KCNAB 
40613 -1.2 0.01 - 
45912 -2.6 0.01 FMN-dependent alpha-hydroxy acid dehydrogenase 
181053 3.1 0.01 ABC transporter 
56390 2.8 0.01 Related to aspartate transaminase D-chain S. cerevisiae 
214022 1.4 0.01 Adenosine kinase 
53262 -1.0 0.01 - 
211267 -1.1 0.01 Kinesin, motor region 
51779 -2.6 0.01 - 
49598 -1.7 0.01 Pyridine nucleotide-disulphide oxidoreductase, class-II 
175034 -1.1 0.01 - 
47399 -0.9 0.01 Aminoacyl-tRNA synthetase, class I 
170610 -1.1 0.01 Cytochrome P450 
129458 -1.2 0.01 - 
36722 2.8 0.01 - 
209480 -0.8 0.01 SNF2 family 
48971 -1.0 0.01 - 
174284 -1.6 0.01 - 
206792 1.3 0.01 RNA polymerase subunit 
171422 2.7 0.01 - 
181735 -1.0 0.01 Fungal specific transcription factor 
52107 -2.0 0.01 Chitinase 
44975 2.0 0.01 Zinc-containing alcohol dehydrogenase 
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42184 -1.2 0.01 pgaX Exopolygalacturonase precursor (ExoPG) (Galacturan 
1,4-alpha-galacturonidase) 
42615 -1.5 0.01 - 
44770 -1.3 0.01 - 
213911 -3.5 0.01 Aldehyde dehydrogenase 
52520 -2.3 0.01 Hypothetical Short-chain dehydrogenase/reductase 
56643 2.4 0.01 Major facilitator superfamily 
50823 0.9 0.01 Hypothetical Acetyl-CoA acetyltransferase 
190362 -0.9 0.01 General substrate transporter 
53471 -1.1 0.01 - 
50154 2.0 0.01 Hypothetical ribulose-phosphate 3-epimerase 
48666 0.7 0.01 - 
202682 1.0 0.01 - 
55650 -1.3 0.01 - 
121359 -0.8 0.01 Glycosyl hydrolase family 20 
51436 -1.1 0.01 - 
179383 -1.0 0.01 - 
203184 -2.2 0.01 O-methyltransferase, family 2 
191636 1.4 0.01 Hypothetical protein. Electronic annotation suggests pyridine 
nucleotide-disulphide oxidoreductase 
56753 -1.7 0.01 Aromatic-ring hydroxylase 
39893 -2.2 0.01 Synaptic vesicle transporter SVOP 
175357 -1.0 0.01 Sugar transporter superfamily 
179947 3.1 0.01 Proline oxidase 
44117 2.8 0.01 Ankyrin-repeat protein 
50719 2.0 0.01 - 
42378 1.6 0.01 Esterase/lipase/thioesterase 
54208 -0.6 0.01 AAA ATPase 
130155 -0.8 0.01 - 
54785 -1.2 0.01 - 
42470 -1.2 0.01 - 
46699 -0.8 0.01 Hypothetical late Golgi protein sorting complex, subunit 
213409 2.1 0.01 Monooxygenase, FAD-binding 
134398 -0.9 0.01 Putative GH family 43 protein with 47% sequence identity to 
an Aspergillus nidulans endo-arabinanase (PMID: 16844780) 
44909 -1.2 0.01 Flavin-containing monooxygenase 
53517 -1.3 0.01 - 
38610 1.2 0.01 possible Translation initiation factor 2B, beta subunit (eIF-
2Bbeta/GCD7) 
192136 1.2 0.01 Hypothetical protein shares amino acid sequence identity 
with the Saccharomyces cerevisiae RRS1 gene product; an 
essential protein that binds ribosomal protein L11 and is 
required for nuclear export of the 60S pre-ribosomal subunit 
during ribosome biogenesis 
172651 -1.0 0.01 Vacuolar sorting protein 9 (VPS9) domain 
53994 -1.6 0.01 - 
36700 -0.8 0.01 AAA ATPase 
40477 -2.5 0.01 Hypothetical. Some similarity to alkylhydroperoxidase 
144038 -1.2 0.01 - 
192694 1.4 0.01 Zinc-containing alcohol dehydrogenase 
171978 -0.7 0.01 FOG: Zn-finger 
176123 -1.2 0.01 - 
196499 1.8 0.01 Major facilitator superfamily 
45712 1.5 0.01 - 
170609 1.6 0.01 - 
56145 1.5 0.01 - 
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133512 1.3 0.01 - 
184563 1.2 0.01 - 
204582 -0.8 0.01 - 
50140 -0.8 0.01 Related to  2,2-dialkylglycine decarboxylase of Burkholderia 
(4.1.1.64) 
170624 -1.2 0.01 - 
177616 -1.3 0.01 Sugar transporter superfamily 
56475 -2.2 0.01 Aldo/keto reductase 
41637 3.3 0.01 Calcium-binding EF-hand 
39581 1.9 0.01 Peptidase C19, ubiquitin carboxyl-terminal hydrolase 2 
207776 -1.3 0.01 Voltage-gated shaker-like K+ channe 
42282 -1.3 0.01 - 
176373 1.8 0.01 - 
133870 -2.2 0.01 Hypothetical alpha-1,6-mannanase. GH family 76  
124156 1.3 0.01 Candidate NAD dependent formate dehydrogenase 
36028 0.9 0.01 Aminotransferase, class IV 
209397 1.0 0.01 - 
37608 -0.6 0.01 - 
52284 -0.9 0.01 Hypothetical protein containing an ATP-dependent DNA 
ligase I motif  
193872 -0.9 0.01 AAA ATPase 
44792 -1.0 0.01 - 
43224 -1.1 0.01 Fungal transcriptional regulatory protein 
210291 1.2 0.01 - 
36502 -1.7 0.01 Hypothetical cytochrome p-450 
119444 2.3 0.01 Hypothetical protein. Possibly a DNA-dependent ATPase 
(SNF2 related) 
137708 1.8 0.01 - 
36079 1.1 0.01 - 
45131 0.9 0.01 Hypothetical aldehyde dehydrogenase (EC 1.2.1.3). 
52362 1.0 0.01 Candidate 40S ribosomal protein S0. 
177916 -1.2 0.01 - 
36162 0.8 0.01 - 
43351 -1.1 0.01 - 
180970 1.3 0.01 - 
180635 1.2 0.01 - 
170891 1.7 0.01 - 
213970 1.4 0.01 - 
170230 -2.1 0.01 - 
199159 1.4 0.01 - 
45514 -0.7 0.01 Hypothetical G-protein with WD-40 repeat 
118624 -1.0 0.01 Putative polyketide synthase 
52916 1.7 0.01 - 
52676 0.9 0.01 60s ribosomal protein gene RPL5. 
48772 -1.1 0.01 Protein kinase 
213187 -0.6 0.01 Vesicle coat protein clathrin, 
51410 -0.8 0.01 - 
185291 -1.1 0.01 - 
126473 1.9 0.01 - 
55967 -0.8 0.01 Cytochrome P450 
56240 -0.8 0.01 - 
208591 -0.9 0.01 Serine carboxypeptidase 
210141 -0.9 0.01 Peptidase 
52565 -0.9 0.01 - 
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172232 -0.9 0.01 Hypothetical alpha-galactosidase; EC 3.2.1.22; 
36613 -1.7 0.01 - 
182426 -1.3 0.01 Hypothetical, ABC transporter 
49639 -2.0 0.01 Short-chain dehydrogenase/reductase 
173132 -0.9 0.01 WD domain, G-beta repeat 
209822 2.1 0.01 Hypothetical ribosomal protein L1 
180653 -0.8 0.01 - 
54235 1.1 0.01 Chorismate synthase 
40603 -1.2 0.01 - 
37678 1.1 0.01 - 
136603 0.9 0.01 Hypothetical transcription initiation factor. A putative YEATS 
domain is present in the sequence 
214408 -0.9 0.01 Nucleic acid-binding OB-fold 
212893 -1.3 0.01 Glycoside hydrolase 
50306 1.8 0.01 Hypothetical ThiamineS, sulfur metabolism 
200680 0.9 0.01 Eukaryotic translation initiation factor 3, subunit 7 
214822 -0.6 0.01 - 
121206 -0.8 0.01 Prolyl-tRNA synthetase 
53410 -0.9 0.01 - 
144147 -1.1 0.01 - 
120638 -1.1 0.01 Fungal transcriptional regulatory protein 
39128 -1.2 0.01 Hypothetical protein related to cytochrome P450 3A7 
53065 -0.6 0.01 - 
38790 1.6 0.01 Hypothetical protein. 
181803 -1.4 0.01 - 
195098 -1.5 0.01 - 
43753 1.2 0.01 Hypothetical protein with predicted C-5 cytosine-specific DNA 
methylase and a peptidase domain; Interpro Id: 1525; 
Interpro description:C-5 cytosine-specific DNA methylase; 
GO Desc.: DNA binding and DNA methylation 
39356 -1.1 0.01 - 
210108 -1.7 0.01 AMP-dependent synthetase and ligase 
37370 -0.8 0.01 - 
209263 2.1 0.01 - 
191243 1.0 0.01 Candidate amidase B (EC 3.5.1.4) 
133158 -0.9 0.01 Fungal transcriptional regulatory protein 
214651 2.4 0.01 Mannitol dehydrogenase 
39268 -1.0 0.01 Fungal specific transcription factor 
210981 -1.2 0.01 Putative extracellular GH family 3 beta-glucosiadse 
172825 -1.8 0.01 - 
40476 -2.2 0.01 - 
191749 0.8 0.01 - 
205501 -0.8 0.01 Hypothetical cell division cycle protein 
183410 -0.7 0.01 - 
209660 -1.6 0.01 SWI-SNF chromatin-remodelling complex protein 
192085 1.9 0.01 - 
173997 1.7 0.01 Deduced translation product shares amino acid sequence 
identity with the Saccharomyces cerevisiae NSR1 gene 
product; a nucleolar protein that binds nuclear localisation 
sequences, required for pre-rRNA processing and ribosome 
biogenesis. 
199092 0.8 0.01 - 
128516 -1.1 0.01 - 
173704 -1.2 0.01 Major facilitator superfamily 
47354 -1.9 0.01 - 
56941 -0.8 0.01 - 
  288
122527 -0.9 0.01 Permease of the major facilitator superfamily 
41808 -1.0 0.01 - 
176070 1.1 0.01 ATP-dependent DNA ligase 
194896 -0.8 0.01 Hypothetical amine oxidase 
42844 -0.9 0.01 - 
35824 2.1 0.01 - 
130434 1.6 0.01 Protein required for normal rRNA processing 
56298 -1.3 0.01 Putative mannosyl-oligosaccharide glucosidase, GH family 
63 
137752 0.7 0.01 60S ribosomal protein L18A 
142587 -1.0 0.01 - 
137102 1.0 0.01 - 
38235 1.9 0.01 U3 small nucleolar ribonucleoprotein (snoRNP) 
173835 -0.8 0.01 - 
39623 -0.9 0.01 - 
183116 -0.9 0.01 - 
55324 -2.0 0.01 Putative extracellular tyrosinase 
209842 1.1 0.01 Phosphoribosyl pyrophosphate synthetase 
172691 -0.8 0.01 Serine/threonine protein kinase 
45278 5.0 0.01 L-kynurenine hydrolase 
178656 -0.8 0.01 - 
140721 -0.9 0.01 - 
40115 -2.5 0.01 Hypothetical protein with four predicted transmembrane 
domains 
127191 -0.7 0.01 - 
47312 -0.9 0.01 Kinesin-like protein 
189874 -1.4 0.02 Short-chain dehydrogenase/reductase 
214112 2.0 0.02 - 
52421 -0.7 0.02 Peptidase M18, aminopeptidase I 
208679 -1.4 0.02 - 
50457 1.3 0.02 Nuclear GTP binding protein 
45693 -1.4 0.02 - 
214735 -1.6 0.02 Non-ribosomal peptide synthetase 
42198 1.5 0.02 - 
56566 -3.3 0.02 Major facilitator superfamily 
209830 -3.0 0.02 Hypothetical FAD/FMN-containing dehydrogenase 
35655 -1.6 0.02 - 
131829 3.1 0.02 - 
38152 1.7 0.02 - 
54662 -0.6 0.02 Hypothetical SNF5/SMARCB1/INI1 protein - a key 
component of SWI/SNF-class complexes; KOG Class: 
Chromatin structure and dynamics; KOG Id: 1649; KOG 
Description: SWI-SNF chromatin remodelling complex, Snf5 
subunit 
37967 -1.7 0.02 - 
49420 2.4 0.02 - 
198577 1.4 0.02 Carnitine O-acyltransferase 
127124 -0.5 0.02 - 
171532 -1.1 0.02 - 
55089 2.0 0.02 The basic-leucine zipper (bZIP) transcription factors of 
eukaryotes are proteins that contain a basic region mediating 
sequence-specific DNA-binding followed by a leucine zipper 
region required for dimerization 
181179 1.6 0.02 Catechol dioxygenase, N-terminal 
206859 0.8 0.02 40S ribosomal protein S14 
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213194 -1.0 0.02 Putative growth response protein 
128882 -1.0 0.02 Predicted transporter (major facilitator superfamily) 
206697 -1.2 0.02 Exocyst component protein and related proteins 
42016 1.6 0.02 - 
46999 -0.8 0.02 Related to prephenate dehydrogenase of Candida albicans 
170910 -1.0 0.02 Glucose/ribitol dehydrogenase 
173677 -1.3 0.02 Hypothetical. Ketopantoate reductase pyrimidin base 
metabolism 
121987 -1.4 0.02 - 
52754 1.3 0.02 Nucleolar protein NOP52/RRP1 
211162 -0.9 0.02 Hypothetical 1,4-alpha-glucan branching enzyme 
52257 -1.1 0.02 Ankyrin repeat 
124027 -1.2 0.02 - 
187859 -1.1 0.02 Kelch motif 
49726 1.7 0.02 Related to the IMP3 gene product of Saccharomyces 
cerevisiae comprising a component of the SSU processome, 
which is required for pre-18S rRNA processing 
38814 -0.6 0.02 - 
134125 -1.1 0.02 Peptidase family M20/M25/M40 
53788 -1.5 0.02 Nucleoside phosphatase 
207380 0.8 0.02 Protein kinase 
143580 0.8 0.02 40s ribosomal protein s10 
53494 0.6 0.02 - 
174132 -0.7 0.02 - 
42449 -0.9 0.02 - 
54127 -1.3 0.02 - 
213343 -1.3 0.02 Predicted 3-hydroxy-3-methylglutaryl-CoA (HMG-CoA) 
reductase 
50029 -1.5 0.02 - 
54128 -1.6 0.02 - 
209757 -1.5 0.02 - 
53037 1.6 0.02 HEAT repeat-containing protein 
38222 -0.8 0.02 - 
46333 -0.8 0.02 RNA polymerase II transcription initiation factor TFIIA 
209244 -1.1 0.02 Oxidoreductase 
119822 -1.2 0.02 Nucleolar GTPase/ATPase p130 
43664 -1.0 0.02 Esterase/lipase/thioesterase 
209597 1.3 0.02 Protein kinase 
120572 -0.7 0.02 N-methyltransferase 
208923 -0.9 0.02 - 
138440 -1.0 0.02 - 
172914 -0.5 0.02 Peptidase, eukaryotic cysteine peptidase active site 
45949 -0.6 0.02 - 
176830 0.9 0.02 WD40 repeat nucleolar protein putatively involved in 
ribosome biogenesis 
129111 -1.7 0.02 Hydantoinase/oxoprolinase 
212044 0.5 0.02 Mitochondrial ADP/ATP carrier proteins 
202623 -0.7 0.02 Hypothetical protein containing a Golgi phosphoprotein 3 
domain 
180613 -1.0 0.02 Hypothetical guanine nucleotide exchange factor 
185623 1.0 0.02 - 
143871 -1.9 0.02 Glycoside hydrolase, starch-binding 
181710 -0.9 0.02 Major facilitator superfamily 
47549 -1.4 0.02 - 
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50038 1.9 0.02 Hypothetical, Identity with cerev. Nob 1, nuclear protein 
involved in proteasome maturation and synthesis of 40S 
ribosomal subunits 
208129 1.4 0.02 Glycine cleavage H-protein 
37001 1.0 0.02 - 
173284 -1.4 0.02 - 
37764 -1.8 0.02 - 
47113 1.8 0.02 - 
47267 1.2 0.02 Hypothetical. Sequence identity with S.cerevisiae LCP5 gene 
product involved in maturation of 18S rRNA.  
207134 0.7 0.02 - 
57395 -0.7 0.02 Glycosyl transferase, family 39 
124912 -0.9 0.02 Choline kinase 
54199 -1.0 0.02 - 
207532 -1.2 0.02 - 
43746 -1.4 0.02 Hypothetical ribonuclease T1 
52177 -1.7 0.02 Glycosyl transferase family 4 
48103 -1.0 0.02 WD40 repeat-containing protein 
211532 -1.1 0.02 Cytochrome P450 
39083 1.0 0.02 - 
211078 -0.6 0.02 Actin/actin-like 
188287 -0.9 0.02 Hypothetical silent information regulator protein of the Sir2 
family 
40959 -0.6 0.02 - 
196476 1.6 0.02 Phospho-2-dehydro-3-deoxyheptonate aldolase 
180928 1.4 0.02 - 
207718 1.1 0.02 Zn-finger, U1-like 
181522 0.9 0.02 - 
45500 -0.6 0.02 G-like protein containing WD-40 repeat 
56504 -0.9 0.02 Hypothetical protein with RCC1 domain  
181032 -0.9 0.02 Fungal specific transcription factor 
36000 -1.6 0.02 - 
180563 -1.6 0.02 - 
178371 1.0 0.02 Splicing coactivator SRm160/300, 
205776 -0.9 0.02 Predicted membrane protein 
174907 1.1 0.02 Mitochondrial carrier protein 
55728 -1.0 0.02 DNA topoisomerase II - ATPase-like, with high homology 
(topB) 
47812 -0.7 0.02 OPT oligopeptide transporter protein 
50075 1.3 0.02 DeoxyUTP pyrophosphatase 
176989 -1.1 0.02 - 
119367 -1.3 0.02 - 
144060 -1.4 0.02 Related to Tar1 of K. lactis 
204276 -2.3 0.02 Zinc-containing alcohol dehydrogenase 
172647 1.5 0.02 Major facilitator superfamily 
40922 1.5 0.02 Predicted dehydrogenase 
202059 1.3 0.02 Isochorismatase hydrolase 
42619 -1.0 0.02 DSBA oxidoreductase 
46429 -1.1 0.02 Glycosyl hydrolases family 35 
56195 -1.2 0.02 Carbohydrate kinase, FGGY 
191214 -1.6 0.02 Hypothetical. Helicase domain 
189637 -1.7 0.02 - 
172079 1.8 0.02 - 
48827 1.0 0.02 - 
48109 -0.9 0.02 Myosin class II heavy chain 
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40924 -0.6 0.02 - 
194286 -0.7 0.02 Flavin-containing monooxygenase FMO 
48067 -2.4 0.02 Hydroxyindole-O-methyltransferase and related SAM-
dependent methyltransferases 
214657 3.8 0.02 - 
36407 -1.9 0.02 - 
181915 0.9 0.02 NB-ARC / TPR repeat 
196617 0.9 0.02 GCN5-related N-acetyltransferase 
187232 -0.9 0.02 - 
188256 1.7 0.02 Hypothetical. Interpro: eukaryotic cysteine peptidase active 
site 
55229 -0.9 0.02 Alpha/beta hydrolase 
200255 -0.9 0.02 Hypothetical cation efflux protein 
138063 -1.8 0.02 - 
44094 -0.8 0.02 - 
197549 1.5 0.02 Sugar (ANd other) transporter 
173711 0.9 0.02 - 
56137 0.7 0.02 - 
42826 -0.5 0.02 Putative growth response protein 
202202 -0.6 0.02 Hypothetical. Ca2+-binding actin-bundling protein 
(fimbrin/plastin) 
53547 -1.6 0.02 - 
185434 -1.9 0.02 Short chain dehydrogenase 
207027 -2.6 0.02 Oxidoreductase, N-terminal 
204746 0.9 0.02 Phosphoribosyl pyrophosphate synthetase 
36288 0.9 0.02 - 
195287 -1.2 0.02 - 
45506 1.7 0.02 - 
44487 -0.6 0.02 - 
55156 -1.1 0.02 FOG: Zn-finger 
44492 -0.7 0.02 ABC transporter 
210672 -1.7 0.02 Short-chain dehydrogenase/reductase SDR 
208917 1.7 0.02 - 
198685 -0.7 0.03 - 
136048 -1.0 0.03 Cytochrome c heme-binding site 
210734 -0.9 0.03 Hypothetical protein with predicted histone deacetylase 
domain, which catalyses the removal of acetyl group of 
acetylated lysine residues in histones; KOG Class: Chromatin 
structure and dynamics; KOG Id: 1343; KOG Description: 
Histone deacetylase complex, 
40878 1.3 0.03 Related to alpha-1,3-glucan synthase 
208722 -0.7 0.03 - 
205821 -1.0 0.03 HPr serine phosphorylation site 
45893 -0.5 0.03 Putative glucosyltransferase 
187212 -0.7 0.03 - 
56449 -0.8 0.03 - 
54864 2.6 0.03 Aromatic-ring hydroxylase 
187934 0.8 0.03 Major facilitator superfamily 
209129 1.2 0.03 - 
207689 -1.4 0.03 Peptidase M20 
35964 -2.1 0.03 Chitin synthase 
209012 -2.3 0.03 Proteins containing the FAD binding domain 
44615 0.7 0.03 - 
171334 0.6 0.03 NADH:flavin oxidoreductase/NADH oxidase 
180093 -1.7 0.03 - 
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122402 0.9 0.03 - 
211773 -1.3 0.03 - 
179092 -1.2 0.03 Serine/threonine protein kinase 
184876 0.6 0.03 - 
134406 -1.0 0.03 - 
36826 1.6 0.03 - 
35734 -0.7 0.03 - 
181551 -1.3 0.03 GPCR, family 2, secretin-like 
54294 0.8 0.03 - 
138876 -1.3 0.03 beta-mannosidase A 
56267 0.8 0.03 - 
129373 -0.6 0.03 - 
52229 -0.8 0.03 Zinc-containing alcohol dehydrogenase 
181068 -0.9 0.03 Ras GTPase-activating protein family - IQGAP 
55524 0.7 0.03 Hypothetical transmembrane protein 
183186 2.1 0.03 Hypothetical Isoflavone reductase 
36961 1.8 0.03 - 
45817 -0.8 0.03 beta-1,6-N-acetylglucosaminyltransferase, contains WSC 
domain 
141246 -1.8 0.03 - 
171092 1.0 0.03 Monooxygenase involved in coenzyme Q (ubiquinone) 
biosynthesis 
119858 -0.9 0.03 Related to alpha-glucosidase; glycoside hydrolase, family 31 
119850 -0.8 0.03 - 
185564 -0.9 0.03 Short-chain dehydrogenase/reductase SDR 
55041 2.4 0.03 - 
214397 1.6 0.03 Candidate aminotransferase, classes I and II 
44464 -0.5 0.03 - 
209060 -0.6 0.03 - 
214831 -1.8 0.03 HPr serine phosphorylation site 
182715 1.8 0.03 Hypothetical alpha-1,3-glucanase 
188089 -0.9 0.03 Hypotehtical protein with galactose oxidase and 
transmembrane domains 
182952 -0.6 0.03 - 
176406 1.6 0.03 Deduced amino acid sequence shares identity with the 
Saccharomyces cerevisiae NHP2 gene product; a nuclear 
protein related to mammalian high mobility group (HMG) 
proteins, essential for function of H/ACA-type snoRNPs, 
which are involved in 18S rRNA proces 
42098 -0.7 0.03 - 
214017 -0.7 0.03 MEKK and related serine/threonine protein kinases 
46980 -0.7 0.03 ABC transporter 
52969 2.0 0.03 Importin-beta, N-terminal 
38463 -0.7 0.03 - 
197269 1.8 0.03 - 
202416 0.6 0.03 40S ribosomal protein S3 
41167 0.5 0.03 - 
176469 0.5 0.03 - 
35439 -0.7 0.03 Hypothetical part of the anaphase-promoting complex 
39297 -0.9 0.03 Hypothetical carboxylesterase 
51449 -1.6 0.03 Hypothetical. Monocarboxylate transporter. Signal P 
suggests secretion 
181768 -0.7 0.03 Short-chain dehydrogenase 
55805 -0.9 0.03 Hypothetical catalytic protein 
125779 -0.9 0.03 - 
170688 -1.4 0.03 - 
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178329 -0.8 0.03 Hypothetical protein with bromodomain & bromo adjacent 
region 
195145 -0.8 0.03 - 
188878 -0.8 0.03 Flavin-containing monooxygenase 
36173 -1.0 0.03 DEAD/DEAH box helicase 
54123 -2.2 0.03 - 
187802 1.1 0.03 - 
208123 -1.2 0.03 Eukaryotic translation initiation factor 
56792 -0.8 0.03 Hypothetical GPI anchor protein 
43317 -1.0 0.03 - 
180050 -0.9 0.03 - 
43031 -0.9 0.03 - 
46719 1.4 0.03 Candidate multiple RNA-binding domain-containing protein. 
187304 -0.5 0.03 Ergosterol biosynthesis ERG4/ERG24 family 
130233 -0.6 0.03 - 
40159 -1.0 0.03 - 
52987 -1.5 0.03 - 
176664 -0.8 0.03 Transcriptional activator FOSB/c-Fos and related bZIP 
transcription factors 
177034 -0.6 0.03 - 
52756 -1.0 0.03 - 
180728 0.5 0.03 - 
190721 -0.8 0.03 Putative transcription factor 
206020 0.9 0.03 Hypothetical. involved in rRNA processing. associates with 
trans-acting ribosome biogenesis factors (yeast); similar to 
beta-transducin superfamily. 
39220 1.3 0.03 - 
185508 1.0 0.03 - 
192063 -0.7 0.03 - 
53033 -0.8 0.03 Related to beta-1,3-glucanosyltransferase 
44216 1.0 0.03 - 
184226 -0.5 0.03 Cell-cycle nuclear protein, contains WD-40 repeats 
172670 1.0 0.03 - 
210620 1.0 0.03 Predicted protein shares amino acid sequence similarity with 
the Saccharomyces cerevisiae UTP6 gene product 
141681 0.8 0.03 - 
56414 -1.0 0.03 - 
45907 -1.4 0.03 - 
45252 -0.7 0.03 - 
129139 -0.8 0.03 Hypothtetical actin regulatory protein 
208463 -0.7 0.03 - 
39772 -0.7 0.03 Kinesin-like protein 
52046 1.7 0.03 Shares amino acid sequence identity with Saccharomyes 
cerevisiae EBP2 encoding an essential protein required for 
the maturation of 25S rRNA and 60S ribosomal subunit 
assembly; localises to the nucleolus; constituent of 66S pre-
ribosomal particles. 
37965 -0.6 0.03 - 
214849 -1.7 0.03 FAD-dependent pyridine nucleotide-disulphide 
oxidoreductase 
52334 -0.6 0.03 - 
40158 -0.7 0.03 Cytochrome P450 
173432 -0.8 0.03 - 
179912 -0.8 0.03 Putative extracellular carboxylesterase, type B 
170414 1.0 0.03 Short chain dehydrogenase 
194701 0.8 0.03 - 
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52402 0.8 0.03 - 
184495 -0.8 0.03 - 
185579 -0.8 0.03 - 
187731 -1.2 0.03 - 
119417 -1.1 0.03 Uso1/p115 like vesicle tethering protein 
51125 1.8 0.03 - 
189824 -0.7 0.03 - 
191996 -1.2 0.03 Hypothetical flavin-containing amine oxidase 
43917 -0.8 0.03 Peptidase S10, serine carboxypeptidase 
55609 1.6 0.03 - 
53082 1.3 0.03 Related to histone 1 protein, H1, with a predicted H1/H5 
domain, histone linker N- terminal, and winged helix DNA 
binding. The protein is essential for chromatin stucture and 
links nucleosomes in higher order structures; KOG Class: 
Chromatin structure and 
36612 -0.6 0.03 - 
43907 -0.7 0.03 - 
128111 -1.0 0.03 - 
119238 -1.2 0.03 Fungal Zn(2)-Cys(6) binuclear cluster domain 
205702 -1.4 0.03 Voltage-gated potassium channel activity 
177282 -0.8 0.03 - 
180223 0.8 0.03 Mitochondrial substrate carrier 
188352 1.2 0.03 TetB, Synaptic vesicle transporter SVOP and related 
transporters (major facilitator superfamily 
43466 -0.5 0.03 - 
194006 0.8 0.03 - 
170262 0.7 0.03 Aldo/keto reductase family proteins 
45864 1.8 0.03 Deduced gene product shares amino acid sequence identity 
with the Saccharomyces cerevisiae NIP7 gene product; a 
nucleolar protein required for 60S ribosome subunit 
biogenesis, constituent of 66S pre-ribosomal particles. 
140013 -0.9 0.03 - 
123434 1.5 0.03 Iron/ascorbate family oxidoreductases 
201697 0.8 0.03 Signal transduction protein with FHA domain 
56235 -1.0 0.03 Peptidase C50, separase 
45504 0.7 0.03 - 
172198 -1.3 0.03 Putative cytochrome P450 monooxygenase 
212736 -1.9 0.03 aglC, alpha-galactosidase; degradation of melibiose; EC 
3.2.1.22; SwissProt ID AGALC_ASPNG; secreted alpha-
galactosidase  
170231 -0.7 0.03 - 
188160 2.3 0.03 - 
206713 0.5 0.03 - 
36656 -0.5 0.03 Peptidase S15 
133280 -0.8 0.03 Phosphatidylinositol-specific phospholipase C 
214738 -1.9 0.03 Iron/ascorbate family oxidoreductases 
120917 -0.6 0.03 - 
55164 -1.3 0.03 - 
206783 -2.1 0.03 - 
38046 -0.4 0.03 Inner centromere protein 
54125 -0.9 0.03 - 
53546 -1.7 0.03 Putative Aconitate hydratase 
214844 0.9 0.03 - 
183599 0.8 0.03 Hypothetical sulfhydryl oxidase 
40895 -1.1 0.03 von Willebrand factor and related coagulation proteins 
57286 -0.8 0.03 RFX family transcription factor 
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194806 -1.0 0.03 Fungal specific transcription factor 
42065 -1.3 0.04 - 
133729 1.3 0.04 RNA-binding protein 
55008 -0.7 0.04 Hypothetical HSP90 co-chaperone CPR7/Cyclophilin 
53576 0.6 0.04 Candidate 60s ribosomal protein gene RPP1. 
46056 -0.6 0.04 - 
209577 -0.9 0.04 - 
205026 1.5 0.04 - 
125186 -1.2 0.04 Dehydrogenase 
39998 -1.3 0.04 Hypothetical subunit of oligosaccharyltransferase 
189922 -1.6 0.04 Cytochrome P450 
52980 -1.7 0.04 - 
209956 1.3 0.04 - 
56167 0.6 0.04 TRIHA 14-3-3 protein homologue, putative kinase regulator 
46227 -0.7 0.04 - 
186514 -0.9 0.04 Chitinase 
184760 -1.3 0.04 - 
180802 -0.8 0.04 - 
171940 -0.6 0.04 - 
35670 -1.3 0.04 GCN5-related N-acetyltransferase 
188517 0.9 0.04 - 
170255 -0.5 0.04 Eukaryotic glutathione synthase 
52241 -0.6 0.04 Glyoxalase 
42146 -0.6 0.04 - 
190884 -0.8 0.04 Cys/Met metabolism pyridoxal-phosphate-dependent 
enzymes 
40615 -1.5 0.04 - 
170954 -1.8 0.04 Transcription factor, MADS-box 
50979 -2.1 0.04 Related to alpha-L-arabinofuranosidase 
193602 0.8 0.04 - 
52023 -1.2 0.04 Adenylosuccinate lyase 
144063 -0.8 0.04 - 
52418 1.2 0.04 Sugar transporter superfamily 
141060 -0.4 0.04 Chloroperoxidase 
52773 1.7 0.04 ABC transporter, transmembrane region 
42932 1.2 0.04 Rhodopsin-like GPCR superfamily 
121738 0.9 0.04 Na+/H+ antiporter 
174228 -0.9 0.04 - 
41246 -1.6 0.04 Fungal transcriptional regulatory protein, N-terminal 
41128 1.0 0.04 - 
136103 -0.7 0.04 - 
209327 -0.7 0.04 Fungal transcriptional regulatory protein, N-terminal 
196638 1.2 0.04 60S acidic ribosomal protein P0 
46018 1.0 0.04 Amidohydrolase 2 
57312 0.7 0.04 Related to C. albicans seryl-tRNA synthase (EC 6.1.1.11) 
41387 -0.8 0.04 - 
183143 1.0 0.04 - 
187553 -0.8 0.04 - 
178411 -0.9 0.04 - 
194526 -2.0 0.04 Putative extracellular HpcH/HpaI aldolase 
56391 -0.9 0.04 - 
35594 -1.0 0.04 - 
37314 -0.4 0.04 - 
181863 -0.7 0.04 - 
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210854 1.8 0.04 - 
185299 -2.0 0.04 Glycosyl transferase, group 1 
121662 -0.6 0.04 Predicted transcriptional regulator 
171186 1.7 0.04 - 
209711 -1.1 0.04 - 
172191 -0.8 0.04 - 
43882 -0.5 0.04 Fungal specific transcription factor 
174680 -0.6 0.04 Candidate glucosyltransferase 
208602 -0.6 0.04 Candidate Ubiquinol cytochrome c oxidoreductase, subunit 
QCR9 
174379 -1.4 0.04 Putative GH family 43 protein classified as beta-xylosidase 
(PTHR22925:SF4) and alpha-L-arabinanase (SSF75005) 
193764 1.3 0.04 RNA polymerase II, large subunit 
129910 1.5 0.04 Cytochrome P450 
56345 1.1 0.04 Major facilitator superfamily 
201349 0.7 0.04 Hypothetical protein with predicted histone deacetylase 
domain, which catalyses the removal of the acetyl group at 
acetylated lysine residues in histones; KOG Class: Chromatin 
structure and dynamics; KOG Id: 1343; KOG Description: 
Histone deacetylase comp 
49207 -0.6 0.04 - 
38580 -0.9 0.04 - 
37992 -1.1 0.04 - 
194381 -1.8 0.04 Putative polyketide synthase 
41676 0.5 0.04 - 
56078 -0.9 0.04 Deduced protein shares amino acid sequence identity with 
the Saccharomyces cereivisiae YRG054W gene product; 
eukaryotic initiation factor (eIF) 2A; associates specifically 
with both 40S subunits and 80 S ribosomes, and interacts 
genetically with both eIF5 
45220 0.6 0.04 - 
38774 0.6 0.04 Amidohydrolase-like 
56389 -0.9 0.04 alpha/beta hydrolase fold 
53315 2.1 0.04 - 
53760 1.8 0.04 Glucose/ribitol dehydrogenase 
144129 -1.0 0.04 - 
39819 0.6 0.04 - 
202429 -0.7 0.04 - 
206654 -0.8 0.04 Fungal transcriptional regulatory protein 
176564 -0.8 0.04 - 
36770 -0.7 0.04 Major facilitator superfamily 
207437 -0.6 0.04 Myb, DNA-binding 
200072 -0.6 0.04 - 
128638 1.4 0.04 Putative polyketide synthase 
52590 -1.6 0.04 Putative alpha-1,3-glucanase, family 71 
126969 -1.1 0.04 CDP-alcohol phosphatidyltransferase/Phosphatidylglycerol-
phosphate synthase 
173423 2.0 0.04 - 
174620 1.1 0.04 - 
171442 0.6 0.04 - 
50449 -0.4 0.04 Hypothetical RNA procesing protein 
174819 -0.5 0.04 - 
44376 -0.6 0.04 - 
209300 -0.8 0.04 - 
191756 -1.5 0.04 - 
170237 -2.5 0.04 Arylacetamide deacetylase 
50781 1.6 0.04 Related to Mitochondrial transport protein amc-1 
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208535 0.6 0.04 - 
50103 1.1 0.04 Hypothetical, Nucleolar GTPase/ATPase  
42654 -0.8 0.04 Hypothetical protein containing Zn-finger and Homeobox 
domains 
52574 -0.6 0.04 - 
44103 -1.1 0.04 - 
38673 -0.6 0.04 Hypothetical Shugoshin_N, nuclear. 
208323 -0.6 0.04 - 
36936 -0.6 0.04 - 
182100 3.2 0.04 Hypothetical alpha-arabinanase (GH family 43) 
201083 0.6 0.04 Phosphatidylinositol transfer protein SEC14 
139753 -0.7 0.04 - 
131182 -0.8 0.04 - 
213492 -1.5 0.04 Glycosyltransferase, family 2 
126001 -0.7 0.04 - 
213629 -0.6 0.04 Drebrins and related actin binding proteins 
54890 1.4 0.04 Carbamoyl-phosphate synthase 
52705 0.9 0.04 Predicted protein shares amino acid sequence identity with 
the Saccharomyces cerevisiae TUF1 gene product; 
mitochondrial translation elongation factor Tu. 
139686 0.7 0.04 - 
121949 -0.9 0.04 - 
52706 -0.7 0.04 Nucleoside phosphatase 
49148 1.3 0.04 - 
206715 -0.9 0.04 Putative calcium-dependent, mannose-binding lectin 
implicated in substrate-specific glycoprotein secreting 
pathway 
213656 -1.2 0.04 C2 domain 
37775 -1.0 0.04 Hypothetical protein containing Zn-finger, C2H2 type domain 
212954 -1.3 0.04 - 
204764 1.3 0.04 - 
41530 -1.2 0.04 Hypothetical glycosylphosphatidylinositol anchor synthesis 
protein 
211774 -1.5 0.04 Amino acid/polyamine transporter I 
36409 -1.6 0.04 Ankyrin repeat 
186422 -0.7 0.04 Sterol O-acyltransferase/Diacylglycerol O-acyltransferase 
51800 1.0 0.04 Predicted protein shares amino acid sequence identity with 
the Saccharomyces cerevisiae TMA19 gene product 
39626 0.5 0.04 Hypothetical protein 
173978 -0.4 0.04 - 
35780 -0.6 0.04 - 
209988 -0.4 0.04 - 
39012 -0.5 0.04 - 
192619 -1.0 0.04 Serine carboxypeptidase 
36287 0.9 0.04 Candidate anbA gene 
37502 -1.0 0.04 - 
42764 -1.4 0.04 - 
38264 1.0 0.04 - 
139793 -1.1 0.04 Fungal specific transcription factor 
41595 -0.8 0.04 - 
43621 -0.6 0.04 SAM (and some other nucleotide) binding motif 
50981 -1.1 0.04 Putative AMP-dependent synthetase and ligase, Acyl-CoA 
synthetase 
214443 -1.3 0.04 Putative Zinc transporter ZIP, Zn /Fe 
51242 -0.5 0.04 CPSF A subunit 
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188782 1.5 0.04 Amino acid transporters 
123724 0.5 0.04 - 
130472 -0.8 0.04 Fungal specific transcription factor 
52639 -1.1 0.04 SAM (and some other nucleotide) binding motif 
173684 2.6 0.04 - 
45703 -0.6 0.04 - 
49539 -0.8 0.04 Candidate nimA 
210220 -1.3 0.04 Short-chain dehydrogenase/reductase SDR 
188056 -1.6 0.04 Cytochrome P450 
55116 -1.6 0.04 Hypothetical short chain dehydrogenase 
41809 -1.8 0.04 Major facilitator superfamily 
39459 1.0 0.04 - 
119945 -0.5 0.04 - 
211367 -0.8 0.04 - 
47819 -1.1 0.04 - 
183336 -0.5 0.04 - 
37022 -0.7 0.04 - 
51512 -1.1 0.04 Cytochrome P450 
124393 -1.3 0.04 Peroxisomal NUDIX hydrolase 
35600 -0.6 0.04 - 
43379 -0.6 0.04 - 
210062 0.5 0.04 - 
42083 -0.5 0.04 - 
189853 0.8 0.04 - 
206534 -1.2 0.04 Zinc-binding oxidoreductase 
182904 -0.4 0.04 - 
124797 -1.4 0.04 Major facilitator superfamily 
124998 1.4 0.04 - 
211845 -1.1 0.04 Glycosyl transferase, family 15 
123304 -1.1 0.04 Amino acid/polyamine transporter 
175633 -1.1 0.04 Cytochrome P450 
53197 1.5 0.04 Hypothetical IMP dehydrogenase 
37320 0.9 0.04 Shares amino acid sequence identity to Saccharomyces 
cerevisiae FAL1 encoding a nucleolar protein required for 
maturation of 18S rRNA; member of the eIF4A subfamily of 
DEAD-box ATP-dependent RNA helicases. 
186889 -0.9 0.04 - 
55422 -0.9 0.04 Related to vesicle coat complex COPII, subunit Sec23/24 
211789 -1.6 0.04 - 
196062 1.7 0.04 Deduced translation product shares amino acid sequence 
identity with the Saccharomyces cerevisiae NOP1 gene 
product; a nucleolar protein, component of the small subunit 
processome complex, which is required for processing of pre-
18S rRNA; has similarity t 
143583 -1.2 0.04 - 
188497 -1.1 0.05 Fungal specific transcription factor 
212470 -0.5 0.05 Peptidase C19 
55540 0.7 0.05 - 
44861 0.5 0.05 - 
197559 0.9 0.05 60S ribosomal protein L22 
176395 -1.2 0.05 WD40 repeat-containing protein 
52769 1.4 0.05 - 
56474 -1.2 0.05 - 
212624 -0.6 0.05 - 
38375 -0.9 0.05 Major facilitator superfamily 
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46410 1.1 0.05 Predicted protein involved in nuclear export of pre-ribosomes 
57320 -0.8 0.05 - 
53694 -0.8 0.05 - 
46834 1.1 0.05 Major facilitator superfamily 
196058 -0.8 0.05 Transcription factor/CCAAT displacement protein 
183896 -0.6 0.05 Fungal specific transcription factor 
193766 1.7 0.05 - 
52416 0.6 0.05 - 
179558 -0.7 0.05 - 
182005 1.0 0.05 Amino acid permease 
35440 -0.6 0.05 Hypothetical phosphatidylserine decarboxylase (EC 4.1.1.65) 
49383 -0.6 0.05 - 
195249 -0.8 0.05 - 
176332 1.1 0.05 - 
120694 0.6 0.05 Candidate Ferric reductase 
53078 -0.6 0.05 - 
52322 -2.7 0.05 - 
38230 -1.0 0.05 Acyl-CoA synthetase 
38316 -1.4 0.05 Non-ribosomal peptide synthetase 
49258 0.9 0.05 Hypothetical aldehyde dehydrogenase. May be a succinate-
semialdehyde dehydrogenase 
190726 -0.6 0.05 - 
206452 -0.7 0.05 klpA Kinesin family protein, motor region, KAR3 
188804 -0.9 0.05 - 
39613 0.7 0.05 Putative extracellular GH afmily 3 beta-glucosidase 
56739 -1.5 0.05 Ornithine-N5-oxygenase 
52163 -0.5 0.05 Actin/actin-like 
181426 -0.5 0.05 WD40 repeat-containing protein 
38291 -0.5 0.05 - 
126879 -0.4 0.05 - 
51281 1.5 0.05 3-hydroxyanthranilate oxygenase HAAO 
123881 -1.1 0.05 - 
183990 -1.2 0.05 Major facilitator superfamily 
206990 0.6 0.05 HMG box-containing protein 
56469 -0.7 0.05 Hypothetical protein with WD40-like region 
46394 -0.8 0.05 Hypothetical methionine aminopeptidase 
47077 -1.2 0.05 Oxidoreductase 
36465 0.8 0.05 Hypothetical protein with predicted histone-fold; KOG Class: 
Transcription; KOG Id: 0871; KOG description: Class 2 
transcription repressor NC2, beta subunit (Dr1) 
55011 -0.8 0.05 51kDa subunit of NADH:ubiquinone reductase (complex I); 
NADH dehydrogenase [Aspergillus niger] 
55417 -1.1 0.05 Serine/threonine protein kinase, active site 
171166 -0.7 0.05 Major facilitator superfamily 
134668 1.9 0.05 - 
193651 -0.5 0.05 Zn-finger, C-x8-C-x5-C-x3-H type 
41492 0.8 0.05 - 
175768 1.4 0.05 HORMA domain 
50549 0.9 0.05 Hypothetical. G-protein. WD40 repeat-containing 
51478 0.6 0.05 (faeB) feruloyl esterase 
37730 1.3 0.05 - 
207862 0.6 0.05 This domain is found in a number of fungal transcription 
factors. The N-terminal region of a number of fungal 
transcriptional regulatory proteins contains a Cys-rich motif 
that is involved in zinc-dependent binding of DNA. 
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177198 -1.1 0.05 - 
54806 -1.3 0.05 - 
38807 -0.8 0.05 Protoporphyrinogen oxidase 
 
 
Identification of the most significantly expressed genes between NW185 and NW185 with 
fum and frds inserted, fold change in log2 ratio (positive number then expression level in 
NW185 strain with gene insertions higher), p. value < 0.05, the general description is taken 
from the JGI annotation database.  
 
JGI_ID Fold change p.value General description 
135002 -1.5 0.01 - 
51515 4.4 0.03 Short-chain dehydrogenase/reductase SDR 
55205 2.8 0.03 Hypothetical short chain dehydrogenase 
43953 -1.9 0.04 - 
45814 1.0 0.04 - 
 
 
